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Residue methods were developed for the determination o f the coccidiostat robenidine in 
egg, the benzimidazoles (13) in liver (albendazole 2-amino albendazole sulphone, 
albendazole sulphoxide, albendazole sulphone, thiabendazole, oxfendazole or 
fenbendazole sulphoxide, hydroxy mebendazole, amino flubendazole, fenbendazole 
sulphone, oxibendazole, mebendazole, flubendazole and albendazole) and the 
triphenylmethane dyes (4) in salmon (malachite green, crystal violet, leucomalachite 
green and leucocrystal violet). The methods were validated according to the criteria 
defined in Commission Decision 2002/657/EC. Robenidine was extracted from egg 
with acetonitrile and the sample extracts analysed by liquid chromatography (LC) with 
ultraviolet (UV) spectrophotometric detection at 317 nm. The decision limit (CCa) and 
the detection capability (CCP) were 10 |xg.kg_I and 17 ng.kg'1 respectively.
The benzimidazoles were extracted from liver samples with ethyl acetate, sample 
extracts were defatted with hexane and cleaned up by automated solid-phase extraction 
(SPE) on Ci8 cartridges. Aliquots o f the extracts were analysed by LC with UV 
detection at 298 nm. The C C a values ranged between maximum residue limit (MRL) + 
12% and MRL + 25% and the CCP ranged between MRL + 25% and MRL + 45%.
The triphenylmethane dyes were extracted from salmon with acetonitrile and pH 3 
buffer, extracts were cleaned up using cation-exchange SPE on sulphonic acid (SCX) 
cartridges and the sample extracts were analysed by liquid chromatography tandem 
mass spectroscopy (LC-MS/MS). C C a for malachite green, leucomalachite green, 
crystal violet and leucocrystal violet were 0.17, 0.15, 0.40 and 0.17 iig-kg'1 respectively 
and CCP were 0.30, 0.35, 0.80 and 0.32 ng.kg 1 respectively.
All research undertaken in this thesis was published in peer reviewed journals. This 
work has made a significant contribution to  residues science as more novel methods 
have become available for surveillance o f  these drugs at national and international level. 
The methods developed in this research also provide a legal basis for prosecuting 
individuals who use these veterinary products without adhering to EU legislation. 
Ultimately the work enhances food safety as methods developed help to eliminate the 
hazards associated with drug residues entering the food chain.
Abstract
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Chapter 1:
General Introduction
1
1.1 Residues in Food
1.1.1 Introduction
The administration o f any pharmacologically active chemical to a food-producing animal 
can lead to the occurrence o f residues in food. In recent years, the issue o f veterinary drug 
residues in foods o f animal origin has become increasingly important. Concerns over 
veterinary drug usage and residues are primarily related to food safety and the possibility 
of the development o f antibiotic resistant pathogens. There is also an increased need to 
meet requirements relating to the levels o f  veterinary residues in food dictated by 
legislation. 1 Failure to meet legislative requirements in relation to levels o f residues in 
food may have serious economic consequences for the country involved. There is also 
growing public concern regarding drug residues in food due to more intense methods o f 
animal husbandry. There is increased consumption o f meat and dairy products, especially 
poultry. To meet this demand, an increasing share o f livestock production is by 
commercial enterprises and intensive or semi-intensive urban production systems rather 
than traditional mixed farming systems with a consequent increase in the use o f 
veterinary compounds such as antibiotics, coccidiostats and growth promoting hormones. 
Aquaculture has also exhibited a rapid growth in recent years accounting for 26% of 
world fish production in 1999. About half o f  global aquaculture production is in 
developing countries. Contamination o f aquaculture products from Asia and Latin 
America with residues has recently been the cause o f international trade interventions 
leading to a loss o f revenue for the exporting countries. 1
Veterinary medicinal products are generally used in animal production for one o f three 
purposes:2
1. Therapeutic treatment o f active infection.
2. Vaccination or prophylactic medication to prevent or to minimise infection.
2
3. Production enhancement-growth promotion and improvement o f feed 
conversion efficiency with antimicrobial drugs and hormones.
1.1.2 Improper or illegal use of veterinary drugs
The occurrence o f residues in food, in breach o f the levels set down in legislation, can 
happen in a number o f ways. These violations result from either the improper use of 
licensed products or the illegal use of unlicensed and prohibited substances. 3 Several 
factors contribute to the improper use o f  licensed products, including, poor treatment 
records or failure to identify treated animals and use o f  a drug other than as described on 
the product label. Mis-use occurs mainly by not observing adequate withdrawal periods 
before slaughter o f animals.
Providing that a licensed drug is used in accordance with its product licence and 
providing that the drug withdrawal periods are respected by farmers, drug residues should 
not occur in human food at concentrations greater than the maximum residue limits 
(MRLs).
Intentional use o f prohibited compounds occurs for a number o f reasons. These include:- 
the use o f growth promoting hormones in order to increase the weight o f  animals, as this 
leads to higher yields at market; the use o f certain banned compounds that can be very 
effective at controlling particular infections eg nitrofurans or these banned compounds 
that maybe very cheap and readily available e.g. phenylbutazone.
Cross contamination in feed mills is also another way in which high levels o f residues can 
occur in food.3 Trace quantities o f medicated feed may be retained at various points along 
the production line, contaminating subsequent batches o f feed as they are processed. The 
electrostatic properties o f some drugs, particularly those in powder form, aggravate the 
problem, making it more difficult to purge the equipment between batches. 
Manufacturers have responded to the problem by producing granular preparations with 
reduced electrostatic properties. The electrostatic properties o f  the drug nicarbazin caused 
problems during the manufacture o f nicarbazin-free feeds, since nicarbazin (NCB) 
powder is strongly electrostatic and could not be removed from feed milling equipment.4 
NCB is a widely used coccidiostat drug, which is licensed as a feed additive for broiler
3
chickens, but not for laying hens. There is a problem in many countries world-wide with 
the occurrence o f NCB residues in poultry tissues and eggs. Cannavan et al.4 have 
reported a proportional relationship between the concentration o f 4,4’-dinitrocarbanilide 
(DNC) and 4,6-dimethyl-3-hydroxypyrimidine (DHP) in eggs, the two marker residues 
for NCB, and the feed levels. Feed contaminated with NCB at concentrations higher than 
2 mg k g _l gave rise to residue concentrations o f  DNC in eggs higher than 100 (ig.kg1.
1.1.3 Environmental contamination
Potential environmental contamination may arise e.g in the case o f commercial fish 
farming where veterinary drugs or other contaminants, which have been given as feed 
additives, accumulate in sediments and may become ingested by marine species in the 
vicinity o f  farms. 3 The presence o f drug residues may pose a health risk, if these wild 
species are harvested for human consumption.
1.1.4 Animal-to-animal transfer
Recycling o f drugs as a result o f ingestion o f  faeces and/or urine significantly contributes 
to the concentration and persistence o f residues in porcine tissues, poultry tissues and 
eggs.3,5 Brief exposure o f  unmedicated animals to the excretions o f medicated animals in 
improperly cleaned housing during transport or in the slaughter house can result in 
violative residues.
Canavan et al.5 have observed a tenfold higher nicarbazin concentration in the liver of 
broiler chickens treated with this drug and housed on flooring where litter can accumulate 
compared with those housed on wire flooring. Complete exchange o f  the litter was the 
only way to  prevent recycling.
1.2 The Risks to Human Health
1.2.1 Toxicity and allergenicity
Quite a large number o f antibiotic and anthelmintic drugs administered in therapeutic and 
subtherapeutic forms to domestic animals are also approved for human use. These drugs 
have been shown to be relatively safe. Acute and chronic toxicities have been evaluated
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and are well documented. 2 The likelihood o f acute toxicity from veterinary drugs and 
their metabolites originating from animal tissues is extremely low. However the 
possibility o f  chronic toxicity expressed in longterm, cumulative allergenic, mutagenic, 
teratogenic or carcinogenic effects are difficult to assess.
Veterinary drugs with high potential to cause one or more o f these toxic effects for 
human health were banned by the EC for veterinary use. Chloramphenicol is one such 
compound; it produces toxic aplastic anemia that is not related to dosage. Sulfonamides 
have been used widely at subtherapeutic and therapeutic concentrations in food-animal 
production, but increasing concern over their carcinogenic and mutagenic potential has 
led to decreased usage, longer withdrawal times and more intensive residue monitoring. 
Tetracycline residues can reversibly slow down the growth o f the skeleton and 
irreversibly discolour the teeth o f children younger than 8 years since tetracyclines are 
deposited in bones and teeth. The residues o f  benzimidazole anthelmintics have a defined 
toxic potential. 6 Some benzimidazoles are mutagenic, but the effect is limited or low in 
mammals even at high doses. Teratogenicity may be considered as a general property of 
this drug group. Tetratogenic metabolites have been identified and quantified in animal 
products such as milk, eggs and meat. For levamisole, the most important o f the observed 
adverse effects, which are rare, were agranulocytosis and neutropenia.7 
To safeguard human health, the EU has established maximum residue limits (MRLs) for 
residues o f  licensed veterinary drugs in animal tissues entering the human foodchain. The 
term MRL may be defined as the maximum concentration o f marker residue (e.g. parent 
compound, metabolites etc) resulting from the use o f a veterinary drug, expressed as mg 
kg *, that is legally permitted or recognised as acceptable in or on a food.1 The MRL is 
related to the acceptable daily intake (ADI). This is an estimate o f the amount o f a 
substance in food and/or drinking water, expressed on a body weight basis that can be 
ingested daily over a lifetime without appreciable health risk to  the consumer on the basis 
o f all the known facts at the time o f the evaluation. It is usually expressed in milligrams 
o f the chemical per kilogram o f body weight. The ADI is determined from the no- 
observable-effect level (NOEL) taking into account a safety factor (usually 100).8 The 
NOEL is the greatest concentration or amount o f  a substance, found by observation or 
experiment, which causes no detectable effect. The maximum acceptable total residue
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level (TRL) is calculated from the ADI considering the consumption pattern. The MRL is 
the detectable proportion o f the marker residue that corresponds to the TRL value. The 
MRL value refers to the permissible level for the marker residue.
In addition to conventional toxicological effects, other issues such as the effects o f drugs 
on the immune system and pharmacological effects including specific effects o f residues 
o f veterinary antibiotics on the human gut flora, should be taken into account when 
considering safe residue levels.9
Besides toxicological problems, hypersensitive reactions in humans from ingesting 
antibiotic contaminated foods o f animal origin can occur. Most reactions result from (3- 
lactam (e.g penicillin) antibiotic residues in milk and meat 1,2 in sensitive individuals. 
Many people that went through prior medical treatment were hypersensitised to such a 
degree that following oral exposure a response was evoked.
Nevertheless, the risk to human health due to  residues o f veterinary drugs in foodstuffs 
have to be taken in context. Microbial contamination o f food is a major health problem 
worldwide. Infections o f poultry products with Salmonella and Campylobacter are greater 
risks to public health than are residues o f veterinary drugs in food. Nevertheless, the 
public risks o f antibiotics and their metabolites are difficult to define, and the presence of 
violative levels in food is illegal and subject to financial penalties in many countries.
1.2.2 Antibiotic resistance
Antibiotic resistance is a well documented major health threat around the world that has 
been given high priority by many health agencies 1,2 The potential o f animal-to-human 
transfer o f resistance exists. Clearly, the use o f  antibiotics in lifestock production has 
been associated with the development o f human antibiotic resistance. Animals fed with 
low (prophylactic) levels o f  antibiotics may give rise to bacteria with evolving resistance 
to these/and other drugs. Humans may be exposed to these bacteria through consumption 
o f food. It has been documented that humans developed drug resistant salmonellosis from 
food o f animal origin. Examples o f drugs which have been shown to cause the growth of 
resistant bacteria in food animals are fluoroquinolones and avoparcin. The resistance o f 
microorganisms arising from subtherapeutic use o f penicillin, tetracyclines and 
sulfonamides in aquaculture is suggested by WHO to be a high priority issue.2
6
1.2.3 Technological problems
The initial concerns with regard to antimicrobial residues in food were not expressed by 
consumers but by dairy processors who found that contaminated milk was inhibiting the 
starter cultures used in the production o f fermented milk products as well as interfering 
with the results o f  dye reduction tests used for milk quality. 1 The sensitivity o f 
thermophilic and mesophilic starter cultures for manufacturing high-value fermented 
products as yogurt, cheese, butter or raw sausages, requires biotechnologically safe raw 
materials.
1.2.4 Effect of processing on residues
Although most food o f animal origin is cooked (except milk and honey) before 
consumption, none o f the required studies for licensed drugs include the effect of 
processing on residues. Information about this influence is required to obtain more 
accurate estimates o f  consumer exposure to residues or possible breakdown products. The 
fate o f several drug residues during normal cooking and processing procedures is 
described by Rose e ta l . , 10 Residues o f  levamisole were found to be stable to heating, but 
a fraction was lost from the meat into the juice. 10 Some evidence o f oxfendazole 
instability in boiling water was found after 3 hours. Heating o f samples with incurred 
residues o f  oxfendazole destroys the drug residues. Moats et a l,  11 reported that ordinary 
cooking procedures for meat, even to “well-done” can not be relied on to break down 
even the more heat sensitive compounds such as penicillins and tetracyclines. The 
relevance to food safety is uncertain since the nature o f the degradation products is 
unknown in most cases. The identity o f these degradation products should be established 
and their toxicity assessed.
The use o f data generated from surveillance o f raw tissue for dietary intake calculations 
and consumer exposure estimates has to be considered in the light o f  the effect o f cooking 
on these residues.
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1.3 Legislative Aspects
1.3.1 Overview of EC Decisions, Council regulations and guidelines
The occurrence o f residues o f  veterinary drugs in food is a world-wide problem. Food- 
producing animals and animal products are transported within EU countries and between 
EU countries and the Third Countries. A lot o f  resources are expended by the EU to 
harmonise European legislation in the control o f residues. The European Commission had 
regulated the inspection o f animals and o f fresh meat for the presence o f  residues of 
veterinary drugs and specific contaminants by Council Directive 86/469/EEC. 12 The 
current monitoring is governed by national surveillance schemes established under 
Council Directive 96/23/EC 14 on measures to monitor certain substances and residues 
thereof in animal products and under Commission Decision 97/747/EC 14 which lays 
down levels and frequencies o f  sampling in order to monitor some substances and 
residues thereof in certain animal products. The EU Decision establishes numbers o f 
samples to be tested for each compound group.
Quality criteria for residue analyses are described in Commission Decision 93/256/EEC
15 which states the methods to  be used for detecting residues o f substances having a 
hormonal or thyreostatic action. Commission Decision 93/257/EEC 16 lays down the 
reference methods and the list o f National Reference Laboratories for detecting residues. 
The two decisions are revised regularly in order to take into account the current scientific 
knowledge and the latest technological improvements. A revised version was submitted 
by the Directorate General for Agriculture as a draft Commission Decision 
SANCO/1805/2000 17 laying down performance criteria for the analytical methods to be 
used for certain substances and residues thereof in live animals and animal products 
according to Council Directive 96/23/EC. 13 This draft document was revised and 
published as Commission Decision 2002/657/EC 18 implementing Council Directive 
96/23/EC 13 concerning the performance o f analytical methods and the interpretation of 
results. The establishment o f MRLs in the EU is governed by Council Regulation 
EEC/2377/90 amended by several EC Regulations. 19 This regulation establishes lists o f 
compounds that have a fixed M RL (Annex 1), that need no MRL (Annex IT), or that have 
a provisional MRL (Annex III). Annex IV o f this regulation is a list o f compounds that
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are prohibited for use in livestock production. Annex V provides information and the data 
needed to determine the MRL values.
In addition to the protection o f consumers from the potential risk o f harmful residues, 
MRLs are also essential to facilitate international trade. However, the introduction of the 
MRL has a severe impact on the availability o f veterinary medicinal products as the data 
required is very complex and the huge number o f experiments and costs involved must be 
furnished by the pharmaceutical company. This is because pharmaceutical companies that 
want to market their products must submit comprehensive dossiers to regulatory 
authorities so MRLs can be set. These dossiers outline toxicological and pharmacological 
properties o f their product. The financial implications o f preparing and carrying out such 
trials makes most companies wary o f carrying out this work so a lot o f compounds that 
may have been used in the past are now no longer available. This maybe encouraging the 
use o f  unlicensed products. Since some drugs are licensed for use in particular species 
only, farmers may use the products in an o ff label manner by administering to a different 
species. The risk o f the occurrence of residues in food when food producing animals are 
treated with un-licensed products or with products used in an off-label manner, is 
considerable.
1.4 Determination of Veterinary Drug Residues
1.4.1 Introduction
Analytical methods include screening, quantitative and confirmatory procedures. In the 
case o f screening methods, they should ideally be rapid, easy to use and give a positive or 
negative result for the test compound at a specified level. Screening tools include rapid 
test kits such as microbial receptor, receptor binding, radio or enzyme immunoassays 
used to screen for veterinary residues. Screening tests can present some problems as they 
are not always sensitive at the required concentration (e.g MRL), are often drug class and 
not compound specific and do not give quantitative information. Therefore additional 
analytical tests are needed to determine if  a sample is actually violative for an animal 
drug residue. Some tests such as immunoassays, provide semi-quantitiative results.
9
Quantitiative methods are designed to separate, quantify and provide some qualitiative 
information on the analyte o f interest. Most gas and liquid chromatographic methods 
would fall into this category. Quantitative assays classify samples as positive or negative 
relative to specific drug concentration.
Confirmatory methods provide unambiguous identification o f the drug residue in 
question. Due to its sensitivity and specificity, mass spectrometry is the preferred method 
for confirmation of drug residues.
1.4.2 Screening assays
A screening assay makes a distinction between compliant and suspect samples i.e 
samples containing residues over an allowed limit, The most important requirement for a 
screening assay is that they yield very few false negatives, in essence the P-error 
(possibility o f  false negative result or a risk for the consumer) should be lower than 5%; 
some false positives are acceptable as these will show a negative result when a 
confirmatory assay is performed. 18
The earliest methods used for detection o f antimicrobial residues in food were based on 
the detection o f  growth inhibition o f various sensitive bacterial strains.1 The major 
drawback o f these assays are that they are not very specific for identification purposes, 
that they are not quantitative and they have a limited detection level for many 
antimicrobials. Moreover, they are time-consuming requiring several hours before results 
are obtained. However they are cheap, easy to carry out, adaptable for screening large 
numbers o f samples and they have a reasonably broad antimicrobial detection spectrum. 
The specificity o f  the immune system is demonstrated by its ability to distinguish subtle 
differences between antigens. Immunoassays exploit this and examples o f such tests are 
enzyme-linked immunosorbent assays (ELISA) and radioimmunoassays (RIA). Jackman 
et al., 20 described class specific enzyme immunoassays for the detection o f most 
benzimidazole drugs. For thiabendazole a compound specific ELISA had to be 
developed. Enzyme immunoassays are powerful tools for screening food products for the 
presence o f veterinary drug residues. Benefits are high through-put o f samples and low 
costs due to instrumental methods, however commercial kits can be expensive. Van der 
Made et al., 21 adjusted the sample preparation procedure o f an enzyme immunoassay
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(RIDASCREEN TM Acetylgestagene EIA o f  R-Biopharm) to create an easier and faster 
assay for the detection o f  medroxyprogesterone acetate (MPA) in kidney fat. A  second 
commercial kit was tested (MPA ELISA o f Euro-Diagnostica B. V) which showed poorer 
sensitivity for MPA. The results showed that screening using the former kit in 
combination with a simplified extraction procedure resulted in a reliable screening 
method to determine M PA in kidney fat o f  pigs. With this test it was shown that 30 
samples could be analysed per day by one technician. Scortichini et ah, 24 described a 
commercial enzyme linked immunosorbent assay (ELISA) test available from Euro­
Diagnostica for the determination o f chloramphenicol (CAP). Peippo et ah , 23 describes a 
simple and rapid time-resolved fluoro immunoassay (TR-FIA) for the screening of 
narasin in poultry plasma. Noot et ah, 22 described a surface plasmon resonance (SPR) 
based immunoassay using the Biacore Q ™  SPR biosensor for multi-sulfonamide 
detection in porcine muscle. Following a simple preparation, results for 40 samples are 
available in just over five hours. After using the Qflex Kit Sulfonamides with Biacore 
Stead et al., 25 describes a rapid screening and subsequent confirmation of
fp i  i  TTV/f
chloramphenicol using Q Flex Chloramphenicol kits employed on a Biacore Q 
system coupled with to LC-MS/MS technology.
1.4.3 Confirmatory methods
1.4.3.1 Introduction
Samples that screen positive need to be further analysed by a confirmatory analytical 
method in order to be unambiguously declared positive. Chromatographic techniques 
play an important role in the confirmatory tests for residues o f  veterinary drugs and 
contaminants. There are several types o f  chromatographic methods currently in use for 
residue analysis. These include thin layer chromatography (TLC), gas chromatography 
(GC) and high performance liquid chromatography (HPLC). TLC has found some use, 
generally for screening or qualitative assays only. Most veterinary drugs are polar, non­
volatile, heat sensitive and or difficult to derivatise for GC. Therefore HPLC is the most 
commonly used analytical technique for residue analysis. For confirmatory analysis
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chromatography with selective detectors is used widely. Mass spectrometry (MS) is the 
preferred detection method for confirmation. Hyphenated techniques such as gas 
chromatography-tandem mass spectrometry (GC-MS) and liquid chromatography-mass 
spectrometry (LC-MS) are the most powerful analytical tools in the analytical laboratory.
1.5 Validation Of Analytical Methods For Use In Veterinary Drug Residue 
Determination
1.5.1 Introduction
National surveillance laboratories within the member states are developing their own 
surveillance methods for veterinary drug residues. These methods have to be validated to 
demonstrate their reliability. Validation parameters to be evaluated for analytical methods 
are described in: Commission Decision 2002/657/EC 18 and they are: specificity, 
linearity, trueness, precision, recovery, analytical limits, stability and ruggedness. The 
criteria laid down in this decision were followed during the validation procedures carried 
out in this thesis.
1.5.2 Validation parameters
1.5.2.1 Specificity
The specificity describes the ability o f  the method to measure the analyte o f  interest in the 
presence o f other components such as interfering analytes, metabolites and sample 
matrix.
1.5.2.2 Linearity
The mathematical relationship between the response and the concentration o f the analyte 
in the matrix has to be established.
1.5.2.3 Trueness
This is a component o f  accuracy and is defined as the difference between the mean value 
measured for an analyte in a Certified Reference Material (CRM) and its certified value,
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expressed as a percentage o f its value. I f  no CRM is available, relevant parameters may 
be evaluated using fortified sample material.
1.5.2.4 Precision
The precision, another accuracy component, is the closeness o f agreement between the 
results obtained by applying the experimental procedure several times under prescribed 
conditions and covers repeatability, within laboratory reproducibility and inter-laboratory 
reproducibility.
1.5.2.5 Recovery
Matrix effects in biological samples can cause loss o f  analyte during the analytical 
procedure and can affect the recovery or extraction efficency. Non matrix-related losses 
can occur due to the analytical procedure. I f  there is no CRM available to calculate 
trueness, the recovery has to be determined by experiments using fortified blank material. 
Whenever possible, incurred residue matrix material has to be used to optimise the 
method to recover as much incurred material as possible.
1.5.2.6 Analytical limits
Two analytical limits are defined in Commission Decision 2002/657/EC and these are the 
decision limit (CCa) and the detection capability (CCp). The decision limit is the limit 
from which it can be decided that a sample is truly violative with an error probability of
a. The a-error, which is the probability that the tested sample is not truly violative, even 
though a violative measurement has been obtained (false positive decision) shall be 1% or 
5% or lower for banned and MRL compounds, respectively. In the case o f banned 
substances, CCa is the lowest concentration level at which a method can discriminate 
with a statistical certainty o f  1- a  whether the identified compound is present. For 
substances with an established MRL, C C a is the concentration above which it can be 
decided with a statistical certainty o f 1-a that the identified compound content is truly 
above the MRL.
The detection capability is the smallest content o f a substance that may be detected, 
identified and quantified in a sample with an error probability o f  p. The P-error, defined
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as the probability that the tested sample is truly violative, even though a non-violative 
measurement has been obtained (false negative decision), should be less than or equal to
5 %. In the case o f  banned substances, CCp is the lowest concentration at which a 
method is able to detect truly residues in samples with a statistical certainty o f l~p. For 
substances with an established MRL, CCP is the concentration at which the method is 
able to detect MRL concentrations with a statistical certainty o f 1 -p .
1.5.2.7 Stability
The validation protocol should always include an investigation o f the stability of the 
analyte or matrix constituents in the sample matrix as well as the stability o f the standard 
analyte in solution. Whenever possible, incurred samples should be used to check the 
stability in the matrix material.
1.5.2.8 Ruggedness
Ruggedness is tested by a separate systematic experimental procedure. Pre-investigation 
studies have to be carried out by selecting factors o f the sample pretreatment, clean-up, 
instrument and analysis, which may influence the measured results. Such factors may 
include the operator, the reagents and the laboratory circumstances. The ruggedness o f 
the method can be tested during determination o f  the within-laboratoiy reproducibility as 
part o f the method validation.
1.5.3 Residue monitoring
Residue monitoring or surveillance programmes require the analysis o f a large number of 
samples. Traditionally screening techniques, such as inhibitory substance tests and 
immunoassays, are used in residue laboratories. Multiresidue screening methods are 
needed. Screening methods reduce the number o f samples requiring more detailed 
analysis. Screening assays are an important part o f the integrated approach to residue 
monitoring. It is necessary to combine different methods in an integrated system in which 
a number o f different tests are applied consecutively depending on the targets or 
objectives o f the analysis. For regulatory purposes such a strategy should include at least 
two or more independent m ethods.1
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• Screening with a method optimised to  prevent false negative results and with an 
acceptable number o f false positive results at a low cost (e.g microbial growth 
inhibition tests).
•  Intermediate tests to identify the residue type.
• Quantitative confirmation with an independent method optimised to prevent false 
positive results.
1.6 Research Objectives and Relevance of the Presented Research Work
1.6.1 Introduction
The two main objectives o f the research work described in three separate chapters in this 
Masters Thesis are:
1 The development o f chromatographic screening methods for quantitative 
determination o f anticoccidial (robenidine) and antiparasitic (benzimidazoles) 
substances in eggs and liver, respectively, and adoption o f criteria governing method 
validation for these substances according to Commission Decision 2002/657/EC. 18
2 The development o f a multi-residue LC-MS/MS confirmatory method for the 
determination o f the banned substance malachite green (MG), its major metabolite 
leucomalachite green (LMG), another related dye called crystal violet (CV) and its 
major metabolite leucocrystal violet (LCV) in farmed salmon and adoption o f the 
rules governing confirmatory method validation for these banned substances 
according to Commission Decision 2002/657/EC. 18
It is the also the objective to apply these methodologies to routine analysis, in which 
simple, reliable, accurate, sensitive methods need to be used due to the high number of 
samples that must be tested for under current legislation. Throughout this research, there 
has been a progression in the analytical technology used. In the first two chapters, 
methods for robenidine and benzimidazoles using HPLC with UV detection are 
described. In the final chapter(s) a LC-MS/MS confirmatory method is described.
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1.6.2 Background to developed methodology in thesis
The work completed on the anticoccidial, robenidine, was carried out at The National 
Food Centre, Teagasc, Dublin. This laboratory is the National Reference Laboratory for a 
range o f drugs including antiparasitics and anticoccidials. No method was available for 
determination o f the feed additive robenidine hydrochloride in eggs by LC-UV. Although 
there were some methods using LC-MS/MS, the laboratory did not have LC-MS/MS 
technology available for this application. In chapter 3, a HPLC with UV detection method 
for robenidine in eggs is described. This method may be implemented into the Irish 
monitoring programme. No such method for the determination o f robenidine in eggs by 
LC-UV existed prior to this study.
The work completed on the benzimidazoles which are anthelmintic veterinary drugs was 
also completed at The National Food Centre, Teagasc, Dublin. This laboratory is the 
National Reference Laboratory for benzimidazole drugs also. There are seven licensed 
groups o f benzimidazoles (MRL compounds) o f  which there are 19 possible metabolites. 
Due to the wide variation in the chemical properties o f these compounds it is very 
difficult to develop a multi-residue method for all o f the licensed groups. In chapter 4, a 
HPLC-UV detection method for the determination o f benzimidazoles using bovine liver 
as a model matrix is described. This method may also be implememted into the Irish 
monitoring programme. Compared to available published methods, the advantage o f the 
developed method is the ability to simultaneously determine six o f  the seven licensed 
groups o f these compounds.
The second part o f  the thesis deals with confirmatory methods. More sensitivity, 
specificity, selectivity and confidence for surveillance purposes is obtained with mass 
spectrometry, and especially so when an LC-MS/MS system is operated in the MRM 
mode. The work completed on MG,LMG, CV and LCV which are anti-fungal dyes that 
are prohibited for use in aquaculture, was carried out at the Marine Institute and the State 
Laboratory in Dublin. The Marine Institute Laboratory is the National Reference 
Laboratory for MG. In 2003, Ireland was audited by the EU Food and Veterinary Office 
(FVO) and a non-conformance regarding the illegal use o f  this compound was raised. In 
response to this audit, a research project was set up to develop an in-house LC-MS/MS 
method for the determination o f MG and LMG in farmed salmon at the Marine Institute.
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As a result o f this study, chapter 5 describes a confirmatory method for the determination 
of MG, LMG, CV and LCV in salmon by LC-MS/MS. The residue method will be 
incorporated from 2006 onwards into the Irish monitoring programme. No such validated 
method according to 2002/657/EC for the determination o f MG,IMG,CV and LCV in 
salmon by LC-MS/MS existed prior to this study.
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Chapter 2: Section A 
Review of current methodology for the determination of robenidine residues
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Coccidiostats are substances that are used to kill or inhibit protozoa that cause 
coccidiosis. The coccidiostat, robenidine hydrochloride is therapeutically used to treat 
coccidiosis. Coccidiosis, is a contagious condition affecting lifestock, especially poultry, 
throughout the world. The disease is carried by unicellular organisms belonging to the 
genus Eimeria in the class Sporozoa.
In the poultry industry, coccidiostats are administered as feed additives. The European 
Commission regulates the inspection o f animals and o f fresh meat for the presence of 
residues o f veterinary drugs and specific contaminants by Council Directive 
86/469/EEC.1 But since coccidiostat drugs are actually feed additives, legislative criteria 
for these feed additives is laid down in Regulation 1831/2003/EC. 10 This legislation 
states that coccidiostats can be used at a prescribed concentration during a certain time 
interval for broilers and young chickens, but these compounds cannot be used for laying 
hens. Currently monitoring o f these feed additives is governed by national surveillance 
schemes within EU member states established under Council Directive 96/23/EC “ on 
measures to monitor certain substances and residues thereof in certain animal products. 
Even when withdrawal times have been established for these licensed feed additives, 
residues are frequently found in products derived from poultry, eggs and meat. One of the 
main reasons for this is cross contamination o f non-medicated feed with medicated feed 
at time o f manufacture. Subsequently another contributory factor to prolonged residues 
in farmed poultry is due to birds recycling their own faeces. This extends the exposure of 
poultry to medicated compounds which are contained in the ingested faecal material. Due 
to the presence o f coccidiostat residues, phasing out o f the use of coccidiostats as feed 
additives is being planned by 31 December 2012. The EC plan to submit a report to the 
European Parliament and the Council on the use o f  these substances as feed additives and 
recommend available alternatives before 1 Jan 2008. This report where appropriate will 
recommend legislative proposals. Until then, there are no maximum residue limits (MRL) 
set for these compounds in eggs and hence no residues o f these compounds are permitted. 
Robenidine hydrochloride is a coccidiostat drug that has a structure that is unique among 
the anti-coccidials. It is the only anti-coccidial o f the guanidine group that is unrelated 
chemically to any other coccidiostat in use and as a result o f this attribute minimises the
2.1 Introduction
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risk o f cross contamination. Cycostat 66 G (Cycostat) contains 6.6% o f the active 
substance, the synthetic chemical robenidine hydrochloride and is marketed 
commercially as the feed additive.
Since it is licensed as a feed additive there is a need to evaluate potential problems related 
to the use o f this compound in the poultry industry. O f all the licensed coccidiostats 
robenidine hydrochloride has been poorly studied.
This review focuses on the main stages o f a residue detection method; namely,
Sample extraction procedures 
Clean-up techniques 
Methods for determination
Each of these stages will be discussed with specific reference to the determination of 
robenidine residues in biological fluids and tissues.
2.2 Sample Extraction Procedures
There are a limited number o f  methodologies available in the literature on the 
coccidiostat robenidine. Typically, methods developed in the 1970’s and early 1980’s 
used a variety o f  extraction methods requiring the use of, amongst other things, 
separatory funnels, volumetric flasks, glass pipettes, columns and evaporation flasks. 
Large sample sizes were used together with consequently large volumes o f organic 
solvents for residue extraction, normally multiple extractions. Such large volumes of 
solvent were evaporated by rotary evaporation and the extracts reconstituted in 
volumetric flasks for further clean-up by liquid/liquid partitioning in separatory funnels 
or by open column chromatography. While such methodologies continue to be used in 
certain areas o f  residue analysis, notably for some applications in pesticide analysis, in 
most areas o f  residue analysis scaling down has occurred. Rather than flask-based 
extractions, test-tube extraction and liquid/liquid partitioning are common. Much smaller 
solvent volumes are used, and this use o f  smaller volumes is compatible with batch - 
based evaporations in heating blocks under nitrogen or in special evaporating apparatus 
such as centrifugal evaporators. Today most column clean-up technologies have been 
scaled down to solid phase extraction (SPE) cartridges. The above description is a
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generalised view o f changes in residue analysis through the decades. These trends are 
exemplified in robenidine analysis. In the 1970’s, methods 3’7’8’9 that were developed for 
the quantitation o f  robenidine residues used large volumes o f solvent. The tissues are 
generally first homogenised and following this they were extracted by liquid extraction 
with organic solvents alone or modified with the addition o f an acid or a base. Smith et 
al., 3 added heparin to blood samples and refrigerated for approximately 8 hr prior to 
extraction. With chicken skin, muscle, fat and liver tissues, ethyl acetate was usually the 
solvent o f choice for extraction. The addition o f the heparin to blood samples prevents 
them from clotting so that the blood can be later centrifuged and the plasma removed. 
This group extracted kidney, liver, plant tissue using acidic acetone and blood and soil 
using acetone and basic methanol. The extraction o f chicken kidney with acidic acetone 
gave rise to a higher background level o f interference so further clean-up was necessary. 
Exhaustive extraction studies o f  various sample matrices indicated that one extraction 
removed > 90% o f  the total robendine meaning repeat extractions may not be necessary. 
Zager et al., 9 extracted feed premix samples with methanol using either manual or 
automated extraction procedures. These authors used a totally automated sample handling 
system called the Solidprep sampler ™  which extracts weighed samples, dilutes and 
filters them onto the HPLC column. This group also used a liquid sampler to 
automatically inject onto the column manually prepared samples for separation and 
quantitation. Dubois et al., 4 added anhydrous sodium sulphate to egg and muscle 
samples before extraction o f  robenidine with acetonitrile. Mortier et a l,  developed simple 
direct methods to  extract egg 5,6 with acetonitrile and feed pre-mixes 6 were extracted 
with methanol.
2.3 Sample Clean-Up Techniques for Different Matrices
Chicken Tissue
Smith et al., 3 showed that clean-up o f  chicken skin, muscle, fat and liver tissues extracted 
after evaporation could be re-dissolved in petroleum ether and successively partitioned 
into acetic acid (1+1) and washed with chloroform. It was found that these partitioning 
steps did not reduce interferences sufficiently for easy determination. Upon evaluation o f
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various column packings, including silica gel, alumina (acidic, basic and neutral), florisil, 
activated charcoal aswell as weak and strong cation exchange resins. It was found that the 
weak acid macroreticular cation exchange resin CG-50 separated robenidine from 
interfering co-extractives. Robendine could be extracted from chloroform layer in 
liquid/liquid partitioning with methanol, transferred to the column, and retained while 
interferences were washed from column with additional methanol (90:10, v/v). 
Robenidine was then eluted from the column with acidic hydrochloride acid in aqueous 
methanol. The eluate was deemed sufficiently clean for direct polarographic 
determination o f robenidine. This group found acidic acetone to be suitable for 
extraction o f robenidine from chicken kidney but it gave rise to huge intereferences so 
further clean-up was deemed necessary. The acidic acetone extract was cooled to 
precipitate high molecular weight co-extractives and filtered while cool, an aliquot of the 
filtrate was evaporated to remove the acetone. Sodium hydroxide was added to make the 
solution basic and partitioning against ethyl acetate was carried out. The ethyl acetate 
layer was dried and residue was dissolved in hexane and a further partitioning was carried 
out against acetic acid (50:50,v/v). This reduced background interferences sufficiently for 
direct polarographic determination o f robenidine in acetic acid extraction without further 
clean-up on CG-50 chromtographic column.
Chicken Eggs
Smith et al., 3 cleaned up egg samples evaporated to dryness by dissolving residue in 
petroleum ether by adding saturated sodium chloride solution to petroleum extract. The 
petroleum extract was partitioned against acetic acid (50:50, v/v) and then washed with 
chloroform. The clean-up on CG-50 column was same as described by this group in the 
clean up o f chicken tissue.
Dubois et al., 4 cleaned up acetonitrile extracts o f egg by passing through a silica solid 
phase extraction cartridge. M ortier et al., 5’ 6 eliminated the need for clean-up o f eggs 
samples by direct analysis o f  the extract by LC-MS/MS.
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Plant Tissue
Smith et a l . ,3 cleaned up plant tissue acidic acetone extracts by rinsing with petroleum 
and successively partitioned against acetic acid (50:50, v/v) and washed with chloroform. 
The same clean-up procedure was utilised as described for animal tissue by this group 
except acetic acid (50:50, v/v) was added to the acidic hydrochloric acid in aqueous 
methanol prior to analysis. The majority o f  plant samples could be polarographed directly 
after clean-up on the CG-50 column. However in a small number o f samples, an 
interfering polarographic wave was obtained which partially distorted the peak shape of 
the robenidine wave to make accurate measurements difficult. I f  a portion o f the column 
effluent was concentrated down to < 1 ml and the residue re-dissolved in acetic acid 
(50:50, v/v). The robenidine wave was sufficiently separated for accurate quantitation.
Chicken Feed
Bories et al., 7 purified feed extracts using thin layer chromatography. Clean-up o f 
acidified extracts o f animal feed was accomplished on a column o f aluminium oxide. The 
robenidine is eluted with acetonitrile containing 2-methoxyethanol and ammonia. In the 
determination o f robenidine in premixes, no clean-up was required. In the preliminary 
study o f animal feeds, it was found that acetonitrile with a low water content must be 
used. The recovery o f robenidine was reduced if  there was more than 3% water present in 
the feed extract. It was also found that different sources o f equivalent grades of 
aluminium oxide did not perform equally as well. Results stated there was a tendency for 
some o f the robenidine to be eluted from the column with wash liquor during the clean-up 
stage. It was found that drying o f the extract with molecular sieves was satisfactory 
whereas drying with anhydrous sodium sulphate resulted in low recoveries so the former 
was utilised in the method. In the clean-up o f turkey feeds containing grassmeal, the use 
o f acidic aluminium oxide was found to be more useful when grassmeal was present in 
turkey feed. But in the absence o f grassmeal, basic aluminium oxide was sufficient. Also 
nitrofurazone, acinitrazole and enheptin were found to interfere in the determination o f 
robenidine by exhibiting a small apparent robenidine content. Gross interference was 
caused by the presence o f  dinitolmide in feed. However on using acidic aluminium oxide
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in place o f basic aluminium oxide, this interference could be overcom e.8 Mortier et a l . ,5 
did not clean-up methanol feed/extracts as extracts were suitable for direct analysis by 
LC-MS/MS.
2.4 Methods for the Determination of Robenidine Residues
Few methods have been developed to analyse for robenidine and the ones that do exist 
are based on spectrometry,8 chromatographic separations,9 thin layer chromatography,7 
polarography3 and liquid chromatography coupled to mass spectrometry detectors. 4,5,6
Spectrometric Methods
Robenidine was determined in feeds after the feed extract was treated with ethanolic 
potassium hydroxide. 8 The absorbances were read at 440 nm and 550 nm. The 
absorbances were corrected by subtracting the absorbances at 440 nm and 550 nm o f  the 
treated eluate after acidification, and the difference between the corrected absorbances is 
directly proportional to the robenidine concentration. For the determination o f robenidine 
in a pre-mix, the drug is extracted into methanolic sodium hydroxide and the extract’s 
absorbance measured without the need for clean-up at 352 nm. A correction for 
background interference was made by subtracting the absorbance at 352 nm o f the extract 
after acidification. The method was applicable to  the determination o f robenidine in 
poultry feeds down to 3 mg kg"1.
Electrochemical Methods
Smith et al., 3 analysed robenidine by cathode ray polarography. This technique provided 
the necessary sensitivity for determining robenidine at trace residue levels. Robenidine 
possesses an electrochemical azomethine group in its structure that is electrochemically 
reducible. This group evaluated polarographic waves in acidic, neutral and basic 
supporting electrolytes. The wave obtained in acidic supporting electrolytes proved to be 
the most useful in respect to stability, sensitivity and linearity. Acetic acid and acidic 
aqueous methanol (50:50, v/v) proved to be suitable supporting electrolytes. The 
differential mode o f cathode ray polarography although, four times less sensitive than the
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direct mode, produced a wave height that was linear and could be accurately quantitated 
with robenidine concentration over the range o f  50 to 500 x 10 9 g ml*1. The linear 
relationship between robenidine concentration and wave height was found to hold in the 
presence o f the various types o f  sample background examined. Due to variability of 
sample background within a given sample type (e.g kidney) and the varying degrees o f 
suppression o f the polarographic response as a result o f such a variation, a general 
linearity curve could not be applied to a given sample type. The standard addition 
technique was used during sample analysis. 14 C-Robenidine hydrochloride was used 
throughout the development o f the polarographic procedure. The use o f  this radiolabeled 
compound greatly facilitated the method development process. Since this technique 
allowed for the investigation o f (a) extractability o f  robenidine from a given sample 
matrix by a given solvent (b) partitioning o f robenidine between two solvents, (c) the 
effect o f  variables such as pH and salt content on this partitioning, and (d) elution o f 
robenidine from various chromatographic supports in the presence o f  sample background 
which otherwise would have prevented direct polarographic determination o f the 
compound. Recoveries o f  robenidine ranged from 64 to 125% with an average overall 
recovery o f  90%. The validated sensitivity was 0.1 mg kg 1 for chicken tissues, soil and 
plants, 0.01 mg 1 kg for eggs and 1 mg kg 1 for litter.
Liquid Chromatographic Separations
Four liquid chromatographic separations for the determination o f robenidine residues 
have been developed. Three o f these have been developed using Cig reverse phase 
systems. 4,5,6 The fourth method evaluated high pressure ion-exchange, reverse phase and 
absorption chromatography with appropriate supports and solvents mixtures. 9 In this 
method a mixture o f  methanol, acetic acid and methylene chloride were used as the 
mobile phase on a CPG-240 controlled pore glass stationary phase. The method provides 
rapid and specific method for the analysis o f  robenidine and is capable o f distinguishing 
the intact drug from its degradation products. A precision study o f  the chromatography 
method was carried out and results indicated that the procedure was capable o f  giving 
quantitative results at a rate o f  10 samples hr 1 with a coefficient o f  variation o f 1.13%.
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These results were achieved when replicate aliquots o f the same sample solution were 
carried out to eliminate precision effects due to sample variation. A recovery o f 101% 
was obtained for robenidine using this method.
Mortier et al.,6 analysed robenidine, diclazuril, dimetridazole, halofuginone and 
nicarbazin by LC-MS/MS separating these compounds using reverse phase 
chromatography comprising o f a Waters Symmetry Ci8 column (150 mm x 2.1 mm, 5 
pim) and a gradient with water (A) and acetonitrile (B) each containing 0.1% formic acid. 
The mobile phase flow rate was 0.25 ml min 1 with a total runtime of 17 min. These 
conditions eluted robenidine at a retention time o f 8.85 min. Dubois et al., 4 separated 
halofuginone, diclazuril, dinitrocarbanilide, robenidine, monesin, lasalocid, narasin, 
salinomycin and maduramicin on a Merck Purospher Ci8 (125 mm x 3 mm, 5 |_im) 
column. The flow rate was 1ml min and a gradient o f water (A) and acetonitrile (B) 
was applied, each containing 0.1% formic acid with a total run time o f 14 .5 min. Zager et 
al., 7 determined the operating conditions for the resolution o f  robenidine hydrochloride 
from 1,2,3- tris(p-chlorobenzylideneamino) guanidine hydrochloride and bis (4- 
chlorobenzal) azine two o f its chemical impurities. The column used for the LC system 
was a 600 mm x 2.1 mm i.d stainless steel tube with end fittings containing 2 [i,m bed 
supports. The column was dry packed with 200 -400 mesh controlled pore glass CPG-10- 
240A packing. Mortier et a l , 5 separated halofuginone, robenidine, diclazuril, nicarbazin, 
dimetridazole and 2-hydroxydimetridazole on a Waters Symmetry Cis column (150 mm x
2.1 |am, 5 p.m). The column temperature was maintained at 35 °C. The mobile phase flow 
rate was 0.25 ml min _! and a gradient o f  eluent A (acetonitrile:water (95:5, v/v) 
containing 0.1 % formic acid) and eluent B (acetonitrile) was used to separate robenidine 
from the other coccidiostats investigated.
Thin Layer Chromatography (TLC) Determination
Bories et al., 5 analysed robenidine in poultry feed by TLC using a plate coated with a 
thick layer o f silica gel. The plate was developed with chloroform: methanol (95:5, v/v) as 
the developing solvent. After development the spots were made visible by spraying with 
Rhodamine B solution and a UV lamp (wavelength 265 nm) was used to detect
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robenidine. The area on the plate containing the coccidiostat was scraped and the powder 
dissolved in dimethylformamide after addition o f sodium hydroxide. The yellow 
coloration on development was measured at 464 nm. Robenidine contains a number o f 
conjugated double bonds that undergo electronic reorganisation in an alkaline medium. 
This re-organisation results in a shift in the absorption maximum to a longer wavelength, 
so on the addition o f potassium hydroxide solution this value shifts to 464 nm and at the 
same time adsorption by interfering substances is minimised. The efficiency of the 
chromatographic purification was tested by spotting with pure robenidine onto the plates, 
either on its own or in the presence o f  extra fatty or pigmented poultry feed. Extracts of 
the feed with no robenidine were measured under the same conditions, and results 
showed negligible blank values. The recovery o f robenidine from poultry feed ranged 
between 96 and 100%.
Liquid chromatography detection systems
Only a small number o f groups have developed methods for robenidine and there are no 
methods developed using UV or fluorescence detection. A limited number o f methods 
have been developed for the determination o f  robenidine in tissue, egg, feed and feed pre­
mixes using mass spectrometric detection. 4,5,6 Dubois et a l, 4 used positive and negative 
ion electrospray modes (ESP) in the separation o f 9 coccidiostats. The first 7.4 min of the 
runtime were in positive ESP mode for robenidine and halofuginone, then switching to 
negative electrospray occurred until 9 min for dinitrocabanilide, DNC-dg, diclazuril, 
diclazuril bis and then back to ESP + mode for the polyethers (monesin, lasalocid, 
salinomycin, narasin, maduramycin). For the unequivocal identification o f each analyte, 
two ions were detected and chosen for multiple reaction monitoring (MRM). The parent 
ion monitored was 334.1 m/z at a cone voltage o f 30-35 V. Daughter ions o f 138.2 and
111.2 m/z were obtained with collision energies o f (eV) 23 and 41. The recovery of 
robenidine from muscle samples fortified at 2 ng kg'1 level was 56 %. The coefficient of 
variation was not repprted in this paper. The CCa and CCP values obtained for 
robenidine were 0.2 and 0.5 pig kg'1.
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Mortier et al., 5 used LC-MS/MS with electrospray ionisation interface (ESI) for the 
detection of robenidine and 4 other coccidiostats in poultry eggs and feed. Detection was 
performed in the selected reaction monitoring mode after ionisation in the positive or 
negative electrospray ionisation mode. The presence o f the [M+M]+ ion for 
dimetridazole, 2-hydrodimetridazole, dimitridazole-d3, halofuginone and robenidine. The 
[M-M]' ion were monitored for diclazuril, diclazuril-bis and dinitrocarbamilide.
The parent ion monitored was 334.1 m/z at a cone voltage o f 50 V. Daughter ions of
138.1 and 155.1 m/z were obtained with collision energies o f (eV) 24 and 18. The 
recovery o f robenidine from fortified egg and feed samples were between 101 -105 % 
and 96 -  102%. The coefficient o f variation was between 4-7% and 5-6% in fortified egg 
and feed samples The CCa and CCP values obtained for robenidine in fortified egg 
samples were 1.0 and 1.2 |xg kg '1. The CCa and CCP values obtained for robenidine in 
fortified feed samples were 8.8 and 12.5 ng. kg
The use o f LC-MS/MS with electrospray ionisation interface (ESI) was used by Mortier 
et al., 6 and robenidine was determined with ESI in the positive mode with [M+H] + ions. 
The parent ion monitored was 334.5 m/z using a cone voltage o f 25 V. The most 
abundant daughter ion was 137.8 m/z which was obtained using a collision energy (eV) 
o f 25. Daughter ions o f  129 and 110.9 m/z were obtained using collision energies (eV) o f 
40 and 45. The recovery o f robenidine from eggs fortified at 5 fig kg'1 level was 42 %. 
The coefficient o f variation was 19 %. The C Ca and CCP values obtained for robenidine 
in eggs were 3 .0 and 4.0 |ig  kg'1.
2.5 Conclusions
The determination o f the coccidiostat robenidine involves liquid partitioning and/or solid 
phase extraction in conjunction with liquid chromatography tandem mass spectrometry. 
This methodology allows for the determination o f robenidine in multi-residue methods 
with other coccidiostats. Dubois et al., 4 has developed the most complete method, 
allowing the determination o f robenidine and 8 other coccidiostat drug residues in 
chicken muscle and eggs with detection by LC-MS/MS. The methods developed by
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Mortier et al., for the determination o f robenidine and 4 other coccidiostats in eggs5’6 and 
feed 5 are also noteworthy.
However difficulties such as the high costs involved in performing analysis by LC- 
MS/MS mean that a variety o f alternative techniques need to be made available so that 
robenidine determination is possible for all designated laboratories in the EU.
To date, however, no method exists that can screen for robenidine by LC-UV, this 
technique being readily available and o f  low cost. The development o f such a method 
would allow for ease o f  determination o f  this compound using very accessible technology 
that is available in most basic analytical laboratories.
Robenidine, as mentioned before, has not been studied extensively hence there is also no 
information regarding the distribution o f robenidine residues within tissues such as 
between egg yolk and egg white.
There is also little information on the depletion o f robenidine in different species o f 
poultry; different species effects may be important in determining withdrawal periods. 
There is also no data on the stability o f  this compound upon storage. A study o f this 
would give rise to vital information which would allow experiments to assess if  harmful 
breakdown products may result from storage conditions.
Another factor to consider is that feed additives eventually end up in manure. Manure is 
dispersed in fields and the mobility o f  drugs in the soil system may pose a threat to 
ground water and soil dwelling organisms and ecosystems.
Further study is required to determine the environmental effects o f administration o f all 
feed additives in animal husbandry.
Since the licensed coccidiostat robenidine may be widely used, it is important to continue 
with the development o f screening, validation or confirmatory methods in the areas where 
shortfalls have been discussed above.
Fundamental to  this work is the development o f a simple residue method capable o f 
screening for the coccidiostat robenidine in eggs and subsequent availability o f  this 
method for implementation into The National Monitoring Plan for Ireland. Egg was 
selected as the matrix since this compound is not licensed for use in laying hens so any 
levels found in egg would be in breach o f regulations. LC-UV methodology was chosen 
over LC-MS/MS technology since this technique is more available in residue
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laboratories. The development of such methodology will provide a legal basis for 
prosecuting individuals who use this feed additive in breach of EU legislation. 
Acetonitrile was chosen as the extraction solvent since it has been widely used in the 
extraction of robenidine from a variety of matrices. There is an obligation on each 
member state in the EU to put methods in place to monitor for coccidiostat residues. For 
these reasons, the development of a residue method capable o f monitoring for robenidine 
is extremely important.
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Chapter 2: Section B 
Review of current methodology for the determination of benzimidazole residues
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2.7 Introduction
Benzimidazoles are a group o f drugs that have a fixed MRL and are therefore in Annex I 
o f Council Regulation EEC/2377/90. Benzimidazoles are broad spectrum anthelmintics 
and have been used for about 40 years in animal husbandry and horticulture to control 
anthelmintic infections. Metabolism o f these drugs is extensive. When the pro-drugs and 
active drugs and metabolites are counted, some 19 possible residues may occur in animal 
tissues.
Table 2.1 presents the pharmacologically active substances involved in the benzimidazole, 
work for this thesis, for food producing animals including the established MRL values. 
The current status (fixed or provisional) o f  the MRL values are indicated. There are seven 
groups o f  benzimidazoles licensed for use and the MRL values range from 10 -  1000 (ig 
kg'1, depending on the compound and matrix. The development o f  a single multi-residue 
method capable o f testing for all the residues in the MRL listings is very difficult since 
there is huge variability in terms o f polarity and pKa within a group o f these drugs and 
between the different groups. It is necessary for each member state to carry out a national 
surveillance scheme, established under Council Directive 96/23/EC 22 for all these 
benzimidazoles drugs. In Ireland, national surveillance o f only 5 o f  these drugs was being 
carried out and work was necessary to improve the number o f these residues detected in 
animals and animal products. This work was necessary not only to protect Irish 
consumers from the potential risk o f harmful residues but also essential to facilitate 
international trade as other countries may be exporting animals treated with unlicensed 
products or concentration o f  residues above the maximum residue level into Ireland. 
Therefore a review of the literature concerning the types o f residue methodologies 
employed for the screening and confirmation o f these compounds was carried out. This 
evaluation would form a foundation for the approach that must be undertaken to 
incorporate a satisfactory multi-residue method into the National Monitoring Plan in 
Ireland to determine all 7 licensed groups.
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Table 2.1: MRL listings for benzimidazole anthelmintic drugs
Drug Marker Residue Animal Species MRL
Og/kg)
Target
Tissue
NETO, ABZ Sum of ABZ-SO, ABZ-S02, and Bovine, ovine 100 Milk
and ABZ-SO ABZ-NH2-S02 expressed as ABZ
100 Muscle
100 Fat
1000 Liver
500 Kidney
FEB, FBZ and Sum of extractable residues which Bovine, ovine 10 Milk
OFZ may be oxidised to FBZ-S02
* Bovine, ovine, porcine and 50 Muscle
equidae
50 Fat
500 Liver
50 Kidney
FLU Sum of FLU and FLU-HMET Porcine, poultry and game 50 Muscle
birds
50 Skin and Fat
400 Liver
300 Kidney
Chicken 400 Eggs
TBZ Sum of TBZ and 5-OH-TBZ Bovine 100 Muscle
100 Fat
100 Liver
100 Kidney
100 Milk
OXI OXI Porcine 100 Muscle
500 Skin and fat
200 Liver
100 Kidney
TCB Sum of extractable residues that may Bovine and ovine 100 Muscle
be oxidised to ketotriclabendazole
100 Liver
100 Kidney
MBZ Sum of MBZ, MBZ-OH and MBZ- Ovine, caprine and 60 Muscle
NH2 expressed as MBZ equidae
60 Fat
400 Liver
60 Kidney
37
This review focuses on the main stages of a residue detection method; namely,
Sample extraction procedures 
Clean-up techniques 
Methods for determination 
Each of these stages will be discussed with specific reference to the determination of 
benzimidazole residues in biological fluids and tissues.
2.8 Sample Extraction Procedures
The presentation o f biological matrices in a suitable format for residue extraction 
involves a sample pre-treatment step. The techniques used in sample pretreatment depend 
on the matrix under consideration, liquids requiring generally less pretreatment than 
tissues. The tissues are first homogenised, and after this step the tissues may be either 
hydrolysed for the release o f  conjugates or bound residues or liquid extraction o f  the 
tissue at high pH into immiscible organic solvent. Many groups investigated the effect 
of deconjugation of residues using enzymatic or acid hydrolysis since many 
benzimidazoles metabolites exist as conjugates. Tocco et al.,1 investigated the urinary 
metabolites o f  TBZ and found that the glucuronide and sulfate conjugates o f 5-OH-TBZ 
were the major metabolites. Conjugates were enzymatically hydrolysed using P- 
glucoranidase or glucosulase or by refluxing in 6N HCL (1 h). Similar procedures were 
later used by Tocco et al.,2 to deconjugate 5-OH-TBZ residues present in cows’ and 
goats’ milk after treatment with TBZ. A more extensive study was completed by 
Chukwudebe et al., 3 into the metabolism o f TBZ in laying hens and lactating species 
using enzymatic and acid hydrolysis and it was found that conjugates were mainly 
present as sulfates. In a study o f bluegill sunfish Van den Heuvel et al.,4 also 
deconjugated 5-OH-TBZ by enzymatic and acid hydrolysis. Kriedel eta l.,5 deconjugated 
the glucuronide o f MBZ-OH after digestion with P-glucuronidase. Glucosulase was used 
to enzymatically hydrolyse ABZ metabolites in urine by Gyurik et al.,6 before detection 
by TLC. The incubation o f urine by Short et al.,7 showed that the majority o f residues
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present in urine were conjugated when tested on animals treated with FBZ and enzymes 
(3-glucuronidase and sulfatase before extraction and determination by mass spectrometry. 
As a result o f  this other authors have included, hydrolysis steps in some residue methods. 
Markus et al.,s subjected liver samples to acid hydrolysis before extracting ABZ-NH2- 
SO2 residues. Arenas et al.,9 used enzymatic hydrolysis to deconjugate 5-OH-TBZ 
sulphate. Coulet et al.,10 used basic hydrolysis to  release protein bound residues o f TBZ 
from tissue.
The polarity and pKa values o f  benzimidazoles can differ to a huge extent between 
metabolites and parents. This not only makes it difficult to develop multi-residue methods 
for different benzimidazole drugs but also a single drug and its metabolites. The usual 
approach to extract benzimidazoles is liquid extraction. Commonly this is achieved using
• 11 12 13aqueous extraction at high pH with partitioning into immiscible organic solvents. ’ ’ 
Many groups developing methodology for the determination o f FBZ and its two 
metabolites OFZ and FBZ-SO2 14*19 have had difficulty in development due to FBZ and 
its metabolites having difficult physical properties, thus making it difficult to extract and 
determine by LC 15,16,20 Similar observations have been made with MBZ and its two 
metabolites MBZ-OH and MBZ-NH2 .13 MBZ and MBZ-NH2 are basic in nature with pKa 
values o f  3.5 and 5.5, respectively. Therefore, only at pH levels >7.5 are both metabolites 
non-ionised. MBZ-OH possesses an acidic OH group with a pKa o f 9.8 which is non­
ionised below pH 7.8. This indicates that only in the pH range 7.5-7.8, are all three 
residues non-ionised. Alternatively, extraction may be carried out using a more polar 
organic solvent without pH manipulation. Some groups have extracted these drug 
residues using a single solvent system, such as acetonitrile 21,22,or binary water/organic 
solvent mixtures which would be around neutral pH.28,20’24’25 Extraction with acidified 
extractants has only been used by a small number o f groups for methods requiring 
hydrolysis or digestion steps 3,8,26,x' or methods including only a limited number o f 
residues.28
The use o f medium polarity water immiscible solvents has been used in the extraction of 
benzimidazoles from muscle, fat, liver and kidney at alkaline pH. A carbonate 
buffer/ethyl acetate system by Wilson et al., 11 to extract 8 benzimidazoles from muscle 
and liver has been used by a variety o f groups 29’30'36.
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The extraction o f TBZ and 5-OH -TBZ from different tissues was achieved using a 
phosphate buffer (pH 7) from different tissues by Cannavan et a l37 
It was found that the ethyl acetate extraction gave rise to extracts that had more 
interferences when used as extraction solvent for cheese samples than acetonitrile, while 
dichloromethane gave low recovery. Takeba et al.,49 used acetonitrile to extract TCB, 
TCB-SO and TCB-SO2 from milk and obtained recovery o f 89-95%. Sorensen et a/.,48 
used a buffer at pH 6.8 to extract levamisole and TBZ from milk. An analogous 
extraction procedure was developed by the same group for eight other benzimidazoles 
using a buffer at pH 11.0.50 Recovery in both methods was >81% . Brandon et al.,51 
found that milk samples needed only to  be diluted in PBS-tween-BS A before detection o f 
FBZ residues by ELISA.
The adjustment o f plasma to pH 7.4 by Bogan et al., 52 in the extraction of FBZ, OFZ and 
ABZ residues with ether has been utilised by a number o f groups extracting ABZ and 
FBZ residues 53, 54 The substitution o f ether with ethyl acetate was carried out by Lehr 
and D am n55 to extract TBZ and TCB and their major metabolites.
Hoaksey et al.,56 extracted ABZ and ABZ-SO from plasma samples with 
dichloromethane after protein precipitation with acetonitrile. Recovery o f ABZ and ABZ- 
SO2 was 97 and 75%, respectively. The extraction o f TCB, TCB-SO and TCB-SO2 from 
plasma by Alvinerie et a l 57 used a simple ethyl acetate extraction procedure and gave 
mean recoveries o f  TCB and its two metabolites between 98 and 104%. Other groups 
17,58 have mixed plasma with ammonium hydroxide or buffered solutions before 
extraction o f residues by SPE.
The extraction of TBZ residues in fruit and vegetable matrices has been achieved using 
ethyl acetate 59-61, methanol 62 or acetone 63,64 and extending the methods to include 
benomyl, thiophanate-methyl and carbendazim. Extraction using binary mixtures usually 
a aqueous alkaline extraction with a less polar immiscible solvent such as 
dichloromethane65, ethyl acetate 23,61,66 or ethyl acetate-hexane67 have also been utilised. 
Aqueous extraction using acetate buffer has also been applied to the extraction o f TBZ
* ¿TO r Q  f j f \
residues with JO and without u' further solvent partitioning. Brandon et a l.,'' extracted 
TBZ from fruit and vegetables with tris-buffer or water, finding that the extracts needed 
only dilution with buffer before determination by ELISA. Shah et al.,11 extracted OFZ
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from feed using 10% glacial acetic acid in methanol (45 °C, 30 min), while Botsoglou el 
al,,72 extracted FBZ from feed using acetonitrile.
Depending on the sample matrix, the presence o f water, lipids, proteins or co-extractives 
can be a source o f problems at the extraction stage or at subsequent stages. Therefore 
sample clean-up becomes important. Sample clean-up methodologies used to minimise 
problems and improve analysis o f the benzimidazoles were subsequently evaluated.
2.9 Sample Clean-up Techniques for Different Matrices
Sample clean-up is dependent on a number o f factors such as on the number o f residues 
to be screened, the extraction procedure used, sensitivity requirements and the 
determination step Extensive clean-up procedures are necessary if  including a wide 
range o f residues and require high sensitivity when extracting from complicated tissue 
matrices. Including sample pre-treatment steps and by using more selective detection 
systems such as fluorescence or mass spectrometry, the extent o f clean-up needed can be 
reduced and sample throughput can be increased. Bushway et al.,65 diluted fruit juice 
samples in mobile phase prior to determination by LC with fluorescence detection. A 
number of groups have analysed benzimidazole fung ;ides by GC with more selective 
detectors such as ECD 23’67’68, NPD 98’136’137 and MS <*>^30,133,134,135,136,137,139,140 ^
found that residues may be determined without extensive clean-up. Kitada et al.60 
extracted citrus fruit with ethyl acetate and the extracts were sufficiently clean for 
analysis without further clean-up. Brandon et al. 24,70 found that sample extracts only 
needed dilution in buffer prior to determination by ELISA.
Liquid-liquid partitioning is the most extensively used method for the elimination of 
polar and non-polar matrix interferences. A widespread approach is to modify the pH of 
extracts to alkaline conditions and partition residues into an immiscible organic solvent 
such as ethyl acetate to get rid o f polar interference. Partitioning between an acidified 
extract (in dilute HCL or ethanol / HCL) and a non-polar solvent (ethyl acetate, heptane 
or hexane) can be used to remove non-polar interference, into the organic fraction. Solid 
phase extraction (SPE) is the most widely used procedure for the clean-up of sample
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extracts. This procedure allows easier handling o f a larger number o f samples and can 
greatly reduce sample clean-up time and solvent usage. SPE can also offer greater 
selectivity. The availability o f SPE sorbents in a wide variety o f  chemistries and 
differences between manufacturers o f similar chemistries allow endless possibilities.
Animal Tissue
• • 29 12 25 28The use o f liquid partitioning only in the clean-up o f benzimidazoles from tissue ’ ’ ’ ’ 
38'41 have only been applied to a limited number o f residues and generally residues from 
the same parent drugs. The most widely adopted procedure in liquid-liquid extraction 
(LLE) is an alkaline buffer-ethyl acetate extraction system for isolation o f these drugs 
from tissue matrices while removing non-polar matrix interference. Samples can also be 
extracted using dilute HCL and non-polar interference removed by partitioning into non­
polar solvent 28. The acidified layer, neutralised and adjusted to alkaline pH before 
extraction with immiscible non-polar solvent. Blanchflower et al.,25 extracted FBZ and 
OFZ from liver with methanol-water before defatting with petroleum spirit and extracting 
with diethyl ether and ethyl acetate. More simple defatting steps were used by Nafstad et 
al.,41 and De Ruyck et al.,39 by washing acetonitrile and methanol, respectively, with 
hexane. Mellergaard et a l.2% extracted MBZ from eel muscle with 0.1N HCL, before 
defatting with heptane. The pH o f the aqueous extracts was further adjusted to pH 9.6 
before extraction into heptane/isoamyl alcohol.
The approach most commonly used in the extraction and clean-up o f benzimidazole 
residues from animal tissue is a combination o f liquid extraction (LLE), liquid-liquid 
partitoning and solid phase extraction (SPE). Wilson et al.,n  purified extracts by 
partitioning between ethanol/0.2M HCL and hexane, before clean-up on C2 SPE 
cartridges. The C2 SPE step was necessary to remove polar compounds that interfered 
with ABZ-NH2-SO2 and TBZ-OH. This group evaluated a number o f reverse phase and 
semi-polar sorbents and found C2 to be most effective. This method was applied for the 
determination o f 15 benzimidazoles in liver by Balizs et al.,30 while Roudaut et al.,33 
modified the method by substituting Oasis HLB cartridges for C2 cartridges and reported 
more reproducible results. Shaikh et al.,29 applied the Wilson et al.,n  method to the
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determination o f  ABZ residues in fish muscle finding that the C2 could be excluded by
using more selective detection. Other groups have adopted similar LLE procedures and
23 13 . . 01  <
further purified tissue extracts by SPE on Cig, amino-propyl, silica, cyano, neutral 
alumina.73 using SPE cartridges Marti et al.,23 and Farrington et a l,,74 developed multi­
residue methods using dual SPE clean-up procedures based on normal phase and Cig 
sorbents. Rose et al.,22 applied strong cation exchange (SCX) SPE to the isolation o f OFZ 
and nine related residues in liver. Stubbings et al.,75 developed an online SCX-SPE 
procedure for the purification o f benzimidazole residues from tissue. Matrix Solid Phase 
Dispersion (MSPD) has been applied by a number o f  groups for the determination o f
n q  |  f  1 o  r j r j r t t  ^  >
benzimidazoles in liv e r/ ’ ^ ’ * This involves packing a tissue/Ci8 mixture into an
a
empty SPE column, washing with hexane and eluting with acetonitrile or hexane.
M ilk and milk products
The removal o f polar interference from milk has been accomplished by liquid/liquid 
partitioning o f  ethyl acetate with water or partitioning o f 0.2 N HCL with ethyl acetate by 
Fletouris et al.,44 and Tsina et al., 45. Fletouris et al.,15 found that acetonitrile was efficient 
at precipitating proteins, while non-polar interference could be removed by partitioning 
into hexane or iso-octane. The extraction o f FBZ, ABZ, OXI and LEV from milk with 
acetonitrile; ethyl acetate was accomplished by De Ruyck et al., 122 The extract was 
washed with di-sodium hydrogen phosphate adjusted to pH 10.
A number o f  different SPE clean-up procedures have been developed using silica,42 C2 ,82 
Cig,21 cation exchange 9,81 and neutral alumina,34 but liquid/liquid partitioning clean-up 
was still necessary prior to SPE.
Benzimidazoles were extracted using aqueous buffer pH 6.5 and pH 11 before 
purification by liquid/liquid partitioning and SPE on Cig by Sorenson et al. 48,50 
MSPD was applied to determine benzimidazoles in milk and cheese by Cinquina et al., 82 
and Longet et a l, 16 The former group found extracts needed further purification by C2 
SPE.
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Plasma, Serum and other biological fluids
Plasma and other biological fluids are much cleaner than tissue and milk samples, 
requiring less clean-up. Bogan et al.,52 developed a simple clean-up procedure for the 
determination o f benzimidazoles in biological fluids. The pH o f samples is adjusted to pH
7.4 and extracted with diethyl ether. This procedure has since been applied by other 
groups 5315483 for the determination o f benzimidazole residues in plasma and blood. 
Similar extraction procedures have been developed by Zhangliu et a/.,84 and Alton et 
al.*5, with partitioning between alkalised samples and non-polar solvents like 
chloroform86,87 and ethyl acetate.88 Allan et a/.,89 evaluated the clean-up procedures 
developed by Alton et a/.,84 and Karlaganis et al,,87 and judged the latter method to be a 
much simpler extraction and clean-up procedure. Allan et al.*9 applied this method to the 
determination o f 4 MBZ related residues in plasma. Other groups 17,58,90,91 have adjusted 
the pH o f samples before purification on SPE cartridges, without prior liquid-liquid 
partitoning.
Rouan et al 92 developed an automated clean-up procedure for the determination o f TCB 
and its metabolites in plasma using Ci8 SPE. Purified extracts were suitable for analysis 
without further clean-up and recovery was typically between 96 and 103%. Chiap et al.,93 
developed an automated clean-up procedure based on dialysis clean-up. Negro et al.,94 
isolated TCB-SO and TCB-SO2 from serum and urine samples using a combination of 
protein precipitation and ultra-filtration through a 30,000 molecular mass cut-off filter. 
This group found that using this clean-up strategy greatly speeded up sample preparation, 
making the procedure faster than commonly used SPE clean-up procedures. Recovery of 
TCB-SO and TCB-SO2 from serum was typically >90%.
Plant matrices
Farrow et a l.95 simply adjusted the pH o f hydrolysed extracts to pH 9.5 before 
partitioning into chloroform. Other groups have developed clean-up procedures based on 
a single LLE step between aqueous buffers and more non-polar solvents.59,60,63’66 More
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extensive LLE and liquid-liquid partitoning procedures have been adopted by other 
groups 67,68 Arenas e t al.,61 and Ito et al.,96 applied cation exchange SPE to the 
determination of TBZ residues in fruit. Young et al.,91 used Oasis® MCX SPE cartridges, 
finding that loading extracts in ammonium hydroxide produced better recovery than 
loading in acidic solution. Di Muccio et a l,63 used a combination o f ExtreElut and SCX 
SPE for the isolation o f TBZ, benomyl and carbendazim residues from fruit and 
vegetables. Oishi et a/.,98 isolated TBZ residues on an ExtreElut cartridge after extraction 
with an alkaline buffer. Zrostlikova et a h ,"  purified TBZ, carbendazim and other crop 
protection agents using Oasis MCX cartridges. Recovery o f  TBZ and carbendazim were 
typically greater than 88%.
Hiemstra et al.,64 developed an on-line clean-up procedure for the isolation o f TBZ and 
carbendazim residues from fruit and vegetable extracts. Samples were purified by liquid­
liquid partitoning prior to automated off-line SPE clean-up on a diol SPE cartridge 
mounted on an ASPEC system. Shah eta l.,71 extracted OFZ from feeds, finding that plant 
pigments interfering with the determination could be removed by precipitation with zinc 
acetate before extracts were further purified by liquid-liquid partitoning. Botsoglou et 
al.,72 extracted FBZ residues from feed, before removal o f  matrix interference by liquid­
liquid partitoning against iso-octane.
The determination o f  the benzimidazoles in a variety o f extracts was subsequently 
evaluated to identify which techniques have worked well for particular groups of 
bezimidazoles and to isolate a single technique that could be employed to develop the 
multi-residue national surveillance method for these licensed drugs.
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Table 2.2: Summary o f  extraction and clean-up procedures used in selected multi-residue methods for isolating benzimidazole
residues from animal tissues
Residues Matrix1 Extraction Clean-up Recovery
(%)
Ref
ABZ, CAM, MBC, MBZ, OFZ, FBZ, 5-OH-TBZ, M, L Ethyl acetate at alkaline pH Acidified ethanol vs 81-100 11
TBZ hexane 
C2 SPE
ABZ, MBZ, OFZ, FBZ, OXI, FLU, TBZ, TCB M, L, K Acetonitrile-H20 LLP
Cig, Florisil SPEs
65-87
39-80 (OFZ)
23
CAM, TBZ, 5-OH-TBZ, 5-NH2-TBZ L DMS0-H20 24
ABZ, ABZ-SO, ABZ-SOz, FBZ, OFZ, FBZ-S02 L DMF-H2O 116
*(MBC, MBZ, FBZ-OH, FLU, 5-OH-TBZ, TBZ)
ABZ, CAM, MBZ, OFZ, TBZ L Ethyl acetate Alumina Ci8 SPE 67-90 74
ABZ, ABZ-SO, ABZ-SO2 , ABZ-NH2-SO2 , CAM, Mk Acetonitrile LLP 62-108 35
FBZ-SO2 , MBZ, OXI, 5-OH-TBZ, TBZ
ABZ, ABZ-SO, ABZ-SO2 , ABZ-NH2-SO2 , FBZ, M, L, K Ethyl acetate at alkaline pH Acidified ethanol vs 44-87 33
OFZ, FBZ-SO2 , OXI, 5-OH-TBZ, TBZ hexane
Oasis HLB SPE
ABZ, ABZ-SO, ABZ-SO2 , ABZ-NH2 -SO2, FEB, M, L Ethyl acetate at alkaline pH Acidified ethanol vs 36-117 30
FBZ, OFZ, FBZ-SO2 , MBZ, OXI, FLU, CAM, hexane 8 (FEB)
TBZ, 5-OH-TBZ, TCB SDB SPE
ABZ, ABZ-SO, ABZ-SO2, FBZ, OFZ, FBZ-S02, M, L, Fish Ethyl acetate at alkaline pH Methanol vs hexane 75-109 127
FLU, MBZ, OXI, 5-OH-TBZ, TBZ, TCB, LEV
ABZ, FBZ, OFZ, FBZ-S02, FBZ-OH, MBZ, TBZ M MSPD MSPD 63-86 77
ABZ, FBZ, OFZ, MBZ, TBZ L MSPD MSPD 55-93 78
ABZ, FBZ, OFZ, FBZ-S02, FBZ-OH, TBZ L MSPD MSPD 61-92 76
ABZ, ABZ-SO, ABZ-SO2, FBZ, OFZ, FBZ-S02, SF-C02 SCX 56-109 120
MBZ, MBZ-OH, FLU, OXI, TBZ
Cia on ASPEC™ABZ, ABZ-SO, ABZ-SO2 , ABZ-NH2-SO2 , FBZ, L Ethyl acetate at alkaline pH 27-120 124
OFZ, FBZ-SO2 , FLU, FLU-NH2 , MBZ, MBZ-OH, 
OXI, TBZ
’Liver, fat, kidney, muscle and milk are abbreviated as L, F, K, M and Mk.
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Table 2.3: Summary of extraction and clean-up procedures used in selected multi-residue methods for isolating benzimidazole
residues from milk
Residues Extraction Clean-up Recovery
(%)
Ref
ABZ, ABZ-SO, ABZ-S02, ABZ-NH2-S02, FBZ, OFZ, FBZ-S02, FBZ- Ethyl acetate at pH 10 79-100 44
OH, MBZ, OXI
a b z -n h 2-s o 2 Acid Hydrolysis (H3P 04) 
Acetonitrile (pH 5-7)
SCX SPE >91 83
FBZ, OFZ, TBZ, 5-OH-TBZ Ethyl acetate at alkaline pH LLP >80 48
Silica SPE 56 (5-OH-TBZ)
ABZ, FBZ, OFZ, FBZ-S02, FBZ-OH, MBZ, TBZ MSPD MSPD 70-107 16
ABZ, ABZ-SO, ABZ-S02 Ethyl acetate at alkaline pH LLP 78-100 14
ABZ, FBZ, TBZ, OXI, LEV Acetonitrile-ethyl acetate LLP 68-85 121
ABZ, FEB, FBZ, OFZ, OXI, TBZ, TCB, LEV Ethyl acetate at alkaline pH 79-110 122
FBZ, OFZ None Diluted 1:10 95-122 51
ABZ, ABZ-SO, ABZ-S02, FEB, FBZ, OFZ, MBZ, OXI Dilute buffer pH 11,0 Cig SPE 81-96 50
TBZ, LEV Defat C18 SPE 81-89 48
Dilute buffer pH 6.5
Table 2.4: Summary o f extraction and clean-up procedures used in selected multi-residue methods for isolating benzimidazole
residues from crops
Residues Matrix1 Extraction Clean-up Recovery
(%)
Ref
BEN, MBC, 2-AB F ,V Ethyl acetate LLP 71-92 26
TBZ, MBC F, V LLE (Ethyl acetate vs 0. IN HC1) LLP 91-97 138
BEN, TBZ F ,V Reflux with Ethyl acetate at alkaline pH 73-109 115
BEN, MBC, 2-AB F, V Benzene at alkaline pH LLP 70-90 136
BEN, MBC, TBZ F, V Reflux in 2N HC1 95
Chloroform at pH 9.5
BEN, MBC, TBZ F,V Methanol LLP 64-105 62
BEN, MBC, TBZ F LLE (Chloroform vs Aqueous NaCl) LLP >90 110
BEN, MBC, TBZ F ,V Acetone LLP, Normal Phase 48-86 104
BEN, MBC, TBZ F, V Acetone Extrelut and SCX SPE >80 63
MBC, TBZ Fruit Juice Dilution Oasis® MCX 74, 97 108
BEN, MBC, T-M F, V sf-c o 2 Ci sTrap 85-93 141
1 Fruit and vegetables are abbreviated as F and V, respectively.
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2.10 Methods for the Determination of Benzimidazole Residues
Early work on benzimidazole analysis was carried out using spectrometric methods 
whereas today they are analysed by a variety o f  analytical techniques. Techniques such as 
mass spectroscopy, chromatographic separations, thin layer chromatography (TLC), 
bioassays in tandem with TLC and immunochemical methods have found widespread 
application in the screening o f residues. Gas chromatography has also been used for the 
analysis o f benzimidazole fungicides in plant based matrices but has not been used 
widely for the determination o f  veterinary drugs. The most widely used procedure for the 
determination o f these veterinary drugs is liquid chromatography coupled to UV, 
fluorescence or mass spectrometry detectors.
Bioassays
There have been few applications o f  bioassays for the determination o f benzimidazoles in 
a biological matrice. Erwin et a l.100 developed a bioassay system for the determination of 
benomyl. Later Petersen and Edginton 101 developed a more sensitive assay, allowing 
detection o f benomyl and carbendazim in plant based materials. Benomyl and 
carbendazim residues were extracted and separated on a silica gel TLC plate, which was 
later sprayed with a combination o f agar and Penicillium  spores and incubated at room 
temperature for 20 h. Benomyl residues were indicated by 2 spots o f inhibited fungal 
growth. The size o f the zone o f  inhibition was related to the concentration o f  the 
fungicide. The method was 10 times more sensitive than UV detection. A multiwell 
screening assay for TBZ, ABZ, ABZ-SO, ABZ-SO2 and MBZ using the larvae o f Ascaris 
suum by Dew et al., 102 showed the method could be used to  screen for anthelmintics in 
edible tissue.
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Spectrometric methods
Pease et al., 103 determined benomyl, after conversion to 2-aminobenzimidazole, by 
fluorescent spectroscopy (Xex 285 nm and Xem 335 nm) or, after derivatisation with 
bromine, by colorimetric detection at 445 nm. The limit o f detection was less than 100 |a,g 
kg'1. The three benzimidazole fungicides, 2-aminobenzimidazole, TBZ and 2-(2-furyl)- 
benzimidazole all fluoresce naturally; however only 2-aminobenzimidazole reacts with 
bromine to produce coloured derivatives. As a result, colorimetric detection after 
bromination is a more selective method for the determination o f 2-aminobenzimidazole. 
Aharonson et al.,104 similarly determined benomyl and TBZ residues in crops by 
fluorescence spectroscopy after selective clean-up by column chromatography. MBZ and 
FLU were determined in pharmaceutical preparations by fluorescence (Xex 300 nm and 
k m  400 nm) after reaction with 0.3% hydrogen peroxide in alkaline solution by Baeyens 
et al. 105 This group showed that the assay could be applied also to  tetramisole, 
dexamisole and levamisole. A novel sorbent extraction procedure was developed by 
Capitan-Valvey et al., 69 for the determination o f TBZ in fruit. Samples were extracted 
using aqueous buffer before dilution o f  the extract in water and mixing with Sephadex G-
15 gel beads. The Sephadex gel beads were isolated by filtration and packed into a glass 
cuvette, before determination using a luminescence spectrometer. The performance o f the 
method developed by Barker et al., 106 was similar to HPLC spectrometric detection 
systems.
Thin Layer Chromatography
TBZ in citrus fruits and carbendazim in crops were determined using a polyamide plastic
1 (Y7 1 ORTLC plate coated by a fluorescent indicator by Norman et al., ' and White et al.," The 
plates were developed using a solvent o f chloroform + ethyl acetate +acetic acid and 
visualised under UV light at 254 nm.
High Performance Thin Layer Chromatography (HPTLC) was investigated by
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Corti et al., 109 for the determination o f TBZ and other residues in potatoes. Cg plates 
were used with a mobile phase o f methanol:water (10:3,v/v) and determination was 
achieved using a scanning densitometer at 248 nm. This technique was compared with 
HPLC but the latter was more sensitive. The same group later developed a method for the 
determination o f benomyl, carbendazim and TBZ in fruit110. Residues were separated on 
NH2 HPTLC plates (derivatised with polyamine) using a solvent o f  chloroform + 
cyclohexane + methanol (6 + 1 + 0.1, v/v/v) to elute carbendazim and TBZ. Residues
* * 73were detected using a scanning densitometer at 285 nm. More recently, Abjean et al., 
developed a TLC screening method for the detection o f ABZ-NH2-SO2 in liver. ABZ- 
NH2-SO2 was separated using a mobile phase o f acetonitrile + ammonium hydroxide (10 
+ 0.6, v/v) on a silica TLC plate coated with a fluorescent indicator. The method was 
used for screening purposes only, based on a negative/positive result.
Immunochemical methods
A radioimmunoassay for the determination o f OFZ in plasma where the polyclonal 
antibodies were raised in rabbits after immunisation with OFZ coupled to a polylysine 
carrier was developed by Nerenbery et al. lu Brandon et al., 24 developed a competitive 
ELISA for the determination o f TBZ in liver, using a monoclonal antibody raised in 
mouse. Haptens o f  TBZ and 5-OH-TBZ were prepared and coupled to the carrier bovine 
serum albumin (BSA) for use as immunogens. It was found that antibodies raised after 
immunisation with the conjugate prepared from TBZ were more specific to TBZ and 5- 
OH-TBZ, While antibodies raised from the conjugates prepared with 5-OH-TBZ were 
found to be less specific and showed good cross-reactivity to CAM and TBZ-NH2 . Cross­
reactivity to benzimidazoles not possessing a thiazolyl ring was also evaluated, but none 
of these residues (namely ABZ, MBZ and FBZ) showed significant cross-reactivity. 
Competitive ELISAs were developed based on the horseradish peroxidase (HRP) 
conjugate and were applied to liver samples extracted using water. This group later 
applied this ELISA for the determination o f TBZ residues in fruit, vegetables and fruit 
juices.113 It was found that fruit juice samples could simply be diluted in buffer prior to 
determination by ELISA
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Bushway etal., 1 1 4 evaluated a commercially available enzyme immunoassay tube kit for 
the determination of TBZ residues in processed/unprocessed fruit-vegetables. The 
polyclonal antibody used in the assay was raised against benomyl-carbendazim, but the 
antibody demonstrated sufficient cross-reactivity toward TBZ for its sensitive detection 
in food. Newsome et al., 115 developed ELIS As for the determination of benomyl and 
TBZ in crops, using polyclonal antibodies raised in rabbits. Immunogens were prepared 
by coupling the carrier human serum albumin (HS A) to the succinamide haptens of TBZ 
and carbendazim (the degradant of benomyl), and were used in rabbits for raising 
antisera. The cross-reactivity of the antibodies was evaluated for different benzimidazole 
residues but was shown only to inhibit the ELISAs at higher concentration levels.
Brandon et al., 110 produced a mouse monoclonal antibody that showed good cross­
reactivity for 11 benzimidazole residues including ABZ, FBZ, OXI, MBZ, FLU, 
carbendazim and some metabolites. The antibody did not show cross reactivity to 
thiazolylbenzimidazoles (TBZ, CAM and 5-OH-TBZ). Antibodies were raised in mouse 
using conjugates prepared after coupling the succinamide hapten of ABZ to BSA carrier 
protein. This group developed a competitive ELISA HRP for the determination of 
benzimidazole residues in bovine liver samples after aqueous extraction. This group later 
developed a method for the determination of FBZ residues in milk using this ELISA step
51. Milk samples were simply diluted in PBS-Tween-BSA before determination by 
ELISA.
Abad et al., 1 1 7 produced monoclonal antibodies raised against a TBZ-ovalalbumin 
conjugate. This group indicated that this was a very novel conjugate because it was 
prepared from a hapten functionalised at the nitrogen atom of the 1-position of the TBZ 
structure. This group developed an indirect ELISA based on HRP for the determination 
of TBZ residues in fruit juices. Moran et al., 1 1 8  produced mouse monoclonal antibodies 
raised against the novel immunogen 5-benzimidazole-carboxylic acid conjugated to the 
lipopeptide Par^Cyst-Tn. The antibodies were produced for the development of ELISAs
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for the determination of protein bound residues of TBZ in tissue, although no applications 
were described.
Liquid Chromatographic separations
The development of chromatography methods for a range of benzimidazoles is difficult 
due to the wide range of polarities within the group and between groups of the 
benzimidazole drugs. The majority o f LC methods for the determination of 
benzimidazoles have been developed using reverse phase systems and ion exchange 
systems. Other types of LC method columns that have been used but to a much lesser 
extent are silica or cation exchange. A normal phase separation was developed for 
separation of TCB, TCB-SO, TCB-SO2  and OFZ on a silica column by Alvinere e ta l,  57 
The determination of MBZ in plasma using a silica column was used by Karlaganis et al. 
8 7  Cation exchange columns were used by Kirkland et al., 2 6  for the determination of 
benomyl residues in plants. Arenas et al., 9 determined TBZ and 5-OH TBZ in milk. The 
use of polymeric columns crops when compared with silica by Hiemstra et a l, 6 4  for the 
analysis of TBZ and carbendazim residues in crops gave better peak shape and a longer 
column lifetime than the silica based columns.
Isocratic separations of benzimidazoles have given rise to long run times and only small 
numbers of residues can be determined due to the wide range of polarity o f these drugs. 
An isocratic separation of eight benzimidazoles on a Ci8 column in 14 min gave poor 
resolution for the substances. 5 2 The separation of FBZ and TCB metabolites was 
accomplished in 12 minutes but a runtime of 40 minutes was necessary if included TCB.
17  Wilson et al,. 11 and Long et al., 18 developed a multi-residue LC methods for the 
determination of 7 and 8  benzimidazoles in less than 13 and 35 minutes. Gradient elution 
of the residues allows for the inclusion of more residues and improved resolution. Studies 
were carried out comparing isocratic and gradient systems for the determination of 5 
benzimidazoles in plasma. 8 9  Sorenson et al., 50 developed a gradient separation of 8  
benzimidazoles in a 40 minute run with an added equilibration time. A Cs column was 
used in the separation of OFZ and its 9 metabolites with a binary gradient in less that 35
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minutes, 2 2 this column was also used in the separation of levamisole (LEV) and 8
» » • 75benzimidazoles with gradient elution.
A base deactivated Ci8 column was used to separate 10 benzimidazoles with a binary 
gradient; all the residues were separated in less than 16 min except OXI and FLU. 33 
Rouan et al., 9 2  separated TCB, TCB-SO, TCB-SO2  and 5 ,6 -dihydro-ll-oxo-llH-dibenz 
[b,e] aze-pine-5-carboxamide which was used as internal standard on a short Cig column 
(33 x 4 . 6  mm) in less than 10 min with detection by UV. Narrow bore columns (2.1 mm) 
have been evaluated (2.1 mm) for the determination of TBZ, MBZ, ABZ and FBZ 
residues. 119 Results showed that the peak heights for the analytes increased by a factor of
5 using narrow bore columns compared to columns of a standard diameter (4.6 mm). 
Isocratic separations were developed by Kan et a l, 12 and Hajee et al., 13 on intermediate 
diameter (3 mm) columns for FLU and MBZ metabolites.
Domany et al.,35 developed an isocratic separation of 10 benzimidazoles on a narrow bore 
(2.1 mm) Cig column. Shaikh et al., 2 9  determined ABZ and its 3 major metabolites using
2  separate isocratic systems and found that the metabolites could be eluted in less than 2 0  
mins. An Xterra Cig column using gradient elution to separate 14 benzimidazole residues 
was carried out by Danaher et al. 120
Ion pair chromatography was investigated for the determination of TCB-SO and TCB- 
SO2 in plasma and urine. 9 4  The optimum mobile phase consisted of 0.05 M phosphate 
buffer, pH 7:acetonitrile (55:45,v/v) containing 0.001 M sodium decanesulphonate when 
the effects of pH, organic modifier content and chain length of sodium alkyl sulphonate 
ion pair reagent were evaluated.
The separation of FBZ and TBZ, ABZ and OXI by ion pairing chromatography was 
achieved using sodium 1 - octane sulphonate with adjustment of mobile phase buffer to 
pH 3 and gradient elution using buffer, acetonitrile and water. 121
The LC method was also used for LEV but with adjustment of mobile phase buffer 
solution to pH 3 and some ion pairing reagent. Gradient elution of LEV is accomplished 
using this buffer, methanol and water. 121 Other ion pairing studies investigated the effect 
of ion-pair reagents and pH on the retention time and peak height of FBZ and OFZ. 19 
These studies showed that decreasing the pH to 2.2 shortened the retention time of FBZ
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sharply and OFZ slightly. Over pH of 3.7 to 6.5 no change in retention time was observed 
with or without the addition of ion pair reagents. The addition of octane sulphonate anion 
increased retention time and tetrabutyl ammonium cation decreased retention time. The 
peak shape for FBZ was poor over the range of pH investigated in the absence of ion pair 
reagents, but addition of ion pair reagents greatly enhances peak shape at pH 2.2 even at 
the longer retention times. This group developed separations for FBZ residues using ion- 
pair chromatography. A multi-residue method was later developed for the separation of
10 benzimidazoles in milk in less than 30 min, using isocratic mobile phase containing
0.01 M pentane sulphonate and 0.5% triethylamine at pH 3.5.
In the area of LC-MS, most groups carry out separations using shorter columns (less than 
150 mm in length). These columns require shorter equilibrium times during gradient 
chromatography because of the lower column volume, which increases LC-MS 
throughput. Blanchflower et al., 2 5 developed an isocratic separation of FBZ and OFZ, 
finding it gave more reproducible MS results than gradient separation. Cannavan et al . , 3 7  
developed a gradient method for the separation of TBZ and 5-OH-TBZ, using a mobile 
phase consisting of acetonitrile and 0 .1M ammonium acetate. Balizs et al . , 3 0  developed a 
method for the determination of 15 benzimidazole residues by LC-MS/MS with a 
gradient separation carried out on a narrow bore column (2.1 mm). The mobile phase 
flow rate ranged between 0.04 and 0.2 fil min ' 1 depending on the ionisation interface 
used. Substances were eluted from the column in less than 6  min but were not resolved. It 
was claimed that, because individual benzimidazoles have different molecular masses 
chromatographic separation was unnecessary. De Ruyck et al., 3 9  developed an LC- 
MS/MS method for the determination of benzimidazole residues using a column of 
similar dimensions to Balizs et a l, 3 0  for the determination of FLU, FLU-HMET and 
FLU-RMET in eggs and muscle tissue. A method was later developed by the same group 
for the determination of levamisole and 7 benzimidazole residues in milk. 122
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Liquid chromatography detection systems
A number of groups have developed LC methods for the determination of benzimidazoles 
in milk, tissue and crops using UV, fluorescence and mass spectrometric detection (Table 
2.5). Benzimidazoles possess a strong UV chromophore and may be determined using 
LC-UV. However, it has been observed that certain benzimidazoles (namely ABZ, TBZ, 
CAM and their metabolites) possess naturally fluorescing chromophores, making them 
suitable for detection by LC fluorescence. Fluorescence is more sensitive and selective, 
but does not have the same range of applicability as UV detection. As a result, UV is the 
most widely used system for the detection o f benzimidazole residues in extracts of 
biological matrices. LC with MS detection is becoming more widely used for the 
determination of benzimidazole residues in biological matrices, offering the capability of 
combined quantitative-confirmatory analysis.
Table 2.5: Summary of detection methods used in LC for the determination of
benzimidazoles
Detector Derivitisation agent Ref
UV - 52,13,12,93,18,36,123,120,42,48,50
UV Peracetic acid 40
UV, MS P-nitrobenzyl bromide in 
presence of potassium 
carbonate
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MS - 25,37,30,21,126,39,122,39,127,128,99,78,129
FL - 9,8,29
UV-FL - 11,74,43,80,64,125
EC “ 86,126
Note: UV wavelengths ranged from 220 nm -318 nm
Detection by UV
Bogan et al., 52 developed a method for the determination of eight benzimidazoles in 
body fluids. MBZ residues were determined in plasma at 313 nm 85 and eel muscle at 254 
nm. 2 8  Karlanganis et al., 8 7  determined MBZ in plasma demonstrating that there was less 
interference at a wavelength of 307 nm compared to 247 nm. Hajee et al.,13 determined 
MBZ, MBZ-NH2 and MBZ-OH in eel muscle at 289 nm. Kan et al., 12 developed a
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method for the determination of FLU and its metabolites in eggs using a wavelength of 
250 nm. Chiap et al. , 9 3  determined ABZ, ABZ-SO and ABZ-SO2  in plasma at 295 nm.
UV photodiode array (PDA) detection has been used to determine 7 benzimidazole 
residues by Long et al. 18 This mode o f detection was investigated as a confirmatory tool, 
but differences in spectra at lower and higher concentration levels were found and the 
PDA detector was not suitable for confirmatory analysis at concentrations lower that 5 ng 
on column. This group also developed methodology for the determination of these 
residues in milk and animal tissue. Neri et al.,36 determined 8  benzimidazoles residues in
123 _ 120tissue and De Buyanski et al., determined TBZ and LEV in tissue. Danaher et al., 
developed a method for the determination of 14 benzimidazole residues in liver tissue. 
FBZ, OFZ, TBZ and 5-OH TBZ were monitored similarly using the dual wavelength 
approach in milk. 4 2  TBZ and 5-OH TBZ were monitored at 318 nm whereas FBZ and 
OFZ residues were monitored at 298 nm. Similarly, Sorensen et a / . , 4 8  determined TBZ 
and levamisole residues in milk. This group also developed a method for the 
determination of 8  other benzimidazoles in milk (ABZ, ABZ-SO, ABZ-SO2 , OFZ, 0X3, 
MBZ, FBZ and FEB) . 50
Most derivatisation carried out in the determination of benzimidazoles has been for GC 
applications and only two papers on derivatisation for LC have been published. The 
conversion of FBZ and OFZ residues to FBZ-SO2  was determined and accomplished by 
Capece et al. 4 0  Residues were derivatised by reaction with peracetic acid and purified by 
liquid partitioning prior to determination by LC-UV. The presence of TBZ residues was 
confirmed by derivatising with p-nitrobenzyl bromide in the presence of potassium 
carbonate (110 °C, 3 h) with LC-UV detection. 5 9 This derivatisation procedure was used 
to provide confirmatory analysis of TBZ residues in suspect samples and for 
quantisation.
Fluorescence detection
The determination of TBZ and 5-OH TBZ in milk can be carried out using fluorescence 
detection with XeX 305 and 318 nm and 380 and 515 nm . 9  In order to achieve a more 
sensitive detection, two chromatographic runs were required. It was determined that in a
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single run these residues could be analysed at their optimum wavelength using a dual 
wavelength monochromator. Markus et al., 8 used fluorescence detection for the 
determination of ABZ-NH2 -SO2 in bovine liver (kex 300 nm and Xem 320 nm). Shaikh et 
a l,29 determined ABZ, ABZ-SO, ABZ-S02 and ABZ-NH2-S02 and three metabolites in 
fish muscle using fluorescence detection with kex 290 nm and Aem 330 nm.
UV and fluorescence detection in series
There are numerous advantages o f coupling UV and fluorescent detectors in series such 
as, an improved sample throughput and reproducibility, increased recovery and provide 
selectivity. It was determined that extracts needed further purification on a C2  SPE 
cartridge to remove matrix components that interfere in the UV detection of 
2 NH2 ABZSO2  and 5-OH TBZ. 11 However, the influence of this matrix interference may 
be removed using fluorescence detection. The determination of ABZ-S02, OFZ, CAM 
and MBZ using fluorescence and UV detectors in series was accomplished by Farrington 
et al.74 Constantinou et al.,43 determined 5 benzimidazole residues in milk using a similar 
approach. TBZ and ABZ residues were monitored using fluorescence (Xex 312 nm, A,em 
355 nm) while other residues were detected at 290 nm.
Fluorescence detection and PDA detection was used to monitor for TBZ and MBZ in 
tissue by Le Boulaire et al.,so and it was found that fluorescence detection was 22 times 
more sensitive than PDA for TBZ. The determination of carbendazim residues in crops 
using UV (280 nm) and fluorescence (5iex 235 nm and Xem 280 nm) was performed and 
confirmation was made by comparison of relative UV spectra and fluorescent responses 
of standards. 6 4  TBZ, carbendazim and thiophanate-methyl were determined by UV at 285 
nm while TBZ and carbendazim were determined also by LC with fluorescence detection 
(kex 305 nm, Xem 345 and A,ex 282 nm, Xem 307 nm respectively) . 1 2 5 It was determined 
that matrix interferences were less with fluorescence detection and that TBZ detection 
was enhanced by this mode of detection. Detection of carbendazim was similar with both 
detectors.
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Electrochemical detection
The determination of MBZ and MBZ-OH residues in biological fluids by electrochemical 
detection was accomplished by Oosterhuis et al.,8 6 with a carbon paste electrode and a 
saturated calomel electrode as the working and reference electrode respectively. 
Flubendazole acted as internal standard for MBZ since has similar oxidative properties to 
MBZ. A method for the determination of a metabolite of carbendazim in urine by LC 
with electrochemical detection was developed by Leenheers et al.126 
*
Mass spectrometry detection
Mass spectrometry detection has been widely used in the determination of 
benzimidazoles. LC-MS with a thermospray interface has been used for the determination 
of FBZ and OFZ residues 25 and TBZ and TBZ-OH residues.3 7  FBZ, OFZ, TBZ and 5- 
OH TBZ were determined by selective ion monitoring as their [M+H+] ions. The 
presence of TBZ and 5-OH TBZ was confirmed using LC-MS with atmospheric chemical 
ionisation (APCI) interface. LC-MS/MS has been investigated using ion-spray and turbo­
spray interfaces in the positive mode by Baliz et al.30 The cross talk effects were 
evaluated and were approximately 10%; however, a 20% effect was observed for FBZ- 
SO2  which was caused by OFZ.
The use of LC-MS/MS with electrospray ionisation interface (ESI) was evaluated by 
Takeba et al.,21 monitoring the compounds as their [M-M]' ions. Young et al.,126 
determined TBZ and carbendazim residues in fruit juices using LC-MS with ESI in the 
positive mode with [M+H]+ ions. Ruyck et al.,39 developed an LC-MS/MS-ESI method 
for the determination of FLU residues. Residues were monitored as their [M+H]+ ions 
and confirmed using multiple reaction monitoring (MRM). The same group later 
developed a multi-residue method based on the LC-MS-MS-ESI for the determination of
8  anthelmintic drugs (LEV, TBZ, OFZ, FBZ, OXI, ABZ FEB and TCB) in milk. 122  
Residues were monitored as their [M+H]+ ions and few additional daughter peaks were
58
generated using multiple reaction monitoring (MRM) for quantitative and confirmatory 
purposes. The method, however, was not applicable for netobimin and ABZ-SO. The 
same group also reported the optimisation of quantitative confirmatory assay by LC- 
MS/MS for the determination of MBZ, MBZ-OH and MBZ-NH2  in sheep muscle, liver, 
kidney, liver and back fat. Atmospheric pressure electrospray ionisation in the positive 
ion mode (ESI*) was applied. 3 9  Edder e ta l.,127 analysed ABZ, ABZ-SO, ABZ-SO2 , TBZ, 
MBZ, FLU, OFZ, FBZ, LEV, TCB, OXI and 5-OH TBZ in meat, liver and fish matrices 
by LCMS/MS using positive electrospray and MRM mode.
The effect of different calibration procedures for the determination of benzimidazole 
fungicides in plant matrices was evaluated by Zrostlikova et al . 1 28 The calibrations were 
carried out using standards in solvent, spiked control samples and a technique called 
echo-peak internal calibration. The most accurate results were achieved using spiked 
controls. Curves that were produced from standards in organic solvent showed a tendency 
to over or under estimate the result due to either ion suppression or matrix enhancement. 
The echo peak method gave accurate results for 6  out of the 8  benzimidazoles. This group 
developed a method for the determination of fungicides in fruit juices using LC-MS 
systems with an ESI interface in the positive ion mode and an ion trap detector "  The 
recovery of FLU, FLU-HMET and FLU-RMET in eggs and poultry muscle using LC­
MS/MS was also developed. 7 8  The compounds were measured by MS/MS transition of 
the molecular ion of the most abundant daughter ion. The same group also evaluated the 
disposition of residues of flubendazole in turkeys and guinea fowl. Atmospheric pressure 
electrospray ionisation in the positive mode (ES+) was applied. The compounds were 
detected by tandem mass spectroscopy using multiple reaction monitoring (MRM) 
functions of the two transitions. 129
Gas chromatography
GC determination of benzimidazoles is difficult because of the basic nature and low 
volatility o f these substances. However, TBZ and TCB are sufficiently volatile to allow 
their determination by GC without derivatisation. The main applications o f GC methods 
have been in determining benzimidazole fungicides in crops. Some researchers have
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found GC coupled to mass spectrometery useful for confirmation of the presence of 
benzimidazole residues, however, GC-MS procedures usually require derivatisation (see 
Table 2.6) of residues to induce volatility and allow the generation of suitable MS spectra 
for confirmatory analysis and, as a result, have been largely replaced by LC-MS/MS. 
There has been little work reported on the analysis of benzimidazoles by GC due to their 
low volatility. However, TBZ and TCB are sufficiently volatile to be determined by GC 
with nitrogen phosphorus detection (NPD) and electron capture detection (ECD) without 
derivatisation. NPD was found to be more sensitive than ECD . 6 7  The separation of TBZ 
was carried out on a fused silica capillary column (25 m x 0.2 mm) by Oishi et al.,9* 
without derivatisation by GC-NPD. Polar amino or hydroxyl groups are reacted with 
alkylating/acylating reagents in the derivatisation of benzimidazoles for GC. Some 
groups also hydrolyse the carbamate functional group to form an amino functionality 
prior to reaction with alkyl/acylating reagent. Alternatively, residues may be derivatised 
directly without hydrolysis. Different funct inal groups form simple methyl esters to 
more complex pentafluorobenzyl groups. TBZ residues were derivatised with 
trimethylsilyl acetamide for analysis by GC-MS 1 3 0 and this method of derivatisation was 
also used in the determination o f CAM and three urinary metabolites. 1 3 1 ,1 3 2
Table 2.6: Summary of derivatisation reagents and detectors used in GC in the
determination of benzimidazoles
Detector Derivitisation agent Ref
NPD, ECD - 67
NPD - 98
NPD Acetic anhydride 136
FID Dimethylfonnamide and dinethyl acetate 135
ECD, MS Pentafluorobenzyl-bromide 68,137,138,139
ECD,NPD, MS Pentailuorobenzyl-bromide and methyl 
iodide
MS Trimethylsilyl acetamide 130,131,132,133,134
MS, HRMS Pentafluorobenzyl-bromide and 
triethylammonium hydroxide in methanol 
Hydrolysis with 2 N HCL followed by 
reaction with N-methyl-N- (t- 
butyldimethylsilyl) trifluoroacetamide 
(MTBSTFA)
140
An on-column methylation procedure for the confirmation of CAM residues by GC-MS- 
EI (electron impact mass spectrometry) in selective ion monitoring was developed by
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VandenHeuvel et al. 133 This group later applied this method for the determination of TBZ 
and 5-OHTBZ. 1 3 4  A column with a polysulfone stationary phase was used because of 
background bleed and its adsorption characteristics were the most suitable of all columns 
evaluated. Methyl derivatives of TBZ were determined by GC with flame ionisation 
detection (FID) by reacting with dimethylformamide and dimethyl acetate in acetonitrile 
( 1 2 0  °C, 40 min) . 135
TBZ was acylated by reaction with pentafluorobenzyl-bromide PFB-Br (120 °C, 30 min) 
before analysis by GC-ECD and confirmation by GC-MS-EI in full scan mode.6 8  
Benomyl residues were derivatised with acetic anhydride (100 °C, 30 min) by capillary 
GC-NPD by Physalo et al. 1 3 6  This technique was evaluated but found to be 10 times less 
sensitive. Bardalaye et al.,137 later modified this procedure and applied it to the 
determination of TBZ residues. TBZ and cabendazim were determined in fru using GC- 
ECD after derivatisation with PFB-BR . 1 3 8 This method was applied to the analysis of 
benomyl also, which is converted to carbendazim during the analysis. A confirmatory 
method was developed by this group using GC-MS-EI. This method was modified by 
Cline et al.,139 for the determination of carbendazim in fruit treated with benomyl.
A range of derivatisation procedures were evaluated for GC determination of 8  
benzimidazoles in animal tissue for substances with amino groups. It was discovered that 
acylation with PFB-BR and methylation with methyl iodide were suitable and were 
determined by GC-ECD and GC-NPD but derivatives were unstable due to the extreme 
temperatures used during injection. 2 3  GC-MS El and GC-MSPICI (+ ion chemical 
ionisation) gave useful structural information and positive ion chemical ionisation 
provided a number of ions suitable for confirmatory analysis. Electron impact spectra of 
methyl derivatives produced fewer ions than the pentafluorobenzyl derivatives. Negative 
ion chemical ionisation was also evaluated and was shown to produce 1 or 2  ions for 
most residues. GC-MS El in SIM mode was used for confirmation of benzimidazole 
residues in tissue and residues were derivatised firstly involving hydrolysis with 2 N HCL 
( 1 1 0  °C, 1 h) to convert the carbamate group to an amino functionality. Hydrolysed 
residues were then reacted with N-methyl-N- (t-butyldimethylsilyl) trifluoroacetamide 
(MTBSTFA), converting the primary and secondary amines to silyl amine. The phenol 
functional group of 5-OH TBZ was converted to a silyl ether and this method used a flash
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alkylation procedure, in the GC injection port (260 °C), after injection for suitable 
applicability to CAM. This technique was used for the confirmation of ABZ-NH2-SO2  
based on this derivatisation procedure with determination by GC-MS-EI.
The determination of TBZ and ABZ residues in tissue using capillary GC with high 
resolution mass spectrometry (HRMS) after derivatisation with PFB-BR was 
developed. 1 4 0 This procedure was later used by Anastassiades et al.,141 for the 
confirmation of benzimidazole fungicides in crops after SFE. The determination of TBZ 
in fruit juices using capillary GC-NPD without derivatisation was carried out by Oishi et 
a i9S
Jacob et al.,130 determined TBZ residues by GC-MS after derivatisation with bis 
trimethylsilyl acetamide. This group later applied the same method to the determination 
of CAM and three urinary metabolites. *3 1 ,1 3 2  VandenHeuvel et a/.,13j developed an on- 
column methylation procedure for the confirmation of CAM residues by GC-MS-EI 
(electron impact mass spectrometry) in selective ion monitoring mode (SIM). Residues 
were dissolved in 0.125 M triethylammonium hydroxide in methanol just prior to 
injection into the GC-MS system. This method was later applied for the determination of 
TBZ and 5-OH-TBZ. 1 3 4  A column with a polysulfone stationary phase was employed 
because its background bleed and adsorption characteristics were more desirable than 
others tested. Tanaka and Fujimoto 135 determined the methyl derivative of TBZ by GC 
with flame ionisation detection (FID). Derivatives were prepared by reacting with 
dimethylformamide (DMF) and dimethyl acetate in acetonitrile (120°C, 40 min). The 
procedure was used to determine TBZ residues in fruit with a limit of detection of 100 jig 
kg"1. Nose et a / . , 6 8  acylated TBZ by reaction with pentafluorobenzyl-bromide PFB-Br 
(120°C, 30 min) before determination by GC-ECD and confirmation by GC-MS-EI in 
full scan mode. Physalo et al.,136 derivatised benomyl residues with acetic anhydride 
(100°C, 30 min) before determination by capillary GC-NPD. GC-ECD was also evaluated 
for determining residues but was 10 times less sensitive. Bardalaye et al.,137 later 
modified this procedure and applied it to the determination of TBZ in fruits. Tjan et al.,139 
determined TBZ and carbendazim in fruit using GC-ECD after derivatisation with PFB- 
Br. The procedure was also applicable to benomyl, which is converted to carbendazim
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during the extraction and clean-up procedure. A confirmatory procedure was also 
developed by Tjan et a / . , 1 3 8  using GC-MS-EI. Cline et a / . , 1 39 later modified this 
procedure and applied it to the determination of carbendazim in fruit treated with 
benomyl.
Marti et al.,23 developed GC methods for the determination of eight benzimidazoles in 
animal tissue, evaluating a range of derivatisation procedures used for substances with 
amino functional groups. They found that acylation with PFB-Br and methylation with 
methyl iodide were suitable. Derivatised extracts were determined by GC-NPD and GC- 
ECD; GC-NPD chromatograms were found to show less matrix interference. Derivatives 
were found to decompose during injection and chromatography because of the high 
temperature used, making quantitative determination impossible. However, GC-MS-EI 
and GC-MS-PICI (positive ion chemical ionisation) provided useful structural 
information. Electron impact spectra of the methyl derivatives produced fewer ions than 
the pentafluorobenzyl derivatives. Similarly, positive ion chemical ionisation provided a 
number of ions suitable for confirmatory analysis, while negative ion chemical ionisation 
produced only one or two ions for most residues.
Wilson et al.,11 used capillary GC-MS-EI in SIM mode for the confirmation of 
benzimidazole residues in tissue. Residues were derivatised in a two-step procedure, 
firstly involving hydrolysis with 2N HC1 (110°C, 1 h) to convert the carbamate group to 
an amino functionality. Hydrolysed residues were reacted with N-methyl-N-(t- 
butyldimethylsilyl)trifluoroacetamide (MTBSTFA), converting the primary and 
secondary amines to a silyl amine. In the case of 5-OH-TBZ, the phenol functional group 
was converted to a silyl ether. The method was not applicable to CAM, which was 
alternatively derivatised using flash alkylation in the GC injection port (260°C) after 
injection in triethylammonium hydroxide in methanol. Markus et al.,140 developed a 
method for the confirmation o f ABZ-NH2-SO2  in tissue based on this derivatisation 
procedure, with determination by GC-MS-EI.
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2.11 Conclusions
The benzimidazole drugs as a whole are a complicated group to develop a single 
surveillance method. The common methodology involves liquid extraction at a high pH 
followed by liquid partitioning alone or in tandem with solid phase extraction. This 
methodology allows for the broadest number of residues to be included in a multi-residue 
method when used in conjunction with LC-UV and LC-MS/MS. Balizs has developed the 
most complete method, allowing the determination of 15 benzimidazole residues in milk 
and liver with detection by LC-MS/MS. 3 0  The methods developed by Roudaut et al , , 33 
Domany et al.?5, Fletouris et al.,44, Danaher et al.,120 and Edder et al.,127 allow 10 to 13 
residues to be monitored.
To date, however, there is no method available that can screen for all the benzimidazole 
metabolites. The development of such a method could be simplified by a single step 
derivatisation technique. A method by Capece et al.,40 used peracetic acid, which 
converted benzimidazoles in the sulphide/sulphoxide form to the sulphone. Extension of 
the number of benzimidazoles that could be derivatised should be investigated in future 
work.
Another approach would be to target the most persistant or prevalent members of each 
licensed group as shown in depletion tissue studies. More depletion work needs to be 
carried out in milk as work on this tissue is not as comprehensive as the other tissues. 
Also there appears to be no depletion data available in milk for OXI and CAM. Adopting 
either o f these approaches reduces the number of residues hence simplifying analysis and 
could allow for the surveillance of all the groups licensed in the MRL listings.
There is also a lack of multi-residue methods, which target the TCB, FLU and MBZ 
licensed groups in conjunction with other residues. Since these drugs are widely used in 
veterinary medicine there is a need to develop such multi-residue methods.
There also appears to be limited depletion data on benzimidazoles in fish even though 
there are single residue methods for ABZ 29, MBZ 28’31’13, FBZ 2 0  and a multi-residue 
method developed by Edder et al.,127 for the determination of ABZ, ABZ-S02, ABZ-SO,
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TBZ, MBZ, FLU, OFZ, FBZ, LEV, TCB and OXI by LC-MS/MS. Potential 
environmental contamination may arise, e.g., from commercial fish fanning where these 
compounds are given as feed additives, can accumulate in sediments and may be ingested 
by marine species in the vicinity of farms. Since substantial amounts of medicated feed is 
not eaten and can pass through the holding cages, it can be absorbed by marine flora and 
fauna.
Another consideration is, drugs used on farms for veterinary purposes will end up 
eventually in manure. Manure is eventually dispersed in fields and the mobility o f drugs 
and drug metabolites in the soil system predicts if  the drugs will be a threat to ground 
water.
The presence o f drug residues therefore may pose a health risk, both directly and 
indirectly so further study is required on the environmental effects of administration of 
not only benzimidazole drugs but all veterinary drugs used in animal husbandry.
Since the benzimidazole class is one of the most widely used classes of anthelmintic 
drugs it is important to continue with the development of screening, validation or 
confirmatory methods in the areas where shortfalls have been discussed above. 
Fundamental to this work is the development of a multi-residue method capable of 
screening for the seven benzimidazole licensed groups and subsequent availability o f this 
method for implementation into the National Monitoring Plan in Ireland. Bovine liver 
was selected as a model matrix in which method development studies were based. LC- 
UV methodology was chosen over LC-MS/MS technology since this technique is more 
amenable to residues laboratories due to the high costs involved in LC-MS/MS analysis. 
A carbonate buffer/ethyl acetate extraction system employed by Wilson et al., 11 and 
generally used in the extraction of benzimidazoles from liver was used in method 
development. The introduction of automated solid phase extraction using the ASPEC 
XL4 for benzimidazole metabolites identified as the most likely to occur as a result of 
tissue depletion studies provides a faster more comprehensive screening method. This 
method has the potential to improve the analysis of the licensed benzimidazole drugs 
beyond current analysis.
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The main aims of residue science are to develop methodology that is accurate, sensitive 
and has a high throughput. Therefore identification of consignments of contaminated 
animal products can be made quickly and decisions regarding isolation and disposal of 
these products can be made. This eliminates the hazards associated with drug residues 
entering the food chain and methods also provide a legal basis for prosecuting individuals 
who use veterinary products without adhering to EU legislation. There is also an 
obligation on each member state in the EU to put methods in place to monitor for 
benzimidazole residues. For these reasons, the development of a multi-residue method 
capable of monitoring for benzimidazole drugs is extremely important.
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Review of current methodology for the determination 
of malachite green and crystal violet residues
Chapter 2: Section C
78
Malachite green (MG) is a synthetic triphenylmethane dye. This compound has been 
used as a topical fungicide and antiprotozoal agent in salmon farming throughout the 
world for just over 60 years. Few known chemicals rival its effectiveness in treating 
external infections o f fish and fish eggs by fungi o f the genus Saprolegnia and by the 
protozoan parasite Ichthyophthirius multifiliis} The occurrence o f  residues o f MG is a 
universal problem. Currently monitoring is governed by national surveillance schemes 
established under Council Directive 96/23/EC. Since 1 st January 2000, the 
administration to food producing animals o f  veterinary medicinal products containing 
pharmacologically active substances which are not listed in Annex I or Annex II is 
prohibited. MG is not registered as a veterinary drug for use in food fish. 
Leucomalachite green (LMG) is the prevalent metabolite o f MG and persists for a long 
time. LMG is stored in fat, and thus its elimination rate from fish muscle is strongly 
dependent on the fat content. Residues o f  MG and LMG have been reported in fish 
tissues, as well as in eggs and fry. Even though the use o f MG in fish culture is not 
allowed under current European Union regulations, residues o f  MG and LMG in fish 
muscles are still being found in the residue monitoring schemes performed by EU 
Member States (EC Rapid Alerts 2003, 2004, 2005,2006). Studies carried out by Culp 
et al., 2 reports in general that LMG treatment resulted in a greater number o f toxic 
effects and that the effects had greater severity. The presence o f N-demethylated and N- 
oxidised M G and LMG metabolites including primary arylamines, was detected in the 
livers o f treated rats. This suggested that both compounds were metabolised in a similar 
manner to carcinogenic aromatic amines. Data on the formation o f  DNA adducts showed 
that DNA adduct increased with increasing dose o f each compound. As this process 
occurs in vivo, studies by this group found it was impossible to  produce adducts in vitro. 
Therefore a more complete evaluation o f the mutagenicity and carcinogenicity in 
relation to DNA adduct formation in rats fed M G was carried out. This study showed 
that the DNA adduct formed in the livers o f  rats fed LMG had little mutagenic or 
carcinogenic consequence.3 W ork carried out by Bose et al.,4 studying the ability o f MG 
to cause DNA damage, cell cycle arrest, apoptosis and possible roles o f extracellular 
regulated kinases (ERKs), Jun-N-terminal kinases (JNK) and p38 kinases (a,P,y). The
2.13 Introduction
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study reports that MG causes DNA damage, induces G2/M cell cycle arrest, apoptosis 
and causes elevated phosphorylation o f  ERK1 and JNK1 and no change in the 
phosphorylation o f p38 kinase. A study by Stammati et al.,5 was undertaken to ascertain 
the cytoxicity o f MG and LMG using two distinct human cell lines. The first the HEp-2 
cell line and the second is the Caco-2 cell line which are already used in food safety 
assessment. M G had a dose dependent toxic effect on Hep-2-cells. On the contary LMG 
gives only slight viability inhibition at the highest concentration tested. Increased signs 
o f cytoxicity were found when Caco-2-cells were exposed to MG. By contrast no signs 
o f cytotoxicity were ever noticed following cells exposure to LMG. LMG has also been 
shown to inhibit thyroid peroxidase, which is the enyme that affects the synthesis of 
thyroid hormone. 6 Other studies have shown that toxicity has been observed in some 
mammals, including organ damage, mutagenic, carcinogenic and developmental 
abnormalities. However, despite the large amount o f  data on its toxic effects residues are 
still being found worldwide. Toxicity is difficult to evaluate and to compare in different 
species o f fish because they are influenced by various factors such as temperature, pH, 
water hardness and dissolved oxygen content o f the water. Histopathological studies 
have revealed that MG causes detrimental effects in liver, gill, kidney, intestine, gonads 
and pituitary gonadotropic cells. 7
MG has been used in aquaculture worldwide for the treatment o f parasitic and fungal 
infections in fish and shellfish. Other dyes (such as crystal violet (CV)) exhibit similar 
antimicrobial properties and are widely marketed for the treatment o f external infections 
in ornamental fish. None o f these compounds are regulated for use in food fish 
production. M G is the primary focus o f this review due to its toxicological properties and 
long history o f use in aquaculture. However upon review of the literature for this 
contaminant it was noted that there is limited data available on the use o f  CV in fish. This 
is probably mainly due to the lack o f analytical methodology available to determine this 
compound. There is a high probability that there is illegal use o f this dye in domestic and 
foreign aquaculture and as a result o f limited methodology there is not sufficient 
surveillance. Currently in Ireland there is no method implemented into the National 
Monitoring Plan for this compound and its metabolite leucocrystal violet (LCV). CV is a 
triphenylmethane dye but which has found use as a feed additive to inhibit mould and
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fungal growth in poultry feed before 1990. 8 The metabolic profile for CV in mice, rat, 
hamster, guinea pig and chicken was the same in all animal species with the reduction of 
CV to LCV 10’ 11 Chicken detoxification o f CV resulted in several demethylated 
metabolites in liver, thigh and breast muscle.9 The fungicidal properties o f this dye make 
it useful in treating infections in a variety o f animal species. The therapeutic applications 
o f dyes is well known but their use in aquaculture is highly restricted because of 
toxicological considerations. Therefore, the need arises to develop a multi-residue 
method to evaluate other dyes.
Each o f these stages will be discussed with specific reference to the determination of MG 
and CV residues.
This review focuses on the main stages o f a residue detection method; namely,
Sample extraction procedures 
Clean-up techniques 
Methods fo r  determination
2.14 Sample Extraction Procedures
Allen et al., 12 discovered that upon routine treatment o f ethyl alcohol:formalin:acetic 
acid (85,10,5,v/v/v) to  preserve fish, any fish exposed to MG residues would develop a 
bluish colour when this treatment was performed. This group exploited this sample pre­
treatment step by measurement o f this colour at the determination step. The determination 
was carried out using colorimetry with the measurement o f absorbance o f the sample 
extracts at 615 nm. The tissues are normally first homogenised, and then the residues are 
extracted using liquid extraction of the tissue at a low pH with organic solvent usually 
around pH 3-4 with acetonitrile. Scherpenisse el al., 13 used McIIvaine buffer at pH 
3:acetonitrile (1:6,v/v), para-toluenesulfonic acid, N,N,N’,N’-tetramethyl-l ,4-
phenyl enediamine dihydrochloride in the primary extraction o f MG and LMG from 
pangasius, rainbow trout, salmon, tilapia and victoria perch tissue. The re-extraction of 
the sample pellet of each species was carried out with the following extraction solvent, 
McIIIvain buffer at pH 6:acetonitrile (1:6, v/v). Valle et al., 14 used this procedure to
81
extract these compounds from salmon muscle. Allen et al., 15 used 1% acetic acid in 
acetonitrile to extract MG and LMG from the eggs and fry o f rainbow trout. This group 
extracted rainbow trout muscle by firstly homogenising the tissue and mixing with 
sodium sulphate anhydrous. This extraction method was used by Mitrowska et al., 1(1 in 
the extraction o f MG and LMG from carp except sodium acetate was used as the buffer 
instead o f ammonium acetate. Doerge et a l, 17 used aqueous ammonium acetate 
containing hydroxylamine HCL and p-toluenesulfonic acid prior to the addition of 
acetonilrile to extract MG and LMG from catfish and trout. This group recognised that 
the demethylation o f LMG can occur during sample preparation. Plakas et al., 158 used 
acetonitrile to extract residues from catfish plasma. This group used an acetonitrile and 
acetate buffer mixture to extract residues from catfish muscle followed by re-extraction 
with acetonitrile. Under the low pH conditions o f extraction, MG (pKa 6.9) exists 
primarily (> 99%) in its ionised, chromatic form. Alderman et al., 19 extracted rainbow 
trout serum and bile tissues using a buffer at pH 4.0. Pentan-l-ol was added to the 
samples and the samples were subsequently extracted for 24 h. Liver, kidney, viscera and 
flank muscle tissues were blended with 2% pepsin and adjusted to pH 2 with HC1 in 
distilled water. The blended samples were left for 18 h at room temperature (20 °C) and 
shaken at intervals, upon evaluation o f the pH at extraction the pH o f the mixture was at 
pH 4. This group found that re-adjustment to pH 4 was un-necessary after the 18 h 
extraction period. Maintenance o f  the low pH was to ensure that M G was in the form of 
the dye ion. Pentan-l-ol was added to samples and samples re-extracted and the samples 
were left to sit at room temperature for 24 h. The muscle samples were found to require 
more pentan-l-ol during extraction when compared with the other samples. Liver tissue 
was found to yield a possible haemolysis product and at low concentrations this could 
affect the determination o f  MG. Van Rhijn et al., 20 used McIIvaine buffer pH 3 and 
acetonitrile (9:1, v/v) to extract MG and LMG from atlantic salmon. Van de Riet et al., 21 
used perchloric acid and acetonitrile to extract MG and LMG from salmon, rainbow trout,
r\r\
shrimp, tilapia and catfish tissue. Plakas et al., used acetonitrile: acetate buffer pH 4.5, 
1 %  hydroxylamine in methanol and para-toluenesulfonic acid (TSA) to  extract MG and 
LMG from catfish plasma. No interconversion o f MG and LMG occurred during 
extraction and analysis o f  individually fortified plasma replicates. This group
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homogenised the hydroxylamine solution, p-toluenesulfonic acid solution and acetate 
buffer with catfish tissue before addition o f  acetonitrile to the extract. Subsequently 
alumina was added and samples were centrifuged. The supernatant was removed and 
decanted into a water and diethylene glycol mixture. It was found that increasing the TSA 
concentration resulted in a 12% gain (from 68 to 80%) in the recovery o f 14C MG from 
the initial extract. The second extraction with acetonitrile resulted in an additional 16 %
♦ • 23gain in recovery. This method o f extraction was used by Tumipseed et al., and 
Anderson et al., 24 in the extraction o f MG and LMG from salmon. Tarbin et al., 25 used 
pH 4 citrate buffer and acetonitrile to extract MG and LMG from trout muscle. It was 
found that recoveries were variable when using acetonitrile on its own as the extraction 
solvent. Roybal et a l, 26 used hydroxylamine hydrochloride, p-toluenesulfonic acid and 
acetate buffer at pH 4.5 with catfish tissue before addition o f acetonitrile. Subsequently 
alumina was added to the extract and samples were centrifuged and the supernatant was 
decanted into water and diethylene glycol mixture. Hydroxylamine hydrochloride was 
added to fish samples to inhibit enzyme action on the analytes since Allen et al., 15 
reported the inter-conversion o f MG to LMG after exposure to fish tissue. Turnipseed et 
al., 27 developed a method which was used by Roybal et a l , 26 to extract MG and LMG. 
Hajee et al., 28 carried out a simple deproteinization o f  eel plasma with 2% trichloroacetic 
acid (50:50, v/v), 6% perchloric acid (50:50, v/v), 10% phosphoric acid (50:50, v/v) or 
acetonitrile (10:90,v/v) before the determination step which resulted in unsatisfactory 
recoveries. This group also found that alkalisation or acidification o f the plasma prior to 
extraction with ethyl acetate also yielded poor results. It was concluded that a further 
clean-up stage in the method was necessary to improve results. Rushing et al., 29 used 
hydroxylamine hydrochloride, aqueous P-TSA and aqueous ammonium acetate (adjusted 
to pH 4.5 with glacial acetic acid) blended with catfish or trout tissue, subsequently 
acetonitrile was added to extract MG and LMG from the tissues. Alumina was then added 
and a second acetonitrile extraction o f sample was carried out. Bergwerff et al., 30 
homogenised catfish, eel, trout, turbot and prawns with McIIvaine buffer pH 3.0, 1 M 
para-toluenesulphonic acid and 1 mg ml _1 methanolic N,N,N’,N’ -tetramethyl 1, 4 -  
phenylenediamine dihydrochloride and then acetonitrile was added to extract MG and 
LMG. A second extraction o f the sample was carried out using McIIvaine buffer at pH
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6.0 and acetonitrile. From correspondence with the author a higher extraction yield of 
LMG was accomplished when pH 6 was utilised in second extraction o f the sample. The 
group found that on inspection o f the liquid extraction process, homogenisation using an 
ultraturrax or household blender gave similar but better recoveries o f the MG residues 
compared to ultrasonification. This group also found that the time interval between the 
moment o f spiking and the moment o f sample processing had a dramatic influence on the 
recovery o f MG. It was shown that recoveries o f 81, 63, 60, 54, and 45% were obtained 
for time intervals o f 1, 15, 30 min and 1 h and 2 h respectively. Since no corresponding 
signal for LMG was observed, MG was apparently not reduced invitro into LMG during 
this incubation. In contrast, little effect was observed on the recovery o f LMG since 
recoveries o f  100, 96, 93, 93 and 95% were obtained for these time intervals respectively. 
Inspection o f  processed fish fillets, showed significant peaks, this suggested degradation 
of MG and especially LMG. Comparison o f the analysis o f  spiked samples with standards 
indicated that this breakdown originated partly from the working up procedure. In this 
work it was found that the addition on TMPD and ascorbic acid to samples could largely 
reduce this degradation. Swarbrick et al., 31 extracted MG and LMG with 
dichloromethane (2 ml), acetonitrile (10 ml) and 0.4 M  perchloric acid in acetonitrile. 
This group evaluated a range o f extraction systems, including several 
solvent/homogenisation and percolation techniques. Their effectiveness was limited by 
strong binding o f the dyes to fish flesh and its oil content (10 -  15%) which causes 
emulsion formation. 3 hours was found to be effective time for the extraction o f the 
analytes in the dark at 60 rpm on a rotary mixer. Acidification o f the extraction solvent 
was shown to be vital for good yields.
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2.15 Sample Clean-up Techniques for Different Matrices
The most widely adopted approach in liquid/liquid extraction o f MG and LMG is a low 
pH buffer and acetonitrile extraction system. The clean-up of extracts is carried out by 
either liquid/liquid partitioning only or in combination with solid phase extraction. Allen 
et ah, 15 carried out only a liquid/liquid partitioning clean-up o f eggs, fry and muscle o f 
rainbow trout tissues. This involved partitioning 1% acetic acid in acetonitrile extract 
after addition o f anhydrous sodium bicarbonate with chloroform. The partitioning 
procedure was repeated twice and the combined chloroform extracts were made suitable 
for analysis directly by LC. This group extracted trout tissue by combining homogenised 
trout tissue with anhydrous sodium sulphate, packing into a column and eluting with 
acetic acid in methanol. The eluate was combined with anhydrous sodium bicarbonate 
and partitioned against chloroform. The chloroform fraction was removed and a second 
partitioning o f the eluate with chloroform was performed. The combined chloroform 
fractions were concentrated and analysed. Valle et ah, 14 and Bergwerff et al. , 30 used a 
McIIIvaine buffer: acetonitrile at pH 3 and pH 6  to extract M G and LMG from salmon 
muscle. The acetonitrile and McIIvaine buffer extracts were washed with 
dichloromethane (DCM). The DCM extracts were isolated from the aqueous extracts, 
combined and purified on a J.T Baker aromatic sulfonic acid cartridge. The analytes were 
eluted with a solution containing 25% ammonia, 1 mg m l_1 methanolic ascorbic acid and 
methanol. Elution studies o f  the MG and LMG from the SPE cartridges using between 1 
to 15 ml o f elution solvent showed that the volume o f elution solvent should be over 6  
ml. The cationic sulfonic acid cartridge was chosen since allows the separation o f the 
analytes from low polarity compounds in the matrix. Due to the ionic character o f MG, 
ion-exchange was the mechanism o f choice. An ammonia gas pre-treatment o f  an 
aromatic sulphonic acid solid phase extraction cartridge with M G and LMG followed by 
elution with methanol showed only marginal losses o f MG and LMG. This author 
suggests that ammonia gas treatment deprotonates MG and LMG, thus disrupting the 
electrostatic interation with the sulphonic acid solid phase extraction column which 
permits elution with a small volume o f methanol. Scherpenisse et ah, 13 purified
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pangasius, rainbow trout, salmon, tilapia, and victoria perch extracts by combining the 
McIHvaine buffer: acetonitrile extraction solvent at either pH 3 or pH 6  against 
chloroform. The organic phase was then passed through a J.T. Baker aromatic sulphonic 
acid cartridge. The addition o f the chloroform was necessary to remove water. Plakas et
al, 18 partitioned catfish tissue extracts into methylene chloride with the final clean-up on
•  * 2]  alumina and propylsulfonic acid solid phase extraction column. Van de Riet et al.,
cleaned up a variety o f aquaculture products including salmon, trout, catfish, tilapia and
several shrimp species using Strata Cis solid phase extraction columns. The column was
eluted with a mixture o f  90 %  methanol, 5 % o f 1 mg ml' 1 ascorbic acid and 5 % o f 25 %
aqueous ammonium hydroxide in methanol. The SPE clean-up was found to give a less
colourless and viscous extract that enhanced MS response when compared with a hexane
partitioning method investigated as an alternative clean-up method. The solid phase
extraction clean-up appeared to remove a great deal o f  the non-polar coloured pigments
and lipids that were possibly causing ion suppression in the MS interface. Plakas et al.,22
partitioned catfish tissue extracts with two portions o f methylene chloride and cleaned up
using dual solid phase extraction (SPE) on an alumina column placed onto a propyl
sulphonic acid (PRS) column. The analytes were eluted from the PRS columns using
* OS • ♦
mobile phase. Similiarly Tarbrn et al., "  washed acetonitrile-citric acid extracts using 
DCM with sodium chloride. The DCM layer after centrifugation was then passed through 
a J.T Baker sulphonic acid cartridge. Roybal et al., 26 washed acetonitrile, acetate buffer 
pH 4.5 extracts with two portions o f DCM. The combined extracts were modified with 
acetonitrile and passed through a dual SPE system using alumina and a propyl sulphonic 
acid solid phase extraction columns. The analytes were eluted with mobile phase, 
hydroxylamine hydrochloride in methanol and 0.005 M p-toluenesulfonic acid. 
Tumipseed et al., 27 purified extracts using a J.T Baker cyano SPE cartridge. The elution 
solvent was an acetonitrile-sodium acetate buffer mixture that was designed to elute only 
the LMG from the cartridge even though MG and LMG are initially retained. Hajee et a l, 
28 cleaned up extracts o f  protein denatured eel plasma using J.T Baker sulphonic acid SPE 
columns. Rushing et al., 29 carried out a liquid/liquid partitioning step and solid phase 
extraction step in the clean-up o f MG and LMG from catfish and trout tissue. The 
partitioning step involved combining distilled water, methylene chloride and diethylene
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glycol with tissue extract o f acetonitrile, ammonium acetate buffer and aqueous para- 
toluenesulphonic acid. This partitioning o f the extract was carried out twice. The samples 
were then cleaned-up up using a dual SPE system which included an alumina cartridge 
and a PRS cartridge.
Bergwerff et a l, 30 cleaned up tissue extracts o f McIIvaine buffer pH 3.0, 1 M para- 
toluenesulphonic acid and 1 mg ml _1 methanolic N,N,N’,N’ -tetramethyl 1, 4 -  
phenylenediamine dihydrochloride and acetonitrile by washing extract with 
dichloromethane, removing the aqueous layer and passing through a Bakerbond aromatic 
sulphonic acid (SCX) solid phase extraction cartridge. The analytes were eluted with 25 
% ammonium hydroxide, 1 mg ml 1 ascorbic acid and methanol.
Swarbrick et a l, 31 used an alternative clean-up using activated charcoal instead of a Cis 
SPE column. This author cleaned up rainbow trout extracts by modifying the extractant 
with water before loading onto a Cis cartridge. The analytes were eluted with HPLC 
mobile phase. After centrifugation o f the initial DCM /acetonitrile /perchloric acid extract 
o f trout tissue, the extract was evaporated to approximately 0.5 mL at 60 °C and diluted 
with mobile phase. This extract was mixed with finely powdered charcoal and 5M nitric 
was added, the mixture shaken vigorously for 1 min and allowed to stand for 5 min. The 
acid was removed by centrifugation and the remaining paste was rinsed twice with water 
and then with HPLC mobile phase prior to dilution o f sample with mobile phase for 
analysis. Sager et al., 32 analysed drinking and river water samples for MG residuals 
following adjustment o f water samples to pH 5. The samples were passed through 
TechElut cyano solid phase extraction cartridges and the analytes were eluted with 
mobile phase. Mitrowska et al., 16 cleaned up tissue extracts o f acetate buffer, 
hydroxylamine hydrochloride, para-toluenesulphonic acid and acetonitrile by partitioning 
extract with DCM. The organic phase was passed through a J.T Baker sulphonic acid 
cartridge. The analytes were eluted with 5 ml o f a mixture containing acetonitrile and 
ammonium hydroxide (25%) (90:10,v/v).
Andersen et al., 24 cleaned up tissue extracts containing ammonium acetate buffer, 
hydroxylamine hydrochloride, para-toluenesulphonic acid and acetonitrile by the addition 
o f water and diethylene glycol to the extract and partitioning twice against methylene 
chloride. The organic phase was then evaporated to dryness and the oily residue was re­
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dissolved in acetonitrile followed by the addition o f 0.001 M  2,3-dichloro-5,6-dicyano- 
1,4-benzoquinone (DDQ). Periodic mixing o f the flask was carried out during the entire 
oxidation period o f 30 min. The oxidised sample was transferred to an alumina solid 
phase extraction cartridge connected on top o f a propylsulphonic acid (PRS) solid phase 
extraction cartridge. After loading o f the sample the alumina solid phase extraction 
cartridge is discarded and the analytes are eluted from the PRS cartridge under gravity 
using mobile phase (ammonium acetate buffer:acetonitrile (50:50, v/v)). The conversion 
efficiency o f DDQ to oxidise LMG to MG was investigated in this study. A 10-fold 
molar excess o f  DDQ added to a 20 ng ml 1 standard solution o f  LMG and this was 
sufficient to completely oxidise LMG to MG. However a 10,000-fold excess o f DDQ was 
required to completely oxidise 20 ng ml 1 LMG to MG in salmon extract. This showed 
that one or more components of the salmon sample consume the majority o f the DDQ. 
The quantity o f alumina added to the sample at extraction was found to be critical to 
achieve a high MG recovery. Upon investigation it was recommended to use 6  g of 
alumina. Tumipseed et al. , 23 used the extraction and clean-up method by Andersen et al., 
24 in the determination o f MG and LMG in salmon.
2.16 Methods for the Determination of Malachite Green and Crystal Violet 
Residues
M G analysis in early work was routinely carried out using spectrometric methods 
whereas today these compounds are analysed by a variety o f analytical techniques. 
Initially, methods for determining MG residues in fish tissues were limited to 
measurements o f  the parent compound on the basis o f its visible light absorption.
Spectrometric Methods
Alderman et al., 19 determined M G in pentan-l-ol extracts o f tank water, serum, liver, 
bile, muscle, kidney and viscera o f rainbow trout using a double beam spectrometer in 
concentration mode. Peak absorption for the MG dye ion in pentan-l-ol was 625 nm. The 
presence o f a small amount o f water in the extract o f pentanol ensured that the MG 
remained in the dye ion. Therefore MG present as dye ion and as carbinol was
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determined as the dye ion. The concentration in the dye extracts was determined by 
calibrating the spectrophotometer using extracts from the spiked control tissues against 
extracts from unspiked control tissues. Allen et al., 12 determined residues o f MG in 
muscle, eggs, and fry o f Atlantic salmon and Chinook salmon by colorimetric analysis 
after fish had been routinely treated with the chemical at fish hatcheries. Ethyl alcohol, 
formalin and acetic acid (85:10:5, v/v/v) was used and the fish exposed to M G developed 
a blue colour. The absorbance o f sample extracts at 615 nm were compared to the 
absorbance o f MG standards in ethyl acohol, formalin and acetic acid, 85:10:5 v/v/v.
Chromatographic Methods
The majority o f LC methods for the determination o f MG have been developed using 
reverse phase systems. A reverse phase separation was developed for MG and LMG on a 
Phenomenex Luna Ci8 column (3 |im, 150 mm * 2mm) by Scherpenisse et al., 13 The LC 
mobile phase consisted o f 50 mM acetate buffer pH 4.5 and acetonitrile (25:75, v/v) at a 
flow rate o f 200 jj.1 min'1. An in-line post-column reactor (20 mm x 20 mm) filled with a 
mixture o f PbC>2 and celite in a weight ratio o f 3:1 converted the lipophillic LMG into the 
cation MG. It was found that the oxidation capacity o f the reactor did reduce noticeably 
over thousands o f  analytical runs. This LC method was suitable for the analysis o f 
catfish, eel, rainbow trout, tropical prawns, salmon and turbot. Valle et al., 74 used an 
isocratic mobile phase containing 60% acetonitrile in aqueous ammonium acetate (50 
mM, pH 4.4) at a flow rate o f 0.7 ml min 1 to detect MG using a Waters Symmetry Cig 
column (5 |im, 4.6 mm * 250 mm). An oxidative pre-column (4.6 mm * 20 mm) for the 
conversion o f LMG into MG was hand packed with a mixture o f 10% lead (IV) oxide and 
celite. The use o f  the oxidative reactor before the LC run allows both compounds, MG 
and LMG, to enter the LC column as MG. The advantage o f merging both compounds 
into one signal is an increase in the signal-to- noise ratio.
A decomposition product o f MG was formed and could be detected as a peak since the 
reactor was located before the LC column. The formation o f the decomposition product 
desmethyl-MG depended on the amount o f the PbC>2 in the reactor and the residence time 
o f the sample inside the reactor.
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Allen et ah, 15 used an isocratic mobile phase containing methanol-water (81:19, v/v), 
buffered with 0.05 M  sodium acetate and 0.05 M  glacial acid with a Waters piBondapak 
C i8 column (10 p.m, 300 mm * 3.9 mm). The flow rate was 1.5 ml min _1. M G and LMG 
were separated on column and LMG was oxidised to MG in a post-column reactor 
(stainless-steel tube, 32 mm long, 4 mm I.D.) packed with 1 0 % PbC>2 suspended in Celite 
545. The reactor was found to be efficient up to approximately 400 injections but it was 
recommended that the efficiency be checked periodically using standards. Doerge et al.,
17 used a Phenomenex Prodigy ODS-3 column (5 |im, 250 mm x 4.6 mm) with a mobile 
phase gradient from 50% acetonitrile in aqueous ammonium acetate (50 mM, pH 4.5) to
100 %  acetonitrile over a 10 min linear ramp period. The flow rate was 1.0 ml min _1 and 
under these conditions MG and LMG eluted at approximately 5.3 and 12.9 min 
respectively.
Bergwerff et ah, 30 used a Phenomenex Luna phenyl-hexyl column (3 |im, 50 mm x 4.6 
mm) followed by a Phenomenex Luna Cg column (3 (j.m, 50 mm x 4.6 mm) as the 
second phase HPLC column in series. The LC columns were eluted with a mixture o f 60 
% acetonitrile and 40% o f 0.05 M ammonium acetate buffer, pH 4.5 at 0.6 ml min _1.
Van Rhijn et ah, 20 used a Waters Symmetry Cig column (150 mm x 3  mm) for the 
separation o f  MG and LM G in gradient mode from 90:10 10 mM formic acid:acetonitrile 
to 10:90, formic acid:acetonitrile using a linear gradient from 1 to 1 0  mins after injection. 
Under these conditions MG and LMG are eluted at 12.5 and 15.5 min respectively. 
Roybal et ah, 26 used a Phenomenex Ultremex 5 Cyano column (5 jim, 150 mm x  4 . 6  
mm) with a isocratic mobile phase o f  acetonitrile:acetate buffer (50:50, v/v). A PbC>2 
post-column oxidation was performed with 1 0 % PbC>2 suspended in Celite. The oxidation 
o f  LMG to  MG 1 by the PbC>2 column occurred at 1 0 1 % conversion. On evaluation o f the 
performance o f the Pb0 2  column in maintaining optimum oxidation o f  LMG, it was 
found that after 67 injections no loss in peak response was noted. Plakas et ah, 22 used a 
Phenomenex Ultremex 5 Cyano column (5 |_im, 250 mm x  4 , 6  mm) with a isocratic 
mobile phase o f acetonitrile:acetate buffer (50:50, v/v) at a flow rate o f 1 mL min *\ 
Under these conditions, retention times o f  LMG and MG were 6.3 and 16.2 min 
respectively. It was found that using the longer column in this study when compared with 
a study by Roybal et ah , 26 improved the separation o f  LMG and other minor metabolites.
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A PbC>2 post-column oxidation was performed with 25% Pb0 2  suspended in Celite 545. 
Allen e ta l., 15 used a Waters pBondapak Cig column (10 pm, 300 mm x 3.9 mm) with a 
mobile phase o f  methanol:aqueous acetate buffer (85:15, v/v) at a flow rate o f 1 .5 ml min 
A reactor was placed after the column and was packed with 1 0 % PbC>2 suspended in 
Celite 545.
Plakas et al. , 18 used a Phenomenex Ultremex 5 Cyano column (5 pm, 250 mm x 4.6 mm) 
with a isocratic mobile phase o f acetonitrile:acetate buffer (50:50, v/v) at a flow rate of 1 
mL min \  A post-column oxidation chamber packed with 25 % lead oxide converted the 
colourless LMG to MG. Tarbin et al., 25 used a Phenomenex Columbus Cis column (5 
pm, 250mm * 2 mm) with a binary gradient o f aqueous ammonium acetate pH 
4.5:acetonitrile (35:65, v/v) and aqueous ammonium acetate pH 4.5: acetonitrile (20:80, 
v/v) with a flow rate o f 0.3 ml min \  A step gradient was used with mobile phase 1 being 
pumped for 10 min before switching to mobile phase 2 for 20 min. A 2 mm internal 
diameter analytical column was choosen since gave suitable chromatography for both 
analytes. Also the flow rate required by this column would be advantageous when 
moving the methodology over to mass spectrometric detection. Post-column oxidation 
was carried out using a column packed with PbC>2 . It was found that if  the pH o f the 
mobile phase was kept at pH 7, then no oxidation occurred. Reduction o f the pH to 4.5 
gave good conversion o f the LMG to MG.
Van de Riet et a l, 21 used a Phenomenex reverse phase Luna Ci8 column (5 pm, 150 cm 
x 2 mm) held at a  temperature o f 35 °C with 30% o f solvent B flowing at 0.25 ml min 
The system was held at 30% B for 1 min. and then a linear gradient was used ramping 
from 30% B to  100% B over 7 min; once at 100% B, the flow rate was ramped to 0.4 ml 
min 1 over 3 min. The system was held at 100 % B for 10 min and returned to 30% B 
over a period o f 1 min. MG and LMG were easily separated from one and other and 
completely eluted from the column in less than 25 min with the linear gradient from 30 
to 100% solvent B at 0.25 ml min ' 1. Hajee et al., 28 analysed MG and LMG and their 
assumed demethylated degradation products on a variety o f different analytical columns 
which included Chromopacks’s Chromospher Cg and Cig, Nucleosil 5 Cig, Hypersil 
ODS, Microspher Cig, Lichrosorb RP - 8  and Chromspher 5B, Polymer Laboratories’ 
PLRP-S and Hamilton’s PRP-1 were tested for effective column efficiency and
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resolution. Studies found that Nucleosil 5 Cig, LichroSorb C - 8  and Chromspher 5B 
showed the best effective column efficiency and resolution o f these compounds. The 
mobile phase was further optimised using the Chromopack Chromspher 5B column (11 x
3.0 mm). The optimum concentrations in the binary electrolyte system of the mobile 
phase appeared to be 25 mM sodium 1-pentane sulphonate and 50 mM sodium 
perchlorate. However, pH adjustment with dipotassiummonohydrogenphosphate 
(K2HPO4) crystals caused poor repeatability o f the retention behaviour o f MG and LMG. 
Also the required pH (3.5-4.5) o f the mobile phase was outside the effective pH buffering 
range o f  phosphate. To overcome these problems, citric acid and acetate were tested as 
buffering agent in the aqueous ion-pair solution o f the mobile phase. Citric acid caused 
clogging o f the in-line post-column oxidation reactor. Sodium acetate was found to give 
no problems in this respect. The best resolution of M G and LMG and the demethylated 
degradation products was obtained when the pH of the aqueous 25 mM acetate-ion pair 
buffer is adjusted to pH 4.0 and an organic modifier content o f 60% o f acetonitrile is 
used. Also the size and PbC>2 content o f the in-line post-column oxidation reactor were 
optimised regarding LMG and MG conversion performance. The large size o f the post­
column oxidation reactor (32 x 4 mm) used by Allen et a l ,  15 is possibly a cause o f band 
broadening o f the MG and LMG peaks. Hajee et al., 28 reduced the size o f the reactor (10 
x 2.1 mm) and this gave much sharper peaks for MG and LMG but the PbC>2 in the 
reactor was rapidly depleted. On increasing the Pb0 2  content in the reactor from 10% to 
25% this markedly prolonged the lifetime o f the reactor. Also a guard oxidation reactor 
containing 50% Pb0 2  in celite (50 x 4.6 mm) between HPLC pump and the auto-injector 
eliminated oxidisable interferences that occurred in the mobile phase and prolonged the 
lifetime o f the post-column oxidation reactor to more than 800 injections. The stability o f 
M G and LMG in mobile phase was investigated at room temperature since it is known 
that these compounds can be photo-oxidatively demethylated to N,N’,N” -tri and/or 
N ,N ’-dimethylated compounds. MG was stable but LMG proved to be unstable. In a 
period o f 13 hours the LMG decreased approximately 25% while the peak areas of the 
assumed demethylated degradation products o f LMG increased. A standard solution o f 
LMG in mobile phase stored at 4 °C did not show this photo-oxidative demethylation. A 
standard solution o f LMG in anti-oxidative mobile phase was also stable at room
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temperature. The anti-oxidative mobile phase contained 10 |j,g ml 1 o f ascorbic acid. The 
presence o f ascorbic acid in standard solutions o f M G and LMG influenced neither the 
stability o f MG or the chromatography o f MG and LMG. Rushing et a l . ,29 investigated 
separation o f MG,LMG,CV and LCV using a Supelco LC-CN column (250 x 4.6 mm) 
in-line with a post-column Pb0 2  oxidation reactor (20 x 2.0 mm) using a mobile phase of 
acetonitrile-buffer (60:40, v/v) with a flow rate o f 1 ml min The separation o f these 
compounds was also investigated on a SynChropak SCD-100 column (150 x 4.6 mm) 
and a PbC>2 oxidative post-column (20 x 2.0 mm) with a mobile phase o f acetonitrile­
buffer (55:45, v/v). The isocratic elution o f the analytes on a cyano column resulted in co­
elution o f  LMG with LCV at a retention time o f 5.8 min. This separation was inadequate. 
Complete separation o f the mixture was achieved on a short-chained deactivated (SCD) 
reverse phase column in under 10 min. After separation on the column the LMG and 
LCV are oxidised by the PbC>2 reactor to their respective chromatic form. Bergwerff et 
al., 30 used an Inertsil ODS-2 HPLC column (100 x 3.0 mm) with a mobile phase o f 50 
mM sodium perchlorate containing 25 mM sodium acetate and 25 mM 1-pentanesulfonic 
acid to pH 4.0 with acetic acid, and acetonitrile in the ratio o f 2:3, v/v. A pre-column 
oxidation reactor (50 x 4.6 mm) filled with P b 0 2 and celite in weight ratio o f 50:50, v/v. 
The robustness o f the LC separation was evaluated on three different HPLC columns and 
each different column was evaluated with three mobile phase batches. All chromatograms 
were similar.
Sager et al., 32 used a Hichrom stainless steel cyano column (5 |im, 250x 4.6 mm) to 
chromatograph MG using a mobile phase o f methanol:0.1 M  sodium acetate pH 4.5 
(70:30, v/v). Acetonitrile if  used in the mobile phase was found to affect the longterm 
stability o f  the carbon fibre o f  the detector when using amperometric detection. 
Mitrowska et al., 16 separated MG and LMG by isocratic elution on a phenomenex Luna- 
phenyl-hexyl (5|im, 150x4.6 mm) analytical column. A phenomenex phenyl-hexyl guard 
column (40 mm x 2 mm) was used prior to the analytical column. The mobile phase 
consisted o f acetonitrile and acetate buffer ((0.05 M, pH 4.5) 60:40, v/v) and the 
separation was accomplished at a flow o f 1 ml min 1 Anderson et al., 24 investigated the 
separation o f M G and LMG on an Alltech Alltima Ci8 (3 |j.m, 150x4.6 mm) with an 
Alltech Cig guard column (5 (am, 7.5x4.6 mm) and a MacMod Analytical Inc Column
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Saver column prefilter (0.5 [im). Mobile phase A consists o f ammonium acetate 
buffer:acetonitrile (50:50,v/v) and mobile phase B consists o f acetonitrile. The LC 
isocratic mobile phase elution profile is 95% A and 5% B. The mobile phase flow rate is 
1 ml min ~l and the column temperature is set at 35 °C. Tumipseed et al.,23 used a Waters 
YMC phenyl 3-4-5 cartridge column (3 p.m, 4.0 x50 mm) with a guard cartridge insert 
(4.0 xlm m ) o f the same composition. The column was maintained at 30 °C and the 
mobile phase flow rate was 700 (j.1 min "'.The analytes were eluted isocratically with 
0.1% formic acid (63:37, v/v) for the first 10 min, followed by an increase to 100 % 
acetonitrile from 10 to 10.5 min, a column wash at 100% acetonitrile was carried out 
from 10.5 to 12 min, return to 0.1% formic acid:acetonitrile (63:37,v/v) from 12 to 12.5 
min and the system was equilibrated at that concentration for a final 2.5 min. Roybal et 
al., 33 used an Alltech Cyano (250 x 4.6 mm, 5 (j.m) for the determination o f CV, its 
demethylated metabolites, LCV in chicken tissue using LC with electrochemical 
detection. The mobile phase was adjusted from acetate buffer:acetonitrile (2:3, v/v) to 
acetate buffer:acetonitrile (50:50,v/v). The flow rate was 1ml min *1. Munns et a l.,34 used 
the method by Roybal et al., in the determination o f LCV in chicken fat. Heller et a l . ,35 
determined LCV in chicken fat with baseline separation o f LCV from matrix 
interferences using a DuPont Zorbax ODS column (150 x 4.6 mm, 5 jim) with a mobile 
phase o f methanol:pH 4 ammonium acetate buffer (90:10,v/v). Thompson et a l.,36 used a 
supelco cyano (259 x4.6 mm, 5 m) PbC>2 oxidative post-column (20 x 2.0 mm). The 
mobile phase was acetonitrile:ammonium acetate pH 4.5 (60:40, v/v) and the flow rate 
was 1 ml min *. The LCV was chromatographed on column as the leuco form but after 
separation on the column it was oxidised by PbC>2 post-column reactor to the chromatc 
form. Doerge et al., 37 used a Synchrom Inc, SCD100 (250 x 4.6 mm, 5 ^m) column 
using a mobile phase o f acetonitrile:aqueous ammonium acetate pH 3.6 at a flow rate o f
1.5 ml min 1 for the separation o f CV and LCV.
Liquid chromatography detection systems
A number o f  groups have developed methods that enable the simultaneous analysis o f  the 
chromatic parent compound and its colourless leuco metabolite. These methods
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incorporate a post-column reactor containing PbC>2 in which the LMG after separation on 
an analytical column is oxidised back into the chromatic compound for visible light 
detection. Others have used electrochemical cells for detection.
Detection in the visible spectrum
Allen et a l, 15 developed a method for the simultaneous analysis o f  chromatic and leuco 
forms o f MG using photometric detection. A reaction chamber containing 10 % Pb02 in 
celite 545 was placed between the column and the spectrometric detector to oxidise the 
leuco form o f MG to its chromatic form. Chromatic and LMG have been quantified by 
their absorbance at 618 nm. The detection limits was 0.12 |ig  kg "‘for the leuco form o f 
the dye and 0.28 jig kg 1 for the chromatic MG oxalate. The detector response was lower 
for chromatic MG due to its different molecular weight. Plakas et al., 18 determined 
residues o f MG in plasma and tissue in channel catfish and holding tank water using a 
post-column oxidation chamber packed with 25% Pb02 converting colourless LMG to 
M G for visible light detection at 618 nm and quantification. The limits o f determination 
for MG and LMG were 0.023 mg L '1 in plasma and 0.005 mg L"1 in muscle. Bergwerff et 
al., 30 determined the persistence o f  residues o f  M G in juvenile eels using post column 
reactor filled with a mixture o f Pb02 and celite in a weight ratio 3:1. The eluate was 
monitored at 620 nm after post column oxidation o f  LMG into chromic MG. The limit of 
detection for each MG and LMG was 1 jig k g 1.
Plakas et a l, 22 using a LC cyano column with a P b 0 2 post-column with visible detection 
at 618 nm. The limits o f  detection for MG amd LMG in plasma were approximately 10 
jig k g _1. The limits o f  detection o f MG and LMG in muscle were approximately 2 |ig k g ' 
The overall mean recoveries o f  parent M G and its major metabolite, LMG from plasma 
were 93 and 87% respectively. The overall mean recoveries o f MG and LMG from 
muscle were 85 and 95% respectively. The relative standard deviations (RSDs) o f 
recoveries at all fortification levels ranged from 4 to 7% for plasma and 2 to 5% for 
muscle. Roybal et a l,  26 determined M G and LMG by liquid chromatography with visible 
detection and post-column oxidation. The advantage o f using the approach o f post­
column oxidation is that LMG is converted into M G and both analytes can be monitored 
by one procedure with a single LC determination. Recoveries o f MG from fortified
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catfish tissues were 73, 75 and 70 % for tissues spiked at 23 |_ig kg'1, 11 ng kg '* and 6 |o.g 
kg The relative standard deviations were 2, 7 and 7 % at each o f  these spiking levels 
respectively. Recoveries o f LMG from fortified catfish tissues were 87, 3 and 88 % for 
tissues spiked at 21 jig g ml, 10 pig kg _1 and 5 jig kg The relative standard deviations 
were 3, 6 and 12 % at each o f these spiking levels. The limit o f detection for MG and 
LMG were 4 and 5 pig k g 1. Allen et al., 15 analysed M G and LMG by liquid 
chromatography with post-column oxidation o f LMG to the chromatic form. Plakas et al.,
18 determined M G using same procedure previously described. 8
Tarbin et a l . ,25 determined MG and LMG in a screening method using HPLC with visible 
detection. Since M G has an absorption maxima in the visible range at 618 nm and its 
leuco metabolite has absorption maxima in the UV region at 265 nm post-column 
oxidation was used in order to see compounds at a single wavelength. The recovery was
71, 69 and 71% for M G when spiked at levels o f  10 p,g kg 5 (ig kg _1 and 2 fxg kg \  
The recovery o f LMG was 91, 97 and 97% when spiked at the same levels.
Hajee et a l, 28 quantified MG and LMG in eel plasma after detection at 610 nm using 
post-column oxidation. The limits o f  detection and quantification were determined to be
3.5 and 5.0 fig kg **, respectively for M G and 0.6 and 0.9 (ig kg 1 respectively for LMG. 
Recovery experiments were carried out in six replicates with blank eel plasma spiked at 
levels o f 20, 50, 100, 200, 1000 and 2500 p.g kg ' '  for both MG and LMG. A good 
recovery at all levels investigated and a low standard deviation for repeatability was 
obtained.
Rushing et al., 29 determined M G and LMG with CV and LCV in catfish or trout muscle 
using in-line post column PbC>2 oxidation reactor permitting visible detection o f all four 
compounds at 588 nm. Recoveries o f LMG and MG from catfish tissues fortified at 10 jag 
kg '* were 75 ± 3% and 61 ± 4% respectively while trout tissues fortified at the same 
level yielded recoveries o f  83 ± 2% and 49 ± 2% (mean ± S.D., n=4), respectively. 
Visible maximum o f 588 nm was chosen in this study rather than 618 nm as in other 
publications since the upper range o f the detector in this study only reached 600 nm. 
Bergwerff et a l.,30 quantified M G and LMG by HPLC with pre-column oxidation and the 
effluent from the column was monitored at 620 nm with a tungsten light source. MG and 
its primary metabolite LM G were successfully determined at 2.5 -  2000 (xg kg _1 in
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catfish, eel, rainbow trout, salmon, tropical prawns and turbot with a limit o f detection o f 
1 |ag kg'1. The recoveries for LMG were between 86 ±  15% (prawn) and 105 ± 14 %  
(eel). MG and LMG were determined by reverse phase HPLC with absorbance detection 
at 610 nm following post-column oxidation of the leuco form to MG using an 
electrochemical detector cell. The limits o f  detection for M G and LMG were 6 (xg kg 1 
and 3 p,g kg 'l respectively. At concentrations in the range o f  25 -  200 (ig kg, recoveries 
in the range o f 73-87% were achieved for MG and 89-98% for LMG.
Andersen et a l . ,24 analysed MG and LMG residues in salmon with insitu LMG oxidation 
upon reaction o f M G with DDQ. The extracts were analysed for MG by LC with visible 
detection at 618 nm using isocratic elution and a Cis column. The recovery and 
coefficient o f variation (CV %) o f M G spiked into farm raised salmon was 95% and 11%. 
The recovery o f MG and the CV % when MG was spiked into canned salmon was 90 and 
3%. The detection limit o f the method was 1 (ig k g _1.
Heller et al., 35 determined LCV in chicken fat by liquid chromatography with UV 
detection. Average recoveries o f  samples fortified at 5, 10 and 20 |xg kg'1 were 76% with 
a CV % o f 5%. The detection limit was 0.4 |a.g kg'1 and the limit o f quantification was 2 
(ig k g _1. Thompson et a l . ,36 described a method for the determination o f CV and LCV in 
channel catfish were LCV was oxidised by Pb02 post-column reactor to the chromatic 
form and both compounds were detected as CV. The limit o f  detection was 0.4 jig kg 1 
and the limit o f quantification was estimated to be 2 |j,g kg 1.
Detection by visible-fluoresceme detection
Mitrowska et al., 16 quantified M G and LMG in carp muscle using LC with visible (X 
=620) and fluorescence detection (Xex^eS and Km 360). Both detectors were connected 
on-line which allowed direct analysis o f the sample extract for MG and LMG without the 
need for post-column procedure. Average recoveries o f  M G and LMG from muscle 
fortified at three levels were 62% and 90% respectively. The relative standard deviations 
were less than 11 and 9% for MG and LMG. The C Ca for MG and LMG were 0.15 and 
0.13 \xg kg '* and CCJ3 were 0.37 and 0.32 |ig kg *\
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Electrochemical Detection
The determination o f LMG and MG residues in rainbow trout flesh by post-column 
electrochemical oxidation was accomplished by Swarbrick et al., 31 An electrochemical 
detector with ESA 5010 analytical cell operating at a potential o f 0.45 V relative to the 
in-built proprietary reference electrode was coupled between the HPLC column and the 
visible detector. A selection o f the operating potentials was achieved by performing 
repeated 10 jxl injections o f standard solutions of MG and LMG in the mobile phase at a 
flow rate o f 0.1 mL min _1 after removal o f  the analytical column. The response of a 
visible detector was recorded at a range o f potentials at the electrode o f the 
electrochemical detector to determine the optimum voltage for analysis. The operating 
potential o f 0.45 V was chosen since it gave maximal oxidation o f LMG. The limits of 
detection for MG and LMG are 6 \xg k g _1 and 3 |j.g kg \  At concentrations between 25­
200 pig kg recoveries in the range o f  73-87% were achieved for MG and 89-98% for 
LMG. Sager et al., 32 determined MG residues in water samples involving 
electrochemical detection using a carbon fibre electrode. The residues were detected 
amperometrically by employing a potential o f +1.2 V at the working electrode. The limit 
o f detection was 0.7 mg L _1. A rapid method for the determination o f LCV in chicken fat 
with electrochemical detection was described by Munns et al., 34 The electrochemical 
detector was set at a potential o f 1.000V. Average recoveries o f LCV from chicken fat 
were 84% with a coeffiecient o f variation (CV%) of 13% for the 5 ^g kg _1 level, 83 % 
with CV% o f 14 % for the 10 (ig kg 1 level and 78 % with CV % of 3 % for the 20 |ig kg 
1 level. Roybal et al., 33 developed a method for the determination o f CV, its 
demethylated metabolites and LCV in chicken tissue. The analytes are detected by 
amperometric electrochemical detection at + 1.000 V. Average recoveries of CV and 
LCV from commercially purchased chicken liver fortified with 20 [ig kg _1 were 92 %, 
CV %  7.6 and 86 %, CV % 8 % respectively. Average recoveries o f CV and LCV from 
control chicken liver fortified with 20 |xg kg '' o f each compound were 80 % with a CV 
% o f  9 %  and 70 % with a CV % of 4 % respectively. Compared to methanol, acetonitrile 
incorporated into the mobile phase improved the sensitivity o f  the LC/ED system and 
also the resolution for the analytes. Ethylenediaminetetraacetic acid (EDTA) was also 
added to the mobile phase as a masking agent to reduce background current and drift.
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Detection by mass-spectrometry
Mass spectrometry has been widely used in the determination o f MG and LMG residues. 
After conversion o f LMG into MG by post-column oxidation with PbC>2, the effluent has 
been analysed by LC-ESI MS/MS in multiple reaction monitoring (MRM) mode.13 The 
mobile phase consisted o f 50 mM acetate buffer pH 4.5:acetonitrile (25:75, v/v) and was 
pumped at 200 (j.1 min'1. Species investigated in this study included salmon, pangasius, 
tilapia, trout and Victoria perch. Recoveries ranged from 66 % in trout spiked at a level of
4 |ig kg'1 to 112 % in pangasius at 0.1 |_ig kg '1. An average decision limit (CCa; a  1%) 
and detection capability (CCP; P 5%) o f 0.11 and 0.18 ng kg'1, respectively.1 was 
achieved. Valle el a l,  14 used pre-column oxidation which converts LMG into MG 
previous to liquid chromatography-atmospheric pressure chemical ionisation-mass 
spectroscopy (LC-APCI-MS). The determination o f the combined signals provides a gain 
in sensitivity. The detection limit using the confirmatory ion m/z 313, was 0.15 |ig kg *. 
The recoveries determined at a spiking level o f  2 |_ig kg _1 were 85 and 70 % for LMG and 
MG respectively, with respective relative standard deviations o f 1 and 3 %. Detection of 
a decomposition product o f MG was identified as a peak which appeared about 1 min 
previous to the M G signal and was identified by LC-MS as desmethyl-MG (m/z 315). 
On using the APCI interface, the intensity o f the signal obtained for MG was found to 
diminish when the mobile phase was enriched with acetonitrile. Van Rhijn et a l, 20 
determined MG and LMG without oxidation o f LMG to MG by LC-MS/MS. Doerge et 
a l, 17 determined M G and LMG using isotope dilution liquid chromatography 
atmosphere pressure chemical ionisation mass spectrometry. Tarbin et al., 25 confirmed 
the presence o f M G in trout muscle using electrospray (ESP) MS. Post-column oxidation 
was used to convert LMG back to the parent M G after chromatographic separation and 
prior to detection. The procedure was validated down to 2 ng kg \  The recoveries were 
in the range o f 61 to 94 % with RSD o f 4-15 %. Investigation o f ESP-MS method without 
post-column oxidation found that adequate sensitivity could be achieved but repeatability 
especially for the leuco compound was poor.
Van de Riet et al.,21 developed a liquid chromatography tandem mass spectroscopy with 
electrospray method for residues o f MG and LMG in a number o f aquatic species.
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Bergwerff et al., 30 determined these residues by LC-ESP-MS/MS with post column 
oxidation prior to the eluent being introduced into the ionisation chamber. Tumipseed et 
a l . ,33 confirmed the identify o f MG and LMG residues in salmon using LCMS/MS with 
no-discharge atmospheric pressure chemical ionisation after their conversion to chromic 
MG in the extraction process. In this study, ESI was compared with no-discharge APCI 
for MS/MS determination o f M G residues by ion-trap LC/MS. MG is a charged species 
(not protonated) in solution with a molecular ion at m/z 329. The product ion spectrum 
obtained by no-discharge APCI was virtually identical to spectrum obtained by ESI. The 
recoveries o f  LMG, measured as MG by the method at fortification levels o f  1-10 |j,g k g '
1 were high (86-109%), with low relative standard deviation (RSD) values (6-13%). The 
presence o f LMG in salmon tissues fortified at 0.25 |ig kg _1 was confirmed by this 
method with an average recovery o f 70 % and an RSD of 12%. Doerge et al., 37 
determined CV and LCV in catfish muscle by LC with atmospheric pressure chemical 
ionisation (APCI) mass spectroscopy. A full scan APCI mass spectra obtained at different 
cone voltages from 100 ng on-column injections o f CV and LCV showed that at 
potentials less than 30 V, the spectra consisted predominantly o f cationic portions o f CV 
(m/z 372) and protonated molecule o f  LCV (m/z 374). As the voltage was raised, 
increasing numbers o f fragment ions with different relative intensities due to CDD 
reactions in the transport region o f the ion source were observed. In the case o f CV, the 
observed fragmentation is consistent with demethylation and dehydrogenation to form 
iminium ions. Fragment ions from LCV were consistent with losses o f methyl and 
methyaniline and dimethylaniline moieties. The initial fragment ion o f (m/z 359) formed 
from LCV is consistent with the loss o f  a methyl radical to yield a cation-radical species. 
This type o f reaction is not a proton transfer typically seen for API-MS. Product ion 
spectra were obtained for APCI mass spectrometry analysis o f  LCV in order to determine 
the fragmentation reactions observed at various cone voltages that produced the ions used 
to monitor for LCV. As the collision energy was increased the same fragmentation ions 
as observed in the CID experiment.
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Gas chromatography
There has been little work on the analysis o f M G and LMG by GC due to their low 
volatility. A gas chromatographic/mass spectrometric (GC/MS) method was developed 
to confirm the presence o f LMG in cat fish tissue .27 MG was not sufficiently volatile and 
decomposes in the gas chromatograph so was removed from sample during clean-up. 
Both MG and LMG are initially retained on the cartridge, but only LMG is eluted with 
the acetonitrile buffer mixture prior to GC/MS analysis.
LMG was chromatographed on a cross-linked poly (dimethylsilicone) Hewlett Packard-1 
12.5-M capillary column (0.2 mm i.d, 0.33 |im  film thickness). LMG was found to 
fragment into several diagnostic ions. LMG was confirmed by SIM at m/z 330 [M ]H, 239 
[M-M]+, 253 [M-Ph]+, 210 [M-C6H4N(CH3)2]+ and 165 [M]++. These ions correspond to 
molecular and fragment ions o f  relative high abundance and specificity for this 
compound. Wilson et a l . ,39 developed a procedure for confirming the identity o f LCV in 
chicken fat by GC-MS/MS. Confirmatory identification o f  LCV was based on matching 
the retention times and relative abundances o f 6 ions in the extract. Data acquisition 
consisted o f selected ion monitoring at m/z 373, 372, 253, 252, 237 and 126. These m/z 
values represent the major ions in the E l mass spectrum o f  LCV. LCV was 
chromatographed on a DB-1 (100% methyl silicone) capillary column (30 * 0.25 mm, 
0.25 (am film thickness). The column temperature was held at 150°C for 1 min, ramped at 
16°C min 1 to 300°C, held for 20 min. The linear velocity o f the helium carrier gas at 
300°C was measured at 25.5cm s'1. LCV eluted at about 18 min. The procedure 
confirmed the identity o f LGV in fat samples fortified at 5 |ig  kg All ions except that 
m/z 126 may be amenable to  application below 5 |ig kg *. An alternative approach 
would be to inject more extract so the m/z 126 can be used.
2.17 Conclusions
The determination o f MG, LMG, CV and LCV involves liquid extraction using 
acetonitrile generally as the organic solvent and a buffer system at a low pH of between
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3-4.  Sample clean-up is accomplished by washing extracts with dichloromethane alone 
or inconjunction with cation solid phase extraction. The determination o f MG, LMG, CV 
and LCV is widely achieved using liquid chromatography separations with detection by 
IJV-VIS spectrometry or tandem mass spectrometry.
A confirmatory method developed by Van Rhijn et al., 20 allows the determination o f MG 
and LMG by LC-MS/MS without incorporating the oxidation o f LMG to M G either pre­
column or post-column. MG and LMG can easily be detected and some of the difficulties 
associated with post-column or pre-column oxidation are thus eliminated. Since MG is a 
banned substance, the development o f confirmatory methods using tandem mass 
spectrometry in MRM mode is the most specific and widely used technique.
To date there is no LC-MS/MS method developed utilising a d5 analogue o f MG as 
internal standard for MG and a dj analogue o f  LMG. These internal standards are the 
preferred compounds in LC-MS/MS analysis as matrix suppression effects at the 
retention time o f each compound may affect the ionisation efficacy differently. MG and 
LMG are well separated on reverse phase chromatography systems and ideally using 
deuterated standards o f  both substances would correctly evaluate any suppression effects 
at the retention time o f each compound.
There are a number o f  single residue methods for MG in fish tissues but no methods on 
the effects that cooking o f the fish tissue has on these residues and if  there are differences 
between these cooking effects between different species.
There is also a lack o f  methods, which target CV and LCV as these are also classed in the 
same group o f B3(e) dyes as MG. These compounds are banned also. It is very difficult 
to obtain certified reference materials for these compounds and their metabolites and 
impossible to  obtain deuterated internal standards.
There is very limited data on the depletion o f the other B3(e) contaminants in fish tissues
Therefore there is a need to  develop a multi-residue LC-MS/MS method, which targets 
MG, LMG and the other Group B 3(e) dyes such as CV, LCV.
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Environmental contamination may arise e.g from commercial fish farming where these 
compounds are given as feed additives, they can accumulate in sediments and may be 
injested by marine species in the vicinity o f  farms. Also substantial amounts o f medicated 
feed is not eaten and can pass through the holding cages and be absorbed by marine flora 
and fauna. Freshwater fish farms are based inland and these compounds may pose a threat 
to groundwater and human water supplies.
There is no published confirmatory method for the simultaneous determination o f MG, 
LMG, CV and LCV in salmon that is validated according to Commission Decision 
2002/657/EC.
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Chapter 3
Development of a Screening Method for the Determination of Robenidine in Eggs by 
High Performance Liquid Chromatography with Ultraviolet Detection
Relevant publication: See Chapter 7
G. Dowling, M. O’ Keeffe and M. Smyth. Anal. Chim. Acta. 539 (2005) 31-34
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3.1 Introduction
Anticoccidials are compounds used extensively both prophylactically and therapeutically 
to treat coccidiosis in poultry. Coccidiosis is caused by unicellular organisms belonging 
to the genus Eimeria in the class Sporozoa and is the most important parasitic disease o f 
poultry. 1 Robenidine (l,3-bis[(p-chlorobenzylidene) amino]- guanidine 
monohydrochloride is a common anticoccidial drug used in the poultry industry. The 
molecular structure o f the compound is shown in Figure 3.1. It is authorised for use in 
poultry and other species under the Additives Directive 70/524/EC. 2 In the European 
Union according to Directive 70/524/EC, the use o f robenidine is not authorised for 
laying hens. The widespread use o f this anticoccidial drug may present a potential risk to 
the consumer if residues enter the food chain.
A range o f methods have been described for the determination o f robenidine in feed, 
including thin layer chromatography 3, a photometric method for feeds and premixes 4, 
and a LC-UV method for the determination o f robenidine and its chemical precursors in 
feed. 5 A polarographic method for determination o f robenidine in tissue, eggs, litter and 
soil 6, and methods for the determination o f  robenidine and other anticoccidials by LC- 
dual mass spectroscopy (MS/MS) in eggs 7,8 have been described. There are no methods 
available for determination o f robenidine in egg by LC with UV detection.
In this study a fast, simple and reliable LC method is described for the detection of 
robenidine in eggs. The method was validated according to procedures described in 
Commission Decision 2002/657/EC. 9
'JH
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Figure 3.1: Structure o f  robenidine (1,3-bis[(p-chlorobenzylidene) amino]- guanidine 
monohydrochloride
109
3.2 Scope of the Research
The objective o f this research is the development of a fast, simple and reliable method for 
the analysis o f robenidine in eggs by LC-UV. The advantage o f UV detection is that it is 
commonly found in use in analytical laboratories and more sophisticated techniques such 
as LC-MS/MS are not accessible to  a number o f laboratories due to excessive costs. 
Following the development, the method was validated according to the procedures 
described in Commission Decision 2002/657/EC. (See introduction). As robenidine is not 
authorised for use in laying hens, the decision limit (CCa) and detection capability (CC3) 
were calculated according to the procedure outlined for banned substances.
3.3 Experimental
3.3.1 Materials and reagents
Water (HiPerSolv grade), acetonitrile (HiPerSolve grade), n-hexane, triethylamine and 
ammonium dihydrogen phosphate (Analytical grade) were obtained from BDH (Merck, 
Poole, Dorset, UK). N,N-dimethylformamide (Analytical grade) was obtained from 
Riedel-de-Haen (Seezle, Hannover, Germany). Robenidine hydrochloride was obtained 
from QMX (Essex CM6 2PY, UK). Ammonium phosphate buffer (0.05M, pH 6.8) was 
prepared by dissolving 5.75 g o f ammonium dihydrogen phosphate in 800 ml LC grade 
water then adding triethylamine (BDH, Merck, Poole, Dorset, UK) to yield pH 6.8 and 
making up to 1 litre with water. A primary stock standard solution o f robenidine was 
prepared in N,N-dimethylformamide at a concentration o f 100 |ig m l'1 and stored at 4 °C. 
Working standard solutions were prepared daily in acetonitrile:water (65:35, v/v) and 
stored at 4 °C.
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3.3.2 LC conditions
The LC system consisted o f a model 600 LC pump (Waters, Milford, USA) and a SIL-
101 AVP autoinjector, a CTO-IO AVP column oven, a SPD-10 AVP UV detector 
operated at 317 nm and a SCL-10 AVP system controller linked to a PC with class-VP 
data handling software (Shimadzu Corporation, Japan). The mobile phase, consisting of 
acetonitrile:buffer pH 6.8 (65:35,v/v), was pumped at a flow of 1.5 ml min'1. A stainless- 
steel Novapak Ci8 analytical column (250 x 4.6 mm I D ) ,  coupled to a Hypersil Ci8, 
Securiguard ™  guard column (3.0 x 2.0 mm. I D), was used. The column temperature 
was maintained at 40 °C.
3.3.3 Procedure for egg samples
Egg samples (100 g approximately), prepared from pooling six individual eggs, were 
homogenised and stored at -  20 °C in 150 ml tubes. Egg samples, from commercial 
production units, previously analysed using method described in this chapter and found to 
contain no detectable residues o f robenidine were used as negative controls.
3.3.4 Sample extraction and clean-up
Egg (2 g) was weighed into 50 ml polypropylene tubes. Acetonitrile (7.5 ml) was added 
and the test portion was vortexed (2 min), sonicated (3 min) and shaken on a mechanical 
shaker (15 min). The test portion was centrifuged (2400g, 10 min, 4 °C). The supernatant 
was transferred to a clean test-tube and the test portion was extracted with acetonitrile as 
before. The supernatants were combined and defatted with hexane (5 ml) by mixing on a 
vortex (30 s). The test portion was centrifuged (1250 x g, 5 min, 4 °C) and the hexane 
layer removed. The sample extract was evaporated to dryness under nitrogen (60 °C) 
before dissolving in 500 |j,l acetonitrile:water (65:35, v/v). An aliquot (100 p,l) was 
injected onto the HPLC column.
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3.3.5 Calibration
Standards were prepared in acetonitrile:water (65:35,v/v) at concentrations of 0, 50, 125, 
250, 500, 1000 and 2000 ng ml-1, equivalent to 0, 12.5, 31.25, 62.5, 125, 250 and 500 |ig 
kg'1 egg, respectively. Calibration curves were prepared by plotting peak area as a 
function o f analyte concentration (0 to 2000 ng ml"1). Concentration o f robenidine 
(ng ml'1) was determined from the peak areas obtained for the test portion extracts, 
calculated from the calibration curve. The robenidine concentration in egg samples (|ig 
kg'1) was calculated, as follows:
Robenidine (|ig kg'1 egg)
= robenidine (ng m l'1 extract) x 0.5 / 2 
Recovery was measured from the peak areas obtained for fortified sample extracts, 
calculated from the calibration curve
3.3.6 Method validation
For estimation o f  recovery, blank egg samples were prepared and fortified with 
robenidine. Test portions (2 g) were fortified at 50, 75 and 100 p.g kg'1 by adding 50, 75 
and 100 (j.1 portions o f a 2000 ng ml-1 robenidine solution, respectively. After 
fortification, the test portions were held for 15 min prior to extraction with acetonitrile, as 
described above. Six replicate test portions, at each o f  the three fortification levels, were 
analysed. Analysis o f  the 18 test portions was carried out on three separate occasions. For 
estimation o f the precision o f the method, within assay repeatability was calculated. The 
decision limit (CCa) and the detection capability (CCP) o f the method were calculated.
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3.4 Results and Discussion
3.4.1 Preliminary experiments
An LC method, developed to analyse for robenidine in animal feed, was applied to the 
separation of robenidine on a Ci8 column with a mobile phase consisting of 
acetonitrile:water:potassium di-hydrogen phosphate:di-sodium hydrogen phosphate 
(65:25:5:5, v/v/v/v). 5 The peak shape was poor, with excessive tailing, using this mobile 
phase. Investigation of various LC conditions, including various percentages of organic 
content in the mobile phase, pH, injection volume and mobile phase flow rate, showed 
that a mobile phase consisting of 65% acetonitrile and 35% phosphate buffer, adjusted 
with triethylamine to pH 6.8, an injection volume of 100 jal and a flow rate of 1.5 ml min
1 gave good peak retention and shape. Following preliminary extraction and liquid 
partitioning between hexane and acetonitrile no further clean-up of the sample extracts 
using solid phase extraction was deemed necessary as the chromatograms were free of 
matrix interference. As no additional steps were necessary this satisfied the aim of 
developing a simple quantitative test method with a minimum of manipulations.
3.4.2 Validation study
Validation of the method was according to procedures described in Commission Decision 
2002/657/EC 9 covering specificity, calibration curve linearity, recovery, repeatability, 
decision limit (CCa) and detection capability (CCP).
3.4.2.1 Specificity
To establish the specificity o f the method, egg samples fortified with robenidine and non­
fortified samples were analysed. No interfering peaks were observed at the retention time 
for the robenidine peak (Figures 3.2 and 3.3).
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Figure 3.2: Chromatogram of negative control egg sample
Figure 3.3: Chromatogram of negative control egg sample spiked at 50 pig kg'1 
3.4.2.2 Linearity of the response
The linearity o f the LC-UV response was evaluated with a six-point calibration curve in 
the concentration range 0-2000 ng/ml (0-500 jig kg'1 egg). The regression coefficients 
(r2) of the calibration curves were 0.98-0.99.
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3.4.2.3 Recovery
The recovery of the method was determined using egg samples fortified at 50, 75 and 100 
Hg kg'1 Mean recovery (n=6) at each of the three levels of fortification and determined in 
three separate assays (n=54, total), was between 79 and 105 % (Table 3.1).
Table 3.1: Intra- and inter-assay variation for recovery of robenidine from egg
Analyte
Fortification 
level 
(MS k g ')
Recovery (%)
Assay 1 Assay 2 Assay 3 Inter-assay
Mean RSD Mean RSD Mean RSD Mean RSD
Robenidine 50 79.5 18.0 94.1 9.5 94.5 6.2 89 13.5
75 95.8 6.7 105.0 8.9 102.8 7.0 101 8.2
100 85.1 12.4 100.1 4.2 93.9 4.4 93 10.0
3.4.2.4 Repeatability
The inter-assay repeatability is shown in Table 3.1. At the three levels o f fortification 
RSD values are < 13.5 %. The repeatability o f the method is satisfactory.
3.4.2.5 C C a and CCp
The decision limit (CCa), in the case o f substances for which no MRLs have been set, is 
the lowest concentration level at which it can be concluded that a sample is non- 
compliant, with an error probability of a= l% . The detection capability (CCp) is the 
smallest content of the substance that may be detected, identified and quantified in a 
sample, with an error of probability o f P= 5%. Both of these parameters were determined 
using the calibration curve procedure in which blank egg samples were fortified at the 
minimum required performance level of the method (50 (_ig kg'1) and at 1.5 and 2 times 
that level. CCa and CCP values o f 10 and 17 jag kg'1, respectively, were determined.
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3.5 Conclusions
This study reports the development and validation of a fast and simple LC method for the 
determination of robenidine in eggs. The method was validated according to the 
guidelines described in Commission Decision 2002/657/EC.
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Benzimidazoles are broad-spectrum anthelmintics and have been used for about 40 years 
in animal health and crop protection. Metabolism of the drugs is extensive. The 
metabolites found depend on the structure o f the parent drug, the tissue and the animal 
species. One or more metabolites can be found in animal tissue for most drugs. 1,2 When 
the pro-drugs, active drugs and metabolites are counted, some 19 possible residues may 
occur in animal tissues. The EU has set maximum residue limits (MRLs) for 
benzimidazoles and their metabolites in animal products. The MRL values range from 10 
to 1000 (J.g kg"1, depending on the compound and matrix. Most benzimidazole drugs, with 
the exception of cambendazole, are licensed for use in food-producing animals. The 
development of a single multi-residue method capable o f testing for all the residues in the 
MRL listings is very difficult.
Netobimin (NETO), albendazole (ABZ) and albendazole sulphoxide (ABZ-SO) are 
licensed for use in the treatment of cattle and sheep. ABZ-SO was used for treatment of 
pheasants, but because an analytical method was not satisfactorily validated for pheasant
•5
tissues, no final MRL values could be proposed for pheasants. NETO is a prodrug, 
converted by the gut microflora to ABZ by splitting o f the side chain and formation of the 
benzimidazole nucleus, and ABZ is converted further to ABZ-SO. In cattle, ABZ-SO, 
albendazole sulphone (ABZ-SO2 ) and 2-amino albendazole sulphone (NH2 ABZ-SO2) 
were found to be the major residues detected in liver. Febantel (FEB), fenbendazole 
(FBZ) and oxfendazole, or fenbendazole sulphoxide, (OFZ/FBZ-SO) are licensed for use 
in cattle, pigs, sheep and horses. FEB is a prodrug, converted to FBZ by cyclization to 
form the benzimidazole nucleus. Animal studies showed that FBZ, OFZ/FBZ-SO and 
fenbendazole sulphone (FBZ-SO2) are the important residues. 4'8 However, depending on 
species, route of administration and time after treatment, the forms of residues may vary 
greatly. Mebendazole (MBZ) is approved for use in goats, horses and sheep. When sheep 
were treated with MBZ it was found that the major residues were hydroxy-mebendazole 
(MBZ-OH) and MBZ. 9 Thiabendazole (TBZ) is licensed for use in cattle. In studies on 
cattle 7 and sheep 10, residues of TBZ and hydroxy-thiabendazole (TBZ-OH) were found
4.1 Introduction
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in liver. Flubendazole (FLU) is approved for use in pigs, chicken, turkeys and game 
birds. FLU and amino-flubendazole (NEfeFLU) are the important residues. In turkeys 
treated with FLU, residues were found in all tissues, with NH2FLU accounting for 68 % 
of the total residues in liver. 11 Triclabendazole (TCB) is licensed for use in sheep and 
cattle. In cattle treated with radiolabelled TCB highest residue levels were detected in 
liver after a short withdrawal period. 12 In a study on lactating goats treated with TCB it 
was found that triclabendazole sulphoxide (TCB-SO) and triclabendazole sulphone 
(TCB-SO2 ) residues could be detected in milk. 13 Oxibendazole (OXT) is licensed for use 
in pigs. The marker residue is the parent drug. In studies on cattle, sheep, pigs and horses, 
total OXI residues were found to be less than 100 |ig kg'1 in muscle and fat.
There are many published methods for analysis of benzimidazoles in animal tissues, 
plants and milk products. A number of methods have been reported for the analysis of 
individual benzimidazoles and their metabolites in food products. 14-17 However, because 
of the large number of benzimidazoles licensed for use, multi-residue methods are more 
attractive. Multi-residue methods have been developed for the analysis of benzimidazole 
residues in milk 18 24 and tissues. 25 TBZ has been determined in fruit and vegetable 
matrices based on an ethyl acetate extraction. 26-28 Alternative solvents, such as methanol 
and acetone ’ have been used. Supercritical fluid extraction (SFE) has been used for 
extracting benzimidazole fungicides from fruit and vegetable matrices 32’ 33 and from 
animal tissues.34 Accelerated solvent extraction has been used to extract TBZ from fruit 
and vegetable samples and processed products.35 Matrix solid phase extraction (MSPD)
has been applied by a number of groups for the determination of benzimidazoles in liver.
6 - 4 5
A combination o f liquid-liquid partitioning and solid phase extraction is the most widely 
adopted approach for the clean-up of animal tissue extracts in benzimidazole residue 
analysis. Wilson et ah, 1 purified tissue extracts by partitioning between ethanol: 0.2 N 
hydrochloric acid and hexane before clean-up on a C2  solid phase extraction cartridge. 
Roudaut et al., 36 modified the method by substituting an Oasis HLB cartridge for the C2 
cartridge. Similar liquid-liquid partitioning approaches and further purification of tissue
119
extracts by SPE have used Ci8 37, aminopropyl38, cyano 39, neutral alumina40 and silica 41 
SPE cartridges. Rose et al., 42 applied strong cation exchange (SCX) SPE to the isolation 
of OFZ and nine related residues in liver. Farrington et a l, 43 developed multi-residue 
methods using dual SPE clean-up procedures based on normal phase and Ci8 sorbents. 
Stubbings et a l, 44 developed an online SCX-SPE procedure for the purification of 
benzimidazole residues from tissue. Hiemstra et a l.,31 developed a clean-up procedure for 
the isolation of TBZ and carbendazim residues from fruit and vegetable extracts, using 
liquid-liquid partitioning prior to automated SPE clean-up on diol SPE cartridges 
mounted on an ASPEC system.
4.2 Scope of the Research
The objective of this work was to develop an improved, automated, quantitative method 
for determination o f an extended range of benzimidazoles in liver within a single multi­
residue method by LC-UV. The advantage of XJV detection is that it is commonly found 
in use in analytical laboratories and more sophisticated techniques such as LC-MS/MS 
are not accessible to a number of laboratories due to excessive costs.
Most o f the published methods, such as that by Wilson et a l, 1, deal only with the 
determination of some o f the benzimidazole drugs. Using the approach of identify ng the 
most likely residues to occur in different animal species, a multi-residue method might be 
developed that would provide more complete surveillance for these compounds. 
Following the development, the method was validated according to the procedures 
described in Commission Decision 2002/657/EC. As the benzimidazoles are authorised 
for use, the decision limit (CCa) and detection capability (CC(3) were calculated 
according to the procedure outlined for authorised substances.
4.3 Experimental
4.3.1 Materials and reagents
Water, methanol, acetonitrile, ethyl acetate and dichloromethane (HiPerSolv grade) were 
obtained from BDH (Merck, Poole, Dorset, UK). Triethylamine, glacial acetic acid,
120
ammonia, hydrochloric acid, dimethyl sulphoxide, acetone, hexane, sodium chloride and 
ammonium dihydrogen phosphate (Analytical grade) were from BDH. Ammonium 
hydroxide (ACS grade) was obtained from Sigma (St, Louis, MO, USA). N,N- 
dimethylformamide and sodium bicarbonate (Analytical grade) were obtained from 
Riedel-de-Haen (Seezle, Hannover, Germany). Mebendazole (MBZ), thiabendazole 
(TBZ), albendazole (ABZ) and oxibendazole (OXI) were purchased from Sigma. 
Flubendazole (FLU), amino-flubendazole (NH2FLU) and hydroxy-mebendazole (MBZ- 
OH) were donated by Janssen (Beerse, Belgium). Fenbendazole sulphone (FBZ-SO2 ) and 
fenbendazole sulphoxide (OFZ/FBZ-SO) were donated by Intervet (Dublin, Ireland). 
Albendazole sulphoxide (ABZ-SO), albendazole sulphone (ABZ-SO2 ) and 2-amino 
albendazole sulphone (NH2 ABZ-SO2 ) were donated by GlaxoSmithKline (Harlow, UK). 
Primary stock standard solutions of TBZ in methanol; OXI, MBZ, OFZ/FBZ-SO and 
FBZ-SO2  in dimethylsulphoxide; MBZ-OH in N,N-dimethylformamide; FLU and 
NH2 FLU in N,N-dimethylformamide:methanol (3:2, v/v); NH2ABZ-S02, ABZ, ABZ-SO 
and ABZ-SO2  in N,N-dimethylformamide:methanol (2:8, v/v), were prepared at a 
concentration of 2 mg ml'1. Working standard solutions were prepared in methanol and 
stored at 4°C. Bond Elut™ Cis cartridges (3ml, 500 mg) were obtained from Varian 
(Harbor City, USA), Solid phase extraction was performed using an ASPEC XL4 
instrument (Gilson, Middleton, USA).
4.3.2 LC conditions
The LC system consisted of a model 616 HPLC pump with a model 717 plus autosampler 
and a model 996 photodiode array detector operated at 298 nm (Waters, Milford, MA, 
USA). A gradient LC system (Table 4.1) using ammonium dihydrogen phosphate buffer 
(pH 6.8), methanol and acetonitrile at a flow of 0.5 ml min'1, was used to separate the 
analytes on a stainless-steel analytical column (150 x 3.0 mm I.D.) equipped with a guard 
column (3.0 x 2.0 mm I.D.), both packed with Xterra™ (3.5 jxm) Cig material (Waters). 
The column temperature was maintained at 40°C. Data acquisition and integration were 
performed using Millenium32 chromatographic management software (Waters).
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Table 4.1: HPLC gradient profile for benzimidazoles
Time
(min)
Component A
(%)
Component B
(%)
Component C 
(%)
0 100 0 0
3 45 55 0
10.5 30 70 0
14 15 85 0
18 0 59 41
23 0 0 100
36 0 60 40
43 100 0 0
A: Ammonium dihydrogen buffer pH 6.8 + methanol + acetonitrile (76 + 15 + 9, v/v/v). 
B: Ammonium dihydrogen buffer pH 6.8 + methanol + acetonitrile (52 + 30 +18, v/v/v)
C: Ammonium dihydrogen buffer pH 6.8 + methanol (18 + 82, v/v).
4.3.3 Procedure for liver samples
Liver samples (100 g approximately) were homogenised in a Robot Coupe™ bowl- 
blender (Montceau-en-Bourgogne, France) and stored at -20°C in 150 ml tubes. Liver 
samples previously analysed using method described in this chapter and found to contain 
no detectable residues o f the analytes were used as negative controls. For the preparation 
of fortified liver samples, 3 g portions of negative control liver were weighed into 50 ml 
test tubes. Samples were fortified at levels corresponding to 0.5 x MRL, 1 x MRL and
1.5 x MRL by adding 50 (j.1 portions o f diluted stock solutions. After fortification, 
samples were held for 15 min prior to extraction.
4.3.4 Sample extraction and clean-up
Sodium sulphate (1.5 g), 4 M potassium carbonate (0.5 ml) and ethyl acetate (5 ml) were 
added and the samples were homogenised (30 sec). Samples were centrifuged (2500 
rpm, 10 min, 4 °C). The supernatant was transferred to a clean test-tube and the sample 
was re-extracted with ethyl acetate as before. The supernatants were combined and 
evaporated to dryness under nitrogen (50°C). Ethanol: 0.2N hydrochloric acid (66:33, 
v/v) (1 ml) and n-hexane (5 ml) were added to the dry residue, vortexed (2 min) and 
centrifuged (1500 rpm, 5 min , 4°C). The upper hexane phase was removed. This clean­
up step was repeated with a second portion of hexane (5 ml). Sample extracts were
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further purified by automated SPE using Qg SPE cartridges. Sample extracts (0.6 ml) 
were modified by addition of 2% potassium bicarbonate solution (4 ml). Modified sample 
extracts (3.8 ml) were loaded onto Ci« cartridges (preconditioned with 6 ml ethyl acetate, 
3 ml ethanol and 3 ml distilled water). The cartridges were washed with distilled water (2 
x 1 ml) and then dried. The Ci8 cartridges were eluted with ethyl acetate ( 3 x 1  ml). The 
eluates were reduced to dryness under nitrogen (50°C ) before dissolving in 400 p.1 
methanol:water (50:50, v/v). An aliquot (50 jj.1) was injected onto the LC column.
4.3.5 Calibration
Standards were prepared at concentrations o f 0, 0.25, 0.50, 0.75, 1.5, 3.75, 7.5 and 15 jxg 
ml'1 in methanol:water (50:50, v/v). Calibration curves were prepared by plotting peak 
area as a function of analyte concentration (0 to 15 p,g ml'1). Recovery was determined 
using the peak area values obtained for fortified sample extracts, calculated from the 
calibration curves.
4.3.6 Method validation
For estimation of recovery, blank liver samples were fortified with benzimidazoles at 0.5,
1 and 1.5 times the MRLs. For estimation of the precision of the method, an intra-assay 
study was carried out by fortifying bovine liver samples at each level (n =  6) and 
extracting and analysing in a single run. The inter-assay study involved fortifying bovine 
liver samples as described and extracting and analysing in three separate assays. The 
decision limit (CCa) and the detection capability (CCP) of the method were calculated 
using the intra-assay validation results. The selectivity/specificity and linearity o f the 
method were also established.
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4.4 Results and Discussion
4.4.1 Preliminary experiments
Previous work in this laboratory had developed a ternary gradient LC method for 
separation of 19 benzimidazole drugs, with detection at 298 nm. 34 This method was 
applied to the separation of benzimidazole drugs in this study. From an evaluation of 
different extraction solvents, ethyl acetate was found to give the best recovery for the 
compounds of interest. Ethyl acetate has good solvating power for weakly basic drugs 
because it can provide emulsion-free extraction from liver and muscle tissue samples. 
Multi-residue extraction of benzimidazoles at a set pH is difficult because of their varied, 
and in some cases multiple, pKa values. The effect of pH was studied over the range pH 5 
to pH 10, based on a method described by Cannavan et a l, 39 for extraction of TBZ from 
tissue using buffering at pH 7 and extraction with ethyl acetate. The possibility of using 
the ChemElut™ diatomaceous earth buffered and unbuffered columns was also evaluated 
but low recoveries were obtained. Wilson et a l, 7 developed an extraction procedure 
based on carbonate buffer/ethyl acetate for ABZ, TBZ-OH, OFZ, TBZ, CAM, MBZ and 
FBZ. Similarly, carbonate buffer extraction and liquid partitioning steps were used by 
Roudaut et a l, 36 for TBZ-OH, TBZ, NH2ABZS02, ABZ-SO, OXI, OFZ, ABZ-S02, 
ABZ and FBZ. After extraction, liquid partitioning between hexane and 
ethanol:hydrochloric acid, 0.2 N (33:66 v/v) was used in both these methods. Further 
clean-up o f the tissue extracts was achieved by solid phase extraction on C2 cartridges 7 
or on Oasis HLB™ cartridges.36
A carbonate buffer/ethyl acetate extraction and liquid partitioning, followed by solid 
phase extraction using Ci8 cartridges was developed in this work and applied to a wider 
range of benzimidazoles to include MBZ-OH, NH2FLU, FBZ-S02 and FLU. TBZ-OH, 
which is a marker residue for thiabendazole, was not included because of incomplete 
chromatographic separation of this analyte from NH2ABZS02; preliminary experiments 
indicate that TBZ-OH is extracted with similar yield as TBZ using the method. In total, 
drugs from six o f the seven classes o f benzimidazoles listed are included; triclabendazole 
and its metabolites are not extractable using this method (Table 2:1).
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Hiemstra et ah, 31 developed an automated SPE clean-up on diol cartridges for 
determination of thiabendazole and carbendazim residues in fruit and vegetable extracts. 
The Ci8 solid phase extraction step in the current method was automated using an ASPEC 
XL4™ system. Compared with the method described by Wilson el ah, 1 the method 
developed here incorporates automated SPE on Ci8 cartridges and has been applied to an 
extended range of benzimidazoles, including most of the marker residues designated by 
EU MRL regulations.
4.4.2 Validation study
Validation of the method was according to procedures described in Commission Decision 
2002/657/EC 46 covering specificity, calibration curve linearity, recovery, repeatability, 
decision limit (CCa) and detection capability (CCP).
The method was validated using bovine liver, as a model matrix, and applying the MRL 
values specified for liver of each species. Preliminary experiments with liver samples of 
other species indicate that comparable extraction yield is obtainable and that the 
developed method may be applicable to liver samples of other species. While most MRL 
values are expressed as the sum of the marker residues, validation was undertaken 
applying the MRL value for each individual marker residue; this was necessary because 
of the variability in the proportions o f marker residues which might occur in samples. 
For benzimidazoles for which MRL values have not been specified for a particular 
species, the method would require further validation according to the procedures 
described in Commission Decision 2002/657/EC for substances for which no permitted 
limit has been established.
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4.4.2.1 Specificity
To establish the selectivity/specificity of the method, liver samples fortified with the 
benzimidazoles and non-fortified samples were analysed. No interfering peaks were 
observed at the retention time for the benzimidazoles (Figure 4.1) except at the retention 
time for ABZ where an interfering peak o f negligible size, relative to the response for 
MRL concentration, was observed.
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Figure 4.1 Chromatogram of blank liver sample and sample fortified at the MRLs
4.4.2.2 Linearity of the response
The linearity o f the chromatographic response was tested with 7 calibration points in the 
concentration range o f 0.25 to 15 pg ml'1. The regression coefficients (r2) for the 
calibration curves used in the study were > 0.99.
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4.4.2.3 Recovery
The accuracy o f the method was determined using bovine liver samples fortified at 0.5 x 
MRL, MRL and 1.5 x MRL for each benzimidazole. Mean recovery (n = 6) o f the 
analytes, determined in three separate assays, was between 60 and 100 % for ABZ-SO, 
ABZ-SO2 , TBZ, OFZ/FBZ-SO, MBZ-OH, FBZ-S02, OXI, MBZ and FLU (Table 4.2). 
Lower mean recoveries o f  approximately 50 % were obtained for NH2 FLU and ABZ. 
NH 2 ABZ-SO2  was recovered at approximately 25 %, probably due to the difficulty in 
extracting this relatively polar compound from tissue.
4.4.2.4 Repeatability
The inter-assay repeatability is shown in Table 4.2. For most analytes and at the three 
levels o f  fortification (0.5 x MRL, MRL and 1.5 x MRL), RSD values were at less than
25 %. In some instances (NH2FLU at 0.5 x MRL, OXI at MRL, and ABZ at MRL), RSD 
values were in excess o f  25 %. More work involving incorporation o f an internal standard 
would be necessary for these compounds. Overall, the repeatability o f the method for 
benzimidazoles is satisfactory.
4.4.2.5 CCa and CCp
The decision limit (CCa) is, in the case o f substances for which MRLs have been 
defined, the lowest concentration level at which it can be concluded that a sample is non- 
compliant, with an error probability o f a = 5 %. The detection capability (CCP) is the 
smallest content o f the substance that may be detected, identified and quantified in a 
sample, with an error probability o f P = 5 %. Both o f these parameters were determined 
using the calibration curve procedure, in which blank bovine liver was fortified around 
the MRL values in equidistant steps (0.5 x MRL, MRL, 1.5 x MRL). The concentration 
at the MRL plus 1.64 times the standard deviation at the MRL gives the CCa value for 
each benzimidazole. The CCP value for each benzimidazole is determined as the 
CCa value + 1.64 times the standard deviation. Table 4.3 lists the CCa and CCP values 
for the benzimadazoles, using the data from Assay 1. With the exception o f NH2ABZ-
1 2 7
S02, CCa values ranged between MRL + 12 % and MRL + 25 % and CCP values ranged 
between MRL + 25 %  and MRL + 45 % for the benzimidazoles included in the study.
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Table 4.2: Intra and inter-assay variability for the recovery o f benzimidazoles from liver
Analyte Fortification Recovery
(%)
level Assay 1 Assay 2 Assay 3 Inter­
assay
(Hgkg1) Mean RS.D Mean R.S.D Mean R.S.D Mean R.S.D
n h 2a b z - s o 2 500 27 10.0 22 17.8 26 15.4 25 15.9
1000 24 10.2 22 3.3 23 6.7 23 7.7
1500 24 12.4 19 12.2 19 21.9 20 16.4
ABZ-SO 500 68 9.3 60 11.0 73 6.4 67 11.7
1000 62 8.7 57 5.3 62 6.3 61 7.5
1500 61 9.8 61 1.1 52 6.5 57 10.2
a b z - s o 2 500 75 6.3 61 8.2 73 10.5 70 12.1
1000 72 9.0 58 8.7 69 17.1 67 15.1
1500 66 7.0 62 1.7 63 10.9 64 7.8
TBZ 50 74 8.6 63 24 96 4.6 78 21.8
100 82 8.9 56 5.4 85 9.1 76 19.2
150 83 5.5 66 8.7 78 7.2 76 11.4
OFZ/FBZ-SO 250 85 5.2 61 5.8 73 6.6 73 15.1
500 83 7.3 57 9.3 67 18.5 69 19.6
750 83 7.0 64 2.6 62 8.9 70 15.8
MBZ-OH 200 83 6.3 63 6.7 103 14.2 83 21.3
400 89 8.4 60 10.9 77 20.5 76 20 9
600 83 7.1 61 5.1 64 8.5 70 16.3
n h2flu 150 62 6.1 40 12.2 35 9.1 46 27.7
300 68 10.5 39 5.7 54 16.7 54 24.3
450 62 7.7 40 14 56 14.5 54 20.7
f b z -s o 2 250 87 4.9 58 4.0 74 5.9 73 17.4
500 86 9.2 55 7.8 71 24.1 71 23.5
750 84 7.3 62 2.8 59 16.3 69 19.2
OXI 100 92 4.3 69 4.9 120 13.6 93 24.9
200 90 10.1 61 7.3 119 22.1 94 32.5
300 85 7.0 66 2.1 76 18.2 76 15.3
MBZ 200 94 3.6 67 6.5 100 5.2 87 17.6
400 87 6.0 59 7.5 84 23.2 77 22.8
600 79 8.1 61 3.4 65 21.7 69 17.2
FLU 200 78 3.0 54 7.7 85 8.2 72 19.9
400 78 7.5 48 8.1 67 15.2 65 21.4
600 69 8.9 53 5.2 54 20.8 59 17.8
ABZ 500 63 3.2 39 7.3 56 6.9 53 20.6
1000 59 9.0 36 8.4 48 30.4 48 27.4
1500 54 9.2 40 12.0 44 21.3 46 19.0
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Table 4.3: Calculated CCa and CCp values based on data from Assay 1 (Table 4.2)
Benzimidazole MRL 
(n9 kg -1)
CCa 
(ng kg -1)
ccp
(U0 kg'1)
NH2ABZ-SO2 1000 1303 1556
ABZ-SO 1000 1164 1343
ABZ-SOz 1000 1225 1417
TBZ 100 116 132
OFZ/FBZ-SO 500 561 627
MBZ-OH 400 481 544
NH2FLU 300 376 435
fbz-s o 2 500 587 670
OXI 200 242 281
MBZ 400 467 520
FLU 400 493 558
ABZ 1000 1216 1397
4.5 Conclusions
A method was developed and validated for quantitative analysis o f 11 benzimidazole 
veterinary drugs in animal liver; ABZ, ABZ-SO and ABZ-SO2 , TBZ, OFX/FBZ-SO and 
FBZ-SO2 , MBZ and MBZ-OH, FLU and NH2FLU, and OXI. TCB and its metabolites, 
TCB-SO and TCB-SO2 , were not quantitatively determined using this method. This 
multi-residue method covers six o f the seven benzimidazole groups that are licensed for 
use within the EU. Future work might concentrate on the development of a separate 
method for the TCB group to allow complete surveillance for the mis-use o f the 
benzimidazole drugs in agriculture. To date however there is no method available that 
can screen for all the benzimidazole metabolites. The development o f such a method 
could be accomplished using the technique o f derivitisation.
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5.1 Introduction
Malachite green (MG) and crystal violet (CV) are triphenylmethane dyes. MG has been 
used as a topical fungicide and antiprotozoal agent in salmonid farming throughout the 
world for over 60 years. Few known chemicals are as effective in treating ectoparasites of 
fish and fish eggs by fungi o f the genus Saprolegnia and by the protozoan parasite 
Ichthyophthirius multifiliis. 1 CV is also known to be effective in the treatment o f fungal 
infections. It had found widespread use as a feed additive to inhibit mould and fungal 
growth in poultry feed before 1990. 2 According to EU law, all substances for veterinary 
use need to be included in annexes 1, 2 or 3 o f  Regulation 2377/90. MG or CV, however, 
are so-called “non-defended” compounds that have never been registered for veterinary 
use. As a result o f these anti-fungal properties there is a serious potential for the mis-use 
o f these drugs in aquaculture. Recently there has been a number o f reports of these 
residues in aquaculture products (cf. EC Rapid Alert Reports for Food and Feed 
2003/2004/2005/2006). Concerns regarding residues o f MG in aquaculture products have 
prompted studies o f the pharmacokinetics and metabolism o f this compound. However 
there is limited data regarding the pharmacokinetics and metabolism of CV. 
Leucomalachite green (LMG) and leucocrystal violet (LCV) are formed by the metabolic 
reduction o f MG and CV and in this form the drug persists in the tissues o f exposed fish.
The U.S Food and Drug Administration explicitly banned the use o f MG in fish farming 
in 1991 due to its suspected carcinogenic properties. MG and CV are structurally related 
to other triphenylmethane dyes such as rosaniline which has been linked to increased risk 
o f human bladder cancer. The leuco form of rosaniline induces renal, hepatic and lung 
tumors in mice. 5 CV has been implicated in the induction o f thyroid and liver tumors. 6 
Studies show that LMG is an in-vivo mutagen and the mutagenicity o f MG and LMG 
correlates with their tumorgenicities in mice. 7 MG has also been shown to cause DNA 
damage. 8 CV was found to be cytotoxic to mammalian cells 9 as was MG. 10 Compared 
to LMG, MG is much less toxic to cells. 10 No safe levels for the presence o f  MG, LMG,
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CV and LCV in fish for human consumption could be established and therefore, detection 
o f these compounds at sub |J.g kg 1 levels is required.
Within the EU, each member state is required to monitor for MG and LMG residues with 
analytical methodology that at least meets the Minimum Required Performance Limit 
(MRPL). The MRPL, a quality parameter for residue laboratories, is set as the sum of 
MG and LMG at 2 fig kg"1.11 There is no MRPL set for CV so developed methods must 
be capable o f monitoring levels as low as is reasonably achievable.
Most methods currently used are based on the solvent extraction o f MG and LMG from 
fish tissues using acetonitrile or methanol with aqueous buffer (pH 3-4.5). 12'25 In the 
clean-up o f these samples a combination o f liquid/liquid partitioning and solid phase 
extraction is used. Bergwerff et a l, 21 purified catfish, eel, trout, turbot and prawn 
samples by partitioning acetonitri 1 e:McITIvaine pH 3 buffer (90:10, v/v) against 
chloroform before passing the chloroform extract through a Bakerbond ™ strong cation 
exchange solid phase extraction cartridge. This clean-up approach has been adopted by 
other groups using a single solid phase extraction cartridge 12"20 or using dual solid phase
3 1619  • 18extraction with aluminia and propylsulphonic acid cartridges. ’ ’ Van Rhijn et al., 
modified the method o f Bergwerff et al., 21 by eliminating the liquid/liquid partitioning 
step. Other methodologies eliminated the liquid/liquid partitioning steps and purified 
tissue extracts directly using C is24 and cyano 22 SPE cartridges. Swarbrick et a l, used an 
alternative clean-up using activated charcoal instead o f Cig SPE. 26
A number o f methods have been reported for the analysis o f  MG,LMG,CV and LCV 
residues by visible light detection with oxidation o f  the leucometabolites carried out
m 1  1 ^  1 Q  »j l  2** < )7
either pre-column or post-column. J’ J’* Other methods developed for the
detection o f these residues are based on this oxidation but with detection by mass 
spectrometry. Detection o f  these residues by mass spectrometry in the absence of
this oxidation has also been accomplished. 1518’24 An alternative oxidation approach using 
2,3-dichloro-5,6-dicyano-l,4- benzoquinone (DDQ) before the determination step to
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oxidise LMG to MG has also been utilised. 30,31 Determination based on electrochemical 
detection,27 GC-MS, 23 and spectrophotometry 17 has also been achieved.
The method developed in this study was based on the method developed by Van Rhijn et 
a l, 18 but adapted to include CV, LCV, and deuterated internal standards for LMG and 
for MG. The method omits the often-proposed pre-column or post-column oxidation step 
used in the determination of MG or CV. The method also omits the liquid/liquid 
partitioning stage often used in the clean-up o f extracts containing these residues. The 
method is a simple extraction with acetonitrile:McIIvaine buffer pH 3 (90:10, v/v), with 
clean-up using aromatic sulphonic acid solid phase extraction and LC-MS/MS analysis. 
The applicability o f  the method for regulatory control will be discussed.
5.2 Scope of the Research
The objective o f this work was to develop a multi-residue confirmatory method for the 
determination o f MG, LMG, CV and LCV by LC-MS/MS. The advantage o f MS 
detection is that it provides unambiguous identification o f unknowns and this technique is 
the method o f analysis o f  choice in screening for banned substances.
To date there is no method that simultaneously determines MG, LMG, CV and LCV by 
LC-MS/MS that is validated according to the guidelines o f  2002/657/EC. Following the 
development, the method was validated according to the procedures described in 
Commission Decision 2002/657/EC. As these dyes are not authorised for use, the 
decision limit (C C a) and detection capability (CC|3) were calculated according to the 
procedure outlined for unauthorised substances.
5.3 Experimental
5.3.1 Materials and reagents
Water, methanol, acetonitrile, ethyl acetate and hexane (HiPerSolv grade) were obtained 
from BDH (Merck, Poole, Dorset, UK). Ammonium hydroxide (ACS grade) was 
obtained from Sigma (St. Louis, MO, USA). Citric acid (ACS grade) was obtained from 
Sigma (St. Louis, MO, USA). Disodium hydrogen phosphate (ACS grade) was obtained 
from Sigma (St. Louis, MO, USA). Ascorbic acid (ACS grade) was obtained from Fluka
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(CH-9470 Buchs, Switzerland). MG, LMG and CV were purchased from Sigma. ds-MG 
and ds-LMG were obtained from Witega (Berlin, Germany). LCV was purchased from 
Dr. Ehrenstorfer (QMX Laboratories, UK). Primary stock standard solutions o f MG, 
LMG, ds-MG, ds-LMG, CV and LCV were prepared in acetonitrile at a concentration of 
100 jig m l'1. Intermediate single standards solutions o f  MG, LMG, ds-MG, ds-LMG, CV 
and LCV were prepared in acetonitrile:water (50:50, v/v) at a concentration o f 1 fig ml'1. 
Mixed standard fortification solutions o f  MG, LMG, CV and LCV were prepared in 
acetonitrile:water (50:50, v/v) at concentrations o f 50 ng m l'1 and 200 ng ml'1. Mixed 
standard fortification solution o f  ds-MG, ds-LMG was prepared in acetonitrile:water 
(50:50, v/v) at a concentration o f 100 ng ml'1. All standards were stored at 4 °C. 
Bakerbond ™ SCX cation exchange solid phase extraction cartridges (3 ml, 500 mg) 
were obtained from J.T Baker (Harbor City, USA). McIIIvaine pH 3 buffer was prepared 
by adding 0.1 M citric acid (250 ml) and adjusting to pH 3 with 0.2 M  disodium 
hydrogen phosphate and diluting to 1000 ml with water. Extraction solvent was prepared 
by making a solution in the ratio o f acetonitrile:McIIIvain pH 3 buffer (90:10, v/v). A 2 
% ammonium hydroxide solution in methanol was used as the solid phase extraction 
elution solvent. Injection solvent consisted o f 1% ascorbic acid in acetonitrile:water 
(50:50, v/v).
5.3.2 LC conditions
The LC system consisted o f a model Finnigan TSQ Quantum Ultra (MS) coupled to a 
Finnigan Surveyor LC Pump and a Finnigan Surveyor Autosampler (Thermo Electron 
Corporation, CA, USA). A  gradient LC system (Table 5.1) using ammonium formate 
:water (5:95, v/v Mobile phase A) and ammonium formate:acetonitrile (5:95, v/v Mobile 
phase B) at a flow o f 0.350 jj,1 min'1, was used to separate the analytes on a Phenomenex
3 (im Cis 100 A (100 x 2.0 mm) (Phenomenex, UK) column equipped with a guard 
column (10.0 x 2.0 mm I.D.) packed with Hypersil ™ (3.0 jim) Cg material (Thermo 
Electron Corporation, UK). The column temperature was maintained at 45°C. Data 
acquisition and integration were performed using XCalibur version 1.4 chromatographic 
management software (Thermo Electron Corporation, CA, USA).The LC system was 
equilibrated for 30 min at a column oven temperature o f 45 °C. A  linear gradient (Table
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5.1) was used ramping from 10 % B to 90 %  B over 7.2 min: once at 90 % B, the system 
was held for 7.3 min and returned to 10 % B over a period o f 2.0 min. The runtime was
21 min. The described gradient LC system was shown to be suitable for the analysis o f 
MG, LMG, CV and LCV (Figures 5.1-5.4 (weak transitions)).
Table 5.1: LC gradient profile for determination o f MG, LMG, CV and LCV.
Time
(min)
Component A 
(%)
Component B 
(%)
0.0 90 10
0.5 90 10
3.0 50 50
7.2 10 90
14.5 10 90
[6.5 90 10
21.0 90 10
Component A: Ammonium formate buffer + water (5 + 95, v/v) with 200 jal o f
formic acid
Component B: Ammonium formate buffer + acetonitrile (5 +  95, v/v) with 200 (il
o f  formic acid
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5.3.3 MS-MS parameters
The analysis was performed using positive-ion electrospray (ESI) interface with multiple 
reaction monitoring (MRM) mode. Two transitions per compound were used and the 
spray and collision voltages were optimised as shown (Table 5.2). The MS/MS detector 
conditions were as follows: Ion mode ESI+; gas sheath pressure 60 psi; capillary 
temperature 375 °C; source CID -10 V; collision pressure 1.5 torr; collision gas argon.
Table 5.2: MS/MS parameters for determination of MG, LMG, CV and LCV
Compound Transition Spray Voltage [V]
Collision
[eV]
Rt
[min]
MG 329>313 (strong) 4000 35 8.1
329>208 (weak) 4000 37 8.1
LMG 331>239 (strong) 4000 35 13.2
331>316 (weak) 4000 23 13.2
d5-MG (IS) 334>318 4000 35 8.1
ds-LMG(IS) 336>239 4000 35 13.2
CV 372>356 (strong) 4000 57 8.7
372>340 (weak) 4000 40 8.7
LCV 374>358 (strong) 4000 35 13.5
374>238 (weak) 4000 30 13.5
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5.3.4 Procedure for Salmon Samples
Whole salmon obtained from a local supermarket were homogenised in a bowl-blender 
(Waring, UK) and stored at -20  °C in 150 ml glass jars. Laboratory samples of salmon 
tissue were previously analysed by method described in this chapter and those found to 
contain no detectable residues o f the analytes were used as negative controls.
5.3.5 Sample extraction and clean-up
Salmon samples (2 g) were weighed into 50 ml polypropylene tubes. Samples were 
fortified with internal standard at levels corresponding to 2.5 fig kg'1 by adding 50 pil 
portion o f 100 ng m l'1 mix solution o f ds-MG and ds-LMG. Samples were fortified at 
levels corresponding to 1, 1.5 and 2 |ig kg'1 by adding 40, 60 and 80 ju.1 portions o f 50 ng 
ml'1 mix solution o f MG, LMG, CV and LCV. After fortification, samples were held for 
15 min prior to extraction. Acetonitrile:McIIIvaine pH 3 buffer (90:10, v/v) (20 ml) was 
added and the samples were homogenised (30 sec). Samples were shaken (5 min) and 
sonicated (15 min). The samples were centrifuged (3000 rpm, 5 min, 4 °C) and the 
supernatant was transferred to a clean polypropylene tube. The samples were re­
extracted with acetonitrile:McIIIvaine pH 3 buffer (90:10, v/v) as before. The 
supernatants were combined and sample extracts were further purified by ion exchange 
solid phase extraction using Bakerbond SCX SPE cartridges. Sample extracts (40 ml) 
were loaded onto the cartridges (preconditioned with 2 ml methanol, 2 ml 
acetonitrile:McIIIvain buffer (90:10, v/v). The cartridges were washed with distilled 
water (1 ml), methanol (1 ml), ethyl acetate (1 ml), hexane (1 ml) and then dried using a 
vacuum pump (3 min). The cartridges were eluted with 2 % ammonium hydroxide in 
methanol ( 3 x 2  ml). The eluates were reduced to dryness under vacuum at 45°C before 
re-dissolving in 250 (j.1 o f  1% ascorbic acid in acetonitrile:water (50:50, v/v). An aliquot 
(20 (il) was injected onto the LC column.
5.3.6 Matrix-Matched Calibration curve
Matrix matched calibration curves were prepared and used for quantification. Control 
tissue previously tested and shown to contain no residues was prepared as above (5.3.4). 
One control tissue sample was used for each calibration standard level. Salmon samples
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(2 g) were weighed into 50 ml polypropylene tubes. Samples were fortified with internal 
standard at levels corresponding to 2.5 |_ig kg"1 by adding 50 nl portion o f 100 ng ml"1 
mix solution o f ds-MG and ds-LMG. Samples were fortified at levels corresponding to 0, 
0.5, 1 and 2 ng kg"1 by adding 0, 20, 40 and 80 |il portions o f a 50 ng ml'1 standard 
solution. Samples were fortified at the 5 and 10 |ig  kg'1 calibration levels by adding 50 
and 100 p.l portions o f a 200 ng ml'1 standard solution. After fortification, samples were 
held for 15 min prior to extraction procedure as above (5.3.5).
Calibration curves were prepared by plotting the response factor as a function o f analyte 
concentration (0 to 10 ng kg ').
5.3.7 Method validation
For estimation o f accuracy, blank salmon tissue samples were fortified with MG, LMG, 
CV and LCV at 1, 1.5 and 2.0 ng kg'*. Six replicate test portions, at each o f  the three 
fortification levels, were analysed. Analysis o f the 18 test portions was carried out on 
three separate occasions. For the estimation o f the precision o f the method, intra-assay 
and inter-assay repeatability was calculated. The decision limit (C C a) o f the method 
were calculated according to the calibration curve procedure using the intercept (value of 
the signal, y, where the concentration, x is equal to zero) and 2.33 times the standard 
error o f the intercept for a set o f  data with 6 replicates at 3 levels. The detection 
capability (CC(3) was calculated by adding 1.64 times the standard error to the CCa.
5.4 Results and Discussion
5.4.1 Preliminary experiments
The LC-MS/MS method was developed to provide confirmatory data for the analysis o f 
salmon for MG, LMG, CV and LCV. The MS/MS fragmentation conditions were 
investigated and collision energies were optimised for each individual compound. For a 
method to be deemed confirmatory one precursor ion (parent mass) and two daughters 
(corresponding to strong and weak ion) must be monitored (Table 5.2) this yields 4 
identification points, which is a suitable confirmatory method in accordance with CD 
2002/657/EC.
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MG and LMG are separated on a Phenomenex Ci8 column with a retention time o f 8.1 
and 13.2 min, respectively. Similarly CV and LCV are separated with a retention time of
8.7 and 13.5 min, respectively. ds-MG was used as I.S for MG and similarly ds-LMG was 
utilised as internal standard for LMG. As there are no deuterated standards o f CV and 
LCV currently available, ds-MG and ds-LMG were used as internal standard for these 
analytes as well.
5.4.2 Validation study
Validation o f the method was according to  procedures described in Commission Decision 
2002/657/EC [29] covering specificity, calibration curve linearity, recovery (accuracy), 
repeatability, decision limit (C C a) and detection capability (CCji).
5.4.2.1 Specificity
The technique o f LC-MS/MS itself offers a high degree o f selectivity and specificity. To 
establish the selectivity/specificity o f  the method, salmon samples were fortified with the 
four analytes and the internal standards and non-fortified samples were also analysed. 
Interfering peaks were observed at the retention time for some transitions but upon 
quantification were so low as to be o f  little significance. (Figures 5.1-5.4)
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Figure 5.1: Chromatogram of Negative Control Salmon (top) and Negative Control Salmon Fortified at 0.5 ng kg'1 with MG
T im e (m in)
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Figure 5.2: Chromatogram of Negative Control Salmon (top) and Negative Control Fortified at 0.5 pg kg 1 with LMG
R T :  0 . 0 0  •  2 0 . 9 9
N L :  1 . 6 9 E 4
8 . 9 6  m/z=  3 1 5 . 6 0 - 3 1 6 . 6 0  F :  +
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Figure 5.3: Chromatogram of Negative Control Salmon (top) and Negative Control Fortified at 0.5 (J.g kg 1 with CV
Time (mln)
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Figure 5.4: Chromatogram of Negative Control Salmon (top) and Negative Control Fortified at 0.5 |ig kg 'with LCV
NL: 4 .0 3 E 3
m/z*= 2 3 7 .6 0 -2 3 8 .6 0  F: +
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5.4.2.2 Linearity of the response
The linearity o f the chromatographic response was tested with matrix matched curves 
using 6 calibration points in the concentration range o f 0 to 10 |ig kg'1. The regression 
coefficients (r2) for all the calibration curves used in this study were > 0.990.
5.4.2.3 Recovery
The recovery o f the method was determined using salmon samples fortified at 1.0, 1.5 
and 2 |ig kg-1 for each dye. Mean corrected recovery (n = 6) o f the analytes, 
determined in three separate assays shown in Table 5.3 was between 77 and 113 % for 
MG, LMG, LCV and CV.
5.4.2.4 Repeatability
The usefulness o f  suitable deuterated standards is demonstrated in the excellent intra 
and inter repeatability obtained for MG and LM G (Table 5.3). Although no deuterated 
analogue is available for LCV, still a very acceptable repeatability is obtained by 
using the IS o f LMG. Less favourable is the situation for CV. The rather high RSD 
values obtained for both the intra and inter repeatability o f  CV (between 20 to 25%), 
even by applying correction by means o f  the IS o f MG indicates the necessity o f  the 
incorporation o f a structurally identical isotopically-labelled IS in the method.
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Table 5.3: Intra- and inter-assay variation for accuracy o f malachite green, 
leucomalachite green, crystal violet and leucocrystal violet from salmon
Analyte
Fortification
level
O^gkg1)
Accuracy
Assay 1 Assay 2 Assay 3 Inter-assay
Mean RSD Mean RSD Mean RSD Mean RSD
MG 1.0 104 1.9 96 6.9 107 2.5 102 6.2
1.5 108 3.3 98 7.1 113 3.7 106 7.6
2.0 104 2.3 96 2.9 109 4.5 103 6.1
LMG 1.0 96 10.9 99 3.0 102 0.1 100 6.3
1.5 97 2.7 97 6.3 103 1.0 90 4.7
2.0 97 1.4 96 4.3 98 3.5 97 3.2
CV 1.0 92 10.4 89 9.3 105 28.8 96 20.2
1.5 102 24.3 81 14.0 94 29.0 92 24.7
2.0 111 15.1 90 20.3 104 23.5 101 20.0
LCV 1.0 77 7.3 99 3.0 100 5.2 92 13.1
1.5 89 6.0 102 9.0 97 2.3 96 8.4
2.0 96 8.7 103 6.0 95 5.8 98 7.6
5.4.2.5 CCa and CCP
The decision limit (CCa) is defined as the limit above which it can be concluded with 
an error probability o f  a, that a sample contains the analyte. In general, for non-MRL 
substances an a  equal to  1 % is applied. The detection capability (CCP) is the smallest 
content o f the substance that may be detected, identified and quantified in a sample, 
with a statistical certainty o f  1-P, were P = 5 %. CCa and CCP were calculated using 
the intercept (value o f the signal, y, were the concentration, x is equal to zero) and the 
standard error o f the intercept for a set o f data with 6 replicates at 3 levels (1, 1.5 and
2 ng kg'1). Blank salmon tissue was fortified at 1, 1.5 and 2 times the MRPL o f 2 jig 
kg"1 set for MG; 1 \xg kg"1 for each compound has been used for the method validation 
in this work as the MRPL is set for the sum of MG and LMG. There is no limit set for 
CV and LCV and the method was validated at the same levels as described in the 
study for MG. CCa is the concentration corresponding to the intercept + 2.33 times 
the standard error o f  the intercept. CCa values o f  0.17, 0.15, 0.35 and 0.17 (ig kg"1 
respectively were achieved for MG, LMG, CV and LCV. CCP is the concentration
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corresponding to the signal at CCa + 1.64 times the standard error o f the intercept (i.e 
the intercept + 3.97 times that standard error o f the intercept). CCP values o f 0.30, 
0.35, 0.80 and 0.32 |j,g kg'1 were achieved for MG, LMG, CV and LCV.
5.5 Conclusions
A relatively fast, simple and selective liquid chromatography-tandem mass 
spectrometric method for the simultaneous detection o f  MG, LMG, CV and LCV in 
salmon has been developed. There is no published confirmatory method for the 
simultaneous determination o f  MG, LMG, CV and LCV in salmon that is validated 
according to Commission Decision 2002/657/EC. The obtained data fulfils the 
requirements laid down in Commission Decision 2002/657/EC and allows the 
calculation o f all relevant performance characteristics. This study shows that the 
required sensitivity for MG and LMG were obtained that easily meets the MRPL of 2 
|ig kg'1 and that the method is suitably sensitive for CV and LCV. The method 
performs very well in terms o f accuracy and repeatability for MG, LMG and LCV. 
For CV improvements can be made if a suitable deuterated analogue becomes 
available.
The reduced number o f analytical steps within the method makes it very amenable for 
high through-put regulatory monitoring o f these compounds. There is no published 
confirmatory method for the simultaneous determination o f MG, LMG, CV and LCV 
in salmon that is validated according to Commission Decision 2002/657/EC. The 
objective o f the work to develop a method for these residues in salmon at sub |jg kg 1 
levels and validate according to  the requirements in Commission Decision 
2002/657/EC therefore has been achieved successfully. 29
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Chapter 6
Conclusions
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This thesis discusses the development and validation o f methodology for 
determination o f the coccidiostat robenidine, the benzimidazoles and the 
triphenyl methane dyes. A particular emphasis is placed on the development of 
methods that allow high through-put sample analysis. The thesis also applies newer 
applications in sample clean-up and detemination o f these residues.
The main objectives o f the research work described in this thesis were:
1 The development o f chromatographic screening methods for quantitative 
determination o f banned (robenidine) and MRL (benzimidazoles) substances in 
chicken eggs and bovine liver respectively and adoption o f criteria governing 
method validation for banned and MRL substances according to Commission 
Decision 2002/657/EC.
2 The development o f a confirmatory method for the quantitative determination o f 
the banned substance MG and its major metabolite LMG, CV and LCV in farmed 
salmon and adoption o f  the rules governing confirmatory method validation for 
these banned substances according to Commission Decision 2002/657/EC.
3 As a byproduct o f the research the implementation o f the developed methods into 
national surveillance schemes in Ireland established under Council Directive 
96/23/EC on measures to control certain substances and residues thereof in animal 
products.
These objectives have been accomplished and a number o f practical developments 
have been made in the areas studied. In chapter 3, The first reported LC-UV method 
was developed for the analysis o f robenidine in eggs. In the future the development o f 
a confirmatory method for this compound by LC-MS/MS could be developed and 
work might also focus on the development o f multi-residue methodology for the 
determination o f other coccidiostats in egg, feed and animal tissues using this 
technique. Although there are a large number o f methods for benzimidazoles, not all 
o f these methods are multi-residue. To date, however there is no method available that 
can screen for all the benzimidzole metabolites. The development o f such a method 
could be undertaken by using a derivitisation technique. Future investigations should 
concentrate on the development o f this technique. Using the approach of identifying 
the most likely residues to occur in different animal tissues, a multi-residue method 
was developed that provides more practical surveillance o f these compounds. The first
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reported multi-residue automated SPE using this approach for the determination o f 
benzimidazoles in liver was described in chapter 4. Further improvements in the 
analysis o f these compounds in liver could be achieved by the implementation o f an 
automated extraction step. This coupled with the automated SPE described in chapter
4 would improve sample handling. In future the possibility o f  developing on-line 
clean-up procedure using trace enrichment cartridges and column switching could be 
investigated. There is also a lack o f multi-residue methods, which target TCB, FLU 
and MBZ licensed groups in conjunction with other residues. Since these drugs are 
used widely in veterinary medicine there is a need to develop such multi-residue 
methods. There is also a need to develop multi-residue methodology for the 
determination o f benzimidazoles in milk.
Although there are a number o f  methods for M G and LMG, there is a lack o f single 
and multi-residue methods that target other Group B3 (e) dyes such as CV, LCV, 
brilliant green, leucobrilliant green, ethyl violet, methyl violet and methylene blue. In 
chapter 5 the first reported multi-residue method for the determination o f MG, LMG, 
CV and LCV in salmon by LC-MS/MS that is validated according to 2002/657/EC 
was described. Future work should concentrate on developing single residue methods 
for the determination o f these dyes in fish. There is also limited data available on the 
depletion o f these dyes from fish tissues. Toxicological studies on these dyes are also 
very limited. Future work should concentrate on expanding the method described in 
chapter 5 to include the other dyes. No such multi-residue method currently exists. A 
future application o f the method would be to  survey a variety o f  fish and aquaculture 
products to determine prevalence o f these residues which is currently unknown. The 
dyes are possibly the least researched o f the three topics investigated in this thesis in 
the world today. There are a number o f  methods available for coccidiostats and 
benzimidazoles but with the exception o f malachite green and its metabolite limited 
information regarding the other dyes.
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Chapter 7
Publications
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1. Conference Papers
G. Dowling, M. O ’Keeffe and MLR. Smyth, Multi-residue method for the 
determination o f benzimidazoles in bovine liver, In: EuroResidue V, 2004, 
Noordwijkerhout, The Netherlands, 10-12 May 2004, 435-440
2. Conference Abstracts and Poster Presentations
G. Dowling, M. O ’Keeffe and M.R. Smyth, Determination o f robenidine in eggs by 
liquid chromatography with UV spectrometric detection, In Fifth International 
Symposium on Hormone and Veterinary Drug Residue Analysis, 2006, Antwerp, 16­
19 June 2006
G. Dowling, M. O ’Keeffe and M  R. Smyth, Confirmatory analysis o f malachite green, 
leucomalachite green, crystal violet and leucocrystal violet in salmon by liquid 
chromatography tandem mass spectroscopy, In Fifth International Symposium on 
Hormone and Veterinary Drug Residue Analysis, 2006, Antwerp, 16-19 June 2006
G. Dowling, M. O ’Keeffe and M .R  Smyth, Multi-residue method for the 
determination o f benzimidazoles in bovine liver, In: EuroResidue V, 2004, 
Noordwijkerhout, The Netherlands, 10-12 May 2004
3. Oral Presentations
Presented work on benzimidazoles at Teagasc Research Seminar to staff at Teagasc 
and international food safety colleagues.
Presented work on robenidine, benzimidazoles and triphenylmethane dyes to 
academic staff and students in DCU.
Presented work on triphenylmethane dyes to Food Safety Promotion Board Ireland 
and staff at the Marine Institute.
4. Awards
Won 1 81 prize at Teagasc Research Seminar for a power-point presentation describing 
the development o f a multi-residue method for the determination o f benzimidazoles in 
bovine liver.
Won 1 st prize at University College Cork Conference on Food Safety for poster on 
benzimidazoles.
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Abstract
A method has been developed to analyse for robenidine drug residues in eggs. Egg samples were extracted with acetonitrile and the 
sample extracts were defatted with hexane and aliquots o f the extracts were analysed by liquid chromatography with UV spectrophotometric 
detection (317nm). The method was validated according to the criteria defined in C om m ission Decision 2002/657/EC. The validation 
parameters linearity, precision, recovery, specificity, decision limit (CCœ) and detection capability (CC/J) were determined. The decision 
limit was 10 jLgkg-1 and the detection capability was 17 p.gkg_1. The results o f the inler-assay study, which was performed by fortifying 
egg samples (n= 6) at three levels in three separate assays, show mean recoveries to be between 79 and 105%. The precision of the method, 
expressed as CV (%) values for the within-laboratory repeatability, was <13.5%.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Anticoccidials are compounds used extensively both pro- 
phylactically and therapeutically to treat coccidiosis in poul­
try. Coccidiosis is caused by unicellular organisms belong­
ing to the genus Eimeria in the class Sporozoa and is the 
most important parasitic disease o f poultry [1]. Robenidine 
(1,3-bis[(//-chlorobenzylidene) amino]-guanidine monohy­
drochloride) is a common anticoccidial drug used in the 
poultry industry. The molecular structure o f the compound 
is shown in Fig. 1. It is authorised for use in poultry and 
other species under the Additives Directive 70/524/EEC [2], 
In the European Union, according to Directive 70/524/EEC, 
the use o f robenidine is not authorised for laying hens. The 
widespread use of this anticoccidial drug may present a po­
tential risk to the consumer i f  residues enter the food chain. 
A range o f  methods have been described for determination o f  
robenidine in feed, including thin layer chromatography [3],
* Corresponding author.
E-mail address: mokeelfe@nfc.teagasc.ie (M. O’Keeffe).
0003-2670/$- see front matter© 2005 Elsevier B.V. All rights reserved, 
doi: 10.1016/j .aca.2005.02.063
a photometric method for feed and premixes [4], and a LC- 
U V method for determination o f robenidine and its chemical 
precursors in feed [5]. A polarographic method for determi­
nation of robenidine in tissue, eggs, litter and soil [6], and 
methods for determination o f robenidine and other anticoc­
cidials by LC-dual mass spectrometry (MS/MS) in eggs [7,8] 
have been described. There are no methods available for de­
termination of robenidine in egg by LC with U V detection.
In this paper a fast, simple and reliable LC method is de­
scribed for the detection of robenidine in eggs. The method 
was validated according to procedures described in Commis­
sion Decision 2002/657/EC [9].
2. Experimental
2.1. Materials and reagents
Water (HiPerSolv grade), acetonitrile (HiPerSolv grade), 
«-hexane, triethylamine and ammonium dihydrogen phos­
phate (Analytical grade) were obtained from BDH (Poole,
32 G. Dowling et al. /Analytica Chimica Acta 539 (2005) 31-34
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Fig. 1. Structure of robenidine (l,3-bis[(p-chlorobenzylidene) amino] -  
guanidine monohydrochloride).
Dorset, UK). A^V-dimetbylformamide (Analytical grade) 
was obtained from Riedel-de-Haen (Seezle, Hannover, Ger­
many). Robenidine hydrochloride was obtained from QMX 
(Essex, UK). A m m onium  phosphate buffer (0.05 M, pH 6.8) 
was prepared by dissolving 5.75 g of ammonium dihydro­
gen phosphate in 800 ml LC grade water then adding triethy- 
lamine to yield pH 6.8 and making up to 11 with water. A  
primary stock standard solution o f robenidine was prepared in 
AyV-dimethylformamide at a concentration of 100 (xgml-1 
and stored at 4°C. Working standard solutions were pre­
pared daily in acetonitrile:water (65:35, v/v) and stored at 
4°C.
2.2. LC conditions
The LC system consisted o f a model 600 LC pump (Wa­
ters, Milford, USA) and a S1L-101 Avp autoinjector, a CTO- 
10 Avp column oven, a SPD-lOAvp UV detector operated 
at 317 nm and a SCL-10 Avp system controller linked to a 
PC with class-VP data handling software (Shimadzu Cor­
poration, Japan). The mobile phase, consisting of acetoni- 
trile:buffer (65:35, v/v) pH 6.8, was pumped at a flow of  
1.5 ml min-1 . A stainless-steel Novapak Cis analytical col­
umn (250m m x 4.6mm ID), coupled to a Hypersil Cis, 
Securiguard™ guard column (3.0mm x  2.0mm ID), was 
used. The column temperature was maintained at 40 °C.
2.3. Egg samples
Egg samples (100 g approximately), prepared from pool­
ing six individual eggs, were homogenised and stored at 
—20 °C in 150 ml tubes. Egg samples, from commercial pro­
duction units, analysed and found to contain no detectable 
residues o f  robenidine were used as negative controls.
2.4. Sample extraction and clean-up
Egg (2g) was weighed into 50 ml polypropylene tubes. 
Acetonitrile (7.5 ml) was added and the test portion was vor- 
texed (2 min), sonicated (3 min) and shaken on a mechanical 
shaker (15 min). The test portion was centrifuged (2400 g, 
10 min, 4 °C). The supernatant was transferred to a clean test­
tube and the test portion was extracted with acetonitrile as 
before. The supernatants were combined and defatted with 
hexane (5 ml) by mixing on a vortex (30 s). The test por­
tion was centrifuged (1250 x  g, 5 min, 4 °C) and the hexane 
layer removed. The sample extract was evaporated to dryness 
under nitrogen (60 °C) before dissolving in 500 [l\ acetoni-
trile:water (65:3 5, v/v). An aliquot (100 (¿1) was injected onto 
the HPLC column.
2.5. Calibration
Standards were prepared in acetonitrile:water (65:35, 
v/v) at concentrations of 0, 50, 125, 250, 500, 1000 and 
2000 ngml-1 , equivalent to 0, 12.5, 31.25, 62.5, 125, 250 
and 500 jjLgkg-1 egg, respectively. Calibration curves were 
prepared by plotting peak area as a function of analyte con­
centration (0-2000ngml-1 ). Concentration of robenidine 
(ngml-1 ) was determined from the peak areas obtained for 
test portion extracts, calculated from the calibration curve. 
The robenidine concentration in egg samples (p.g kg-1 ) was 
calculated, as follows:
robenidine (p.g kg-1 egg)
=  robenidine (ngml-1 extract) x  0.5 2
2.6. Method validation
For estimation of recovery, blank egg samples were pre­
pared and fortified with robenidine. Test portions (2 g) were 
fortified at 50, 75 and lOOjigkg-1 by adding 50, 75 and 
100 |xl portions o f  a 2000ngml-1  robenidine solution, re­
spectively. After fortification, the test portions were held 
for 15 min prior to extraction with acetonitrile, as described 
above. Six replicate test portions, at each of the three fortifi­
cation levels, were analysed. Analysis o f the 18 test portions 
was carried out on three separate occasions. For estimation 
of the precision o f the method, within assay repeatability was 
calculated. The decision limit (CCa) and the detection capa­
bility (CCf)) o f  the method were calculated.
3. Results and discussion
3.1. Preliminary experiments
An LC method, developed to analyse for robenidine in 
animal feed, was applied to the separation o f robenidine on 
a Cig column with a mobile phase consisting o f acetoni- 
trile:water:potassium di-hydrogen phosphate:di-sodium hy­
drogen phosphate (65:25:5:5) [5]. The peak shape was poor, 
with excessive tailing, using this mobile phase. Investiga­
tion of various LC conditions, including various percentages 
of organic content in the mobile phase, pH, injection vol­
ume and mobile phase flow rate, showed that a mobile phase 
consisting o f 65% acetonitrile and 35% phosphate buffer, 
adjusted with triethylamine to pH 6.8, an injection volume 
of 100 jjd and a flow rate of 1.5 ml min-1 gave good peak 
retention and shape. Following preliminary extraction with 
acetonitrile, liquid partitioning between hexane and acetoni­
trile was carried out. Further clean-up o f the sample ex­
tracts was not necessary; the chromatograms were free of 
matrix interference and satisfied the aim of developing a sim-
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Table 1
Intia- and inter-assay variation for recovery of robenidine from egg
Fortification level (p,gkg 1 ) Recovery (%)
Assay 1 Assay 2 Assay 3 lnter-assay
n Mean RS.D. n Mean R.S.D. n Mean R.S.D. n Mean RS.D.
50 6 79.5 18.0 6 94.1 9.5 6 94.5 6.2 18 89 13.5
75 6 95.8 6.7 6 105.0 8.9 6 102.8 7.0 18 101 8.2
100 6 85.1 12.4 6 100.1 4.2 6 93.9 4.4 18 93 10.0
Fig. 2. Chromatogram of negative control egg sample.
pie quantitative test method with a minimum of manipula­
tions.
3.2. Validation study
Validation of the method was according to procedures de­
scribed in Commission Decision 2002/657/EC [9], covering 
specificity, calibration curve linearity, recovery, repeatability, 
decision limit (CCœ) and detection capability (CC/J).
3.2.1. Specificity
To establish the specificity of the method, negative control 
egg samples (n = 3) and egg samples fortified with robenidine 
were analysed. No interfering peaks were observed at the 
retention time for the robenidine peak (Figs. 2 and 3).
3.2.2. Linearity o f the response
The linearity of the LC-U V response was evaluated with 
a six-point calibration curve in the concentration range 
0-2000 ng/ml (0-500 ^g kg-1  egg). The regression coeffi­
cients (r2) of the calibration curves were 0.98-0.99.
Fig. 3. Chromatogram of negative control egg sample spiked at 50 ngkg 1.
3.2.3. Recovery
The accuracy o f the method was determined using egg 
samples fortified at 50, 75 and 100 jig kg-1 . Mean recovery 
(n = 6), at each of the three levels of fortification and deter­
mined in three separate assays (n =  54, total), was between 
79 and 105% (Table 1).
3.2.4. Repeatability
The inter-assay repeatability is shown in Table 1. At the 
three levels of fortification residual standard deviation (RSD) 
values are <13.5%. The repeatability o f  the method is satis­
factory.
3.2.5. CCoe and CCft
The decision limit (CCtx), in the case of substances for 
which no MRLs have been set, is the lowest concentration 
level at which it can be concluded that a sample is non- 
compliant, with an error probability o f  ct= 1%. The detec­
tion capability (CC/3) is the smallest content of the substance 
that may be detected, identified and quantified in a sample, 
with an error probability o f P — 5%. Both of these parame­
ters were determined using the calibration curve procedure 
in which blank egg samples were fortified at the minimum 
required performance level o f the method (50 (xgkg-1 ) and 
at 1.5 and 2 times that level. CCa and CC/9 values o f 10 and 
17 (xgkg-1 , respectively, were determined for the method.
4. Conclusions
This paper reports the development and validation of a fast 
and simple LC method for the determination of robenidine in 
eggs. The method was validated according to the guidelines 
described in Commission Decision 2002/657/EC.
Acknowledgements
This work was funded by the Teagasc Walsh Fellowship 
programme. The authors thank staff at The National Food 
Centre, Teagasc, Dublin for their practical assistance.
References
[1] H.D. Chapman, Avian Dis. 47 (2003) 1
34 G. Dowling et al. /  Aiialvtica Chimtca Acta 539 (2005) 31-34
[2] Council Directive 70/524/EEC, Off. J. Eur. Commun. L. 270 (1970) 
1.
[3] G.F. Bories, Analyst 100 (1975) 567.
[4] Analytical Methods Committee, Subcommittee, B, Analyst 100 (1975) 
668.
[5] J.B. Zilger, P.P. Ascione, G.P. Chrckian, J. AOAC 58 (1975) 822.
[6] J.E. Smith, N.R. Pasarela, J.C. Wyckoff, J. AOAC 60 (1977) 1310.
[7] L. Mortier, E. Daesclcirc, P. Dclahaut, Anal. Chim. Acta 483 (2003) 
27.
[8] M. Dubois, G. Pierrct, P. Delahaut, J. Cliromatogr. B 813 (2004) 181.
[9] Commission Decision 2002/657/EC, Off. J. Eur. Commun. L. 221
(2002) S.
A ppendix 2
Available online a t www.sciencedirect.com
ANAIYTICA
SCIENCE f / D  OIHEOT* CHIMICAiMC6@ l
ACTA
ELSEVIER Analytica Chimica Acta 529 (2005) 285-292
www.elsevier.com/locate/aca
M ulti-residue method fo r the determination 
o f benzimidazoles in  bovine liver
Geraldine Dowling3’b, Helen Cantwell3, M ichael O ’Keeffe11 *, M alcolm R. Smythb
a The National Food Centre, Teagasc, Ashtown, Dublin 15, Ireland 
b School of Chemical Sciences, Dublin City University, Glasnexin, Dublin 9, Ireland
Received 3 June 2004; received in revised form 23 July 2004; accepted 23 July 2004 
Available online 1 September 2004
Abstract
A method has been developed to analyse for 12 benzimidazole drug residues in bovine liver. Liver samples were extracted with ethyl 
acetate, sample extracts were defatted with hexane and cleaned-up by automated SPE on CiS solid phase extraction cartridges. Aliquots of 
the extracts were analysed by LC with UV detection (298 nm). The method was validated in bovine liver, according to the criteria defined 
in Commission Decision 2002/657/EC. The decision limit (CCM) was between MRL + 12% and MRL + 25% and the detection capability 
(CCp) was between MRL + 25% and MRL + 45% for the range of benziniidazoles investigated. The results o f the inter-assay study, which 
was performed by fortifying bovine liver samples (n =  6) in three separate assays, show the mean recovery to be between 60% and 100% for 
albendazole sulphoxide, albendazole sulphone, thiabendazole, oxfendazole/fenbendazole sulphoxide, hydroxy-mebendazole, fenbendazole 
sulphone, oxibendazole, mebendazole and flubendazole. Lower mean recovery was obtained for amino-flubendazole and albendazole (ap­
proximately 50%) and amino-albendazole sulphone (approximately 25%). The precision of the method, expressed as R.S.D. values for the 
within-laboratory repeatability, was generally below 25%.
© 2004 Elsevier B.V. All rights reserved.
Keywords: Benzimidazoles; Automated solid phase extraction; Residue analysis; Liver; Method validation
1. Introduction
Benzimidazoles are broad-spectnun anthelmintics and 
have been used for about 40 years in animal health and 
crop protection. Metabolism o f the drugs is extensive. The 
metabolites found depend on the structure of the parent 
drug, the tissue and the animal species. One or more 
metabolites can be found in animal tissue for most drugs 
[1,2]. When the pro-drugs, active drugs and metabolites are 
counted, some 19 possible residues may occur in animal 
tissues. The EU has set maximum residue limits (MRLs) for 
benzimidazoles and their metabolites in animal products. 
The MRL values range from 10-1000 pig kg-  *, depending 
on the compound and matrix (Table 1). Most benzimidazole
* Corresponding author.
E-mail address: mokeeffe@nfc. teagasc. ie (M. O’Keeffe).
0003-2670/$ — see fiont matter © 2004 Elsevier B.V. All rights reserved. 
doi:10.1016/j.aca.2004.07.064
drugs, with the exception o f cambendazole, are licensed for 
use in food-producing anim als. The development o f  a single 
multi-residue method capable o f testing for all the residues 
in the MRL listings is very difficult.
Netobimin (NETO) albendazole (ABZ) and albendazole 
sulphoxide (ABZ-SO) are licensed for use in the treatment 
of cattle and sheep. ABZ-SO was used for treatment of 
pheasants, but because an analytical method was not satis­
factorily validated for pheasant tissues, no final MRL val­
ues could be proposed for pheasants [3]. NETO is a pro­
drug, converted by the gut microflora to ABZ by splitting 
o f  the side chain and formation o f the benzimidazole nu­
cleus, and ABZ is converted further to ABZ-SO. In cattle, 
ABZ-SO, albendazole sulphone (ABZ-SO2 ) and 2-amino al­
bendazole sulphone (NH2 ABZ-SO2 ) were found to be the 
major residues detected in liver. Febantel (FEB), fenbenda- 
zole (FBZ) and oxfendazole, or fenbendazole sulphoxide,
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Table 1
EU MRL values for benzimidazole anthelmintic drugs (based on Council Regulation No. 2377/90 and Commission Regulation Nos. 508/1999, 2385/1999, 
2393/1999 and 807/2001)
Benzimidazole Marker residue Animal species MRL (|xgkg_1 ) Target tissue
Netobimin (NETO), Sum of ABZ-SO, albendazole sulphone Bovine, ovine 100 Milk
albendazole (ABZ), (ABZ-SO2) and amino-albendazole sulphone 100 Muscle
albendazole (NH2ABZ-SO2), expressed as albendazole 100 Fat
sulphoxide(ABZ-SO) 1000 Liver
500 Kidney
Febantel (FEB), Sum of extractable residues that may be oxidised Bovine, ovine 10 Milk
fenbendazole (FBZ) to fenbendazole sulphone (FBZ-SO2)
and oxfendazole (OFZ) Bovine, ovine, porcine, 50 Muscle
equidae 50 Fata
500 Liver
50 Kidney
Flubendazole (FLU) Sum of FLU and amino-llubendazole (NH2FLU) Porcine, game birds, 50 Muscle
chicken, turkey 50 Fata
400 Liver
300 Kidney
Chicken 400 Eggs
Thiabendazole (TBZ) Sum of TBZ and hydroxy-thiabendazole(TBZ-OH) Bovine 100 Muscle
100 Fat
100 Liver
100 Kidney
100 Milk
Oxibendazole (OX1) OXI Porcine 100 Muscle
500 Fat“
200 Liver
100 Kidney
Triclabendazole (TCB)b Sum of extractable residues that may be oxidised Bovine, ovine 100 Muscle
to keto-triclabendazole 100 Liver
100 Kidney
Mebendazole (MBZ)': Sum of hydroxy-mebendazole (MBZ-OH) and Ovine, caprine, equidae 60 Muscle
amino-mebendazole (NH2-MBZ), expressed as 60 Fat
mebendazole equivalents 400 Liver
60 Kidney
1 For porcine, and/or poultry, species this MRL relates to “skin and fat in natural proportions”. 
b Not for use in animals from which milk is produced for human consumption.
(OFZ/FBZ-SO) are licensed for use in cattle, pigs, sheep and 
horses. FEB is a prodnig, converted to FBZ by cyclization to 
form the benzimidazole nucleus. Animal studies showed that 
FBZ, OFZ/FBZ-SO and fenbendazole sulphone (FBZ-SO2 ) 
were the important residues [4-8]. However, depending on 
species, route o f administration and time after treatment, the 
forms o f residues could vary greatly. Mebendazole (MBZ) 
is approved for use in goats, horses and sheep. When sheep 
were treated with MBZ it was found that the major residues 
were hydroxy-mebendazole (MBZ-OH) and MBZ [9]. Thi­
abendazole (TBZ) is licensed for use in cattle. In studies 
on cattle [7] and sheep [10], residues o f TBZ and hydroxy- 
thiabendazole (TBZ-OH) were found in liver. Flubendazole 
(FLU) is approved for use in pigs, chicken, turkeys and game 
birds. FLU and amino-flubendazole (NH2 FLU) are the im­
portant residues. In turkeys treated with FLU, residues were 
found in all tissues, with NH2 FLU accounting for 68% o f  
the total residues in liver [11]. Triclabendazole (TCB) is 
licensed for use in sheep and cattle. In cattle treated with 
radiolabelled TCB highest residue levels were detected in
liver at early withdrawal period [12]. In a study o f lactat- 
ing goats treated with TCB it was found that triclabendazole 
sulphoxide (TCB-SO) and triclabendazole sulphone (TCB- 
SO2 ) residues could be detected in milk [13]. Oxibendazole 
(OX1) is licensed for use in pigs. The marker residue is the par­
ent drug. In studies on cattle, sheep, pigs and horses total OX1 
residues were found to be less than 100 jig kg-1 in muscle 
and fat.
There are many published methods for analysis of benz- 
imidazoles in animal tissues, plant tissues and milk products. 
A number o f methods have been reported for the analysis of 
individual benzimidazoles and theirmetaboUtes in food prod­
ucts [14-17]. However, because o f the large number of benz- 
imidazoles licensed for use, multi-residue methods are more 
attractive. Multi-residue methods have been developed for 
the analysis o f benzimidazole residues in milk [18-24] and 
tissues [25]. TBZ has been determined in fruit and vegetable 
matrices based on an ethyl acetate extraction [26-28]. Alter­
native solvents, such as methanol [29] and acetone [30,31] 
have been used. Supercritical fluid extraction (SFE) has been
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used for extracting benzimidazole fungicides from fruit and 
vegetable matrices [32,33] and from animal tissues [34]. Ac­
celerated solvent extraction has been used to extract TBZ 
from fruit and vegetable samples and processed products 
[3 5]. Matrix solid phase dispersion (MS PD) has been applied 
by a number of groups for the determination of benzimida- 
zoles in liver [6,45].
A combination o f liquid-liquid partitioning and solid 
phase extraction is the most widely adopted approach for the 
clean-up of animal tissue extracts in benzimidazole residue 
analysis. Wilson et al. [7] purified tissue extracts by parti­
tioning between ethanol:0.2N hydrochloric acid and hexane 
before clean-up on a C2  solid phase extraction cartridge. 
Roudaut and Gamier [36] modified the method by substi­
tuting an Oasis HLB cartridge for the C2 cartridge. Similar 
liquid-liquid partitioning approaches and further purification 
o f tissue extracts by SPE have used Cis [37], aminopropyl 
[38], cyano [39], neutral alumina [40] and silica [41] SPE 
cartridges. Rose [42] applied strong cation exchange (SCX) 
SPE to the isolation o f OFZ and nine related residues in liver. 
Farrington et al [43] developed multi-residue methods using 
dual SPE clean-up procedures based onnonnal phase and Cjg 
sorbents. Stubbings et al. [44] developed an online SCX-SPE 
procedure for the purification of benzimidazole residues from 
tissue. Hiemstra et al. [31] developed a clean-up procedure 
for the isolation o f TBZ and carbendazim residues from fruit 
and vegetable extracts, using liquid-liquid partitioning prior 
to automated off-line SPE clean-up on diol SPE cartridges 
mounted on an ASPEC system.
Most o f the published methods, such as that by Wilson 
et al. [7], deal only with the determination o f  some o f the 
benzimidazole drugs. Using the approach of identifying the 
most likely residues to occur in different animal species, a 
multi-residue method might be developed that would pro­
vide more complete surveillance for these compounds. The 
objective of this work was to develop an improved, au­
tomated, quantitative method for determination o f an ex­
tended range o f  benzimidazoles within a single multi-residue 
method.
2. Experimental
2.1. Materials and reagents
Water, methanol, acetonitrile, ethyl acetate and dichloro- 
methane (HiPerSolv grade) were obtained from BDH 
(Merck, Poole, Dorset, UK). Triethylamine, glacial acetic 
acid, ammonia, hydrochloric acid, dimethyl sulphoxide, 
acetone, hexane, sodium chloride and ammonium dihy­
drogen phosphate (Analytical grade) were from BDH. 
Ammonium hydroxide (ACS grade) was obtained from 
Sigma (St. Louis, MO, USA). A^jV-dimethylformamide and 
sodium bicarbonate (Analytical grade) were obtained from 
Riedel-de-Haen (Seezle, Hannover, Germany). Meben­
dazole (MBZ), thiabendazole (TBZ), albendazole (ABZ)
Table 2
LC gradient profile tor determination of benzimidazoles
Time (min) Component A (%) Component B (%) Component C (%)
0 100 0 0
3 45 55 0
10.5 30 70 0
14 15 85 0
18 0 59 41
19 0 60 40
23 0 0 100
36 0 60 40
43 100 0 0
Component A: ammonium dihydrogen phosphate buffer pH 6.8 + methanol 
+ acetonitrile (76 + 1 5 + 9 ,  v/v/v); component B: ammonium dihydrogen 
phosphate buffer pH 6.8 + methanol f acetonitrile (52 + 30 + 18, v/v/v); 
component C: ammonium dihydrogen phosphate buffer pH 6.8 + methanol 
(18 + 82, v/v).
and oxibendazole (OXI) were purchased from Sigma. 
Flubendazole (FLU), amino-flubendazole (NH2 FLU) and 
hydroxy-mebendazole (MBZ-OH) were donated by Janssen 
(Beerse, Belgium). Fenbendazole sulphone (FBZ-SO2 ) and 
fenbendazole sulphoxide (OFZ/FBZ-SO) were donated 
by Intervet (Dublin, Ireland). Albendazole sulphoxide 
(ABZ-SO), sulphone (ABZ-SO2 ) and 2-amino albendazole 
sulphone (NH2 ABZ-SO2 ) were donated by GlaxoSmithK­
line (Harlow, UK). Primary stock standard solutions o f TBZ 
in methanol; 0X1, MBZ, OFZ/FBZ-SO and FBZ-SO2 in 
dimethylsulphoxide; MBZ-OH in AT^V-dimethylformamide; 
FLU and NH2 FLU in AT^V-dimethylformamide:methanol 
(3:2, v/v); NH2ABZ-S02, ABZ, ABZ-SO and ABZ-SO? in 
iV ,yV-dimethylformamide:methanol (2:8, v/v), were prepared 
at a concentration of 2 mg ml-1 . Working standard solutions 
were prepared in methanol and stored at 4 °C. Bond Elut™ 
Cis cartridges (3 ml, 500 mg) were obtained from Van an 
(Harbor City, USA). Solid phase extraction was performed 
using an ASPEC XL4 instrument (Gilson, Middleton, USA).
2.2. LC conditions
The LC system consisted o f a model 616 HPLC pump with 
a model 717 plus autosampler and amodel 996 photodiode ar­
ray detector operated at 298 nm (Waters, Milford, MA, U SA). 
A gradient LC system (Table 2) using ammonium dihydro­
gen phosphate buffer (pH 6.8), methanol and acetonitrile at 
a flow o f 0.5mlmin-1 , was used to separate the analytes 
on a stainless-steel analytical column (150mm x  3.0 mm 
i.d.) equipped with a guard column (3.0 mm x  2.0 mm i.d.), 
both packed with Xterra™ (3.5 |jum) Cjg material (Waters). 
The column temperature was maintained at 40 °C. Data ac­
quisition and integration were performed using Millenium32 
chromatographic management software (Waters).
2.3. Liver samples
Liver samples (100 g approximately) were homogenised 
in a Robot Coupe™ bowl-blender (Montceau-en-Bour-
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gogne, France) and stored at -20 °C in 150ml tubes. Liver 
samples analysed and found to contain no detectable residues 
of the analytes were used as negative controls.
2.4. Sample extraction and clean-up
Liver (3 g) was weighed into 50 ml polypropylene tubes. 
Samples were fortified at levels corresponding to 0.5 x  MRL, 
1 x  MRL and 1.5 x  MRL by adding 50 jxl portions o f di­
luted stock solutions. After fortification, samples were held 
for 15min prior to extraction. Sodium sulphate (1.5 g), 4M  
potassium carbonate (0.5 ml) and ethyl acetate (5 ml) were 
added and the samples were homogenised (30 s). Samples 
were centrifuged (2500 rpm, lOmin, 4 °C). The supernatant 
was transferred to a clean test-tube and the sample was re­
extracted with ethyl acetate as before. The supernatants were 
combined and evaporated to dryness under nitrogen (50 °C). 
Ethanol: 0.2N hydrochloric acid (66:33, v/v) (1 ml) and n- 
hexane (5 ml) were added to the dry residue, vortexed (2 min) 
and centrifuged (1500 rpm, 5 min, 4°C). The upper hexane 
phase was removed. This clean-up step was repeated with a 
second portion o f hexane (5 ml). Sample extracts were fur­
ther purified by automated SPE using Cis SPE cartridges. 
Sample extracts (0.6 ml) were modified by addition of 2% 
potassium bicarbonate solution (4 ml). Modified sample ex­
tracts (3.8 ml) were loaded onto Cig cartridges (precondi­
tioned with 6 ml ethyl acetate, 3 ml ethanol and 3 ml dis­
tilled water). The cartridges were washed with distilled wa­
ter ( 2 x 1  ml) and then dried. The Cis cartridges were eluted 
with ethyl acetate (3 x  1 ml). The eluates were reduced to 
dryness under nitrogen (50 °C) before dissolving in 400 (xl 
methanol:water (50:50, v/v). An aliquot (50 jjlI) was injected 
onto the LC colum n.
2.5. Calibration
Standards were prepared at concentrations o f0,0.25,0.50, 
0.75,1.5,3.75,7.5 and 15 [igm l-1 in methanol :water (50:50, 
v/v). Calibration curves were prepared by plotting peak area 
as a function o f analyte concentration (0-15 (jugml-1 ). Re­
covery was determined using the peak area values obtained 
for fortified sample extracts, calculated from the calibration 
curves.
2.6. Method validation
For estimation o f recovery, blank liver samples were 
fortified with benzimidazoles at 0.5, 1 and 1.5 times the 
MRLs. For estimation o f the precision o f the method, an 
intra-assay study was carried out by fortifying bovine liver 
samples at cach level (n = 6) and extracting and analysing 
in a single run. The inter-assay study involved fortify­
ing bovine liver samples as described and extracting and 
analysing in three separate assays. The decision limit (CC„) 
and the detection capability (CCp) o f the method were 
calculated using the intra-assay validation results. The se­
lectivity/specificity and linearity of the method were also 
established.
3. Results and discussion
3.1. Preliminary experiments
Previous work in this laboratory had developed a ternary 
gradient LC method for separation of 19 benzimidazole 
drags, with detection at 298 nm [34]. That method was ap­
plied to separation o f benzimidazole drugs in this study. From 
an evaluation o f different extraction solvents, ethyl acetate 
was found to give the best recovery for the compounds of 
interest. Ethyl acetate has good solvating power for weakly 
basic drugs because it can provide emulsion-free extraction 
from liver and muscle tissue samples. Multi-reSidue extrac­
tion of benzimidazoles at a set pH is difficult because of 
their varied, and in some cases multiple, p^ Ta values. The 
effect of pH was studied over the range 5-10, based on 
a method described by Cannavan et al. [39] for extraction 
of TBZ from tissue using buffering at pH 7 and extraction 
with ethyl acetate. The possibility o f using the ChemElut™ 
diatomaceous earth buffered and unbuffered columns was 
also evaluated but low recoveries were obtained. Wilson 
et al. [7] developed an extraction procedure based on car­
bonate buffer/ethyl acetate for ABZ, TBZ-OH, OFZ, TBZ, 
CAM, MBZ and FBZ. Similarly, carbonate buffer extrac­
tion and liquid partitioning steps were used by Roudaut and 
Gamier [36] for TBZ-OH, TBZ, NH2ABZS02, ABZ-SO, 
OX1, OFZ, ABZ-SO2 , ABZ and FBZ. After extraction, liq­
uid partitioning between hexane and ethanohhydrochloric 
acid, 0.2N (33:66, v/v) was used in both these methods. Fur­
ther clean-up o f the tissue extracts was achieved by solid 
phase extraction on C2 cartridges [7] or on Oasis HLB™  
cartridges [36].
A carbonate buffer/ethyl acetate extraction and liquid par­
titioning, followed by solid phase extraction using Cig car­
tridges was developed in this work and applied to a wider 
range o f benzimidazoles to include MBZ-OH, NH2FLU, 
FBZ-SO2 and FLU. TBZ-OH, which is a marker residue for 
thiabendazole, was not included because of incomplete chro­
matographic separation of this analyte from NH2ABZSO2 ; 
preliminary experiments indicate that TBZ-OH is extracted 
with similar yield as TBZ using the method. In total, drugs 
from six of the seven classes of benzimidazoles listed in 
Table 1 are included; triclabendazole and its metabolites are 
not extractable using this method.
Hiemstra et al. [31 ] developed an automated SPE clean-up 
on diol cartridges for determination o f thiabendazole and 
carbendazim residues in fruit and vegetable extracts. The 
Cis solid phase extraction step in the current method was 
automated using an ASPEC XL4™  system. Compared with 
the method described by Wilson et al. [7], the method devel­
oped here incorporates automated SPE on Cig cartridges and 
has been applied to an extended range o f  benzimidazoles,
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including most of the marker residues designated by EU 
MRL regulations.
3.2. Validation study
at the retention time for the benzimidazoles (Fig. 1) except at 
the retention time for ABZ where an interfering peak o f neg­
ligible size, relative to the response for MRL concentration, 
was observed.
Validation o f the method was according to procedures de­
scribed in Commission Decision 2002/657/EC [46] covering 
specificity, calibration curve linearity, recovery, repeatability, 
decision limit (CCa) and detection capability (CCp).
The method was validated using bovine liver, as a model 
matrix, and applying the MRL values specified for liver of 
each species. Preliminary experiments with liver samples of  
other species indicate that comparable extraction yield is ob­
tainable and that the developed method may be applicable 
to liver samples o f other species. While most MRL values 
are expressed as the sum of the marker residues (Table 1), 
validation was undertaken applying the filRL value for each 
individual marker residue; this was necessary because o f  the 
variability in the proportions of marker residues which might 
occur in samples. For benzimidazoles for which MRL values 
have not been specified for a particular species, the method 
would require further validation according to the procedures 
described in Commission Decision 2002/657/EC for sub­
stances for which no permitted limit has been established.
3.2.1. Specificity
To establish the selectivity/specificity o f the method, liver 
samples fortified with the benzimidazoles and non-fortified 
samples were analysed. No interfering peaks were observed
3.2.2. Linearity o f  the response
The linearity of the chromatographic response was tested 
with seven calibration points in the concentration range of 
0.25- 15 jjLg ml-1 . The regression coefficients (r2) for the cal­
ibration curves used in the study were >0.99.
3.2.3. Recovery
The accuracy o f  die method was determined using bovine 
liver samples fortified at 0.5 x  MRL, MRL and 1.5 x  MRL 
for each benzimidazole. Mean recovery (n = 6) o f the an­
alytes, determined in three separate assays, was between 
60% and 100% for ABZ-SO, ABZ-SO2 , TBZ, OFZ/FBZ- 
SO, MBZ-OH, FBZ-SO2 , OXJ, MBZ and FLU (Table 3). 
Lower mean recoveries of approximately 50% were obtained 
for NH2 FLU and ABZ. NH2 ABZ-SO2  was recovered at ap­
proximately 25%, probably due to the difficulty in extracting 
this relatively polar compound from tissue.
3.2.4. Repeatability
The inter-assay repeatability is shown in Table 3. For most 
analytes and at the three levels of fortification (0.5 x  MRL, 
MRL and 1.5 x  MRL), R..S.D. values were at less than 25%. 
In some instances (NH2FLU at 0.5 x  MRL, 0X1 at MRL, 
and ABZ at MRL), R.S.D. values were in excess of 25%.
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Fig. 1. Chromatogram of blank liver sample and liversample fortified at MRLs.
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Table 3
Intra- and inter-assay variation for recovery of benzimidazoles from liver
Analyte Fortification 
level (|Ag kg*1)
Recovery (%)
Assay 1 Assay 2 Assay 3 lnter-assay
Mean ÏLS.D. Mean R.S.D. Mean R.S.D. Mean R.S.D.
NH2ABZ-S02 500 27 10.0 22 17.8 26 15.4 25 15.9
1000 24 10.2 22 3.3 23 6.7 23 7.7
1500 24 12.4 19 12.2 19 21.9 20 16.4
ABZ-SO 500 68 9.3 60 11.0 73 6.4 67 11.7
1000 62 8.7 57 5.3 62 6.3 61 7.5
1500 61 9.8 61 1.1 52 6.5 57 10.2
ABZ-SO2 500 75 6.3 61 8.2 73 10.5 70 12.1
1000 72 9.0 58 8.7 69 17.1 67 15.1
1500 66 7.0 62 1.7 63 10.9 64 7.8
TBZ 50 74 8.6 63 24.0 96 4.6 78 21.8
100 82 8.9 56 5.4 85 9.1 . 76 19.2
150 83 5.5 66 8.7 78 7.2 " 76 11.4
OFZ/FBZ-SO 250 85 5.2 61 5.8 73 6.6 73 15.1
500 83 7.3 57 9.3 67 18.5 69 19.6
750 83 7.0 64 2.6 62 8.9 70 15.8
MBZ-OH 200 83 6.3 63 6.7 103 14.2 83 21.3
400 89 8.4 60 10.9 77 20.5 76 20.9
600 83 7.1 61 5.1 64 8.5 70 16.3
NH2FLU 150 62 6.1 40 12.2 35 9.1 46 27.7
300 68 10.5 39 5.7 54 16.7 54 24.3
450 62 7.7 40 14.0 56 14.5 54 20.7
FBZ-SO2 250 87 4.9 58 4.0 74 5.9 73 17.4
500 86 9.2 55 7.8 71 24.1 71 23.5
750 84 7.3 62 2.8 59 16.3 69 19.2
0X1 100 92 4.3 69 4.9 120 13.6 93 24.9
200 90 10.1 61 7.3 119 22.1 94 32.5
300 85 7.0 66 2.1 76 18.2 76 15.3
MBZ 200 94 3.6 67 6.5 100 5.2 87 17.6
400 87 6.0 59 7.5 84 23.2 77 22.8
600 79 8.1 61 3.4 65 21.7 69 17.2
FLU 200 78 3.0 54 7.7 85 8.2 72 19.9
400 78 7.5 48 8.1 67 15.2 65 21.4
600 69 8.9 53 5.2 54 20.8 59 17.8
ABZ 500 63 3.2 39 7.3 56 6.9 53 20.6
1000 59 9.0 36 8.4 48 30.4 48 27.4
1500 54 9.2 40 12.0 44 21.3 46 19.0
Overall, the repeatability o f the method for benzimidazoles 
is satisfactory.
3.2.5. CCa and CCp
The decision limit (CCa) is, in the case o f  substances for 
which MRLs have been defined, the lowest concentration 
level at which it can be concluded that a sample is non- 
compliant, with an error probability of a  = 5%. The detection 
capability (CCp) is the smallest content of the substance that 
may be detected, identified and quantified in a sample, with 
an error probability o f ft = 5%. Both of these parameters 
were determined using the calibration curve procedure, in
which blank bovine liver was fortified around the MRL val­
ues in equidistant steps (0.5 x MRL, MRL and 1.5 x  MRL). 
The concentration at the MRL plus 1.64 times the standard 
deviation at the MRL gives the CCa value for each benz­
imidazole. The CCp value for each benzimidazole is deter­
mined as the CCa value + 1.64 times the standard deviation. 
Table 4 lists the CC„ and CCp values for the benzimada- 
zoles, using the data from Assay 1. With the exception of 
NH2 ABZ-SO2 , CCa values ranged between MRL + 12% 
and MRL + 25% and CCp values ranged between MRL + 
25% and MRL + 45% for the benzimidazoles included in 
the study.
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Table 4
Calculated CCa and CC3 values based on data from Assay 1 (Table 3)
Benzimidazole MRL ((j.gkg ' *) CCh (p-gkg ’) CCp (ngkg ')
NH2ABZ-SO2 1000 1303 1556
ABZ-SO 1000 1164 1343
ABZ-SO2 1000 1225 1417
TBZ 100 116 132
OFZ/FBZ-SO 500 561 627
MBZ-OH 400 481 544
NH2FLU 300 376 435
FBZ-SO2 500 587 670
OXI 200 242 281
MBZ 400 467 520
FLU 400 493 558
ABZ 1000 1216 1397
4. Conclusions ,
This paper reports the development and validation o f a 
relatively fast and simple LC method for the simultaneous 
determination of albendazole, albendazole sulphoxide and al­
bendazole sulphone, thiabendazole, oxfendazole and fenben- 
dazole sulphone, mebendazole and hydroxy-mebendazole, 
flubendazole and amino-flubendazole, and oxibendazole. Tri- 
clabendazole and its metabolites, triclabendazole sulphoxide 
and triclabendazole sulphone, were not quantitatively deter­
mined using this method. This multi-residue method covers 
six o f the seven benzimidazole groups that are licensed for 
use within the EU.
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Abstract
Benzimidazoles are anthelmintic agents widely used in the treatment o f parasitic infections in a range of species and as fungicidal agents 
in the control o f spoilage o f crops during storage and transport. In this paper, the more important benzimidazoles are introduced and their 
pharmacological effects and physiochemical properties discussed. The metabolism of these drugs is described relating to the occurrence and 
persistence o f  residues in biological matrices, providing information for selection of suitable matrices and target residues for testing. Methods for 
determination o f benzimidazoles are reviewed for a range o f  biological matrices. The importance o f selecting suitable extraction and clean-up 
procedures is discussed, along with the difficulties encountered in  adapting single residue methods to multi-residue methods. The importance of 
suitable detection systems for determination of benzimidazoles, namely, screening, HPLC, GC and confirmatoiy methods is described in detail. 
The future for benzimidazole residue analysis is discussed, focusing on selection of appropriate residues for screening methods and protocols for 
confirmation of benziinidazole residues.
© 2006 Published by Elsevier B.V.
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ing similar activity came on the market, such as parbendazole 
Benzimidazoles are veterinary drugs widely used for pre- (PAR) [2] cambendazole (CAM) [3] mebendazole (MBZ) [4]
vention and treatment o f  parasitic infections in agriculture and and oxibendazole (OX1) [5].
aquaculture. Some benzimidazoles have also found applications Benzimidazoles possessing sulphide and sulphoxide func-
as pre- or post-harvest fungicides for control o f a wide range o f tional groups were subsequently introduced, offering a wider
fungi affecting field crops, stored fruit and vegetables. Thiaben- spectrum o f activity and improved efficacy. Albendazole (ABZ)
dazole (TBZ) was the first benzimidazole to be marketed over [6 ], fenbendazole (FBZ) [7] and oxfendazole (OFZ) [8 ] were the
40 years ago [ 1]. It has been used widely for control of gastroin- first such benzimidazoles to be successfully used in the treatment
testinal nematodes, lungworms and as a fungicidal agent. After of all growth stages o f gastrointestinal nematodes. They may be
Please cite this article as: Martin Danaher et al., Review of methodology for the determination of benziinidazale residues in biological matrices,
Journal of Chromatography B (2006), doi:10.1016/j,jchromb.2006.07.046.
83
84
85
88
87
88
89
90
31
92
93
94
95
96
97
9S
9 9
100
101
102
103
104
1C»
106
107
10B
109
110
111
112
113
114
115
110
117
11B
119
120
121
122
123
124
125
12fl
127
128
129
130
131
132
133
134
135
7
9
0
3
4
5
6
7
8
1
2
3
7
a
1
+■ Model
CHROM B146891-37
M. Danaher f  t al. /  J. Chmmatogr. B xxx (2006) xxx-xxx
used also in the treatment of lungworms, tapeworms and adult 
stages o f  liver fluke. The benzimidazole, triclabendazole (TCB) 
was later introduced as an anthelmintic agent for treatment o f all 
stages o f liver fluke, but it is ineffective against nematodes [9]. 
Luxabendazole (LUX) is another benzimidazole-sulphide used 
in the treatment of food-producing animals but is not licensed 
for use in the EU [10]. The low solubility o f benzimidazole sul­
phides and sulphoxides leads to their low absorption from the 
gut, resulting in low bioavailability [11,12]. Netobimin (NETO) 
[13] and febantel (FEB) [14], which are the pro-drugs o f ABZ 
and FBZ, respectively, have greater water solubility resulting in 
improved absorption and increased bioavailability. Similar pro- 
benzimidazoles have found widespread use as fungicidal agents, 
including benomyl (BEN) and thiophanate-methyl (TM), which 
are precursors o f  carbendazim (MBC).
In this paper, a comprehensive review of methodologies for 
the determination of benzimidazole residues in biological matri­
ces is presented. Firsdy, an introduction is given on benzimida­
zole residues in relation to their mode of action, activity and 
toxicity. The metabolism and pharmacokinetics o f these sub­
stances is then presented and discussed in relation to MRLs, 
and the selection o f appropiate residues to monitor the presence 
o f residues in food. Methodology for determination of benzim­
idazole residues in food is subsequently discussed in terms of 
sample handling, analysis, residues included and sensitivity. The 
paper concludes with comments on method validation, a general 
summary and notes on future perspectives.
2. Mode of action, biological activity and toxicity
2.1. Mode o f action
A number o f  different modes o f action have been proposed 
for benzimidazole drugs. ABZ has been shown to block glucose 
uptake in the larval and adult stages o f susceptible parasites, by 
depleting their glycogen reserves and thereby decreasing ATP 
formation [15]. Blocking o f  glucose uptake was shown to be 
a mechanism o f action for MBZ and TBZ [16]. A number of 
researchers have shown that benzimidazoles inhibit the enzyme 
fumaric acid reductase in the parasite, thus blocking the forma­
tion o f succinic acid [16—18]. Consequently, this disturbs the nor­
mal operation o f  the dicarboxylic acid cycle, which replaces the 
Krebs cycle in anaerobic parasites [ 19,20]. The dicarboxylic acid 
cycle starts by fixing CO2 on pyruvate, or preferably on phos- 
phoenolpyravate, to form oxaloacetate, and proceeds via malate 
and fumarate to form succinate as an end-product. Therefore, 
this cycle runs in anaerobic parasites in an opposite direction to 
the Krebs cycle, and its final electron receiver is fumarate. It is 
also coupled with a special electron transport system particular 
to anaerobic parasites for production o f  ATP. By blocking the 
cycle at the fumarate level, TBZ deprives the parasites o f  a sig­
nificant source o f  energy, thus ultimately causing their paralysis 
and death [2 1 ,2 2 ].
Inhibition o f microtubule formation has been identified as 
the primary mode o f  action o f  benzimidazole drugs by a num­
ber o f  researchers [15,23,24]. Many o f the processes proposed 
as targets for benzimidazoles are dependent on the integrity of
the microtubule matrix. Microtubules are associated with the 
following cellullar functions—formation of the mitotic spindle 
in cell division, maintenance of cell shape, cell motility, cel­
lular secretion, nutrient absorption and intracellular transport. 
In view o f the crucial roles microtubules play in many cellu­
lar processes, their drug-induced destruction eventually leads to 
the death o f the organism. The dynamics of microtubule forma­
tion has been described in a number of papers, which should 
be consulted for more detail [25-28]. Inhibition o f microtubule 
formation has been investigated in detail with the classical antim­
itotic agent colchicine showing that this compound binds to 
tubulin prior to its polymerisation [29]. Inhibition of micro­
tubule assembly appears to be achieved through addition of 
colchicine-bearing tubulin to the end o f a growing microtubule 
and loss o f  the ability of these subunits to accept other tubu­
lin molecules for further microtubule growth. Data obtained 
from fluorescence spectroscopy and labelling experiments have 
indicated that the colchicine binding site is on the 3 -tubulin 
monomer, obviously close to the a ,3  subunit interface [30,31]. 
Other spectroscopic analyses suggest that inhibition of tubu­
lin polymerisation is due to a drug-induced local unfolding 
o f a small region within the 3 -tubulin monomer [29]. A sim­
ilar mechanism may be responsible for inhibition of tubulin 
polymerisation by benzimidazoles, as the binding site of these 
compounds appears also to be located on the 3 -tubulin monomer 
[32-34],
The reason for selective effect o f benzimidazoles towards 
parasites and high safety in host species is not well understood. 
Friedman and Platzer [35] demonstrated that the binding of FBZ 
and MBZ was 250- to 400-fold greater in parasite tubulin than 
mammalian tubulin. This provided the first evidence that the 
species selectivity o f the benzimidazoles may derive from dif­
ferences in their affinities for host and parasite tubulin. Kohler 
and Bachmann [36] showed in subsequent work that selectivity 
was more likely achieved by differential drug pharmacokinetics 
in the host and parasite. Russell et al. [37] found that the rate 
o f dissociation o f  MBZ from parasite tubulin was much lower 
than the rate for dissociation of MBZ from m am m alian tubulin. 
Therefore, it would appear that the selective toxicity o f benzim­
idazoles may be due to differences in the strength o f binding in 
parasite and host tubulin.
2.2. Activity
A  summary o f the activity o f different benzimidazole drugs 
in the major food-producing animals is presented in this sec­
tion. More detailed reports o f drug activity are described else­
where [11,38]. At the recommended dosage rates in cattle, TBZ 
( 6 6  mg/kg bw) and OX1 (10 mg/kg bw) are effective only against 
adult and developing larval stages o f the common gastrointesti­
nal (G.l.) roundworms. FEB shows additional activity against 
lungworms. ABZ-SO2 , FBZ and OFZ have broader spectra of 
activity which include adult larvae. ABZ-SO and OFZ are also 
effective against tapeworms. The spectra o f activity are extended 
further to include adult fluke for NETO and ABZ although the 
dosages have to be increased to 2 0  and 1 0  mg/kg, respectively, 
for efficacy against this parasitic disease. TCB is ineffective
Pfeasecite this article as: Martin Danaher et al., Review o f methodology for the determination o f benzimidazole residues in biological matrices,
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against nematodes and cestodes but has excellent activity against 
all stages o f the fluke (a trematode).
2.2.1. Sheep
OX1 is effective against adult and developing larval stages 
o f the common G.l. roundworms. TBZ and MBZ have addi­
tional activity against lungworms, although TBZ has to be given 
at a higher dose rate for treatment of G.l. roundworms and 
lungworm. At a higher dose rate, TBZ is also effective against 
developing G.l. roundworms. MBZ is also active against tape­
worms. ABZ-SO, FEB, FBZ and OFZ are effective against all 
stages o f G.l. roundworms, they are also effective against lung­
worms and tapeworms. NETO and ABZ have similar activity 
to this group but are also effective against adult stages of fluke 
if  given at an increased dose rate. TCB is effective against all 
stages o f fluke.
2.2.2. Goats
M BZ and FBZ are effective against all the major G.l. round­
worms, lungworms and tapeworms in goats.
2.2.3. Horses
A ll benzimidazoles and probenzimidazoles licensed for use 
in horses are effective against adult G.l. roundworms, although 
TBZ needs to be given at an increased dose rate for efficacy 
against P. equorum. TBZ, OX1 and FBZ are effective against 
G.l. roundworms if given at an increased dose. FBZ and OFZ 
are effective against migrating G.l. roundworm larva, although 
FBZ must be given at a much higher dose rate.
2.2.4. Pigs
OXI, flubendazole (FLU) and FEB are effective against G.l. 
roundworms in pigs. FLU, FEB and FBZ are also effective 
against lungworm. FBZ should be given at a higher dose rate 
for lungworms if  treatment is being carried out on a single occa­
sion.
2.2.5. Poultry
CAM is effective against larval and adult stages o f G.l. round­
worms in pigeons at a dose rate of 75 mg/kg given on two 
consecutive days. In pheasants, partridges and waterfowl, MBZ 
is effective against gapeworm and G.l. roundworms. FLU offers 
the broadest spectrum of activity o f benzimidazoles in poul­
try and game birds, showing activity against G .l. roundworms, 
gapeworms and tapeworms.
2.3. Toxicity
McKellar and Scott [11] have reviewed the toxicity of ben­
zimidazole veterinary drugs in detail. Excerpt from this review 
are summarised in this section. Benzimidazoles are regarded as 
safe up to 20 to 30 times the recommended dose. Acute toxic­
ity is difficult to induce with these drugs and LD50  values are 
almost impossible to define for drugs such as TBZ and FBZ. 
Reports o f acute toxicity of benzimidazoles in animals are very 
limited. The main toxic effect o f the benzimidazole compounds 
involves their teratogenic effect, which was first reported for
PAR [39]. Congenital malformations resulting from administra­
tion o f  benzim idazo le anthelmintics during gestation in ewes 
have been observed with CAM [40], OFZ [4L] and ABZ [42]. 
However, FEB [43], FBZ [44], MBZ [45] and OXI [46,47] do not 
appear to exert a teratogenic effect in sheep when administered 
in early gestation. Polyploidy was observed in cultured hamster 
ovary cells incubated with OXI and, as a result, OXI has been 
restricted to use in weaning piglets or at batch formation [48]. In 
breeding poultry, treatment with FLU in feed caused transient 
diarrhoea but there was no effect on egg production, fertility and 
hatchability [49]. In general, if  these drugs are to be used in early 
pregnancy, it must be for good reason and at the lowest recom­
mended doses. Seiler observed anaemia in dogs after prolonged 
treatment with TBZ [50]. In calves, treatment with cambenda- 
zole caused pulmonary oedema and necrotic lymphadenopathy, 
which was fatal in some cases [51].
O f particular note is the fact that some benzimidazole metabo­
lites are more toxic than the parent drug; for example, hydroxy- 
mebendazole (MBZ-OH) has been found to be more embry- 
otoxic than MBZ, in rat [52]. In rat, OFZ is teratogenic at about 
one-half the highest reported no-effect level for FBZ [52].
3. Important physical and chemical properties of 
benzimidazoles
The benzimidazoles are the largest chemical family used 
to treat endoparasitic disease in domestic animals. This group 
includes thiabendazole analogues and benzimidazole carba­
mates; substitution o f  various side chain and radicals on the 
parent benzimidazole nucleus produces the individual members. 
Newer benzimidazole carbamates are characterised by novel 
substituents on the benzimidazole nucleus and replacement of 
the thiazole ring by methylcarbamate. Such modifications have 
given rise to a new generation o f benzimidazoles with much 
slower rates o f elimination, higher potencies and broader activ­
ity spectra.
Much information about the physical and chemical properties 
of benzimidazoles can be found in reference books, from chem­
ical suppliers and by simple calculations. However, information 
relating to important properties such as octanol-water parti­
tion coefficients and piTa values are not readily available. Some 
researchers have referenced pATa values in published papers for 
determination o f benzimidazole residues in biological matrices, 
but information regarding determination of p/Ca values (either by 
experimentation or computer software) is generally not quoted 
[12,53-56]. These properties, pÆTa values in particular, provide 
important information regarding solubility and ion exchange 
properties o f residues. It is known that benzimidazoles pos­
sess an imidazole ring containing both acidic and basic nitrogen 
atoms. Under suitable conditions, the molecule may be proto- 
nated (piCa ~ 5 -6 )  or deprotonated (pATa ~  12), as shown in Fig. 1 
[57].
The p v a l u e s  o f  a limited number o f benzimidazoles 
have been quoted in the literature but mostly only one piTa 
value, is listed when two or more usually exist. A  summary 
of the piTa values and octanol-water partition coefficients (K0w) 
are listed in Table 1 (N =  acidic or basic nitrogen groups and
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Fig. 1. Ionisation  o f  th e b en zim id azo le  m o lecu le  under acid ic  (A ) and  b a sic  (B )  
con d ition s.
OH = hydroxyl groups) [57]. Experimental (from literature) and 
calculated (using computer software) values are quoted for each 
benzimidazole listed, where available. Each benzimidazole in 
Table 1 has p/fa values listed relating to acidic and basic nitro 
gen atoms on the imidazole ring. Other benzimidazoles, namely
CAM, TBZ, TCB, FLU reduced metabolite (FLU-RMET) and 
hydroxy mebendazole (MBZ-OH), are more complex molecules 
possessing more than two ionisable groups. FLU-RMET and 
MBZ-OH possess acidic hydroxyl groups, with p/Ca values of 
13.1 and 13.8, respectively. This has important consequences 
for extraction and clean up o f  5-hydroxy thiabendazole (5-0H - 
TBZ) residues from biological matrices. A common approach is 
to carry out aqueous extraction of residues under acidic or, more 
commonly, alkaline conditions, before adjusting the pH and par 
titioning into ethyl acetate. Unfortunately, because 5-OH-TBZis 
ionised over the complete pH range, it is readily soluble in most 
acidic or basic solutions and, therefore, difficult to extract into 
ethyl acetate. In the case of CAM, TCB and TCB metabolites, 
two or more pJCa values are indicated for each substance. Again, 
for these molecules it can be seen that the pH of the extraction 
solvent needs careful manipulation. Triclabendazole (TCB), tri- 
clabendazole sulphoxide (TCB-SO), triclabendazole sulphone 
(TCB-SO2 ) and CAM are neutral in the ranges of pH 7.3-10.9, 
5.0-9.0, 3.8-8.0 and 7.4—11.1, respectively. Therefore, die only 
pH range that would give non-ionised forms of these molecules 
is 7.4—8.0. The problem gets more complicated when the other
Table 1
L istin g  o f  im portant p hysica l and ch em ica l properties o f  b en zim id azo les
B en z im id a zo le C A S  num ber O cta n o l-w a ter  partition  co e ffic ien t pÄTa values“ pH  range at w hich substance 
is in  neutral state
E xperim ental C alcu lated 11 Experim ental pKa C alcu lated
B asic  groups A cid ic  groups
A B Z 5 4 9 6 5 -2 1 -8 2 .2 - 2 .9 2 N : 5 .5 4 N : 13.11 7 .7 -1 1 .2
A B Z -S O 5 4 0 2 9 -1 2 -8 0 .8 2 - 0 .9 4 7.8 N : 5 .69 N : 13.25 7 .6 -1 1 .2
A B ^ S O , 0 .9 -1 .0 1 N : 3 .50 N: 11 .20 5 .5 -9 .2
A B Z  N H 2 -S O 2 8 0 9 8 3 -3 4 -2 0 .6 9 -0 .7 5 N : 5 .98 N : 13 .30 7 .9 -1 1 .3
F B Z 4 3 2 1 0 -6 7 -9 1.95 3 .0 7 ^ 1 .0 1 N: 5 .12 N : 12 .72 7 .1 -9 .8
O FZ 5 3 7 1 6 -5 0 -0 1 .8 8 -2 .1 3 N: 4 .13 N : 11 .79 6 .1 -9 .8
F B Z -S O 2 2 .1 3 —3 .3 0 N : 3.41 N : 11.12 5.4—9.2
F L U 3 1 4 3 0 -1 5 -6 1 .9 8 -2 .4 1 N: 4 .1 0 N: 11 .76 6 .1 -9 .8
F L U -H M E T 1.72 N: 6 .58 N : 13 .87 6 .5 -1 1 .9
F L U -R M E T 1.94 N: 5 .57 N : 13 .14  
OH: 13 .68
7 .6 -1 1 .2
M B Z 3 1 4 3 1 -3 9 -7 2 .4 4 - 2 .5 2 3.5 N: 4 .13 N : 11 .79 6 .1 -9 .8
M B Z -O H 2 .2 2 -2 .6 1 9.8 N : 5 .60 N : 13 .16  
OH: 13 .77
7 .6 -1 1 .2
m b z - n h 2 1 .8 4 -2 .2 7 5.5 N : 6.61 N: 13.89 8 .6 -1 1 .9
O X I 2 0 5 5 9 -5 5 -1 1 .8 6 -2 .6 3 N: 6 .26 N: 13.78 8 .2 - 1 1 .8
T B Z 1 4 8 -7 9 -8 5 .3 -Ó .2 1 .5 8 -1 .7 6 2 .5 ,4 .7 N : 5 .22 N : 12.83 7 .2 -1 0 .9
5 -O H -T B Z 1 .2 9 -1 .3 7 4 .5 N : 7 .65 Phenol: 5 .4 6  
N : 15.10
A lw a y s  in ion ised  state
TC B 6 8 7 8 6 -6 6 -3 4 .9 0 -6 .6 6 1 0 .5 ,2 .5 N : 5 .31  
N: 1.82
N: 12.91 7 .3 -1 1 .0
T C B -S O 3 .3 9 -3 .6 6 N : 3 .00  
N: 1.82
N: 10.95 5 .0 -9 .0
T C B -S O 2 3 .5 8 - 5 .1 4 N : 1.86  
N : 1.82
N: 9 .99 3 .8 -8 .0
C A M 2 6 0 9 7 -8 0 -3 1 .8 1 -1 .9 1 N : 5 .44  
N: - 4 .6 2
N: 13 .04  
N : 15.97
7 .4 -1 3 .1
M B C 1 0 6 0 5 -2 1 -7 1 .2 9 -1 .6 9 9 .52 N: 5 .5 2 N: 13 .09 7 .5 -1 1 .1
B en z im id a zo le 1.5 0 .8 - 0 .9 5 4 .3 6 , 16.4 N : 5 .30 N : 12 .90 7 .3 -1 0 .9
PAR 1 4 2 5 5 -8 7 -9 1 .8 6 -2 .6 3 N : 5 .99 N : 13.53 7 .9 -1 1 .6
N , ion isab le  n itrogen a to m . O H , ion isab le h ydroxyl group . 
a p/£a values ca lcu la ted  using Pallas S oftw are V ersion 3 .0  (C om puD rug International Inc., G randview  D rive, South San Francisco , C A  94 0 8 0 , U SA I. 
h O ctan o l-w ater  partition  c o e ific ien t ca lcu lated  u sin g  C hem D raw  U ltra Softw are Version 6 .0 .1  (C am bridgeSoft, 100 C am bridge P a r k D n v e , M A  0 2 1 4 0 , U S A ).
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benzimidazoles are included; predicted pKa values indicate that 
at a pH value o f 8.0 most molecules are in their non-ionised 
state. However, a few exceptions exist, such as amino mebenda­
zole (MBZ-NH2 ) and OXl which exist in a non-ionised form at 
pH values o f >8 . 6  and 8.3, respectively.
The octanol—water partition coefficient, Kow, although not 
generally quoted in the scientific literature, is also a very impor­
tant property. It can provide an indication of the solubility of 
these residues in different solvents and give an indication of the 
elution conditions necessary for liquid chromatography. Most of 
these molecules have similar KUVJ values, which are generally in 
the range 0.8-3.3. However, FBZ and the TCBs residues appear 
to be much more lipophilic in nature than the other benzimi­
dazoles; these properties appear to be in good agreement with 
the polarity o f the molecules, as indicated by chromatographic 
elution order in reversed phase LC systems.
4. Factors affecting the occurence of benzimidazoles in 
tissues of animal origin
4.1. Route of administration
Benzimidazoles are typically administered as an oral or 
intraruminal dose or in feed. The bioavailability o f benzimi­
dazoles depends greatly upon the route of adminstration and the 
drug in question. After administration o f intraruminal doses of 
FBZ and ABZ to sheep, improved bioavailability of the drag 
was observed compared to oral doses [58]. Earlier work pro­
posed that a portion of the oral dose can on occasion bypass 
by the rumen and rapidly enter the abomasum by closure of 
the oesophageal groove, reducing bioavailability [59]. In the 
case o f NETO, the drug rapidly cleared from (he plasma 12 h 
post-treatment, when administered parentally in sheep and cat­
tle [60-62]. It was found that over 94% of the dose was excreted 
in urine as parent drug, with ABZ metabolites making up the 
remainder of residues [60]. This metabolism profile was reversed 
after intra-ruminal administration at the same dose [60]. In con­
trast to the other pro-benzimidazole drugs, FEB and NETO are 
not transformed by liver microsomal enzymes. NETO is con­
verted in the gastro-intestinal tract, leading to greater bioavail­
ability of the active form o f the drug after intraruminal adminis­
tration [63]. Group administration entails the inclusion o f drugs 
in feed supplements and drinking water. Results show that there 
is great variation between farms in rate o f consumption o f feed 
blocks and between sheep on the same farm in their plasma 
levels o f the drug [64,65].
4.2. Physiochemical properties o f the drug
Drug particles must dissolve in the enteric fluids to facili­
tate absorption o f the benzimidazole molecule through the G1 
mucosa. The dissolution rate influences the rate and extent of 
its absorption (systemic bioavailability), its maximal plasma 
concentration and its subsequent distribution and disposition 
kinetics. Drugs such as TBZ and CAM, the most hydrosoluble 
moeities among the benzimidazole anthelmintics, are exten­
sively dissolved in aqueous ruminai fluid and rapidly absorbed
reaching maximal plasma concentrations as early as 4h  post 
administration to cattle [11]. Newer benzimidazole compounds 
show limited G1 absorption due to their poor solubility in water, 
resulting in extended residence times for active metabolites of 
the substituted benzimidazole compound compared with those 
o f TBZ or CAM [66,67]. Prichard et al. [67] showed that max­
imal plasma concentrations o f TBZ in cattle occurs 4 h  post 
treatment, compared with 24h  for FBZ, and that FBZ persists 
much longer than does TBZ in plasma and the G1 tract. Consis­
tently, TBZ and its metabolites are recovered in urine much more 
rapidly than are FBZ and its metabolites. This difference in phar­
macokinetics in many ways accounts for the greater anthelmintic 
potency of FBZ compared with TBZ. Similar slow absorption of 
M BZhas been observed and residues can be found for 15 and 30 
days post-treatment [6 8 ]. Different distribution patterns among 
benzimidazole sulphides (FBZ, ABZ), sulphoxides (OFZ, ABZ- 
SO) and sulphone (FBZ-SO2 , ABZ-SO2 ) metabolites, based on 
their differential lipophilicities, may be expected. The distri­
bution rate depends on molecular weight, lipid solubility, and 
plasma protein binding of each drug metabolite. The majority 
o f benzimidazole compounds show a binding of less than 50% 
to plasma protein, relatively high volume o f distribution, and a 
relatively fast elimination rate [11], In contrast, TCB is strongly 
bound to plasma proteins, especially albumin which reduces its 
distribution in the body and increases its elimination half-life 
[69,70].
4.3. Animal species
On administration o f  either NETO prodrug or ABZ, ABZ-SO 
and ABZ-SO2 are the major metabolites recovered in plasma of 
both sheep and cattle. However, pronounced differences in the 
plasma disposition and in the bioavailability o f these metabolites 
between sheep and cattle have been shown [60-62,71,72]. Stud­
ies have shown the ratio o f  plasma area under curve (AUC) for 
ABZ-SO2/ABZ-SO obtained in cattle to be higher in compari­
son to sheep, after treatment with NETO [60-62]. In addition, 
the elimination half-life and mean residence of the ABZ-SO 
metabolite were significantly longer in sheep compared to cattle 
[73]. The bioavailability o f  OFZ and its metabolites after oral 
administration was significantly lower in goats than in sheep 
[74,75]. However, the intravenous administration of OFZ in both 
species resulted in similar AUC values. In addition, FBZ was 
more rapidly cleared from plasma in goats than in cattle, and the 
detection of the sulphone metabolite [FBZ-SO2] in plasma was 
delayed in cattle compared to goats [76,77].
4.4. Animal husbandry
Animal husbandry factors can have major effects on the dis­
position of benzimidazole drugs. Prichard et al. [78] found that 
the passage of digesta could influence the kinetics of orally 
administered benzimidazole drugs via binding o f benzimida­
zoles to dietary fibre, modifiying bioavailability. Hennessy et 
al. [79] demonstrated that an increased rate o f digesta passage 
through increased feed intake reduced bioavailability of OFZ 
and its metabolites in sheep. Lanusse et al. [73] proposed that
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bacterial population in microflora can play an important role on 
biotransformation o f benzimidazole drugs in the gasrointestinal 
tract. In particular, bacteria-mediated reduction o f benzimida­
zole sulphoxides (OFZ and ABZ-SO) back to the parent drug 
(FBZ and ABZ), extending residence time o f the active drug in 
the animal’s body. Therefore, changes in microflora populations 
and variations in ruminal pH, based on dietary modifications, 
may affect the reductive activity o f the GI fluids. This could 
lead to differences in pharmacokinetic behaviour and clinical 
efficacy between animals fed on grain-based diets and those 
reared exclusively on pasture.
5. Metabolism and distribution of benzimidazole 
residues in tissues
5.1. Metabolism o f benzimidazoles
It has been found in anim al studies that metabolism of these 
drugs is extensive (Figs. 2 -7 ), with one or more major metabo­
lites found in anim al tissue or milk for each drug [11,52,80-82]. 
The metabolites found depend on the structure o f the parent drug, 
the tissue and animal species. The drugs ABZ, FBZ, and TCB 
possess a sulphide linkage, which is susceptible to oxidation. As 
a result, two metabolites o f the parent sulphide are possible, a 
sulphoxide (SO) and a sulphone (SO2 ). M BZ and FLU possess 
a carbonyl group that may be reduced to form a hydroxy group. 
ABZ, FBZ, MBZ and FLU possess carbamate groups that may 
be hydrolysed to form an amino-benzimidazole. TBZ may be 
oxidised, resulting in the formation o f 5-OH-TBZ. A 4-hydroxy 
metabolite o f TCB and a keto metabolite have also been observed 
in rat, goat and sheep [18]. For other drugs, such as CAM, LUX,
FEB
FBZ
O r c d
OFZ
FBZ-SO2
F ig . 3 . M ajor m etabolites o f  febantel and  fen b en dazo le related drugs in tissu e  
and m ilk .
0X 1 and PAR, little information has been reported. The struc­
tures o f these drugs, along with some benzimidazole fungicides, 
are shown in Figs. 8  and 9. In the case o f the pro-drugs FEB and 
NETO, they are converted into their benzimidazole form after 
dosing. FEB is rapidly converted into FBZ and does not persist 
as a major residue. NETO is rapidly converted into ABZ with 
only low levels o f NETO residues occurring in tissue.
5.2. Albendazole, albendazole sulphoxide and netobimin
In catde treated with single oral doses of radiolabelled ABZ, 
it was shown that residues mainly occur in the liver followed 
by the kidney with lower levels o f residues detected in other 
tissues [83]. In calves, 90% o f residues were extractable at 1 
day after treatment with an oral dose o f radiolabelled ABZ [83]. 
However, 4—10 days post-treatment only 20-30% o f residues 
were extractable. The parent drug and its marker metabolites 
(sulphoxide, sulphone and amino-sulphone) accounted for 27
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SO2 was the major metabolite detected at 1 day post-treatment 
in liver and kidney [84]. A similar residue depletion profile was 
observed in poultry and pheasant [84]. In cattle and sheep treated 
with oral doses o f NETO, ABZ was the major residue detected at 
18 h post-treatment [85]. ABZ-SO and ABZ-NH2 -SO2  were the 
major residues found at 3 days post-treatment [85]. Depletion 
studies of ABZ in trout, tilapia and salmon up to 120 h after treat­
ment showed that ABZ-SO and ABZ-NH2 -SO2 were the major 
residues found in trout and tilapia muscle and skin tissue. In 
salmon ABZ and ABZ-SO were the major residues found [8 6 ].
F ig . 6 . M ajor m etabolites o f  m eb en d azo le  in tissue.
and 52% of total extractable residues at 1 day post-treatment, 
respectively. At 4  days post-treatment, ABZ was not detected in 
tissues and marker metabolites accounted for40-50%  of the total 
extractable residues. In sheep treated with a single oral dose of 
ABZ, 100% o f residues were extractable at 1 day post-treatment. 
The distribution o f residues in tissues was similar to that in cat­
tle. However, only 37 and 13% o f  residues were extractable 
at 4  and 8  days post-treatment, respectively. In sheep treated 
with an intra-ruminal dose o f ABZ for 7 and 14 days, it was 
shown that the marker residues accounted for 80-100, 52-58  
and 47—74% of total extractable residues in muscle, liver and 
kidney at zero days post-treatment, respectively [83]. in sheep 
treated with an oral dose o f ABZ-SO, it was shown that ABZ-
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l T \
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5.3. Febantel, fenbendazole and oxfendazole
Studies on animals treated with FEB, FBZ and OFZ have 
shown that FBZ, OFZ and FBZ-SO2 were the major residues 
[25-29]. Similarly to ABZ, FBZ and related drug residues are 
mainly found in the liver and kidney, with lower levels found in 
the muscle and fat tissues. In cattle treated with an oral dose o f  
FEB, 90% of residues were readily extractable 18 h post treat 
ment [87]. At this time-point, FBZ, OFZ, FBZ-SO? and FEB 
accounted for 30 -41 ,4—19,14—15 and 3-6% o f total extractable 
residues. At 10 days post-treatment, <25% o f residues were 
readily extractable from liver. The major residue found at 10 
days post-treatment was the FBZ amino-sulphone (FBZ-SO2 - 
NH2), which accounted for 12-35% o f total residues. In sheep 
treated with an oral dose o f  FEB, residues were shown to occur 
mainly in liver, with much lower levels o f residues being found 
in other tissues [8 8 ]. Separate studies in cattle and sheep treated 
with oral doses o f FBZ reported approximately 20 and 50 times 
higher residue levels, respectively in liver than in the next high­
est residue containing tissue [89]. Blanchfloweretal. [90] found 
that OFZ was the major residue found in the liver o f sheep after 
administration o f  an oral dose o f FBZ (5 mg/kg bw); FBZ was 
also detected but at lower levels. In pigs treated with an oral 
dose o f FEB (5 mg/kg bw), residue levels in liver were 10 times 
higher in liver than in other edible tissues [8 8 ]. C apeceetal. [91] 
investigated the distribution of oxidised FBZ residues in tissues 
after treatment o f pigs with FBZ in medicated feed (5 mg/kg 
bw per day for 5 days). The study showed that highest residue 
levels were detected in the liver with lower levels found in kid­
ney, followed by fat and muscle [91]. Sorensen and Hansen 
[92] investigated the distribution o f  FBZ and metabolites in the 
muscle and skin o f trout after administration in medicated feed 
(1 g/kg feed for 1 week). The study showed that FBZ and OFZ 
residues were slightly higher in skin compared to muscle tissue, 
with lower levels o f FBZ-SO2 found.
5.4. Flubendazole
In pigs treated with FLU in medicated feed (1.2 mg/kg bw 
per day for 5 days), 71, 80 ,90  and 89% of residues were shown 
to be readily extracted from liver, kidney, muscle and fat tissues, 
respectively [93]. At 5-30  days post-treatment, approximately 
50% o f residues were readily extractable from liver and kidney. 
At 6  h post-treatment, the hydrolysed metabolite o f FLU (FLU- 
HMET) was the major residue found and accounted for47 ,94 ,94  
and 31% of total extracted residues in liver, kidney, muscle and 
fat tissues, respectively. At 10 days post-treatment, FLU-HMET 
accounted for 18 and 23% of residues in liver and kidney. In lay­
ing hens treated with FLU (2 .7mg/kg bw per day for 7 days), 
it was shown (hat 76-79% of residues were extractable at 24 h 
post-treatment from muscle, skin and fat tissues [93]. At this 
time-point, 49 and 61% of residues were extractable from kid­
ney and liver tissues, respectively. At later time-points, 30-35%  
o f residues were extractable from liver and kidney. Residues 
were distributed mainly in the liver and kidney with much lower 
levels being found in muscle, skin and fat. It was reported that 
the parent drug accounted for <3% of total extracted residues 
in liver and kidney tissues at 24 h post-treatment. The major­
ity of residues comprised of FLU-HMET and FLU RMET (the 
reduced metabolite of FLU). De Ruyck et al. [94] investigated 
the fate of FLU residues in turkey after administration of FLU in 
medicated feed (1.2 mg/kg bw for 7 days). They found thatFLU-
11 MET was the major residue present in turkey breast muscle 
with lower levels o f the parent drug being present. De Ruyck et 
al. investigated the fate o f FLU residues in the tissues of guinea 
fowl in a separate study, finding that FLU-RMET was the major 
residue present in liver and muscle tissues [95]. FLU was also 
detected with lower levels o f FLU-HMET present. It was shown 
that 80% of FLU are readily extractable from the eggs of laying 
hens treated with this drug. FLU was the major residue found in 
eggs, accounting for 40% of total residues at 1 and 9 days post-
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the findings of this study. 26, 25 and 15% of residues found. 617
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in  sheep treated with an oral dose o f mebendazole (15 mg/kg 
bw). 7 4 ,9 5 ,9 2  and 99% of residues were extractable from liver, 
muscle, kidney and fat tissues at 1 day post-treatment, respec­
tively [97]. At 7 and 14 days post-treatment, 87 and 74-78%  
o f residues were extractable from liver and kidney, respectively. 
The parent drug, accounted for 8 ,3 ,2 0  and 30% o f total residues 
in liver, muscle, kidney and fat, at 1 day post-treatment. At the 
same time-point, MBZ-OH accounted for 47, 90, 14 and 67% 
of total residues in liver, muscle, kidney and fat, respectively. 
At 3 days post-treatment, MBZ and MBZ-OH accounted for 
2 and 3.5% of total residues. De Ruyck et al. [98] found a 
similar distribution pattern o f residues in the tissues of^sheep 
treated with an oral dose of MBZ (2 0 mg/kg bw). The fate of 
MBZ residues in goat was found to be similar to that of sheep 
[97]. In horse, it was shown that the major residue found in edi­
ble tissues is MBZ-NH2 , with much lower levels o f MBZ and 
MBZ-OH detected [97]. Residues were found at highest levels 
in the liver and kidney, with lower levels found in muscle and 
fat. Iosifidou et al. [99] investigated the fate o f MBZ in farmed 
eel, finding that residues mainly occurred in the liver and kidney 
with lower levels found in skin and muscle. MBZ-NH2 was the 
major residue found with lower levels o f MBZ and MBZ-OH 
present.
5.6. Thiabendazole
In calves treated with an oral dose of TBZ, it was found 
that residues mainly occurred in the liver and kidney [100]. At
1 day post-treatment, residues were found to occur mainly in 
the kidney with lower levels found in liver. At later withdrawal 
periods (>2 days), residues were mainly found in the liver [ 100]. 
Chukwudebe et al. [101] investigated the fate o f TBZ residues 
in goats treated with oral doses (120 mg per animal daily for
7 days). Residues were shown to occur mainly in the liver and 
kidney. The major residue found in tissue at 1 day post-treatment 
was TBZ, with lower levels o f  5-OH-TBZ present. The same 
study showed that at 1 day post-treatment, 5-OH-TBZ was the 
major residue detected in the tissues o f  laying hen, with lower 
levels o f TBZ found [101]. Residues occurred mainly in the 
kidney with lower levels found in the liver. Wilson et al. [102] 
investigated the fate of TBZ in cattle, sheep and pig liver. In sheep 
treated with an oral dose of TBZ (50 mg/kg bw), animals were 
sacrificed at 7 and 10 days post-treatment. TBZ was the only 
residue found and in one animal at 10 days post-treatment. In 
pigs, treated with an oral dose (50 mg/kg bw), residues were not 
detected in liver at 7 and 10 days post-treatment. In cattle treated 
with an oral dose (50 mg/kg bw), TBZ was the major residue 
found with lower levels o f 5-OH-TBZ. Couletet al. [103] carried 
out an in vitro study o f the metabolism of TBZ in the cultured 
hepatocytes of rats, rabbits, sheep, calves and pigs, finding 5- 
OH-TBZ to be the major metabolite in calf and pig hepatocytes. 
Several metabolites were found in sheep, consisting mainly o f
In cattle and sheep treated with oral doses of TCB it 619
was shown at early withdrawal periods (2 days) that residues 620
occurred at higher levels in the liver and kidney, with lower lev- ki
els found in muscle and fat [104]. At longer withdrawal periods 622
(>28 days), it was found that similar levels o f  residues could be 623
found in muscle, liver and kidney. The contribution of individual 624
TCB metabolites to the marker residues in animal tissues has not 62s
been reported. Most studies report the depletion of total marker 626
residues and not individual components. 627
5.8. Oxibendazole 62a
There is very little information available on the metabolism 629
o f OXI, but studies indicate that the drug is significantly 030
metabolised in the liver and kidney [47,105]. Two metabolites aai
5-OH-OXI and 6-OH-OXI have been identified in urine and tis- 632
sues, but only accounted for 15-20% of the total residues (the 533
remainder are unidentified) [105]. 634
5.9. Cambendazole sas
Early studies on the drug found that it was rapidly metabolised 636
producing at least 13 urinary metabolites [106.107]. The identi- 637
fication o f markerresidues in animal tissues is not well described eaa
because the drug is not marketed for use in food producing ani- ess
mals. 640
5.10. Benomyl 641
Gardiner et al. [108] investigated the elimination of benomyl 642
(BEN) residues in animals, finding 5-OH benzimidazole carba- ^
mate to be the major metabolite, with lower levels o f  the 4-OH 644
metabolite present. 645
5.11. Summary 646
In cattle and sheep treated with ABZ, ABZ-SO or NETO, it 647
has been shown that ABZ-SO or ABZ-SO2  are the most likely 64a
residues to be found in the case o f an MRL violation. ABZ-NH2 - 049
SO2 is perhaps the most persistent residue in tissue but generally 6»
occurs at levels below the MRL. There is very little information 551
available on the presence o f individual FBZ residues in animal 652
tissues, although Blanchflower et al. [90] found that OFZ was «¡a
the major residue present in the tissues o f sheep treated with 554
FBZ. In cattle treated with FEB, FBZ was the major residue ess
found at early withdrawal periods, with lower levels o f OFZ and 05«
FBZ-SO2 found. 657
FLU parent drug is the major residue found in the eggs of 668
laying hens, while FLU-HMET is the major metabolite present 659
in pig and turkey tissues. A recent study has shown that FLU- eeo
RMET is the major residue found in the tissue o f  guinea fowl, eei
indicating that it should be listed as a marker residue. MBZ-OH 682
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and MBZ-NH2 are the major MBZ residues found in sheep and 
horse liver, respectively. In cattle, goats and sheep treated with 
TBZ, the parent drug was shown to be the major residue found 
in liver after treatment. The 5-OH-TBZ metabolite occurs only 
at low levels in these species, but was shown to be the major 
metabolite in poultry at early withdrawal periods. There is very 
litde information available on the occurrence o f individual TCB 
residues in tissues. However, pharmacokinetic dataindicates that 
TCB-SO and TCB-SO2  would be the most likely residues to be 
found. Very little data has been published on the metabolism and 
distribution o f CAM and OX1 residues in tissues.
6. Depletion of benzimidazole residues in tissues
6.1. Netobimin, albendazole and albendazole sulphoxide
In cattle treated with an oral dose o f ABZ-SO (12m g/kg bw), 
ABZ-SO marker residues were below the MRLs in liver and 
kidney at 2 days post-treatment [84]. At 1 day post-treatment, 
ABZ-SO2 was detected in liver and kidney at levels of 2953 and 
1355 p-g/kg, respectively. ABZ-SO was detected at 1 day post­
treatment in liver and kidney at levels o f 294 and 233 p-g/kg. 
In cattle treated with an oral dose o f netobimin (20 mg/kg bw), 
marker residues were below the MRL at 3 days post-treatment
[85]. At lOh post-treatment, ABZ, ABZ-SO, ABZ-SO2  and 
ABZ-NH2 -SO2 , were found at levels o f 7354, 771, 5289 and
0  p-g/kg in liver, respectively. These parent/metabolite residues 
were at levels o f 3285, 467, 1879 and 0 |xg/kg in kidney, 792, 
1909, 1740 and 0 p-g/kg in muscle; and 556, 195, 474 and
0 p-g/kg in fat, respectively. ABZ residues were detectable at
1 day post-treatment with NETO but were not detected at 3 
days. At 3 days post-treatment and thereafter, the only residue 
present was ABZ-NH2 -SO2 , which could be found at levels o f 
243, 213 and 81 p-g/kg at 3, 7 and 14 days post-treatment. In 
sheep treated with an oral dose o f NETO (20 mg/kg bw), marker 
residues were below the MRL at 3 days post-treatment [85]. At
18 h post-treatment, ABZ, ABZ-SO, ABZ-SO2 and ABZ-NH2 - 
SO2 , were found atlevels o f 18,000; 3100; 4200 and78 p-g/kg in 
liver, respectively. At 18 h post-treatment, these residues were at 
levels o f 7400 ,2400 ,110  and 110 p-g/kg in kidney, 2200, 3400, 
1100 and 0 (ig/kg in muscle, and 303, 983, 555 and 0 p-g/kg in 
fat, respectively. At 3 days post-treatment, ABZ-SO and ABZ- 
NH 2 -SO2  were found at levels o f 150 and 770 p-g/kg in liver 
tissues, respectively. At 3 days post-treatment, ABZ-NH2 -SO2 
was found in kidney at a level o f  226 p-g/kg. At 10 days post­
treatment, ABZ-NH2-S 0 2 was the major residue found in liver 
and kidney at levels of 150 and 31 p-g/kg, respectively.
In pheasant treated with ABZ-SO in medicated feed 
(17 mg/kg bw per day for 3 days), residues were found to be 
below the MRL at 1 day post-treatment [84]. At this time-point, 
combined ABZ-SO and ABZ-SO2 residues were found atlevels 
o f 168, 479 and 366 p-g/kg in muscle, liver and kidney tissues, 
respectively. Combined ABZ-SO and ABZ-SO2 residues were 
more persistent in liver than other tissues and were found at levels 
o f 90 and 45 p-g/kg at 3 and 7 days post-treatment, respectively. 
ABZ-NH2-S 0 2 was only found in liver tissue and atlevels o f  24, 
168 and 99 p-g/kg at 1,3 and 7 days post-treatment, respectively.
Shaikh et al. investigated the depletion of ABZ and its metabo- 717
lites in salmon, tilapia, trout after treatment with ABZ (oral dose 71 b
lOmg/kgbw) [86]. In salmon, ABZ and ABZ-SO were found in 719
muscle tissue at levels of 22 and 39 p-g/kg, respectively at 24 h 720
post-treatment. ABZ-SO2 and ABZ-NH9 -SO2 were also present 721
but at lower levels, typically less than 5 and 10 p-g/kg, respec- 722
tively. ABZ was found in tilapia at a level o f  678 p-g/kg at 8 h 723
post-treatment but was not present at later time-points. ABZ-SO 724
was found at levels o f 39 and 31 p-g/kg at 8 and 12h post- 725
treatment, respectively. ABZ-SO was generally at 7 p-g/kg or 720
lessat24h.A B Z -S02w asatorbelow 7p.g/kgatalltim e-points. 727
ABZ-NH2 -SO2 was the more persistent residue, present at lev- 72s
els o f 18, 100 and 53 p-g/kg at 8, 72, and 120 h post-treatment, 729
respectively. ABZ parent drug was not found in trout muscle. The 730
major residues found were ABZ-SO (18—4-7 p-g/kg) followed by 731
ABZ-SO2 (5 -14  p-g/kg) and ABZ-NH2 -SO2 (3-10 p-g/kg). 732
6.2. Febantel, fenbendazole and oxfendazole 733
In cattle treated with FBZ (oral dose 7.5 mg/kg bw), animals 734
were sacrificed at 7 and 21 days post-treatment. Marker residues 735
(FBZ, OFZ and FBZ-SO2) were below the MRL in all tissues 736
at 7 days post-treatment at levels o f 5, 7, 8 and 194 p-g/kg in 737
fat, kidney, muscle and liver, respectively [89]. In sheep treated 7as
with FBZ (oral dose 10 mg/kg bw), animals were sacrificed at 5 739
and 9 days post-treatment [89]. At 9 days post-treatment, marker 740
residues were below the MRL in all tissues, with the exception 741
o f liver. At this time, combined marker residues were present 742
at levels o f <5, <6, 6 and 745 p-g/kg in kidney, fat, muscle and 743
liver, respectively. At 5 days post-treatment, marker residues 744
were found to be at levels of 79 and 3659 p-g/kg in kidney and 745
liver. In sheep treated with an oral dose o f OFZ (5 mg/kg bw), 74a
animals were sacrificed at 10 and 24 days post-treatment [109]. 747
Marker residues were below the MRLs at 10 days post-treatment. 74a
Highest residue levels (at 10 days post-treatment) were found in 749
the liver at a level o f476 p-g/kg. In sheep treated with an oral dose 750
of FEB (5 mg/kg bw), animals were sacrificed at 3 and 7 days 751
post-treatment [88]. Marker residues were above the MRL at 7 752
days post-treatment. At this time-point, marker residues were 753
found at a level o f  942 p-g/kg in liver (nearly twice the MRL). 754
At 3 days, marker residues were found at levels o f40 ,4617 ,199  755
and 133 p-g/kg in muscle, liver, kidney and fat, respectively. 750
In pigs treated with an oral dose o f FEB (5 mg/kg bw), ani- 757
mals were sacrificed at 12, 20 and 34 days post-treatment [88]. 750
Marker residues were below the MRL at 34 days post-treatment. 759
At 24 days post-treatment, marker residues were found at lev- 700
els o f 402, 6, 12 and 100 p-g/kg in liver, muscle, kidney and 761
fat, respectively. The marker residues were above the MRL in 702
fat, which is 50 p-g/kg. Blanchfiower et al. [90] investigated the 703
depletion o f FBZ and OFZ in sheep treated with an oral dose o f 704
FBZ (5 mg/kg bw). Animals were sacrificed at 1 ,2 ,4 ,7 ,1 0  and 705
15 days post-treatment. It was shown in this study that marker 70s
residues were typically below the MRL of 500 p-g/kg at 14 days 787
post-treatment in liver. At 2 days post-treatment, OFZ and FBZ 7ea
were both found at levels o f approximately 3000 p-g/kg. OFZ 709
was shown to be a much more persistent residue in liver tissue 770
than FBZ. Capece et al. [91] monitored the depletion o f oxi- 771
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772 dised FBZ residues in pigs after treatment with an oral dose of
773 FBZ (5 mg/kg bw per day for 5 days). Marker residues were
774 below the MRLs in all tissues at 2 days post-treatment. At 1
775 day post-treatment, marker residues were found in liver, kid-
776 ney, muscle and fat, at levels o f  5552 ,917 ,623  and 1423 (Jig/kg,
777 respectively. Sorensen and Hansen [92] investigated the deple- 
77a tion o f FBZ, OFZ and FBZ-SOi in trout after treatment with an
779 oral dose o f FBZ in medicated feed (1 g/kg feed for 1 week). At
780 1 day post-treatment, FBZ, OFZ and FBZ-SO2 were found at
781 levels o f 56-389, <2-252 and <4-53 (¿g/kg, respectively. At 6 
7S2 weeks post-treatment, only low concentrations o f residues were 
7B3 reported.
784 6.3. Flubendazole
785 Pigs treated with FLU in medicated feed (1.2 mg/kg bw per 
7B6 day for 7 days), animals were sacrificed at 6 h-and 10 days post-
787 treatment [93]. Residue depletion data showed that FLU marker
788 residues (FLU and FLU-HMET) were below the MRL at 10 days 
739 post-treatment. At 6 h post-treatment, FLU-HMET was found at
790 levels o f 1817, 2517, 246 and 66 jxg/kg in liver, kidney, muscle
791 and fat, respectively. FLU was found at levels o f 39, 51, 30
792 and 62 jig/kg in liver, kidney, muscle and skin-fat, respectively.
793 In turkeys treated with FLU in medicated feed (30 mg/kg feed
794 per day for 7 days), birds were sacrificed at 6 h, 1 day, 3 days,
736 7 days and 9 days post-treatment [93]. Marker residues were
796 found to be below the MRL at 1 day post-treatment. At 6 h post-
797 treatment, FLU was found at levels o f 64, 67, 18 and 60 (JLg/kg
798 in liver, kidney, muscle and skin-fat, respectively. At 6h  post-
799 treatment, FLU-HMET was found at levels o f 29, 11, 0 and
am 0 pug/kg in liver, kidney, muscle and skin-fat, respectively. At 6 h 
B01 post-treatment, FLU-RMET was found at levels o f 200, 80, 42 
B02 and 32 (JLg/kg in liver, kidney, muscle and skin-fat, respectively. 
ao3 FLU and FLU-HMET are the marker residues for FLU in all 
a« species. De Ruyck et al. [94] monitored the depletion of FLU 
aos marker residues in turkeys (1.2 mg/kg bw per day for 7 days). At 
bo» 1 day post-treatment, combined FLU and FLU-HMET residues 
so? were at levels o f 102 and 120 (JLg/kg in thigh muscle, respectively, 
aos In liver, combined FLU and FLU-HMET residues were found at 
B09 a level o f 2334 (JLg/kg. At 2 days post-treatment, marker residues 
bio were below the MRL in all tissues.
an In laying hens treated with FLU in medicated feed (3.6 mg/kg
ai2 bw per day for 7 days) eggs were collected at 7 and 11 days 
sis post-treatment [93]. FLU levels in egg ranged between 118 and 
a« 230 (ag/kg at 7 days post-treatment to 13 |xg/kg at 11 days post­
a l treatment. Kan et al. [96] investigated the depletion of FLU 
aie residues in eggs collected from laying hens treated with rations 
si/ o f medicated feed containing different concentrations o f FLU 
aia (2 .6 ,9 .4  and 27 mg/kg feed) for 21 days. The study showed that 
ai9 FLU residues in egg reached a maximum level o f  150 (jLg/kg in
820 whole egg during the treatment period after consuming the ration
821 containing the highest levels o f FLU. In pheasant treated with
a22 FLU in medicated feed (3.6 mg/kg bw per day for 7 days), birds
823 were sacrificed at 6h , 1 and 10 days post-treatment [93]. This
824 group monitored the depletion o f FLU only and not metabo-
825 lites. At 6h  post-treatment, FLU was found at levels o f 35, 58,
82b 18.5 and 76 (JLg/kg in liver, kidney, muscle, and skin-fat, respec­
tively. FLU was more persistent in skin-fat and could be found 
at levels o f 29 and 12 (xg/kg at 1 and 7 days post-treatment, 
respectively. De Ruyck et al. [95] investigated the depletion of 
FLU and it’s metabolites in guinea fowl after administration in 
medicated feed (56 mg/kg feed for 7 days). The highest con­
centration in thigh muscle during the treatment period for FLU- 
RMET (Day 3) and FLU plus FLU-HMET (Day 4) was 312 and
114 [JLg/kg, respectively. At 1 day post-treatment, FLU-RMET 
and combined FLU plus FLU-HMET residues were detected 
in thigh muscle at levels o f 81 and 50 |xg/kg, respectively. In 
liver, highest levels o f FLU, FLU-HMET and FLU-RMET dur­
ing treatment were 108, 23 and 1043 |xg/kg, respectively. At 1 
day post-treatment, FLU, FLU-HMET and FLU-RMET were 
17, 11 and 283 fig/kg in liver, respectively.
6.4. Mebendazole
In horse treated with an oral dose o f MBZ (8 .8  mg/kg bw), 
animals were sacrificed at 1 and 28 days post-treatment [97]. At
1 day post-treatment, MBZ-NH2 was the major residue, which 
was found at concentrations o f 5047, 5851, 497 and 156 jig/kg 
in liver, kidney, muscle and fat, respectively. At the same time­
point, MBZ was found at levels o f 728, 29, 16 and 57 (JLg/kg in 
liver, kidney, muscle and fat, respectively. MBZ-OH was found 
at levels o f 293, 85, 84 and 60 (JLg/kg in liver, kidney, muscle 
and fat, respectively. At 28 days post-treatment, MBZ-NH2 was 
the only marker residue detected in liver and kidney, at lev 
els o f  182 and 23 (xg/kg, respectively. In sheep treated with an 
oral dose o f MBZ (20 mg/kg bw), animals were sacrificed at
1, 7, 14, 21 and 28 days post-treatment [97], At 28 days post­
treatment, marker residues (MBZ, MBZ-OH and MBZ-NH2 ) 
were below the MRL in all tissues. At 1 day post-treatment, 
MBZ was at 1016, 1460, 21 and 343 (JLg/kg; and MBZ-OH was 
at 7582, 1531, 1783 and 758 (ig/kg; and MBZ-NH2  was at 18, 
147, 0 and 0  (JLg/kg in liver, kidney, muscle and fat, respectively. 
At 7 days post-treatment, residues were only detectable in liver 
and kidney. MBZ, MBZ-OH and MBZ-NH2  were determined in 
liver at levels o f 56, 272 and 27 (JLg/kg, respectively. In kidney, 
MBZ, MBZ-OH and MBZ-NH2 were determined at 27, 38 and 
44 (JLg/kg, respectively. De Ruyck et al. [98] carried out a sim­
ilar study in sheep at the same dosage. However, in this study 
residues were shown to be below the MRL in ail tissues at 7 
days post-treatment. In goats treated with an oral dose o f MBZ 
( 2 0  mg/kg bw), animals were sacrificed at 1 and 28 days post­
treatment [97]. At 28 days post-treatment, marker residues were 
below the MRL in all tissues. In liver, MBZ-OH and MBZ-NH2 
were found at levels o f  308 and 19 (ig/kg, respectively. At 1 day 
post-treatment, highest residues levels were found in the liver, 
where MBZ, MBZ-OH and MBZ-NH2 were present at levels of 
1020, 7502 and 151 (JLg/kg, respectively.
6.5. Thiabendazole
A number of studies reporting the depletion o f  combined 
marker residues (TBZ and 5-OH-TBZ) have been described in 
different species after treatment with TBZ [100]. In sheep treated 
with an oral dose of TBZ (44 mg/kg bw), marker residues were
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found in liver at levels o f 4680,326,825 and <50 (xg/kg at 1, 2, 3 
and 4  days post-treatment, respectively [100]. In calves treated 
with an oral dose of TBZ (75 mg/kg bw), combined marker 
residues at 1, 2 and 6  days post-treatment were 472, 215 and 
63 jxg/kg in liver; 638, 97 and <50 jJLg/kg in kidney; 75, 50 and 
<28 n-g/kg in muscle and 89, <50 and <50 |xg/kg in fat [100]. 
Wilson et al. [102] reported the depletion data for individual 
TBZ marker residues in a study in sheep and cattle. In sheep 
treated with an oral dose o f  TBZ (50 mg/kg bw), animals were 
sacrificed at 7 and 10 days post-treatment. TBZ was found in one 
animal at a level o f  72 |xg/kg at 10 days post-treatment. In cattle 
treated with an oral dose of TBZ (50 mg/kg bw), animals were 
sacrificed at 1 and 2 days post-treatment. Marker residues were 
below the MRL in the liver of cattle at 2 days post-treatment. 
TBZ was the major residue found at this withdrawal period at 
a level o f 71 jxg/kg. At 1 day post-treatment, TBZ and 5-OH- 
TBZ were found in one animal at levels o f 677 and 259 jxg/kg, 
respectively.
6.6. Triclabendazole
In cattle treated with an oral dose o f TCB (12 mg/kg bw), ani­
mals were sacrificied at 2 and 42 days post-treatment [104]. At
2 days post-treatment, combined marker residues (TCB, TCB- 
SO) and TCB-SO2 ) were found at levels o f 5870, 4300, 1420 
and 2470 jxg/kg in liver, kidney, muscle and fat, respectively. At 
42 days post-treatment, combined marker residues were found 
at levels o f  80, 75, 100 and <60 jxg/kg in liver, kidney, mus­
cle and fat, respectively. In a second study, cattle treated with 
an oral dose o f TCB (12 mg/kg bw) showed, at 2 days post­
treatment, combined marker residues at levels o f 3250, 3050, 
875 and 1800 [xg/kg in liver, kidney, muscle and fat, respectively 
[104]. At 28 days post-treatment, combined marker residues 
were found at levels o f 5 2 ,4 7 ,2 3  and <3 |xg/kg in liver, kidney, 
muscle and fat, respectively. In a study on cattle treated with an 
oral dose o f a combination product (12 mg/kg bw (TCB) and
7.5 mg/kg bw (levamisole)), the cattle were slaughtered at 1, 
21 and 28 days post-treatment [104]. At 1 day post-treatment, 
marker residues were found at levels o f 7050, 5800, 1400 and 
5800 jxg/kg in liver, kidney, muscle and fat, respectively. At 28 
days post-treatment, TCB marker residues were found at levels 
o f 144, 102, 142 and <40 ng/kg in liver, liver, kidney, muscle 
and fat, respectively. In a similar study on sheep treated with 
an oral dose o f a combination product (12 mg/kg bw (TCB) 
and 7.5 mg/kg bw (levamisole)), the animals were sacrificed at
2 and 28 days post-treatment [104]. At 2 days post-treatment, 
TCB marker residues were found at levels o f  3500, 3100, 1420 
and 1350 |xg/kg in liver, kidney, muscle and fat, respectively. 
At 28 days post-treatment, TCB marker residues were found 
at levels of 127, 119, 95 and <29 jxg/kg in liver, kidney, mus­
cle and fat, respectively. In a study on sheep treated with an 
oral dose of a combination product (10 mg/kg bw (TCB) and
7.5 mg/kg bw (levamisole)), the animals were slaughtered at 1,
21 and 28 days post-treatment [104]. At 1 day post-treatment, 
TCB marker residues were found at levels o f  7400,6800, 2100 
and 1 0 ,1 0 0  jxg/kg in liver, kidney, muscle and fat, respectively. 
At 28 days post-treatment, TCB marker residues were found at
levels o f 238,198,321 and 23 |xg/kg in liver, kidney, muscle and 
fat, respectively
6.7. Summary
The marker residues o f ABZ, ABZ-SO and netobimin are 
rapidly cleared from the edible tissues of cattle and sheep; and 
are typically below the MRL at 4  days post-treatment. Results 
of studies verily the suitability o f the withdrawal periods that 
are specified in cattle (14 days) and sheep (3-10 days) [110]. 
FLU marker residues were shown to be below the MRLs in 
turkey and pigs at 1 and 10 days post treatment, respectively. The 
withdrawal period specificed for FLU marker residues in turkey 
and pig is 7 days. Two separate studies have been carried out in 
eggs, showing that FLU residues do not occur at levels above the 
MRL during or after treatment. As a result, a zero withdrawal 
period has been specified for FLU in eggs. Marker residues for 
FBZ and related drugs (OFZ and FEB) were shown to be below 
the MRL in the edible tissues o f  cattle, sheep and pig at 10,7 and
2 days post-treatment, respectively. The withdrawal periods for 
FBZ related drugs in cattle, sheep and pigs range between 14—35, 
7-21 and 3-35 days, respectively. MBZ and TCB have been 
identified as the most persistent benzimidazole drug in animal 
tissues. In horse and sheep, MBZ marker residues were below  
the MRL at 28 days post-treatment. TCB residues were shown 
to be below the MRL in cattle at 28 to 42 days (two separate 
studies) and above the MRL in sheep at 28 days post-treatment. 
As a result, withdrawal periods for MBZ and TCB are typically 
>14 and 28 days, respectively. TBZ is rapidly cleared from the 
edible tissues of cattle and sheep, to below the listed MRLs, at
6  and 4  days post-treatment, respectively. N o withdrawal period 
has been specified for TBZ, which may be an indication that 
this drug has been withdrawn from the market. The depletion of 
others benzimidazole drugs, namely OX1 and CAM, are not well 
described for the edible tissues of food-producing animals. The 
withdrawal period for OX1 is 7 days in pig, indicating that it is 
one o f the least persistent benzimidazole residues. CAM is not 
approved for treatment o f food-producing species and detailed 
residue depletion studies have not been conducted.
7. Depletion of benzimidazole residues in milk
7.1. Netobimin, albendazole and albendazole sulphoxide
In dairy cows treated with NETO (oral dose 20 mg/kg 
bw), ABZ-SO residues were found at levels o f 7374, 2278 
and 210 (xg/kg at 7.5, 22 and 31.5h  post-treatment, respec­
tively. ABZ-SO2 residues were found at levels o f  2336, 3410 
and 81 jxg/kg at 7.5, 22 and 31.5 h post-treatment, respec­
tively. Residues o f  NETO, ABZ and ABZ-NH2 -SO2 were not 
detectable at any timepoint [85]. Fletouris et al. [111] investi­
gated the depletion o f ABZ, ABZ-SO and ABZ-SO2  in the milk 
of dairy cows treated with ABZ (oral dose 15 mg/kg bw). At
12 h post-treatment, ABZ-SO and ABZ-SO2  were found at lev­
els o f 163 and 931 ixg/kg, respectively. At 24 h post-treatment, 
ABZ-SO and ABZ-SO2  residues were found at levels o f 800 and 
853 jxg/kg, respectively. ABZ-SO and ABZ-SO2  residues were
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987 below the MRL at 36 h post-treatment. Cinquina et al. [112] 
gas investigated the depletion of ABZ residues in the milk of sheep 
ass and goats treated with ABZ (oral dose 3.75 mg/kg bw). At 24h  
990 post-treatment, ABZ-SO residues were found approximately 
sai at 1100 and 1700 [xg/kg in goat and sheep milk, respectively.
992 At 24h  post-treatment, ABZ-SQj residues was found at an
993 approximate level o f 500 |xg/kg in goat and sheep milk. At 48 h
994 post-treatment, ABZ-SO and ABZ-SO2 were the major residues
995 found in sheep milk. At 48 h post-treatment, ABZ-NH2 -SO2
998 was the major residue found in goat milk, with lower levels o f 
997 ABZ-SO2 present. At 72 h post-treatment, residues were typi- 
99a cally at less than 100 [xg/kg in goat and sheep milk. De Liguoro
999 et al. [113] investigated the depletion o f  ABZ marker residues
1000 in milk from sheep treated with ABZ (oral dose 12.5 mg/kg).
1001 ABZ residues were not detected in milk at any time-point.
1002 At 12 h post-treatment, ABZ-SO and ABZ-SO2  were found
1003 at levels o f  3896 and 902 [xg/kg, respectively. At 48 h post-
004 treatment, ABZ-SO and ABZ-SO2 were found at levels o f 62
005 and 106 (xg/kg, respectively. ABZ-NH2 -SO2  was only found at
008 36 h post-treatment and at a level o f  89 [xg/kg. Chu et al. [114]
007 investigated the depletion of ABZ marker residues in cows milk
008 after treatment with ABZ (oral dose 10 mg/kg bw). At 24 h post- 
00s treatment, combined marker residues were found at a level of
010 576 |xg/kg. At 48 h post-treatment, combined marker residues
011 were found at a level o f 67 [xg/kg.
012 Moreno et al. [115] compared the milk residue profiles o f
013 ABZ marker residues in dairy cows treated with ABZ oral (oral
014 dose 5 mg/kg bw) and ABZ-SO aqueous injectable (3 mg/kg
015 bw) formulations. At 12 h post-treatment, ABZ-SO and ABZ- 
01B SO2  residues were found at levels o f 280 and 860 [xg/kg after 
017 oral administration, respectively. After administration by sub- 
01a cutaneous injection ABZ-SO and ABZ-SO2  were at levels o f
019 180 and 80 [xg/kg, respectively. In both studies, residues were
020 not detectable at 36 h post-treatment.
«i 7.2. Febantel, fenbendazole and oxfendazole
022 Hetouris et al. [111] investigated the depletion of FBZ marker 
osa residues in the milk o f  a dairy cow treated with FBZ (oral dose 
024 10 mg/kg bw). At 12 h post-treatment, FBZ, OFZ and FBZ-
026 SO2 residues were found at levels o f 85, 196 and 48 |xg/kg, 
02* respectively. Marker residues were shown to be below the MRL
027 at 84 h post-treatment. In dairy cows treated with FEB (unde- 
02a scribed dosage), marker residues depleted from 268 to <5 [xg/kg
029 at 24—130 h post-treatment, respectively [89]. Residues were
030 below the MRL at 106 h post-treatment. In sheep treated with
ion FEB (undescribed dosage), marker residues depleted from 
>032 357 to <5 [xg/kg at 10-130 h post-treatment, respectively [88].
1033 Residues were below the MRL at 120 h post-treatment. Tai et
1034 al. [116] investigated the depletion o f  FBZ and OFZ residues 
■ o3g in the milk o f dairy cows treated with FBZ (oral dose 10 mg/kg 
loso bw). At 28 h post-treatment, FBZ and OFZ residues were found 
1037 at levels o f 105 and 441 (xg/kg, respectively. OFZ residues were 
to38 found to be more persistent in milk than FBZ residues and OFZ
1039 could be found at a level o f  29 |xg/kg at 76 h post-treatment.
1040 Moreno et al. [115] compared the milk residue profiles o f OFZ 
io«i marker residues in dairy cows treated with oral (5 mg/kg bw)
and aqueous injectable (3 mg/kg bw) formulations. At 12 h post­
treatment, OFZ, FBZ and FBZ-SO2  residues were found at levels 
of 390, 90 and 70 [xg/kg after oral administration, respectively. 
Residues were not detectable after 72 h post-treatment. After 
administration by subcutaneous injection OFZ and FBZ-SO2 
were the only residues detected. OFZ and FBZ-SO2 , reached 
maximum milk levels at 12 h (30 [xg/kg) and 36 h (42 |xg/kg), 
respectively. In both studies, residues were not detectable after 
72 h post-treatment.
7.3. Thiabendazole
hi cows treated with TBZ (oral dose 6 6  mg/kg bw), marker 
residues (TBZ and 5-OH-TBZ) were found at a level o f 
5175 [xg/kg at 12hpost-treatment [100]. Residues were found to 
be present at a level o f 45 (xg/kg at 84 h post-treatment (below the 
MRL o f 100 jxg/kg). Tocco et al. [6 6 ] investigated the depletion 
o f TBZ residues in the milk of dairy cows and goats treated with 
TBZ (oral dose 6 6  and 150 mg/kg bw, respectively). The sulfate 
conjugate o f 5-OH-TBZ was found to be the major and most 
persistent residue found in milk. At 6  and 72 h post-treatment, 
5-OH-TBZ was found in goat milk at levels o f 39,000 and and
800 |xg/kg, respectively. In cow’s milk, TBZ was only found to 
be present at a level o f 60 [xg/kg at 12 h post-treatment. At 12 and 
48 h post-treatment, 5-OH-TBZ was found at a level o f 1860 and 
80 [xg/kg, respectively. Taietal. [116] found that the sum of TBZ 
and 5-OH-TBZ residues were below the MRL of 100 mg/kg in 
cows milk at 48 h post-treatment (oral dose of 100 [xg/kg bw).
7.4. Triclabendazole
Kinabo and Bogan [117] showed that TCB-SO and TCB- 
SO2 could be detected up to 3 and 6  days in the milk o f  goats 
treated with an oral dose o f TCB (12 mg/kg bw). TCB parent 
drag was not detectable at any timepoint. Highest residue levels 
o f TCB-SO and TCB-SO2  were found at 1 (160 [xg/kg) and 3 
(640 [xg/kg) days post-treatment, respectively. Counotte et al. 
[118] investigated the depletion o f TCB residues in the milk of 
cows treated with an oral dose o f TCB (12 mg/kg bw). TCB- 
SO2 was the major residue present with lower levels of TCB- 
SO determined. At 50 h post-treatment, TCB-SO2 and TCB- 
SO were found at levels o f  1415 and 100 [xg/kg. Residues of 
TCB-SO and TCB-SO2 could be detected up to 45 and 240 h 
post-treatment. The study showed that 1.5% of the administered 
dose was excreted in milk. Takeba et al. [119] carried out a 
similar study in cows treated with an oral dose of TCB (12 mg/kg 
bw). This group only reported residue data for the first 48 h 
post-treatment. A t48 h post-treatment, TCB, TCB-SO and TCB- 
SO2 were found at levels o f 6 -35, 17-114 and 51-595 [xg/kg, 
respectively.
7.5. Summary
In dairy cows, sheep and goats treated with ABZ, levels 
o f marker residues in milk were typically below the MRL at 
7 2 h post-treatment [83,111-113]. At early withdrawal periods, 
ABZ-SO was found to be the major residue, ABZ-SO2 was
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M R L  listin g s  for b en zim id azo le  anthelm intic drugs
D rug M arker residue A n im a l sp ec ie s M R L  (ligflcg) Target tissue
1 0 0 M ilk
1 0 0 M u scle
N E T O , A B Z  and S um  o f  A B Z -S O , A B Z -S O 2 , and B ov in e, o v in e 1 0 0 Fat
A B Z -S O A B Z -N H 2-S O 2 , exp ressed  as A B Z 1 0 0 0 Liver
500 K idney
B o v in e , o v in e 10 M ilk
5 0 M u scle
S um  o f  extractable residu es w hich  m ay be
F E B , F B Z  and O FZ
ox id ised  to  F B Z -S O 2 B o v in e , o v in e , p orcin e  and  equidae
5 0
5 0 0
Fat
Liver
5 0 K idney
5 0 M u scle
P orcin e, poultry  and 5 0 S kin  and fat
F L U S u m  o f  F L U  and F L U -H M E T g a m eb ir d s 4 0 0 Liver
300 K idney
C hicken vtOO E ggs
1 0 0 M u scle
1 0 0 Fat
T B Z S um  o f  T B Z  and  5-O H -T B Z B o v in e 1 0 0 Liver
1 0 0 K idney
1 0 0 M ilk
1 0 0 M u scle
5 0 0 Skin  and fat
O X I O X I P orcine 2 0 0 Liver
1 0 0 K idney
1 0 0 M u scle
T C B
S u m  o f  extractable residu es that m ay be
B o v in e  an d  ov in e 1 0 0 Liver
o x id ised  to  k etotriclab en d azole
1 0 0 K idney
6 0 M u scle
S u m  o f  M B Z , M B Z -O H  and M B Z -N H 2 O vine, cap rine and 6 0 Fat
M B Z exp ressed  as  M B Z equidae 4 0 0 Liver
6 0 K idney
found to be the pre-dominant residue at later timepoints. The 
withdrawal periods for ABZ and related drugs in species pro­
ducing milk for human consumption range between 36 and 72 h. 
In dairy cows treated with FBZ, OFZ and FEB, marker residues 
were shown to be below the MRL at 84, 72 and 120 h post­
treatment, respectively [89,115,116]. The withdrawal periods 
for FBZ and related drugs in milk range between 2 and 7 days. 
In dairy cows treated with TBZ, marker residues were typically 
below the MRL at 84 h post-treatment. 5-OH-TBZ was found to 
be the major residue in cow and goat milk [66,100,116]. TCB 
is not licensed for use in lactating species. Kinabo and Bogan 
[117] found that TCB residues could be detected in goat milk 
for up to 6  days post-treatment. Counotte et al. [118] found that 
TCB residues could be detected in cow milk up to 10 days post­
treatment. TCB-SO2 was shown to be the most persistent residue 
in the milk o f cows and goats.
8 . M onitoring for benzim idazole residues in  food
It has been shown that some twenty or so different benzimi­
dazole residues could occur in animal tissue. However, it would 
be difficult to develop and maintain a robust residue method that
would cover all o f these residues. Such a method would probably 
require the application of expensive LC-M S/M S technology. An 
alternative approach would be to select the most likely residues 
of a particular benzimidazole drug that would give rise to a MRL 
violation or that would be most persistent in tissue (to identify 
unapproved use). It is important to be aware o f the depletion 
pattern o f  benzimidazole residues in tissues before developing 
a residue method. Non-compliant benzimidazole residues may 
occur in tissues because products are administered to the wrong 
species, are administered at more than the recommended dose, 
withdrawal periods are not observed or because animals con­
sume contaminated feed.
For most benzimidazoles, the marker residue is defined as 
the sum of the parent drug or/and its’ major or most persis­
tent metabolites. After administration o f  ABZ related drugs, 
the residues found depend on the drug used (ABZ, ABZ-SO 
or NETO), route o f  administration, target tissue or time that has 
elapsed since treatment. At early withdrawal periods, the most 
likely marker residues to be found are ABZ-SO and ABZ-SO2 , 
while at longer withdrawal periods the most prevalent residue 
is ABZ-NH2 -SO2 . As a result, the marker residue is defined as 
the sum o f ABZ-SO, ABZ-SO2 and ABZ-NH2 -SO2 , expressed
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T able 3
Identification of target analytes for monitoring residues of benzimidazoles in liver and milk
Drug Target analytes
L iver M ilk
N E T O , A B Z  o r  A B Z -S O A B Z -S O 2 , and  A B Z -N H 2 -S O 2 A B Z -S O 2 , and A B Z -N H 2-S O 2
F E B , F B Z  or O FZ F B Z , O F Z  and  F B Z -S O 2 O F Z  and F B Z -S O 2
F L U F L U  and F L U -H M E T N o t defined
T B Z T B Z 5-O H -T B Z
O XI O X I N o t  defined
TCB T C B -S O  and T C B -S O 2 TC B-SO -.
M B Z M B Z -O H , M B Z -N H 2 N o t defined
as ABZ. The MRLs for ABZ related drugs have been set at
100 jxg/kg for milk, muscle and fat, 500 |xg/kg for kidney, and 
1000 n-g/kg for liver in bovine and ovine species (Table 2) [120]. 
Similarly, for FEB, FBZ an£ OFZ the marker residue is defined 
as the sum o f FBZ, OFZ and FBZ SO2 , expressed as FBZ-SO2 . 
Data fromresidue depletion studies indicate that OFZ and FBZ- 
SO2 are the most suitable residues to test for in tissues. The 
MRLs range between 10 |Jig/kg for milk and 500 [ig/kg for liver, 
in the listed species.
The marker residue for FLU is defined as FLU parent drug 
in eggs and as the sum o f FLU and FLU-HMET in other 
edible tissues o f avian and porcine species. The MRLs range 
between 50 |xg/kg for muscle and 400 ng/kg for eggs and liver. 
The marker residue for MBZ is defined at the sum of MBZ, 
MBZ-OH and MBZ-NH2 , expressed as MBZ. Residue deple­
tion data indicate that MBZ-NH2 or MBZ-OH are the most 
persistent residues and most likely contribute to an MRL vio­
lation. The MRLs in ovine, caprine and equine species are set 
at 60 pug/kg for muscle, fat and kidney and 400 jJ ig /k g  for liver. 
The marker residue for TBZ is defined as the sum o f TBZ and 
5-OH-TBZ. In edible tissues, the parent drug is the most likely 
residue to be found. While the sulfate conjugate o f 5-OH-TBZ 
is the predominant metabolite in milk. The MRL for bovine 
tissues and milk is 100 [ig/kg. The marker residue for TCB is 
defined as the sum o f extractable residues (TCB, TCB-SO and 
TCB-SO2) that may be derivatised to form ketotriclabendazole. 
Residue depletion studies in tissue have been published report­
ing the depletion of the sum o f extractable residues derivatised 
to form ketotriclabendazole, but do not indicate the contribu­
tion o f individual residues. Studies indicate that because TCB 
is not licensed for use in lactating species and it should be 
best monitored as its’ most persistent residue, TCB-SO2 . The 
MRL for TCB is 100 [tg/kg for muscle, liver and kidney. The 
marker residue for OX1 is the parent drug and MRLs are set 
at 1 0 0  ^g/kg for muscle and kidney, 2 0 0  jig/kg for liver, and 
500 [x-g/kg for skin and fat. Other benzimidazoles such as CAM, 
LUX, PAR and BEN have no EU MRL listings because they are 
not licensed as veterinary drugs in food producing animals. It is 
recommended that target certain target residues (as indicated in 
Table 3) should be selected in the event that all marker residues 
of benzimidazole are not included in a method. In the event 
that a positive residue is detected, a method capable of detect­
ing the complete range of marker residues o f a drug should be 
applied.
9. Sample extraction and clean-up procedures
9.1. Sample pre-treatment
9.1.1. Incorporation of hydrolysis steps
Hydrolysis may be used as a pre-treatment step to release pro­
tein bound residues, drug conjugates or simply convert residues 
to a common structure. However, in the area o f benzimidazole 
analysis most hydrolysis steps have been used to release con­
jugates. Tocco et al. [121] found that urinary metabolites of 
TBZ mainly occurred as glucuronide and sulfate conjugates 
o f 5-OH-TBZ. Conjugates were released using enzymatic (|3- 
glucoranidase or glucosulase) or acid hydrolysis (refluxing in 
6 N HC1 (1 h)). Tocco et al. [6 6 ] later used similar procedures 
to deconjugate 5-OH-TBZ residues present in the milk of cows 
and goats treated with TBZ. Chukwudebe et al. [ 101] completed 
a more detailed study into the metabolism o f TBZ in laying hens 
and lactating species, using enzymatic and acid hydrolysis, and 
found that conjugates were mainly present as sulfates. Vanden- 
Heuvel et al. [122] also deconjugated 5-OH-TBZ by enzymatic 
and acid hydrolysis in a study in bluegill sunfish. Kriedel et al. 
[123] deconjugated the glucuronide of MBZ-OH after diges­
tion with 3-glucuronidase. Gyurik et al. [124] used glucosulase 
to enzymatically hydrolyse ABZ metabolites in urine before 
detection by TLC. Short et al. [76] incubated urine samples 
from animals treated with FBZ with (3-glucuronidase and sulfa­
tase before extraction and determination by mass spectrometry, 
showing that the majority of residues present in urine were con­
jugated.
As a result o f these studies, hydrolysis steps have been 
included in some residue methods. Markus and Sherma [125] 
subjected liver sample extracts to acid hydrolysis to allow 
conversion o f ABZ metabolite residues to a common ABZ- 
NH2 -SO2 residue. Arenas and Johnson [126] used enzymatic 
hydrolysis to deconjugate 5-OH-TBZ sulfate, in a method for 
determination o f TBZ residues in milk. Coulet et al. [103] used 
basic hydrolysis to release protein bound residues o f TBZ from 
tissue.
9.2. Extraction and clean-up of benzimidazole residues
Liquid extraction is a common approach used to extract ben­
zimidazoles, usually with aqueous extraction at high pH with 
partitioning into an immiscible organic solvent [53,96,102].
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However, polarity and pK-d can differ greatly between parent 
benzimidazoles and metabolites, not only making it difficult 
to develop a multi-residue method for different benzimidazole 
drugs, but also for individual drugs and their metabolites. This 
has been observed by many researchers developing methodology 
for determination of FBZ and its two metabolites OJFZ and FBZ- 
SO? [127-131]. FBZ has differing physical properties to its two 
metabolites, making it difficult to extract and determine by LC 
[128,129,132,133]. Similar difficulties have been encountered 
with M BZ and its two metabolites MBZ-OH and MBZ-NH2 
[53]. MBZ and MBZ-NH2  are basic in nature with pKd values 
of 3.5 and 5.5, respectively. Therefore, only at pH levels >7.5 
are both metabolites non-ionised. MBZ-OH possesses an acidic 
OH group with a pKd o f 9.8 which is non-ionised below pH 7.8. 
This indicates that only in the pH range 7 .5-7 .8 , are all three 
residues non-ionised. Alternatively, extraction may be carried 
out using a more polar organic solvent without pH manipula­
tion. Some researchers have extracted these drug residues using 
a single solvent system, such as acetonitrile [ 119,134], or binary 
water/organic solvent mixtures which would be around neutral 
pH [131,135-137], Extraction with acidified extractants has only 
been used by a small number of researchers for methods requir­
ing hydrolysis or digestion steps [101,125,136,137] or methods 
including only a limited number of residues [138].
9.2.1. Plasma, serum or other biological fluids
Benzimidazole residues may be extracted from biological flu­
ids using water immiscible organic solvents with or without pH 
adjustment and analysed withoutfurther purification. Bogan and 
Marriner [139] adjusted the pH o f plasma to pH 7.4 before 
extracting FBZ, OFZ and ABZ residues with diethyl ether. 
Bogan’s procedure has been applied for isolation of benzimida­
zole residues from plasma and blood [140-142]. Other groups 
have developed alternative procedures, while substituting sol­
vents such as chloroform [143,144] and ethyl acetate [145-147] 
for diethyl ether. Hoaksey et al. [148] extracted ABZ and ABZ- 
SO from plasma samples with dichloromethane after protein pre­
cipitation with acetonitrile. Alvinerie and Galtier [149] extracted 
TCB, TCB-SO and TCB-SO2  directly from plasma without pH 
adjustment using a simple ethyl acetate extraction procedure. 
Galtier et al. [150] later applied this method for determination 
o f TBZ and 5-OH-TBZ in plasma.
Allan et al. [151] simply diluted plasma samples in acid prior 
to application onto a Cis SPE cartridge. The SPE cartridge was 
washed with water (20 ml), methanol + water (40 + 50, 0.5 ml) 
and methanol (0.4 ml) prior to elution with 1.6 ml of methanol. 
Recovery o f mebendazole and its metabolites was typically 
greater than 80%. The procedure was subsequently applied by 
Galtier et al. [150] and Behm et al. [152] to determine meben­
dazole in plasma. Hennessy et al. [70] subsequently modified 
this procedure and applied it to investigate the pharmacokinetics 
of TCB. Hennessy et al. also found the procedure to be suit­
able for determination of TCB in bile (after pH adjustment) but 
samples required liquid-liquid extraction (LLE) clean-up into 
ethyl acetate before SPE. This procedure was later applied by 
other researchers to determine ABZ related residues in plasma 
[60,153].
The use of automated purification systems has been shown 
to enhance reproducibility, improve throughput of samples and 
reduce manual handling. Rouan et al. [154] described an auto­
mated Cig clean-up procedure for isolation of TCB residues 
on an ASPEC system. They demonstrated, with a limited num­
ber o f samples, that recovery values greater than 90% could 
be obtained under optimal conditions. Chiap et al. [155] devel­
oped an automated procedure based on dialysis clean-up for 
isolation of albendazole and its metabolites from plasma with 
on-line determination by HPLC through the use of switching 
valve technology. Recovery of ABZ residues from plasma was 
typically greater than 65%. Negro et al. [56] isolated TCB-SO 
and TCB-SO2  from serum and urine samples using a combina­
tion of protein precipitation and ultra-filtration through a 30,000 
molecular mass cut-off filter. This approach was shown to greatly 
reduce sample preparation time in comparison to conventional 
off-line clean-up procedures. Recovery o f TCB marker residues 
from serum and urine were typically greater than 82%.
9.2.2. Tissue
Benzimidazole residues are typically extracted from ani­
mal tissues using organic solvent and purified by LLP and/or 
SPE. Some researchers have opted to carry out comprehen­
sive purification o f residues through LLP and SPE, usually 
with determination by HPLC-UV. Other groups have moved 
towards the development of simple clean-up procedures based 
on LLP only, with determination by more selective fluorescence 
and LC-MS/MS systems. These simpler clean-up procedures 
(although less selective) may be more suitable to allow for iso­
lation o f a broad range o f benzimidazoles, which are difficult to 
recover using more comprehensive clean-up procedures. Bran­
don et al. [135] extracted TBZ residues from liver tissues using 
DMSO-H2 O (10:90, v/v) and diluted extracts in PBS Tween 
prior to determination by ELISA. Brandon et al. [156] devel­
oped a similar type o f  extraction procedure for determination of 
some 11 benzimidazole residues in liver tissues. To allow recov­
ery o f a range of benzimidazole residues including the poorly 
water soluble FBZ, samples had to be extracted in DMF-H2 O 
(10:90, v/v).
Originally procedures for tissue samples were based on multi­
ple LLP and/or SPE clean-ups. Marti et al. [134] extracted eight 
benzimidazole residues from muscle, liver and kidney tissues 
using acetonitrile. Extracts were subsequently purified using a 
series of LLP steps which included washing with hexane, sat­
urated NaCl and dichloromethane. Extracts were concentrated 
and further purified using a combination o f Cis and Florisil SPE 
prior to analysis by HPLC-UV or confirmation by GC-MS. 
Recovery of benzimidazole residues was typically >65% for 
all residues with the exception o f OFZ, which gave a lower 
recovery of 45 and 39% for liver and kidney, respectively. Far­
rington et al. [157] extracted five benzimidazole residues from 
liver tissue using ethyl acetate and purification on acid alumina 
and Cis SPE before determination by HPLC-UV. Recovery of 
benzimidazoles ranged between 73 and 90%. Blanchflower et 
al. [90] extracted FBZ and OFZ from liver and muscle tissues 
using methanol-waler (20:7, v/v). Extracts were washed with 
light petroleum, diluted with phosphate buffer and extracted with
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diethyl ether-ethyl acetate (60:40, v/v). Recovery of FBZ and 
OFZ was typically greater than 80 and 70%, respectively, de 
Buyanski et al. [158] developed a simple procedure for extrac­
tion of TBZ and levamisole from muscle tissue at alkaline pH 
using ethyl acetate with subsequent partitioning into 0.5 M HC1. 
The ethyl acetate layer was discarded before alkalisation of 
the aqueous phase and extraction with chloroform. Levan and 
Barnes [159] developed a labour intensive procedure for extrac­
tion of five benzimidazole residues from fiver tissue using large 
volumes o f  organic solvent. Samples were purified using LLP 
steps prior to purification on silica SPE cartridges.
Wilson et al. [102] developed a simpler procedure based 
on ethyl acetate extraction for isolation o f eight benzimidazole 
residues from muscle and liver tissues. Ethyl acetate was chosen 
as the extraction solvent because of its good solvating power 
for weakly basic drugs and its ability to form emulsion-free 
interfaces with muscle and liver tissues. Samples were sub­
sequently purified using LLP (acidified ethanol versus hexane 
wash) and C2 SPE clean-up prior to determination by HPLC- 
UV or GC-MS. This group concluded that C2 was the most 
effective sorbent material for removing polar matrix interfer­
ence while giving good recovery of benzimidazole residues in 
comparison to other SPE sorbent materials evaluated. Wilson’s 
method is the most widely used method for isolation o f benzim­
idazole residues from animal tissues. In some cases, researchers 
have reported modifications o f this method, such as size o f sam­
ple used, extraction pH and SPE cartridge clean-up.
A  number of researchers have applied the Wilson method, 
modified to exclude the SPE clean-up. Domany and Kovacsics 
[160] found that the method could be extended to 1 0  benzimida­
zole residues in liver and muscle tissues, while excluding SPE 
clean-up. Shaikh et al. [8 6 ] found that ABZ marker residues 
could be determined in salmon, tilapia and trout without the 
need for SPE clean-up through the application o f  a more selec­
tive HPLC fluorescence detection system. They found that ABZ 
recovery increased after adding dimethyl sulphoxide (0.5 ml) to 
the extraction solvent (ethyl acetate, 5 ml), while extraction effi­
ciency for ABZ marker residues did not vary greatly over the 
pH range from 9 to 11. It was also found that addition o f sodium  
metabisulfite to the extraction medium inhibited the oxidation of  
ABZ-SO to ABZ-SO2 , resulting in increased recovery for ABZ- 
SO. Recovery o f ABZ, ABZ-SO, ABZ-SO2  and ABZ-NH2 -S 0 2 
was typically greater than 82, 78, 75 and 63%, respectively.
Hajee and Haagsma [53] extracted MBZ, MBZ-OH and 
MBZ-NH2 from eel muscle with ethyl acetate after adjusting 
the pH to 7.5 with phosphate buffer. They concluded that only 
in the narrow pHrange between 7.5 and 7.8 were all MBZ marker 
residues in a non-ionised state thereby facilitating their extrac­
tion using ethyl acetate. Ethyl acetate extracts were modified 
with hexane prior to application onto a preconditioned amino- 
propyl SPE cartridge. The authors evaluated a range of normal 
phase and reverse phase SPE systems but found aminopropyl 
to be most suitable. After loading of sample extract, the amino- 
propyl cartridge was washed with iso-octane and MBZ marker 
residues were eluted with methanol. Mean recovery o f MBZ, 
MBZ-NH2 and MBZ-OH was typically greater than 80, 60 and 
85%, respectively. Cannavan et al. [161] developed a simple pro­
cedure for isolation of TBZ and 5-OH-TBZ from liver, kidney 
and muscle tissues based on an ethyl acetate extraction at pH 7.0, 
and SPE clean-up on cyanopropyl (CN) SPE cartridges. Deuter- 
ated TBZ was used as an internal standard to improve repro­
ducibility. Recovery of TBZ and 5-OH-TBZ ranged between 
96-103 and 70-85% , respectively. It was concluded that repro­
ducibility o f 5-OH-TBZrecovery could be improved through the 
introduction o f a deuterated internal standard for 5-OH-TBZ.
Acetonitrile was found to be an effective solvent for extrac­
tion of benzimidazoles from animal tissues by some researchers. 
Sorensen and Hansen [92] extracted the marker residues of 
FBZ from the muscle and skin tissues of trout using acetoni­
trile. Extracts were washed with hexane prior to purification on 
C ]r and CN SPE cartridges. Under acidic conditions benzim­
idazole residues may become ionised making them amenable 
for more selective ion exchange SPE clean-up. Rose extracted 
nine metabolites o f OFZ from liver using acetonitrile prior to 
purification on strong cation exchange (SCX) SPE cartridges 
[133], Acetonitrile extracts were modified using acetic acid 
and applied onto the SCX cartridge, which was subsequently 
washed with acetone, methanol and acetonitrile. The cartridge 
was eluted with acetonitrile containing 5% ammonia (5 ml). 
Recovery o f benzimidazoles varied between 28 and 117%. Su 
et al. [162] extracted six benzimidazole residues from muscle 
and liver tissues using acetonitrile after adjusting the pH to 10. 
Dibutyl hydroxytoluene (BHT) was added to prevent oxidation 
of 5-OH-TBZ. Extracts were further purified on C is SPE prior 
to determination by HPLC. Recovery ranged between 71 and 
105%.
Polymeric sorbents have been successfully applied to iso­
late benzimidazole residues from animal tissue in some multi­
residue methods. Roudaut and Gamier [163] extracted lObenz- 
imidazole residues from liver using the Wilson procedure, while 
substituting Oasis HLB for C2 SPE cartridges. Sample extracts 
were loaded onto HLB cartridges in methanol-0.1 M ammo­
nium acetate (50:50, v/v, 1.0 ml) and eluted with methanol 
(1 ml) before determination by HPLC-UV. They compared a 
number o f other polymeric SPE cartridges including Isolute
101 and Nexus but found that Oasis HLB gave the cleanest 
sample extracts and most satisfactory recovery. Balizs loaded 
muscle extracts onto styrol-divinyl-benzene SPE cartridges in 
methanol-0.1 M ammonium acetate (50:50, v/v, 1.0 ml) and 
eluted them with methanol-ethyl acetate (1:4, v/v, 3 ml) before 
analysis by LC-MS/MS [164]. Balizs applied the method to iso­
late 15 benzimidazole residues from muscle tissues. Recovery of 
benzimidazole residues was typically in the range of 36-117%. 
A low recovery o f 8 % was obtained for FEB.
Capece et al. [91] extracted FBZ marker residues from mus­
cle, fat and kidney samples using ethyl acetate after adjusting 
the pH to 8.0. Extracts were analysed by HPLC without further 
purification. De Ruyck et al. [94] extracted FLU, FLU-HMET 
andFLU-RMET from egg and muscle tissues with ethyl acetate 
at alkaline pH. Extracts were subsequently evaporated to dryness 
and purified by LLP (methanol versus hexane) before analysis 
by LC-MS/MS. Recovery o f FLU marker residues was typi­
cally greater than 70% (eggs) and 87% (muscle). De Ruyck 
et al. [98] subsequently applied this method to the determina­
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tion o f  MBZ marker residues in sheep liver. Mean recovery o f  
MBZ marker residues was typically greater than 85%. Edder 
et al. [165] extracted 11 benzimidazoles and levamisole (LEV) 
from liver and muscle tissues at alkaline pH while using MBC  
as an internal standard. Extracts were further purified by LLP 
(methanol versus hexane), before determination by LC-MS/MS. 
Recovery of residues was typically greater than 70%.
Some novel procedures have been developed for isolation 
o f benzimidazole residues from animal tissues. Fletouris et al. 
[166] isolated ABZ-SO, ABZ-SO2  and ABZ-NH2 -SO2 residues 
from muscle, liver, kidney and fat tissues using a LLP proce­
dure based on ion-pair extraction with octane sulphonate under 
acidic conditions. Extracts were further purified by partitioning 
between phosphate buffer pH 8.5 and ethyl acetate. However, 
this group concluded that the ion pair extraction was critical for 
purification of tissue extracts. Recovery of ABZ-SO, ABZ-SO2 
and ABZ-NH2 -SO2 was greater than 81, 8 8  and 76%, respec­
tively. Techniques such as matrix solid phase dispersion (MSPD) 
[77,129,131,167-171] and supercritical fluid extraction [172] 
have been applied for isolation of benzimidazoles residues from 
liver. Long et al. [ 168] developed an MSPD method for isolation 
o f five benzimidazole residues from fiver tissue. Liver samples 
(0.5 g) were blended with C is material and packed into a SPE 
column between two frits. The column was washed with hexane 
and eluted with acetonitrile prior to determination by HPLC- 
UV. Recovery of the benzimidazole residues ranged between 
55 and 93%. Danaher et al. extracted 13 benzimidazoles from 
fortified liver samples using unmodified supercritical CO2  (601,
690 bar and 80 °C) [172]. Benzimidazole residues were trapped 
off-line on a neutral alumina SPE cartridge and further puri­
fied on a SCX cartridge prior to determination by HPLC-UV. 
Mean recovery for 10 benzimidazoles ranged between 51 and 
113%. TBZ, CAM and TCB-SO2  residues were also extracted 
but results were not quantitative.
Some groups have implemented automated SPE clean-up 
procedures. Stubbings et al. [173] developed an automated on­
line clean-up system for isolation o f benzimidazole residues 
from liver and tissue samples. Benzimidazole sample extracts 
were purified on SCX cartridges prior to on-line clean-up on 
cation exchange trace enrichment cartridges. Dowling et al. 
[174] modified the method developed by Wilson and extended 
it to isolate 12 benzimidazole residues from liver tissue. Purifi­
cation o f samples was carried out on Cis SPE cartridges using 
an automated SPE system (ASPEC™). They found that this 
automated system allowed unattended clean-up of samples and 
enhanced reproducibility of assay results. Mean recovery o f  
residues was typically in the range of 60-100% . Lower recovery 
o f 25% was observed for ABZ-NH2 -SO2 . HPLC-UV chro­
matograms o f negative control and fortified liver samples are 
presented in Fig. 10.
9.2.3. Milk and milk products
Milk samples are generally easier to manipulate than corre­
sponding solid tissue samples. In addition, milk contains less 
pigments and matrix interence components that typically occur 
in tissue. Important purification issues that need to be overcome 
with milk samples include removal of proteins and fat through
Minutes
F ig . 10. C hrom atogram  o fb la n k  liver sam p le  and liver sam p le  fortified  at M R Ls  
(R eprinted from  reference [1 7 4 ], w ith  perm ission  from  E lsev ier, C opyright  
2 0 0 5 ).
introduction o f  precipitation and defatting steps. A number of 
groups have simply adjusted the pH o f samples prior to extrac­
tion with an immiscible solvent such as ethyl acetate, chloroform 
or dichloromethane. The required pH adjustment may depend 
on the type or number o f drug residues included in a particu­
lar method. Tocco et al. [6 6 ] found that TBZ and 5-OH-TBZ 
could be successfully extracted from milk samples at pH 6.0 
with ethyl acetate. Fletouris et al. [175] showed that ABZ, ABZ- 
SO and ABZ-SO2 were best extracted at pH 9.8 with ethyl 
acetate, giving recovery values o f 81, 78 and 100%, respec­
tively. Fletouris et al. [ I l l ]  later extracted 10 benzimidazole 
residues from milk samples at pH 10 with ethyl acetate. They 
evaluated extraction efficiency over the range pH 3-11.5, find­
ing pH 10 gave best recovery for the majority o f benzimidazole 
residues selected. Mean recovery for benzimidazole residues 
was typically in the range o f  79-100% . A  lower recovery in 
the range o f 56-66%  was obtained for FBZ. Fletouris et al. 
[128] developed an alternative acetonitrile based extraction pro­
cedure that gave recovery near to 100% for FBZ over the pH  
range 2-9 , indicating pH adjustment o f milk samples was unnec­
essary with acetonitrile. They later used a similar extraction 
procedure for determination o f ABZ residues in cheese [176], 
and FBZ metabolites in milk [128]. It was found that solvent 
extraction with ethyl acetate extraction gave dirtier extracts for 
cheese samples than acetonitrile, while dichloromethane gave 
low recovery. Samples (0.5 g) were extracted with acetonitrile 
(3 ml), defatted with hexane, evaporated to dryness and further 
purified by LLP (ethyl acetate versus phosphate buffer pH 8.5). 
Recovery of ABZ-SO, ABZ-SO2  and ABZ-NH2 -SO2 were typ­
ically greater than 83, 80 and 74%, respectively. De Ruyck et 
al. [177] later scaled this method up (larger volmes of solvent 
and sample) and applied it for extraction of four benzimida­
zole residues from milk. Mean recovery o f FBZ, TBZ, ABZ 
and OXl was typically between 6 8  and 77%. De Ruyck et al. 
[178] subsequently developed a procedure to isolate eight ben- 
zimidazoles and levamisole from milk samples at alkaline pH 
using ethyl acetate with determination by LC-M S/M S. Recov-
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1537 ery of benzimidazole residues was typically in the range of 
,538 79-110%.
.sag The amount o f purification required to successfully isolate
is« benzimidazole residues from milk samples may depend on the
i54i number o f residues included and the detection system being
.542 used. Brandon et al. [179] simply diluted m ilk samples in phos- 
i54a phate buffer saline prior to direct determination by ELISA. They 
15*4 found that milk samples had to be diluted 1 0 -fold to eliminate 
is« matrix effects and ensure good agreement between standards
1548 prepared in buffer and fortified or incurred samples. Fletouris et
1547 al. [ I l l ]  extracted 1 0  benzimidazoles from milk samples (1  ml)
isa at pH 10 with ethyl acetate ( 6  ml). Samples extracts were subse-
1549 quently evaporated to dryness and reconstituted in mobile phase
1550 before determination by HPLC. Other researchers have devel-
1551 oped more labour intensive sample preparation procedures using 
552 multiple LLE/LLP/SPE steps that require larger quantities of 
i553 organic solvent, glassware and cumbersome rotary evaporation 
554 steps [116,180]. Tai et al. [116] extracted four benzimidazole 
1555 residues from milk at alkaline pH using large volumes o f ethyl 
55a acetate (150 ml). Sample extracts were purified by LLP (phos- 
1557 phoric acid versus hexane wash) and back extracted into ethyl
558 acetate after alkalisation. Sample extracts were further purified
559 on silica SPE prior to determination o f residues by HPLC-UV. 
™ Recovery of FBZ, OFZ, TBZ and 5-OH-TBZ was greater than 
!5Bi 78, 8 6 , 81 and 25%, respectively. They proposed that the poor 
502 recovery of 5-OH-TBZ might be due to degradation during the 
sea long extraction procedure. Constantinouetal. [180] developed a
584 similarly labour intensive procedure for isolation o f  OFZ, FLU,
585 ABZ and FBZ from milk based on LLE, with further purifica- 
5BB tion on C is SPE. Recovery of TBZ, OFZ, FLU, ABZ and FBZ 
5B7 were greater than 6 8 , 63, 57, 24 and 29%, respectively.
s«  Other researchers have developed simpler sample prepara­
ses tion procedures based on solvent extraction and SPE. Moreno et 
57c al. [115] deproteinised milk samples (0.5 ml) with acetonitrile 
i57i (0.5 ml) and applied the supernatant layer onto a preconditioned 
;s72 C ]8  SPE cartridge, which was washed with water (0.5 ml) and 
57a eluted with methanol (2 ml). The method was suitable for deter- 
-574 mination of ABZ, FBZ and their metabolites. Mean recovery 
1575 ranged between 77 and 97%. Sorensen and Petersen [181] mixed 
■57B milksamples (5 ml) with phosphate buffer pH ll(5m l)an d in cu -  
i577 bated the mixture in a water bath (45 °C, 20 -3 0  min) prior to 
157a application onto a Cjs SPE cartridge. The cartridge was washed 
1579 with water (5 ml) and eluted with acetonitrile ( 6  ml). Samples 
5M were evaporated to dryness and further purified by LLP (phos- 
5ai phate buffer pH 9 versus dichloromethane extraction) before 
saz determination by HPLC-UV. Mean recovery o f  ABZ-SO, ABZ- 
583 SO2 , OFZ, OXl, ABZ, MBZ, FBZ and FEB was in the range 
1584 81-96% . Sorensen and Petersen [182] developed an alternative
isas procedure for determination o f TBZ and LEV in milk. Defat- 
1588 ted milk samples (10 ml) were mixed with phosphate buffer pH 
¡5B7 6.5 (10 ml) and incubated in a water bath (45 °C, 20-30  min.) 
lEaa prior to passing through a C is SPE cartridge. The cartridge was 
isas washed with phosphate buffer (5 ml) and eluted with methanol
1590 (2 ml). Sample extracts were evaporated to dryness and further
1591 purified by LLP (phophate buffer pH lOversus dichloromethane
1592 extraction) before determination by HPLC-UV. Mean recovery 
159a o f TBZ and LEV was 81-89% , respectively.
A  number o f novel methods, including use of MSPD, 
have been developed to allow determination o f benzimidazole 
residues in milk and milk products. Long et al. [129] mixed milk 
samples (0.5 ml) with Cis material (2g) and packed the mix­
ture between two filter paper discs in a 10 ml syringe barrel and 
compressed to a volume of 4.5 ml. The column was washed with 
hexane (8 ml), air-dried and eluted with dichloromethane-ethyl 
acetate (1:2, v/v, 8 ml). Recovery o f the benzimidazole residues 
was typically in the range 81-108%. A slightly lower recovery 
o f 69% was obtained for FBZ. De Liguoro et al. [113] extracted 
ABZ residues from milk, whey and whey solubles using ace­
tonitrile, prior to defatting with hexane, LLP clean-up and Cis 
SPE. Recovery o f  ABZ, ABZ-SO, ABZ-SO2  and ABZ-NH2 - 
SO2 were typically greater than 78 ,82 ,79  and 81%, respectively. 
De Liguoro et al. [113] developed an MSPD procedure for deter­
mination o f  ABZ residues in cheese. Cheese samples (1 g) were 
mixed with Ci8 material and packed between two filter paper 
discs in a 10 ml syringe barrel and compressed to a volume of 
7 ml. The column was washed with hexane (10 ml), air-dried 
and eluted with methanol-acetic acid (97:3, v/v). The eluate 
was defatted with hexane and further purified by Cig SPE prior 
to determination by HPLC. Recovery of ABZ metabolites were 
similar to those achieved by the procedure developed for milk 
(77-86% ).
Residue scientists face similar problems when trying to deter­
mine benzimidazole residues in milk as in animal tissue. Devel­
opment of methods that will cover the complete number of 
marker residues or most persistent or predominant metabolites is 
most difficult. As a result, a number of important benzimidazole 
residues are not included in multiresidue methods. TCB and it’s 
metabolites have been included in few milk residue methods. De 
Ruyck et al. [178] developed a method that included TCB parent 
drug but not the more important TCB-SO2 metabolite, which is 
the most persistent residue o f  TCB in milk. Some researchers 
have developed methods to isolate TCB and its metabolites from 
milk but methods do not include other benzimidazole drugs. 
Takebaet al. [119] extracted TCB, TCB-SO and TCB-SO2 from 
milk using acetonitrile with subsequent defatting with hexane. 
H ie acetonitrile fraction was modified with carbonate buffer and 
extracted with dichloromethane prior to further purification on 
C is SPE and determination by HPLC-UV. Mean recovery was 
in the range o f 89—95%. Kinabo and Bogan [117] extracted TCB 
and it’s metabolites from milk (4m l) with acetone (4ml). Ace­
tone extracts were simply diluted with water and applied onto 
Ci8 SPE cartridges, which were washed with water (5 ml) and 
eluted with methanol (3 ml). Purified extracts were subsequently 
determined by HPLC fluoresence. Su et al. [162] demonstrated 
that their earlier method for the determination of benzimidazole 
residues in animal tissues was also applicable to milk samples 
with minor modification.
Furthermore, few multi-residue methods for determination 
o f benzimidazole residues in milk include a deconjugation step. 
Inclusion o f such a step is particularly important when testing for 
residues o f  TBZ in milk, which mainly occur as the sulfate con­
jugate of 5-OH-TBZ. Arenas and Johnson [126] subjected milk 
samples (5 ml) to acid hydrolysis in the presence of concentrated 
HC1 (85-90  °C, 4 h) to free the sulphate conjugate o f  5-OH-TBZ.
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Hydrolysed extracts were neutralised with NaOH and adjusted 
to pH 8.0 before extraction with ethyl acetate. Ethyl acetate 
extracts were subsequently purified on PRS cation exchange car­
tridges prior to determination by HPLC fluorescence. Recovery 
of TBZ, 5-OH-TBZ and the sulphate conjugate o f 5-Oli-TBZ  
were typically greater than 87,98 and 96%, respectively. Arenas 
and Johnson proposed enzymatic hydrolysis as an alternative to 
acid hydrolysis but required an overnight incubation. One fac­
tor to be considered when including an acid hydrolysis step is 
that benzimidazole carbamate residues (ABZs, FBZs, MBZs and 
FLUs) may be hydrolysed to amino benzimidazoles. Chu et al. 
[114] included an acid hydrolysis in a method for determination 
o f ABZ metabolites in milk samples. Milk samples were sub­
jected to acid hydrolysis (1 h, 100 °C), followed by purification 
on SCX SPE cartridges. In this procedure, acid hydrolysis was 
used to convert ABZ metabolites to a common residue (ABZ- 
NH 2 -SO2 ). The procedure should be suitable for determination 
of ABZ-SO2 , ABZ-NH2 -SO2 and their conjugates as ABZ- 
NH 2 -SO2 . However, the procedure was not demonstrated to be 
suitable to allow determination o f ABZ, netobimin or ABZ-SO 
as ABZ-NH2 -SO2 - Chu et al. demonstrated that the method was 
suitable for determination o f more than 40% of ABZ residues 
in cow’s milk 36 -1 2 0 h  post-treatment. Recovery by the method 
was typically in the range o f 91-105%.
9.2.4. Plant matrices
There are fewer benzimidazole compounds used in the treat­
ment o f crops compared to animal health. TBZ and thiophanate- 
methyl (TM) are used in crop protection and animal health, while 
BEN is used in crop protection only. The purpose of this section 
is to give an overview o f  methods for determination of BEN, 
TBZ, TM and their breakdown products in crops. Those inter­
ested in reading in more detail should consult the reviews by 
Gorbach [183] and Singh and Chiba [184]. It will be found 
throughout this section that the techniques used to isolate ben­
zimidazole fungicides from crops are typical of those applied 
in a pesticide laboratory. In general, larger weights o f sample 
and volumes of solvent are used in procedures for isolation of 
benzimidazoles from crops. Samples are typically purified by 
LLE/LLP steps, which require relatively large volume glass­
ware and concentration o f  samples one at a time using rotary 
evaporation. In recent years, researchers in this area of testing 
have moved towards scaling down methods to reduce solvent 
usage and increase sample throughput.
The control o f  sample pH is critical to ensure satisfactory 
recovery o f benzimidazole residues from crops. Benzimidazole 
residues have been extracted from certain crops with [185-187] 
or without [188-190] adjustment of sample pH. However, when 
extracting acidic samples such as citrus fruits, sample pH should 
be controlled to ensure a robust method [188-190], A prin­
ciple applied in most LLE/LLP procedures for isolation of 
benzimidazole residues is that they are highly soluble in dilute 
acid and less soluble in aqueous solutions at higher pH values 
(>7.0). This allows the washing or extraction of water immis­
cible organic extracts with basic or acidic aqueous solutions, 
respectively. In a typical ethyl acetate extraction, extracts may 
be washed with water or alkaline buffers (to remove polar inter­
ference) and extracted with 0.1N HC1 (while non-polar matrix 
components remain in the ethyl acetate). The acidified extracts 
are subsequently adjusted to alkaline pH with NaOH and re­
extracted with ethyl acetate, which is evaporated to dryness or 
reduced to a small volume prior to analysis. Alternative extrac­
tions have been developed by other researchers using solvents 
such as ethanol-dichloromethane [191] or hexane-ethyl acetate 
[192]. Corti et al. [193] extracted TBZ from samples using 
a saturated sodium chloride-dichloromethane system. Other 
researchers have extracted samples with more polar solvents 
such as methanol [191] or water [194], prior to dilution of sam­
ple extracts and determination by ELISA.
Extraction and clean-up procedures that include BEN, TM 
and their marker residue (MBC) are more complex than those 
used to isolate TBZ. The approach adopted in most methods is to 
convert the parent fungicides to MBC or 2-aminobenzimidazole 
(2-AB) through acid or basic hydrolysis prior to analysis. Acid 
hydrolysis converts BEN to MBC, while basic hydrolysis con­
verts MBC to amino-benzimidazole. Pease and Gardiner [195] 
extracted BEN residues from fruit and vegetable matrices using 
ethyl acetate. Samples were subjected to acid and basic hydroly­
sis prior to LLP and determination by fluorescence spectropho­
tometry. Recovery o f BEN from fortified fruit, vegetable, animal 
tissue and soil was typically greater than 76%. Pease and Holt 
[196] later improved this clean-up procedure through the intro­
duction o f alkaline wash steps to remove matrix components 
that interfered with fluorescent quenching, allowing the more 
effective determination of BEN in oranges.
Kirkland et al. [136] extracted BEN from soil and crops by 
refluxing in the presence of methanol and IN  HC1. Hydrolysed 
extracts were purified by a series o f LLP steps prior to HPLC 
determination. The method allowed the determination of BEN 
and MBC (both as MBC), and 2-aminobenzimidazole. Recov­
ery o f the respective residues was 92, 8 8  and 71%, respectively. 
Physalo [197] later modified this clean-up procedure and used it 
to isolate MBC and 2-AB from crops, prior to determination by 
GC. Recovery ranged between 70 and 90%. Tjan and Jansen 
[186] extracted BEN, MBC and TBZ from crops with ethyl 
acetate-0. IN  HC1. After adjustment o f the acidified fraction to 
pH 7.5, residues were extracted with ethyl acetate, concentrated, 
derivatised and determined by GC. Recovery o f BEN, MBC 
and TBZ were typically greater than 91, 93 and 95%, respec­
tively. Farrow et al. [198] extracted BEN, MBC, TM, TBZ and 
some non-benzimidazole fungicides from citrus fruit by reflux­
ing in 2N HC1. Sample extracts were washed with chloroform 
and adjusted to a high pH prior to extraction with chloroform. 
Recovery of BEN, MBC, TM and TBZ were typically greater 
than 70, 6 6 , 32 and 84%, respectively.
Gilvydis and Walters [199] extracted five benzimidazole 
residues from crops using acidified methanol and partitioning 
into dichloromethane after dilution in NaCl solution, prior to 
HPLC determination. This fraction contained TM. The acidi­
fied fraction (containing the other benzimidazoles) was adjusted 
to pH 7.7-8.0 and extracted with dichloromethane. Recovery 
o f BEN, MBC, TBZ and TM were typically greater than 78,
87, 81 and 63%, respectively. Corti et al. [200| extracted BEN, 
MBC and TBZ from fruit and vegetable samples using satu­
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rated NaCl solution-chlorofonn. The chlorofotm extract was 
re-extracted with 0.1N HC1 and incubated at 50 °C (30min.). 
Acidified extracts were alkalised and extracted with chloroform 
prior to determination by HPLTC or HPLC. Recovery o f BEN, 
MBC and TBZ was typically greater than 91, 93 and 94%, 
respectively.
The application o f sorbent based clean-up for isolation o f ben­
zimidazole residues has become more popular in recent years. 
However, there was some application of sorbent clean-up in early 
methods, using either column chromatography or preparative 
TLC. Aharonson and Ben-Aziz [201] extracted BEN, MBC and 
TBZ from crops using acetone, with subsequent purification on 
magnesium oxide-celite-alumina columns prior to determina­
tion by TLC or fluorescence spectrophotometry. Recovery of 
BEN, MBC and TBZ were typically greater than 6 8 , 60 and 
70%, respectively. White and Kilgore [202] extracted BEN from 
different fruits with benzene and partitioned residues into 0. IN 
HC1, before converting the BEN to MBC at room temperature. 
Sample extracts were purified by LLP and preparative TLC prior 
to determination by UV spectrophotometry. Recovery of BEN  
was >87%. More recently, groups have developed procedures 
on commercial SPE materials. Oishi et al. [203] adjusted fruit 
juice samples to pH 8 -9  before application onto an Extrelut™  
cartridge (supported LLE), which they subsequently eluted with 
hexane-ethyl acetate (3:1, v/v). This group found that the high­
est recovery was achieved at pH values >4. Recovery of TBZ  
ranged between 90 and 96%.
The development o f  chemically more sophisticated cation 
exchange and polymeric sorbent materials has resulted in 
improved procedures for isolation of benzimidazole fungicide 
residues from crops. Di Muccio et al. [204] extracted MBC and 
TBZ from crops using an aqueous-acetone mixture. A portion 
of the aqueous-acetone extract ( 2 0  ml) was dispersed over the 
diatomaceous earth material (Extrelut-20) packed into a SPE 
cartridge. Acetone was removed by passing nitrogen through 
the cartridge from bottom to top. Residues were subsequently 
eluted with 0 .1 M phosphoric acid and isolated on a phenyl- 
SCX cartridge attached to the end o f the Extrelut™ cartridge, 
while leaving material poorly soluble in dilute phosphoric acid 
retained on the Extrelut™  cartridge. The Extrelut™ cartridge 
was disconnected and the SCX cartridge was washed with water, 
methanol and eluted with acetonitrile-methanol-ammonium  
formate buffer pH 6 . 8  (50:25:25, v/v/v). Arenas and John­
son [205] extracted TBZ from banana with ethyl acetate and 
appUed extracts onto PRS-SCX cartridges. TBZ was eluted with 
0.1 M KH2 PO4  in acetonitrile and purified extracts were deter­
mined by HPLC with fluorescence detection. Recovery of TBZ 
ranged between 87 and 101%. Arenas et al. [206] later modi­
fied this procedure through the inclusion o f sample pH control 
and applied it to determine TBZ in citrus fruits. Young et al.
[207] developed two procedures for the isolation o f TBZ and 
MBC residues from fruit juice samples using Oasis® mixed 
mode cation exchange (MCX) SPE cartridges. They found that 
isolation of TBZ and MBC residues from orange juice could 
be effectively achieved using MCX operating sequentially in 
SCX and reversed phase retention modes. Orange juice samples 
were loaded at pH 2 and catridges were washed with 0. IN HC1,
methanol and high aqueous basic solutions, prior to elution with 
NH4 OH in methanol. In contrast, MCX operating sequentially in 
reversed phase and SCX modes provided a more effective clean­
up for apple and grape juice samples. It was proposed that the 
apple and grape juice samples contained polyphenolic (acidic) 
interferences which were strongly retained after loading under 
acidic conditions. Young et al. [208] later applied this clean-up 
in an LC-MS assay, showing that the matrix effect from puri­
fied extracts had little or no ion suppression effects. Recovery 
of MBC and TBZ in both methods was typically greater than 74 
and 90%, respectively. Zrostlikova et al. [209] isolated 17 crop 
protection agents including TBZ and MBC from fruit samples 
using Oasis® MCX cartridges. Capitan-Valvey et al. [210] devel­
oped a novel sorbent extraction procedure for the determination 
of TBZ in fruit. Samples were extracted using aqueous buffer 
before dilution o f the extract in water and mixing with Sephadex 
G-15 gel beads. The Sephadex gel beads were isolated by filtra­
tion and packed into a glass cuvette, before determination using 
a luminescence spectrometer.
There have been some applications of automated extrac­
tion and clean-up procedures for isolation of benzimidazole 
residues from crops in recent years. Hiemstra et al. [54] devel­
oped an automated on-line clean-up procedure to isolate MBC 
and TBZ residues from crops. Samples were extracted using 
acetone and partitioned into dichloromethane-petroleum ether. 
Sample extracts were evaporated to dryness and reconstituted in 
methanol (2 ml) and an aliquot (1 ml) was applied onto a Diol 
SPE cartridge using an ASPEC™  system. The cartridge was 
washed with methanol (1  ml) and eluted with methanol-0 .1 M  
H3PO4  (2 ml) into a vial containing 1M NaOH (100 |xl). Recov­
ery o f MBC and TBZ ranged between 97 and 108%. Supercriti­
cal fluid extraction (SFE) has been used by some researchers 
to isolate benzimidazole residues from crops. Aharonson et 
al. [211] mixed samples (2g) with hydromatrix (HMX) prior 
to extracting BEN, MBC, TM and TBZ residues using super­
critical carbon dioxide modified with 3% methanol. Optimum 
extraction was achieved using 90 g of SF-CO2 (400 atm, 60 °C). 
Residues were trapped off-line on a Cis trap maintained at 25 °C 
and desorbed with methanol (10 ml). It was found that recov­
ery of residues was affected by the water content in samples 
but this variable could be controlled using a HMX to sample 
ratio of 1:1. At higher ratios o f HMX recovery of residues 
was reduced and at ratios greater than 3:1 residues were not 
recovered. Mock and Scherbaum [212] extracted TBZ and other 
non-benzimidazole fungicides from fruit using unmodified SF- 
CO2 (350 bar, 50 °C), with off-line trapping on a C is trap main­
tained at 20 °C. Recovery of TBZ ranged between 63 and 70%. 
Anastassiades and Schwack [213] extracted MBC and TM from 
crops using unmodified SF-CO2  (329 atm, 55 °C). Extracts were 
trapped off-line on a Cis Lrap maintained at 10 °C before des­
orption with acetonitrile (1.3 ml, 50 °C). This group investigated 
the influence of pH on the extraction of residues from fortified 
fruit juice samples, finding that sample pH had to be adjusted 
to pH 7 to ensure quantitative extraction of MBC. Mean recov­
ery of MBC and TM ranged between 85 and 93%. Kakimoto 
et al. [214] extracted TBZ and other fungicides from fruit and 
vegetable samples and processed products using accelerated sol­
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R esid u es M atrix Extraction C lean-up R ecovery  (%) R ef.
A B Z , C A M , M B C , M B Z , OFZ, FB Z , 5 -O H -T B Z , T B Z M , L E th yl acetate at alkaline pH A cid ified  ethanol v s . hexane  
C 2 SPE
8 1 -1 0 0 [ 1 0 2 ]
A B Z , M B Z , O FZ, F B Z , O X I, FLU, T B Z , TC B
C A M , T B Z , 5 -O H -T B Z , 5 -N H 2-T B Z
A B Z , A B Z -S O , A B Z -S O 2 , F B Z , O FZ, F B Z -S O 2 
* (M B C , M B Z , F B Z -O H , F L U , 5 -O H -T B Z , T B Z )
M ,L , K
L
L
A ceto n itr ile -H zO
D M S O -H 2O
D M F -H 2O
L L P
C ,g , F lorisil SPE s
6 5 -8 7
3 9 - 8 0  (OFZ)
[134]
[135] 
[156]
A B Z , C A M , M B Z , O FZ , T B Z L Ethyl acetate A lu m in a  C |s  SPE 6 7 -9 0 [157]
A B Z , A B Z -S O , A B Z -S O 2 , A B Z -N H 2-S O 2 , C A M , 
F B Z -S O 2 , M B Z , O X I, 5 -O H -T B Z , T B Z
M k A ceton itr ile I . I P 6 2 -1 0 8 [160]
A B Z , A B Z -S O , A B Z -S O 2 , A B Z -N H 2 -S O 2 , F B Z , OFZ, 
F B Z -S O 2 , O X I. 5 -O H -T B Z . T B Z
M , L , K E th y l acetate at alkaline pH A cid ified  ethanol v s . h exane  
O asis H LB SPE
4 4 -8 7 [163]
A B Z , A B Z -S O , A B Z -S O 2 , A B Z -N H 2 - S 0 2, F E B , FB Z . 
O F Z , F B Z  S 0 2, M B Z , O X I, F L U , C A M , TBZ, 
5-O H -T B Z , TC B
M ,L E th y l acetate at a lk aline pH A cid ified  ethanol v s . hexane? 
S D B  SPE
3 6 -1 1 7  
8  (FE B )
[164]
A B Z , A B Z -S O , A B Z  S 0 2 , F B Z , O FZ , F B Z -S O 2 , F L U , 
M B Z , O X I, 5 -O H -T B Z , T B Z , TC B , L E V
M , L , fish E th yl acetate at a lk aline p H M eth an ol v s . h exane 7 5 -1 0 9 [165]
A B Z , F B Z , O FZ , F B Z -S O 2 , F B Z -O H , M B Z , T B Z M M S P D M S P D 6 3 -8 6 [167]
A B Z , F B Z , O FZ , M B Z , T B Z L M S P D M S P D 5 5 -9 3 [168]
A B Z , F B Z , O F Z , F B Z -S O 2 , F B Z -O H , T B Z L M S P D M S P D 6 1 -9 2 [170]
A B Z , A B Z  S O , A B Z -S O 2 , F B Z , O F Z , F B Z -S O 2 , 
M B Z , M B Z -O H , F L U , O X I, T B Z
SF-C O 2 S C X 5 6 -1 0 9 [172]
A B Z , A B Z -S O , A B Z -S O 2 , C A M , F B Z , O FZ, 
F B Z -S O 2 , M B Z , L E V
L , M , M k , F ish A ceton itrile S C X  SPE  
O n -lin e  TEC
5 7 -8 9 [173]
A B Z , A B Z -S O , A B Z  SO 2 , A B Z -N H 2 - S 0 2, F B Z , O FZ , 
F B Z -S O 2 , F L U , F L U -N H 2 , M B Z , M B Z -O H , OXI, 
T B Z
A B Z , A B Z -S O , A B Z -S O 2 , F B Z , O FZ, F B Z -S O 2 , 
M B Z , O X I. F L U
L
L
E thyl acetate at a lk aline pH  
D ilu tion  ju ice
C [s  o n A S P E C ™ 2 7 -1 2 0 [174]
[230]
a L iver, fa t. k idney, m u sc le  and m ilk  are abbreviated  as L, F, K , M  and M k .
vent extraction (ASE). Samples were mixed with diatomaceous 
earth prior to extraction with acetonitrile or methanol (100 °C, 
2000 psi) over a 20m in period. Mean recovery of TBZ ranged 
between 90 and 110%. Pawlowski and Poole [215] extracted 
MBC and TBZ from crops using subcritical water (40 ml, 75 °C, 
50 bar). The pH o f aqueous extracts was adjusted to pH 8 -9  with 
1 M NaOH before partitioning into ethyl acetate. Mean recovery 
of MBC and TBZ ranged between 80 and 101%.
Some methods have been described for isolation o f  benzimi­
dazole veterinary residues from medicated feed. Shah et al. [216] 
extracted OFZ from medicated feeds using methanol-acetic acid 
(90:10, v/v) at 45 °C. Plant pigments and other feed excipients 
were removed using zinc acetate treatment and LLP prior to 
determination by HPLC-U V. Mean recovery o f  OFZ from forti­
fied feed samples were at 98%. Botsoglou et al. [217] extracted 
ABZ residues from medicated feed using acetonitrile and wash­
ing with hexane. Recovery o f  ABZ was typically greater than 
98%. This group later developed a method for the isolation of  
FBZ from medicated feed using acetonitrile before washing with 
iso-octane and determination by HPLC-UV [2 J 8 ], Mean recov­
ery of FBZ from fortified feed samples ranged between 95 and 
100%.
9.3. Summary on sample preparation
The extraction and purification o f  benzimidazole residues 
from biological tissues offers a difficult challenge. However, 
some of these molecules possess common functional groups, 
which in some cases allows the selective isolation of a range 
of residues through extraction at a particular pH or through ion 
exchange SPE clean-up. However, to extract a wide range of 
residues a more generic acetonitrile based extraction procedure 
might be required, with hexane defatting and washing with sat­
urated sodium chloride to remove polar components. Extracts 
may invariably require further purification by SPE prior to deter­
mination o f  residues.
At present, the majority of methods used for isolation of 
benzimidazole residues from animal tissues and milk may be 
described as screening methods. This is because the majority 
do not generally include the complete range o f marker residues
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Table 5
Sum m ary o f  extraction  and ciean -up  procedures u sed  in  se lec ted  m u lti-resid ue m eth od s for  iso la tin g  b en zim id azo le  residues from  m ilk
R esidues Extraction Clean-up R ecovery (%) R ef.
A B Z , A B Z -S O , A B Z - S 0 2l A B Z -N H 2- S 0 2, FB Z , OFZ, E th y l acetate at pH  10 7 9 -1 0 0 [ I l l ]
FB Z -SC h, F B Z -O H , M B Z , 0X 1
A B Z -N H 2 - S 0 2 A cid  h y d ro ly sis  (H 3PO 4 ) 
A ceton itr ile  (pH  5 - 7 )
S C X  S P E >91 [114]
A B Z -S O , A B Z -S O ,, F B Z , O FZ, F B Z -S O 2 A ceton itr ile C is 7 7 -9 7 [115]
F B Z , OFZ, T BZ, 5 -O H -T B Z E thyl acetate at a lk a line pH LLP
S ilica  SPE
>80
56  (5-O H -T B Z )
[116]
A B Z , F B Z , O FZ, F B Z -S O 2 , F B Z -O H , M B Z , T B Z M S P D M S P D 7 0 -1 0 7 [129]
A B Z -S O , A B Z -S O 2 , A B Z rN H 2 - S 0 2, 5 -O H -T B Z , T BZ, A ceton itr ile  a t pH  10 in p resen ce  o f  B H T C is 71 -1 0 5 % [162]
M B Z
A B Z , A B Z -S O , A B Z -S O 2 E th y l acetate a t alk a line p H L LP 7 8 -1 0 0 [175]
A B Z , F B Z , T B Z , O X I, L E V A ceto n itr ile -e th y l acetate LLP 6 8 -8 5 [177]
A B Z , F E B , F B Z , O FZ , O X I, T B Z , T C B , L E V E th y l acetate at a lk a lin e  pH 7 9 -1 1 0 [178]
F B Z , OFZ N o n e D ilu ted  1:10 9 5 -1 2 2 [179]
A B Z , A B Z -S O , A B Z - S 0 2, F E B , F B Z , O FZ, M B Z , O X I D ilu te  buffer pH  11.0 C is  SPE 8 1 -9 6 [181]
T B Z , L E V D efa t
D ilu te  buffer p H  6 .5
C 18 SPE 8 1 -8 9 [182]
me for each substance. Some researchers have developed methods 
917 for a wide range o f substances using LC-M S/M S but these 
91 b methods do not include the complete range o f  marker residues 
9i9 [164,165,178]. These multi-residue screening methods are sum­
marised in Tables 4 and 5. In some cases, it can be seen from the 
methods that they are suitable for determination o f the marker 
residues o f certain substances such as ABZ, FBZ, 0X 1 and TBZ. 
However, the majority o f these methods fall short when it comes 1923
1920
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Table 6
Sum m ary o f  m ethods suitable for th e iso la tion  o f  m arker resid u es  o f  in d iv id u al b en z im id azo le  drugs from  fo o d  o f  an im al orig in
R esid ues M atrix“ E xtraction C lean-up R ecovery (%) R ef.
M B Z , M B Z -O H , M B Z rN H 2 E el E th yl acetate at pH  7 .8 N H 2 SPE > 8 3 , > 83 , > 5 9 [53]
A B Z , A B Z -S O , A B Z -S O z A BZ^N H 2 - S 0 2 Fish E fliy l ace tate -D M S O  a t p H  11 82 , 78 , 75  and 63 [8 6 ]
F B Z , O FZ L M eth an ol—H 2O LL P 80, 70 [90]
FB Z , O FZ , F B Z -S O 2 M , F, K E th y l acetate at pH  8 .0 [91]
F B Z , O FZ, F B Z -S O 2 Fish , M , S k A ceton itr ile  an d  hexan e w ash C is  and C N  SPE [92]
F L U , F L U -H M E T , F L U -R M E T E, M E th yl aceta te at p H  10 M eth an ol v s . h exan e > 7 0  (E ) and > 8 7  (M ) [94]
M B Z , M B Z -N H 2, M B Z -O H L E th y l acetate at pH  10 M eth an ol v s . h exan e > 85 [98]
A B Z -S O , A B Z -S O 2 , A B Z -N H 2 -S O 2 M k A ceton itr ile LLP 7 4 -9 0 [ 1 1 2 ]
A B Z , A B Z -S O , A B Z -S O 2 , A B Z -N H 2-S O 2 D airy products A ceton itr ile LL P 7 8 -8 6 [113]
T C B , T C B -SO , T C B -S O 2 M k A ceto n e C is 7 6 -9 2 [117]
T C B , T C B -S O , T C B -S O 2 M k A ceton itr ile  and  hexan e wash C 18 8 9 -9 5 [119]
A B Z  m arker residues L A c id  h y d ro ly sis  
E th yl acetate at pH  8 - 9 .5
C 18 S P E > 7 5 [125]
T B Z , 5 -O H -T B Z , 5 - H S 0 4-T B Z M k A c id  h yd ro ly sis  (HC1) 
E th y l acetate at pH  8 .0
PR S SPE 8 7 -1 1 5 [126]
N in e  m etabolites o f  O F Z L A ceton itr ile S C X  S P E 2 8 -1 1 8 [133]
T B Z , 5 -O H -T B Z M , L , K E th yl acetate at pH  7 .0 C N  S P E > 9 6 , > 7 0 [161]
A B Z -S O , A B Z -S O 2 , A B Z -N H 2 -S O 2 M , L , F, K A ceton itr ile Ion-pair extraction  
LLP
> 8 1 , > 8 8 , > 76 [166]
A B Z -S O , A B Z -S 0 2 , A B Z -N H 2 -S O 2 M k A ceton itr ile LLP 7 3 -8 5 [175]
E g g , fat, k idney, liver, m u sc le , m ilk  and skin, are abbreviated a s  E , F, K , L, M , M k  and Sk.
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R esid u es M atrix“ Extraction Clean-up R ecovery (% ) R ef.
M B C , T B Z F, V A ceto n e LLE
D io l SPE  on  A SP E C
9 7 -1 0 8 [54]
B E N , M B C , 2 -A B F, V E th yl acetate L L P 7 1 -9 2 [136]
T B Z , M B C F, V L L E  (ethyl acetate v s . 0 .1 N  11C I) LLP 9 1 -9 7 [186]
B E N , T B Z F ,V R eflu x  w ith  eth y l aceta te at a lk a lin e  p H 7 3 -1 0 9 [227]
B E N , M B C , 2 -A B F, V B en zen e at alkaline p H LLP 7 0 -9 0 [197]
B E N , M B C , T B Z F, V Reflux, in  2N H C 1  
C hloroform  at pH  9 .5
[198]
B E N , M B C , T B Z F, V M eth an ol L L P 6 4 -1 0 5 [199]
B E N , M B C , T B Z F L L E  (ch loroform  v s . aqueous N aC l) L L P > 9 0 [2 0 0 ]
B E N , M B C , T B Z F, V A ceto n e LLP, norm al phase co lum n  chrom atography 4 8 -5 6 [2 0 1 ]
B E N , M B C , T B Z F, V A ceto n e Extrelut an d  S C X  SP E > 8 0 [204] -
M B C , T B Z Fruit ju ice D ilu tion Oasis®  M C X 7 4 ,9 7 [207 ,208 ]
M B C , T B Z F A ceton itrile Oasis®  M C X > 8 8 [209]
B E N , M B C , T B Z , T-M F, V SF -C O 2 C is  Trap 7 8 -1 0 2 [2 1 1 ]
B E N , M B C , T-M F, V S F -C O 2 C | 8 Trap 8 5 -9 3 [213]
T B Z , M B C F, V H 20  (1 0 0 ° C , 5 0b ar) LLP 8 0 -1 0 1 [215]
1 Fruit an d  vegetab les are abbreviated  as F  and V, resp ectively .
to the inclusion o f the marker residues of FLU, M BZ and TCB. 
It may be proposed that these methods are suitable for residue 
monitoring purposes. However, in some cases, if  the most persis­
tent and/or predominantly occurring residues such as MBZ-OH  
in sheep, MBZ-NH2  in horse, and the sulphate conjugate o f TBZ 
and TCB-SO2 in milk are not included in methods then this is not 
strictly true. It may be concluded that for more effective determi­
nation o f benzimidazole residues in food o f animal origin, more 
residues need to be included in methods. Alternatively, laborato­
ries should apply methods that are suitable for the determination 
o f individual marker residues such as those outlined in Table 6 , 
in combination with multi-residue methods.
The methodology developed for the isolation o f benzimi­
dazole fungicides from crops is generally fit for purpose. In 
general, there are only a few benzimidazole fungicides used 
in crop protection, requiring methods for the isolation o f four 
residues BEN, MBC, TBZ and TM. A  summary o f  these meth­
ods are outlined in Table 7. It may be concluded that methods 
that have been developed for the determination of MBC and TBZ 
are suitable for the determination o f benzimidazole fungicides 
in crops. Some have looked at the researcher’s applicability of 
these extraction and purification procedures also for recovery of 
the pre-benzimidazoles (BEN and TM).
10. Methods for measurement of benzimidazole residues
10.1. Bioassays
Bioassays have been used to detect benzimidazole residues 
in food but are more routinely used to evaluate the potency of 
anthelmintic substances. A  common approach adopted in most
bioassays is to first separate residues on a TLC plate and sub­
sequently spray the plate sequentially with nutrient agar and a 
solution containing an indicator organism. The presence of ben­
zimidazole residues is indicated by a zone of inhibited growth on 
the TLC plate. The size o f the zone of inhibition is related to the 
concentration o f the benzimidazole residue. Erwin et al. [219] 
developed a bioassay method for determination o f  BEN. Later 
Petersen and Edginton [220] developed an assay to detect BEN  
and MBC in crops. BEN and MBC residues were extracted and 
separated on a silica gel TLC plate, which was subsequently 
sprayed with a mixture of agar and Penicillium spores prior 
to incubation (ambient, 20 h). The authors concluded that the 
bioassay was 10 times more sensitive than detection by U V spec­
trometry. The procedure offered a number of advantages over an 
alternative bioassay procedure developed by Erwin et al. [219]. 
These advantages included the possibility to allow separation of 
different metabolites and improved sensitivity. Dew et al. [221] 
developed a multiwell screening assay for TBZ, ABZ, ABZ- 
SO, ABZ-SO2  and MBZ using larvae of Ascaris suum. The 
effect o f different drugs and concentrations was evaluated on 
the different larval development stages (L2-L4). L2 is defined 
as larvae hatched from eggs, L3 the first moult and L4 the second 
moult. A ll o f the benzimidazole residues selected were shown 
to inhibit development o f the L2-L3 stage at a concentration of 
10 ng/ml. The L3—L4 stage was also inhibited by each o f the 
benzimidazole residues. However, inhibition of this larval stage 
was strongly influenced by the concentration and benzimida­
zole type. ABZ, MBZ, TBZ, ABZ-SO and ABZ-SO2  inhibited 
larval development at concentrations o f 1 0 , 1 0 , 1 0 0 , 1 0 0  and
1000 ng/ml, respectively. The bioassay was proposed as a low  
cost screening system for detection of benzimidazole residues
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in food. However, it can be concluded that the variable sensi­
tivity o f test organisms to benzimidazole metabolites or marker 
residues is a key issue that needs to be evaluated more closely.
10.2. Direct spectrometric detection
In early work, a number of groups developed spectrometric 
methods for determination of benzimidazole residues in crops. 
Pease and Gardiner [195] determined BEN, after conversion to 
2-aminobenzimidazole (2-AB), by fluorescence spectrophotom­
etry (Xex 285 nm and A.em 335 nm) or by colorimetric detection 
at 445 nm after derivatisation with bromine. The limit o f detec­
tion was less than 100 |xg/kg. The three benzimidazole fungi­
cides, 2-AB, TBZ and 2-(2-furyl)-benzimidazole all fluoresce 
naturally; however, only 2-AB reacts with bromine to produce 
coloured derivatives. As a result, colorimetric detection after 
bromination is a means o f discriminating between 2-AB and  ^
other benzimidazole fungicide residues. Aharonson and Ben- 
A ziz [201] similarly determined BEN and TBZ residues in crops 
by fluorescence spectroscopy after selective clean-up by col­
umn chromatography. Baeyens et al. [222] determined MBZ 
and FLU in pharmaceutical preparations by fluorescence (Xex 
300 nm and ).em 400 nm) after reaction with 0.3% hydrogen per­
oxide in alkaline solution. This group indicated that the assay 
could be applied also to tetramisole, dexamisole and levamisole. 
In summary, spectrometric methods may be suitable for quantita­
tion of high levels o f benzimidazole residues in food. However, 
when quantitation o f benzimidazoles in the low pg/kg range 
and greater selectivity is required, chromatographic separation 
of residues prior to spectrometric detection is generally required.
10.3. Thin layer chromatography
TLC is a suitable technique to detect benzimidazole residues 
in food, while providing semi-quantitative analysis. The tech­
nique has been applied to allow cost-effective detection o f ben­
zimidazole residues in crops and animal tissues. Norman et al. 
[185] determined TBZ in citrus fruits by TLC with fluorescence 
detection (A.ex 302 nm and Aem 360 nm). White and Kilgore 
[202] determined MBC in crops at a concentration lower than 
50 pg/kg on polyamide plastic TLC plates coated with a flu­
orescent indicator. Plates were developed using a solvent of 
chlorofonn-ethyl acetate-acetic acid (190:10:4, v/v/v) and visu­
alised under UV light at 254 nm. Corti et al. investigated the use 
o f high performance TLC (HPTLC) for determination o f  TBZ 
and other residues in potatoes [193]. The residues were separated 
on Cg plates using a mobile phase o f methanol-water (10:3, v/v) 
and quantitation was completed using a scanning densitometer 
at 248 nm. The sensitivity of the method was compared with 
HPLC, but HPLC was found to be much more sensitive. The 
same researchers later developed a method for determination o f  
BEN, MBC and TBZ in fruit [200]. Residues were separated on 
NH2 HPTLC plates (derivatised with polyamine) using a sol­
vent o f chloroform-cyclohexane-methanol (6 :1 :0 . 1 , v/v/v) for 
MBC and TBZ. Residues were detected using a scanning den­
sitometer at 285 nm. More recently, Abjean [223] developed 
a TLC screening method for detection of ABZ-NH2 -SO2  in
liver. ABZ-NH2 -SO2 was separated using a mobile phase of 
acetonitrile-ammomum hydroxide (10:0.6, v/v) on a silica TLC 
plate coated with a fluorescent indicator. The limit of detection 
o f the method was less than 500 pg/kg.
10.4. Immunochemical methods
Immunoassays can provide simple, sensitive and selective 
detection of benzimidazole residues in biological matrices. In 
some cases, samples such as plasma, serum and milk may 
be analysed directiy or diluted prior to analysis. In early 
work, radioimmunoassays were applied to detect benzimidazole 
residues in animal tissue and crops. Nerenberg et al. [224] devel­
oped a radioimmunoassay for determination o f OFZ in plasma. 
Polyclonal antibodies were raised in rabbits after immunisation 
with OFZ coupled to a polylysine carrier. In subsequent work, 
the assay was applied to OFZ residues in sheep fat tissue [137]. 
Newsome and Shields [225] developed a radioimmunoassay 
using a polyclonal antibody for determination of BEN in crops, 
as it’s major residue MBC. Polyclonal antibodies were raised in 
rabbits after immunisation with the hapten 2 -amino benzimida­
zole coupled to a human serum albumin (HS A) carrier.
In recent years, enzyme linked immunoassays (ELIS As) have 
found widespread application and have largely taken over from 
radioimmunoassays. There have been a number o f significant 
applications o f ELISA technology in the area of benzimidazole 
analysis. Brandon et al. [135] developed a competitive ELISA 
for determination o f TBZ in liver, using a monoclonal antibody 
raised in mouse. Haptens o f TBZ and 5-OH-TBZ were prepared 
and coupled to the carrier bovine serum albumin (BSA) foruse as 
immunogens. It was found that antibodies raised after immuni­
sation with the conjugate prepared from TBZ were more specific 
for TBZ and 5-OH-TBZ, while antibodies raised from the con­
jugates prepared with 5-OH-TBZ were found to be less specific 
and also showed good cross-reactivity to CAM and TBZ-NH2 . 
Cross-reactivity to benzimidazoles not possessing a thiazolyl 
ring was also evaluated, but none of these residues (namely ABZ, 
MBZ andFBZ) showed significant cross-reactivity. Competitive 
ELlSAs were developed based on the horseradish peroxidase 
(HRP) conjugate and were applied to liver samples extracted 
using water. They later applied this ELISA for determination 
o f TBZ residues in fruit, vegetables and fruit juices [226]. It 
was found that simple dilution o f fruit juice samples in buffer 
was sufficient prior to determination by ELISA. Brandon et 
al. [156] later produced a mouse monoclonal antibody that 
showed good cross-reactivity to 11  benzimidazole carbamate 
residues including ABZ, FBZ, OX1, MBZ, FLU, MBC and some 
metabolites. The antibody did not show cross reactivity to thia- 
zolylbenzimidazoles (TBZ, CAM and 5-OH-TBZ). Antibodies 
were raised in mice using conjugates prepared after coupling the 
succinamide hapten o f  ABZ to BSA carrier protein. They devel­
oped a competitive ELISA based on HRP for determination of 
benzimidazole residues in bovine liver samples after aqueous 
extraction and later developed a method for determination of 
FBZ residues in milk using this ELISA [179]. M ilk samples 
were simply diluted in PBS-Tween-BSA before determination 
by ELISA.
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Bushway et al. [191] evaluated a commercially available 
enzyme immunoassay tube kit for determination of TBZ 
residues in processed/unprocessed fruit and vegetables. The 
polyclonal antibody used in the assay was raised against BEN- 
MBC, but the antibody demonstrated sufficient cross-reactivity 
towards TBZ to allow its sensitive detection in food. N ew ­
some and Collins [227] developed ELlSAs for determination 
of BEN and TBZ in crops, using polyclonal antibodies raised 
in rabbits. Immunogens were prepared by coupling the carrier 
human serum albumin (HSA) to the succinamide haptens of  
TBZ and MBC (the breakdown product of BEN), and were used 
in rabbits for raising antisera. Abad et al. [228] produced mon­
oclonal antibodies raised against a TBZ-ovalbumin conjugate. 
They indicated that this was a very novel conjugate because 
it was prepared from a hapten functionalised at the nitrogen 
atom of the 1-position of the TBZ structure. They developed 
an indirect ELISA based on HRP for determination of TBZ 
residues in fruit juices. Moran et al. [229] produced mouse 
monoclonal antibodies raised against the novel immunogen 5- 
benzimidazole-carboxylic acid conjugated to the lipopeptide 
Pam3Cyst-Tn. The antibodies were produced for development 
of ELlSAs for determination of protein-bound residues of TBZ 
in tissue, although no applications were described.
Crooks [230] later produced a polyclonal antibody that 
showed good cross-reactivity to eight benzimidazole carbamate 
residues. Antibodies were raised in sheep using conjugates pre­
pared after coupling the succinamide hapten o f ABZ to HSA car­
rier protein. This group developed a competitive ELISA based 
on HRP for determination o f  benzimidazole residues in the tis­
sue juice produced from bovine liver. Johnsson et al. [231] later 
applied the antibody produced by Crooks in a Biacore® biosen­
sor assay for detection o f benzimidazole residues in bovine 
serum. They evaluated the effect o f  different sample processing 
conditions on the biosensor assay response, finding that benz­
imidazole standard curves prepared in serum, without protein 
precipitation did not agree with standards in buffered solutions. 
The assay was shown to give good cross-reactivity (>74%) to 
five benzimidazoles. The results also indicated an improved 
cross-reactivity to FLU (75%) compared to the original ELISA  
developed by Crooks (23%). The LOD and LOQ o f  the method 
were determined using 2 0  blank serum samples to be 2 . 6  and 
4.8 ng/ml, respectively.
10.5. Liquid chromatography based separations
Benzimidazole drugs and their metabolites may differ greatiy 
in terms o f  physical and chemical properties. As a result, devel­
opment o f  a chromatographic method for a range of benzim­
idazole residues is a challenging process. A number of prob­
lems need to be overcome including resolution, peak shape, 
peak sharpness and reasonable run time. The majority o f LC 
methods for determination o f benzimidazoles have been devel­
oped using reversed phase columns (Cs or Cis) and ion sup­
pression based mobile phase systems. In early work, some 
methods were developed using alternative column types such 
as silica or cation exchange. Karlaganis et al. [144] deter­
mined MBZ in plasma using a silica column with a mobile
phase of acetonitrile-water saturated chloroform-formic acid ¡ue 
(75:92.5:0.25, v/v/v). Alvinerie and Galtier [149] developed a 2147 
normal phase separation of TCB, TCB-SO, TCB-SO2 and OFZ sub 
on a silica column achieving good separation in a 15min run. 2ns 
Kirkland et al. [136] used a cation exchange column for determi- 2150 
nation of BEN residues in plants and soil. Arenas and Johnson 2151 
[126] determined TBZ and 5-OH-TBZ in milk using a strong 2152 
cation exchange column. Hiemstra et al. [54] used a polymeric 2153 
column for analysis of TBZ and MBC residues in crops giving 2154 
better peak shape, separation and longer column lifetime than 2155 
silica-based columns. 2156
In early work, Bogan and Marriner [139] developed an iso- 2157 
cratic separation for eight benzimidazole residues on a Ci8 215a 
column in 14min, but the substances were poorly resolved. 2153 
Bull and Shume [130] later separated metabolites o f FBZ and 2ieo 
TCB in a 40 min run time. Long et al. [131] and Wilson et al. 2161 
[102] developed multi-residue LC methods for determination of 2162
7 and 8 benzimidazoles in less than 13 and 35 min, respectively. 2103 
Other researchers have developed gradient separations achiev- 2164 
ing improved separation or inclusion of more residues. Allan et 2105 
al. [151] compared isocratic and gradient systems for determi- 21 bb 
nation o f five benzimidazoles in plasma. Sorensen and Petersen 2167 
[181] developed a gradient separation of eight benzimidazoles in 216a 
a 40 min run with additional time needed for equilibration. Rose 21 fa 
[133] separated OFZ and nine metabolites in less than 35 min 2170 
using a binary gradient on a Cg column. Similarly, Stubbings 2171 
et al. developed a gradient separation for levamisole and eight 2172 
benzimidazoles on a Cs column [173]. More recently, Roudaut 2173 
and Gamier [163] separated 10 benzimidazoles using a binary 2174 
gradient on a base deactivated Cis column, all residues with the 2175 
exception of OX1 and OFZ were separated in less than 16min. 2176 
Rouan et al. separated TCB, TCB-SO, TCB-SO2 and an inter- 2177 
nal standard on a short Ci8 column (33 mm x  4.6 mm) in less 217a 
than 10 min [154]. Porter and Johnston [232] evaluated nar- 2179 
row bore c o l u m n s  (2.1mm) for determination o f TBZ, MBZ, 21 bo 
ABZ and FBZ residues. This group found that the peak heights 2101 
for analytes increased by a factor o f  five using narrow bore ?1B2 
columns compared to a column of standard diameter (4.6 mm). 2183 
This group concluded that use of narrow bore columns resulted 21B4 
in a reduction in solvent usage, analysis time and pump wear. 21 as 
Kan et al. [96] and Hajee and Haagsma [53] developed iso- 21 ea 
cratic separations on columns of intermediate diameter (3 mm) 2ia7 
for FLU and MBZ metabolites, respectively. Likewise, Domany 2ibb 
and Kovacsics [160] developed an isocratic separation of 10 ben- 2139 
zimidazoles on a narrow bore (2.1 mm) Cig column. Shaikh et 2190 
al. found that ABZ and its three major metabolites could not be 2191 
eluted in less them 20 min without the use of gradient elution 2192
[86]. This group chose to determine ABZ and its three metabo- 219a 
lites using two separate isocratic systems. Danaher et al. [ 172] 2194 
separated 14 benzimidazole residues on an Xterra® Cig column 2195 
using gradient elution in a run time of 60 min. 2196
Negro et al. [56] evaluated the use o f ion-pair chromatography 2197 
for determination o f TCB-SO and TCB-SO2  in plasma and urine. 219a 
They investigated the effect o f pH, organic modifier content and 2199 
the chain length o f the sodium alkylsulphonate ion-pair reagent 2200 
on chromatography. The optimum mobile phase consisted of 2201
0.05 M phosphate buffer pH 7.0-acetonitrile (55:45, v/v) con- 2202
27
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taining 0 .001M sodium decanesulphonate. De Ruyck et al. [ 177] 
developed an ion pair gradient separation for FBZ, TBZ, ABZ, 
OXI and LEV. Satisfactory separation conditions were achieved 
with sodium 1 -octanesulphonate as the ion-pairing agent and 
adjustment of the mobile phase buffer solution to pH 3.5 with 
ortho-phosphoric acid. Botsoglou et al. [132] investigated the 
effect o f ion-pair reagents and pH on the retention time and 
peak height of FBZ and OFZ, and showed that decreasing the pH 
to 2.2 shortened the retention time of FBZ markedly and OFZ 
slightly. Addition of octane-sulphonate anion increased reten­
tion time and tetrabutyl ammonium cation decreased retention 
time. Over the range of pH 3.7 to 6.5 no change in retention time 
was observed with or without the addition o f ion-pair reagents. 
It was found that the peak shape of FBZ was poor over a range 
o f pH values in the absence o f ion-pair reagents, but addition of 
ion-pair reagents greatly enhanced peak shape at pH 2.2, even 
at longer retention times. The same group developed a range of 
separations for FBZ residues using ion-pair chromatography. A 
multi-residue method was later developed for separation o f 1 0  
benzimidazoles in milk in less than 30min, using an isocratic 
mobile phase. Macri et al. [233] developed an ion-pair separa­
tion of eight benzimidazoles using a mobile phase containing
0.01 M  pentane-sulphonate and 0.5% tiiethylamine at pH 3.5.
In the area of LC-M S, most groups carry out separations 
using shorter columns (less than 150 mm in length). These 
columns require shorter equilibration times during gradient 
chromatography because of the lower column volume, which 
increases LC-M S throughput. Blanchflower et al. [90] devel­
oped an isocratic separation o f FBZ and OFZ, finding it gave 
more reproducible MS results compared to gradient separa­
tion. Cannavan et al. [161] developed a gradient method for 
separation o f TBZ and 5-OH-TBZ, using a mobile phase con­
sisting o f acetonitrile and 0.1M  ammonium acetate. Balizs
[164] developed a method for determination o f 15 benzimida­
zole residues by LC-MS/MS with a gradient separation carried 
out on a narrow bore column (2.1 mm). The mobile phase flow 
rate ranged between 0.04 and 0.2 m]/min depending on the ion­
isation interface used. The benzimidazoles were eluted from 
the column in less than 6  min but were not resolved. It was 
claimed that, because individual benzimidazoles have different 
mass-to-charge values, chromatographic separation was unnec­
essary. De Ruyck et al. [94] developed an LC-M S/M S method 
for determination o f benzimidazole residues using a column of 
similar dimensions for determination o f  FLU, FLU-HMET and 
FLU-RMET in eggs and muscle tissue. Later, they developed a 
method for determination o f levamisole and seven benzimida­
zole residues in milk [178].
10.5.1. Liquid chromatography detection systems
The determination o f  benzimidazoles in milk, tissue and 
crops is routinely carried out using UV, fluorescence and mass 
spectrometric (MS) detection systems coupled to LC. Benzim­
idazoles possess a strong UV chromophore and may be deter­
mined using LC-UV. However, it has been found that certain 
benzimidazoles (namely ABZ, CAM, FLU, TCB, TBZ, and their 
metabolites) possess naturally fluorescing chromophores, mak­
ing them suitable for detection by LC fluorescence. Fluorescence
is more sensitive and selective, but does not have the same range 2250 
o f applicability as UV detection. As a result, UV is the most 2260 
widely applied system to detect benzimidazole residues in bio- 22«! 
logical extrac ts. MS detection is becoming more widely used for 2202 
determination o f benzimidazole residues in biological matrices, 2263 
offering the capability for combined quantitative-confirmatory 2264 
analysis. 220=
10.5.1.1. Detection by UV. Alton etal. [146] determined MBZ z>w 
residues in plasma by UV detection at 313 nm. Karlaganis et 2207 
al. [144] determined MBZ in plasma, finding less interference 226a 
at a wavelength of 307 nm compared to 247 nm. Bogan and 226s 
Marriner [139] developed a method for determination o f eight 2270 
benzimidazoles in body fluids, using U V  detection at 292 nm. 2271 
Mellergaard et al. [138] determined MBZ residues in eel muscle 2272 
at 254 nm. Hajee and Haagsma [53] determined MBZ, MBZ- 2273 
NH 2  and MBZ-OH in eel muscle at 289 nm. Kan et al. [96] 2274 
developed a method for analysis o f FLU and its metabolites in 2275 
eggs using UV detection at 250 nm. Chiap et al. [155] deter- 2276 
mined ABZ, ABZ-SO and ABZ-SO2 in plasma at 295 nm. 2277
Long et al. [131] determined seven benzimidazole residues 227a 
in tissue using UV photodiode array (PDA) detection. They also 2279 
investigated the use of PDA as a confirmatory tool, but found 22m  
differences between spectra at lower and higher concentration 22B1 
levels. The PDA detector was not suitable for confirmatory 2202 
analysis at lower concentrations (5 ng on-column). They later 2203 
developed methodology for determination of these residues in 2234 
milk and animal tissues. De Buyanski et al. [158] determined 2sas 
TBZ and levamisole in tissue using PDA detection at 300 and 221a  
240 nm, respectively. Danaher et al. [172] determined 14 benz- 22a? 
imidazole residues in liver tissue using U V detection at 298 nm. 22m  
Tai et al. [ 116] adopted a dual wavelength approach for deter- 2209 
minalion o f FBZ, OFZ, TBZ and 5-OH-TBZ residues in milk. 2290 
FBZ and OFZ residues were monitored at 298 nm, while TBZ 2291 
and 5-OH-TBZ were monitored at 318 nm. Similarly, Sorensen 2292 
and Petersen [182] determined TBZ and levamisole residues in 2299 
milk using a PDA detector at wavelengths of 300 and 220 nm, 2294 
respectively. This group also developed a method for determi- 2295 
nation o f eight other benzimidazoles in milk (ABZ, ABZ-SO, 229s  
ABZ-SO2 , OFZ, OXI, MBZ, FBZ and FEB) [181]. 2297
A  range of derivatisation methods can be used for determi- 229s  
nation of benzimidazoles. Most o f these have been used for GC 2259 
applications and only two papers on derivatives for LC have 23m  
been published. Capece et al. [91] converted FBZ and OFZ 2301 
residues to FBZ-SO2 and measured the sum of total residues as 2302 
this peak. Residues were derivatised by reaction with percetic 2303 
acid and purified by liquid-liquid partitioning prior to determi- 2304 
nation by LC-UV. Tafuri et al. [234] confirmed the presence of 2305 
TBZ residues, by derivatising with p-nitrobenzyl bromide in the 231* 
presence o f potassium carbonate (110 °C, 3 h) with detection 2207 
by LC-UV. The derivatisation procedure was used to provide 230a 
quantitative and confirmatory analysis o f TBZ residues in sus- 2209 
pect samples. 2310
10.5.1.2. Detection by fluorescence. A  number o f researchers 2311 
have developed methods for determination of benzimidazole 2312 
residues using HPLC coupled to fluorescence detection. Wilson 23«
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et al. [102] found that sample extracts needed further purifi­
cation on Co SPE cartridges to remove matrix components that 
interfered with UV detection o f ABZ-NH2 -SO2 and 5-OH-TBZ. 
However, the influence o f this matrix interference could be 
greatly reduced using fluorescence detection. It was proposed 
because less clean-up is required with fluorescence that recov­
ery and reproducibility of assays should improve. Le Boulaire 
et al. [169] determined TBZ and MBZ in tissue, finding fluo­
rescence to be 20 times more sensitive than UV detection for 
TBZ. Kinabo and Bogan [117] developed a method for deter­
mination of TCB and its metabolites in milk using fluorescence 
detection (A.ex 300 and A.em 676 nm). The limit o f detection of 
the method was 2 0 ,4 0  and 40 |xg/l for TCB-SO2 , TCB-SO and 
TCB, respectively. Arenas and Johnson determined TBZ and 
5-OH-TBZ in milk using fluorescence detection with Aex 305 
and 318 nm and Xem 380 and 515 nm, respectively [126]. Two 
separate chromatographic runs were required to achieve more 
sensitive detection, but it was concluded that these residues could 
be determined at their optimum wavelengths in a single run using 
a dual grating monochromator. The LOD and LOQ were 5 and 
50 (j.g/1, respectively. Markus and Sherma [125] used fluores­
cence detection for determination o f ABZ-NH2 -SO2 in bovine 
liver (A.ex 300 nm and Xem 320 nm). Shaikh et al. [86] deter­
mined ABZ, ABZ-SO, ABZ-SO2 and ABZ-NH2 -SO2 and three 
metabolites in fish muscle using fluorescence detection with Aex 
290 nm and Xem 330 nm. LOQs for the method were 20 ,1 .5 ,0 .5  
and 5 jxg/kg for ABZ, ABZ-SO, ABZ-SO2 and ABZ-NH2 -SO2 , 
respectively. Aharonson et al. [211] determined benzimidazole 
fungicides in fruit and vegetable matrices using UV and fluores­
cence detection. TBZ, MBC and TM were determined by UV at 
285 nm while TBZ and MBC were determined also by fluores­
cence (Aex 305 nm, A.em 345 nm and A.ex 282 nm, ie m  307 nm, 
respectively). It was found that detection o f TBZ residues could 
be enhanced using fluorescence instead of UV detection, but 
detectability of MBC was similar using both detectors. How­
ever, matrix interference was found to be less significant with 
fluorescence detection.
10.5.1.3. Detection by UV and fluorescence in series. The use 
o f fluorescence detection can offer added sensitivity and selec­
tivity to methods, potentially reducing the need for extensive 
sample clean-up. These added advantages may allow the devel­
opment o f  multiresidue methods that would allow the determi­
nation o f all major benzimidazole residues, a task that has not 
yet been completed by any researcher. However, since some 
benzimidazoles do not fluoresce naturally (namely FBZ, OFZ, 
FBZ-SO2 , MBZ, FLU, MBZ-NH2 and FLU-NH2), UV is still 
required as it applicable to all benzimidazole residues.
Some researchers have developed methods for the determi­
nation o f benzimidazole residues using U V  and fluorescence 
detection in series, these methods are described in this sec­
tion. Farrington et al. [157] determined benzimidazole residues 
(ABZ-SO2 , OFZ, CAM and MBZ) using U V  and fluorescence 
detectors in series. ABZ-SO2 , TBZ and CAM were monitored 
using fluorescence detection (Aex 312 nm, A.em 355 nm), while 
OFZ and MBZ were monitored using U V detection at 290 nm. 
Su et al. [ 162] developed a method for determination of benzimi-
dazole residues using UV and fluorescence detection. A generic 
wavelength o f 290 nm was found to be suitable for detection 
of ABZ-SO, ABZ-SOj, ABZ-NH2 -SO2 and TBZ. This group 
found that more selective detection o f 5-OH-TBZ and MBZ 
could be achieved using UV at 320 nm. Fluorescence detec­
tion (A.ex 290 nm, Aem 320 nm) was found to be suitable for 
the determination o f ABZ-SO, ABZ-SO2 , ABZ-NH2 -SO2 and 
TBZ. Fluorescence detection was found to be unsuitable for 
the detection of 5-OH-TBZ and MBZ because o f  weak signal 
and lack o f fluorescent characteristics, respectively. Constanti- 
nou et al. [180] determined five benzimidazole residues in milk 
using a similar approach. TBZ and ABZ residues were moni­
tored using fluorescence ( le x  312 nm, Aem 355 nm) while other 
residues were detected by UV at 290 nm. Hiemstra et al. [54] 
determined MBC residues in crops using UV (280 nm) and fluo­
rescence (A.ex 235 nm, Xem.280 nm) detectors in series. Residues 
were confirmed by comparing the relative UV and fluorescence 
responses for positive samples with standards.
10.5.1.4. Detection by electrochemical potential. Therearefew  
reported applications of electrochemical detection for benzim­
idazole residues. Oosterhuis et al. [143] determined MBZ and 
MBZ-OH residues in biological fluids by electrochemical detec­
tion. The electrochemical detector consisted of a carbon paste 
electrode and a saturated calomel electrode; MBZ residues were 
determined at 950 mV versus the reference electrode. FLU, 
which possesses sim ilar oxidative properties to MBZ, was used 
as internal standard. Leenheers et al. [235] similarly developed 
a method for determination of a metabolite of MBC in urine by 
HPLC with electrochemical detection.
10.5.1.5. Detection by mass-spectrometry. It will be seen from 
the applications reviewed in this section thatLC-MS is the tech­
nique o f choice for sensitive and selective detection of a wide 
range o f benzimidazole residues in complex biological matri­
ces. In contrast to traditional LC-UV methods, LC-MS can 
be used to allow stand-alone determination and confirmation 
o f benzimidazole residues. LC-fluorescence could be applied as 
an alternative technique to allow determination and confirmation 
of selected benzimidazole residues. However, not all benzimi­
dazole residues fluoresce naturally. In this section, the suitability 
o f LC-M S methods for determination and confirmation o f  ben­
zimidazole residues will be reviewed.
Some early methods were reported for determination of ben­
zimidazole residues in animal tissues using single quadrupole 
MS instruments equipped with thermospray ionisation inter­
faces, while operating in selected ion monitoring (SIM) mode. 
The disadvantage with such systems is that insufficient frag­
mentation o f molecules is achieved and resulting mass spectra 
do contain a suitable number of diagnostic ions for confirmatory 
purposes. Blanchflower et al. [90] used LC-MS with a thermo­
spray interface for determination o f FBZ and OFZ residues in 
tissue. FBZ and OFZ were determined in SIM mode as their 
[M + H]+ ions. Cannavan et al. [161] used LC-MS with a ther­
mospray interface for determination of TBZ and 5-OH-TBZ 
residues in bovine tissue, while using a deuterated TBZ internal 
standard to improve reproducibility. TBZ and 5-OH-TBZ were
29
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monitored in SIM mode as their [M + H]+ ions. Cannavan et 
al. confirmed the presence of residues on a single quadrupole 
instrument equipped with an atmospheric pressure chemical 
ionisation (APC1) interface. They demonstrated that suitable 
fragmentation could be induced with an APC1 interface to pro­
duce four diagnostic ions, which were suitable for confirmation 
of residues. Other researchers have developed methods for deter­
mination or confirmation of benzimidazole residues using single 
quadrupole instruments equipped with electrospray ionisation 
(ESI) interfaces. Takeba et al. briefly described a method for 
confirmation of TCB marker residues, which were monitored 
as their [M — H ]~ ions [119]. The LOD of the method ranged 
between 4  and 6 j-Lg/kg in bovine milk. The protocol used for con­
firmation o f residues was poorly described and it was not clear 
if residues could be confirmed at these low levels. Young et al.
[208] determined TBZ and MBC residues in fruit juices using 
a single quadrupole LC—MS instrument equipped with an ESI 
interface in positive ion mode. TBZ and MBC were monitored 
as their [M + H]+ ions. The LOQ o f the method was 2 ^g/kg in 
fruit juice. TBZ and MBC residues were fragmented through in­
source collision induced dissociation at different cone voltages 
to produce five and six diagnostic ions for confirmation o f MBC  
and TBZ, respectively.
In the last decade, the application of tandem mass spec­
trometry (MS/MS) has resulted in improved determination and 
confirmation of benzimidazole residues in biological matrices. 
Most o f  these methods have been reported on triple quadrupole 
instruments operating in multiple reaction monitoring (MRM) 
mode or using the MS/MS capabilities o f ion trap instruments. 
Balizs [164] developed a method for determination of 15 benz- 
imidazoles using a triple quadrupole instrument equipped with 
ionspray and turbospray interfaces while operating in positive 
ion mode. [M + H]+ ions were fragmented through C1D and 
monitored as a single daughter transition through MRM. The 
LOQ ranged between 5 and 30 jig/kg in meat. De Ruyck et al. 
[94] developed an LC—MS/MS-ES1 method for determination of 
FLU and metabolites in muscle, liver and eggs. Residues were 
monitored as their [M + H]+ ions and confirmed using MRM 
o f two daughter ion transitions. Quantitation was carried using 
the most abundant daughter ion while using chlorobenzimida- 
zole as an internal standard and matrix matched calibration. The 
LOQ was approximately 1 (jLg/kg in egg and meat tissues. They 
also reported an LC-MS/MS-ES1 for determination o f  MBZ, 
MBZ-OH and MBZ-NH2 in sheep muscle, liver, kidney, liver 
and back fat [98]. The limit o f detection of the method was less 
than 1 (ig/kg. De Ruyck et al. [178] later developed a multi­
residue method based on the LC-MS/MS-ES1 for determination 
of eight anthelmintic drugs (LEV, TBZ, OFZ, FBZ, OX1, ABZ  
FEB and TCB) in milk (Fig. 11). Residues were monitored as 
their [M + H]+ ions and confirmed using MRM. The decision 
limit (CCrx) and the detection capability (CCP) were calculated 
by analysing samples fortified at 1 p-g/kg (for non-permitted sub­
stances) and at the MRL (for permitted substances). Edder et al.
[165] determined levamisole and 11 benzimidazole residues in 
meat and liver by LC-MS/MS using positive ESI and MRM 
mode. They similarly confirmed the presence of residues based 
on two daughter transitions. The LOD and LOQ of the method
were 5 and 10 [xg/kg (except for ABZ. which were 10 and 2482
20 jjig/kg), respectively. 2483
A limited number of LC-M S methods have been devel- 2484 
oped for determination o f benzimidazole residues on ion trap 24as 
instruments. Zrostlikova et al. [209] reported a method for deter- 2<bs 
mination of TBZ, MBC and other crop protection agents in fruit 2487 
using an LC-M S system equipped with an ESI interface in pos- 2488 
itive ion mode and an ion trap detector. Benzimidazole parent 2489 
[M + H]+ ions were fragmented using collision induced dissocia- 2490 
tion through the MS/MS capability o f the ion trap and monitored 2491 
as a single product ion transition. The LOQ o f the method for 2492 
MBC and TBZ was 2 and 4.8 |xg/kg, respectively. 2493
10.6. Gas chromatography 2494
GC determination of benzimidazoles is difficult because o f 2495 
the basic nature and low volatility of these substances. However, 2496 
TBZ and TCB are sufficiently volatile to allow their determi- 2497 
nation by GC without derivatisation. The main applications o f 249a 
GC methods have been in determining benzimidazole fungi- 2499 
cides in crops. Some resreachers have found GC coupled to mass 2500 
spectrometery useful for confirmation of the presence of benzim- 2501 
idazole residues. However, GC-MS procedures usually require 2502 
derivatisation of residues to induce volatility and allow the gen- 2503 
eration of suitable MS spectra for confirmatory analysis and, as 2504 
a result, have been largely been replaced by LC—M S/M S. Quan- 2505 
titative GC methods have been developed by some researchers 250a 
to determine the presence o f benzimidazole fungicides in crops. 2507 
Lafuente et al. [192] determined TBZ residues in fruit by direct 250a 
GC using nitrogen-phosphorous detection (NPD) and electron 2509 
capture detection (ECD). Separation was carried out on a wide- 2510 
bore capillary column (10 m x 0.53 mm) with a silicone-bonded 2511 
phase. NPD was found to be more sensitive than ECD. The 2512 
LOD of the method was 10 (Ag/kg. Oishi et al. [203] simi- 2513 
Iarly determined TBZ (without derivatisation) by GC-NPD. The 2514 
separation was carried out on a fused silica capillary column 2515 
(25 m x  0.2 mm), giving a LOD of 10 p.g/kg. However, most GC 2516 
methods for determination of benzimidazoles include derivati- 2517 
sation steps, where more polar amino or hydroxyl groups are 251a 
reacted with suitable alkylating/acylating reagents. An overview 2519 
of these derivatisation procedures is outlined in Fig. 12 and 2520 
Table 8. Some researchers hydrolysed the carbamate functional 2521 
group to form an amino functionality prior to reaction with 2522 
the alkylating/acylating reagent. Alternatively, residues may be 2523 
derivatised directly without hydrolysis. A  wide range of alky- 2624 
lating and acylating reagents have been used to derivatise ben- 2525 
zimidazoles, these are summarised in Table 8. These allow the 2526 
introduction of functioned groups ranging from simple methyl 2527 
esters to more complex pentafluorobenzyl groups. 252B
Jacob et al. [236] confirmed the photolysis products 2529 
of TBZ residues by GC-MS after derivatisation with 2530 
bis(trimethylsilyl)acetamide. They later applied the same 2531 
method to confirm the structures o f  urinary metabolites o f CAM 2532 
[106,237]. VandenHeuvel et al. [238] developed an on-column 2533 
methylation procedure for confirmation of CAM residues by 2534 
GC-MS-E1 (electron impact mass spectrometry) in SIM mode. 2535 
Residues were dissolved in 0.125 M triethylammonium hydrox- 2530
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ide in methanol just prior to injecting into the GC-MS system. 
They later applied this method for TBZ and 5-OH-TBZ [239]. 
They used a column with a poly sulfone stationary phase because 
its background bleed and adsorption characteristics were more 
desirable than others tested. Tanaka and Fujimoto [188] deter­
mined the methyl derivative o f TBZ by GC with flame ionisation 
detection (FID). Derivatives were prepared by reacting with 
dimethylformamide and dimethyl acetal in acetonitrile (120 °C, 
4 0 min). The procedure was used to determine TBZ residues
in fruit with a limit o f detection o f 100 jxg/kg. Nose et al. 254s 
[190] acylated TBZ by reaction with pentafluorobenzyl-bromide 254? 
PFB-Br (120 °C, 30 min) before determination by GC-ECD 254a 
and confirmation by G C-M S-EI in full scan mode. Physalo 2549 
derivatised BEN residues with acetic anhydride (100 °C, 30 min) 2550 
before determination by capillary GC-NPD [197]. TheLOD was 2551 
10 |j.g/kg. GC-ECD was also evaluated for determining residues 2552 
but was 10 times less sensitive. Bardalaye and Wheeler later 2553 
modified this procedure and applied it to the determination of 2554
II .(Ml
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Table 8
S um m ary  o f  derivatisation  reagents, reaction  con d ition s and fu nction al group m odifications
D erivatisation  reagent R esid u es C ond ition s R5 R ef.
M T B S T F A M B C , T B Z , 5-O H -T B Z , I 1 0 ° C , 2 h
— S i(C H 3) 2
[1 0 2 ,213 ,241 ]
A B Z -N H 2 -S O 2 , F B Z , M B Z , C (C H 3)3
O FZ
B S A  in pyrid in e C A M , T B Z 6 0  °C , 30  m in — S i(C H 3) 2 
C (C H 3)3
FW F
„  /  V
[1 0 6 ,236 ,237 ]
P F B -B r + K 2C 0 3 T B Z , T C B , A B Z , F B Z , OFZ, 
M B Z , F L U , O X I, M B C
1 0 0 °C , 3 h o r 6 0 ° C ,  3 h - f i r y c
F  F
w
[1 3 4 ,186 ,240 ]
P F B -C 0 -C I + N a 2 C 0 3 (T B Z ) T B Z I 2 0 ° C , 3 0 m in  or 100 °C , 4 5 m in  C ° " \  f f  F [1 3 4 ,187 ,190 ]
F  F
PF B -C O -C 1 +  N a 2 C 0 3  (o th er  b en zim id azo les) N o  reaction [134]
C H 3-I T B Z , T C B , A B Z  F B Z  O FZ, 
M B Z , F L U , 0 X 1
6 0  °C , 30  min — c h 3 [134]
T rim ethylphenylaram onium C A M , T B Z , 5-O H -T B Z O n -colum n  m éthylation — c h 3 [1 0 2 ,238 ,239 ]
h yd rox id e  in m ethanol
D M A -D M F T B Z 120 °C , 4 0  m in — c h 3 [188]
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TBZinfm its [187]. Tj an and Janssen [186] determined TBZ and 
MBC in fruit using GC-ECD after derivatisation with PFB-Br. 
The procedure was also applicable to BEN, which was converted 
to MBC during the extraction and clean-up procedure. The LOQ 
o f the method was 50 |xg/kg. Tjan and Janssen also developed 
a confirmatory procedure using GC-M S-EI. Cline et al. [240] 
later modified this procedure and applied it to determine MBC 
in fruit treated with BEN. The LOD of the method was 10 |xg/kg.
Marti et al. [134] developed GC methods to confirm the pres­
ence o f eight benzimidazole residues in animal tissue, while 
evaluating a range of derivatisation procedures used for sub­
stances with amino functional groups. They found that acylation 
with PFB-Br and méthylation with methyl iodide gave satisfac­
tory results. Derivatised extracts were determined by GC-NPD  
and GC-ECD; GC-NPD chromatograms were found to con­
tain less matrix interference than GC-ECD chromatograms. 
However, derivatives were found to>decompose during injec­
tion and chromatography because o f the high temperature used, 
making quantitative determination difficult. The main advan­
tages o f these derivatives could be seen with G C-M S-EI and 
GC-M S—positive ion chemical ionisation (P1C1) determina­
tion where particularly useful structural information was pro­
vided for confirmatory analysis. Electron impact spectra of 
the methyl derivatives produced fewer ions than the pentafluo- 
robenzyl derivatives. Positive ion chemical ionisation provided 
a similar number o f ions suitable for confirmatory analysis, 
while negative ion chemical ionisation produced only one or 
two ions for most residues. Wilson et al. [102] used capil­
lary G C-M S-EI in SIM mode for confirmation o f  benzimida­
zole residues in tissue. Residues were derivatised in a two-step 
procedure, firstly involving hydrolysis with 2N  HC1 (110°C , 
lh )  to convert the carbamate group to an amino function­
ality. Hydrolysed residues were reacted with Af-methyl-A^i- 
butyldimethylsilyl)trifluoroacetamide (MTBSTFA), converting 
the primary and secondary amines to a silyl amine. In the case of 
5-OH-TBZ, the phenol functional group was converted to a silyl 
ether. The method was not applicable to CAM, which was alter­
natively derivatised using flash alkylation in the GC injection 
port (260 °C) after injection in triethylammonium hydroxide in 
methanol. Markus and Sherma [241] developed a method for 
confirmation o f ABZ-NH2 -SO2  in tissue based on this derivati­
sation procedure, with determination by G C-M S-EI. Balizs and 
Erbach [242] determined TBZ and ABZ residues in tissue using 
capillary GC with high-resolution mass spectrometry (HRMS), 
after derivatisation with PFB-Br. Anastassiades and Schwack 
later applied a similar GC-M S procedure for confirmation o f  
benzimidazole fungicides in crops after SFE [213].
10.7. Summary on detection systems
At present most methods for the determination o f  benzimida­
zole residues in biological matrices using HPLC with U V and/or 
fluoresence detection. HPLC-UV is a more universal detection 
system but fluoresence is generally more selective and in some 
cases more sensitive. In the last 10 years, L C -M S(-M S) has 
found more widespread application in benzimidazole residue 
analysis offering more sensitive detection and increased con-
fidence in reporting results. In the future, with an increasing 2510 
demand to include additional residues in methods there should 2011 
be an increase in the number of LC—MS/MS methods. Such 2012 
methods can offer the ability to include additional residues in 2013 
methods and offer improved limits of detection. In particular, 2014 
when testing for low levels of residues, such as those that may 2615 
occur in milk due to unapproved used of licensed veterinary 2B13 
drugs, LC-MS/MS is the technique of choice. Alternatively, 201? 
HPLC coupled to UV and fluorescence detection in series may 2bib 
offer a low cost alternative to LC-MS/MS, and may be partic- 2019 
ularly effective for independently confirming the presence of 2020 
MRL substances in food. 2021
It is important to emphasise the need for rapid methods to 2022 
detect the presence of residues in food prior to its entry into the 2023 
marketplace. There have been considerable developments in the 2024 
area of immunochemical screening methods. No antibody has 2025 
been developed yet that shows cross-reactivity to the complete 2020 
range of benzimidazole residues. Future work in this area should 2027 
concentrate on exploring the cross-reactivity of antibodies to 262s 
important residues and improvement of cross-reactivity through 2029 
genetic engineering of antibodies. The application immuno- 2630 
biosensor assays has been explored in a limited study in serum. 2031 
However, future work should investigate the application of this 2032 
technique to allow more sensitive detection of residues and 2033 
reduce non-specific binding effects. 2034
11. Conclusions 2035
There has been intensive research in the last decade into 263« 
developing methods for the determination of benzimidazole 2037 
residues in food. At present, methodology for the determina- 203a 
tion of benzimidazoles in crops would appear to be fit for 2*39 
purpose. However, methodology for determination of benzim- 2040 
idazole residues in foods of animal origin needs improvement. 2041 
This is not a reflection on the quality of the research that has 2042 
been published but of the difficult challenge faced, owing to the 2043
33
extensive metabolism o f  these molecules. 2044
The authors o f this paper have carefully considered these 2545
problems and have com e up with the following recommenda- 2546
tions: 2647
•  There is a need to develop multi-residue methodology that 2040 
will allow the determination o f the complete range of benz- 2049 
imidazole veterinary drug residues in foods o f  animal origin. 2660
•  Sample preparation techniques need to be developed to allow 2051
simultaneous extraction o f  polar residues such as TBZ and 2052 
non polar residues such as TCB. 2863
•  These methods may require the application o f more selective 2054
detection such as LC-M S/M S or a combination of HPLC- 2055 
UV-fluoresence or through the application o f  a combination 205® 
of more specific analytical methods. 2057
•  An alternative approach might be to include a rational sci- 205» 
entific selection o f benzimidazole residues according to their 2059 
occurrence/persistence in the tissues o f treated animals. How- 2000 
ever, in the event that a drug residue is found the presence o f 2661 
other marker residues o f the drug should be checked. The dis- 2082 
advantage o f such an approach is that it would necessitate the 2083
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664 validation of alternative residue methods for confirming the
Bes marker residues of each drug.
see • The need for rational selection of residues particularly applies 
6R7 when testing for benzimidazole residues in milk. In the case
66a of TBZ and TCB the most prevalent and persistent residues
fifia in milk are the sulfate conjugate of 5-OH-TBZ and TCB-
670 SO2, respectively. This would indicate that hydrolysis steps
671 should be included to allow the effective determination of
B72 TBZ residues in milk. To monitor for the unapproved use of
«13 TCB in dairy animals, TCB-SO2 in milk would be the most
374 appropriate residue to select.
B75 • One problem encountered when selecting residues for a
67B method is that the most prevalent/persistent residue is not
a?? always clearly identifiable. This is the case with benzimida-
s7s zole veterinary drugs, where the residue is often expressed as
s7s the sum of marker residues. The marker residues of ABZ may
uso be expressed as the hydrolysed/oxidised residues and FBZ as
BBi the sum of oxidised residues. In the case of TCB, residues are
afi2 expressed as the sum of residues, which may be derivatised to
ex< form keto-TCB. It is not clear whether keto-TCB is a metabo-
684 lite or an artifact of derivatisation. In the interest of food safety,
ass it would be more appropriate if residues were expressed as the
am individual metabolites to allow rational selection of marker
BS7 residue(s) for analysis.
ess •  Another problem faced, is that current validation criteria for 
esa testing of foods of animal origin, as outlined in Commission
BM Decision 2002/657/EC, are not appropriate for all approved
691 benzimidazoles because MRLs are often expressed as the sum
ms of marker residues. This indicates that determination of CCa
Baa and CCP is not always appropriate. This is a particular prob-
194 lem for MBZ and FLU because no method is available that
B9s allows the determination of total marker residues.
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Abstract
A method has been developed to analyse for malachite green (MG), leucomalachite green (LMG), crystal violet (CV) and leucocrystal violet 
(LCV) residues in salmon. Salmon samples were extracted with acetonitrileiMcIIIvain pH 3 buffer (90:10 v/v), sample extracts were purified 
on a Bakerbond strong cation exchange solid phase extraction cartridge. Aliquots of the extracts were analysed by LC-MS/MS. The method 
was validated in salmon, according to the criteria defined in  Commission Decision 2002/657/EC. The decision limit (CC„) was 0.17, 0.15, 0.35 
and 0.17 (jLgkg-1 , respectively, for MG, LMG, CV and LCV and for the detection capability (CCp) values of 0.30, 0.35, 0.80 and 0.32 n,gkg-1 , 
respectively, were obtained. Fortifying salmon samples (n —6) in three separate assays, show the accuracy to be between 77 and 113% for MG, 
LMG, LCV and CV. The precision o f the method, expressed as RSD values for the within-laboratory reproducibility, for MG, LMG and LCV 
at the three levels o f fortification (1, 1.5 and 2.0 |xgkg~'), was less than 13%. For CV a more variable precision was obtained, with RSD values 
ranging between 20 and 25%.
© 2006 Published by Elsevier B.V.
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1. Introduction
Malachite green (MG) and crystal violet (CV) are triphenyl- 
methane dyes. MG has been used as a topical fungicide and 
antiprotozoal agent in salmonid farming throughout the world 
for over 60 years. Few known chemicals are as effective in treat­
ing ectoparasites o f fish and fish eggs by fungi o f the genus 
Saprolegnia and by the protozoan parasite Ichthyophthirius mul- 
tifiliis [1]. CV is also known to be effective in the treatment of 
fungal infections. It had found widespread use as a feed addi­
tive to inhibit mould and fungal growth in poultry feed before 
1990 [2]. According to EU law, all substances for veterinary use 
need to be included in annexes 1-3 o f Regulation 2377/90. MG
* C orresponding author. Tel.; + 3 5 3  1 5 0 5 7 0 0 0 ; fax; + 353  1 5 0 5 7 0 7 0 . 
E-mail address: G era ld in e.D ow !in g@ statelab .ie  (G . D ow lin g ).
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or CV, however, are so-called “non-defended” compounds that 
have never been registered for veterinary use. As a result o f these 
anti-fungal properties there is a serious potential for the miss-use 
of these drugs in aquaculture. Recently there has been a number 
of reports of these residues in aquaculture products (cf. EC Rapid 
Alert Reports for Food and Feed 2003-2006). Concerns regard­
ing residues o f MG in aquaculture products have prompted stud­
ies o f the pharmacokinetics and metabolism of this compound. 
However there is limited data regarding the pharmacokinetics 
and metabolism o f CV. Leucomalachite green (LMG) and leu­
cocrystal violet (LCV) are formed by the metabolic reduction 
o f MG and CV and in this form the drug persists in the tissues 
o f  exposed fish [3,4].
The US Food and Drug Administration explicitly banned the 
use of MG in fish farming in 1991 due to its suspected carcino­
genic properties. MG and CV are structurally related to other 
triphenylmethane dyes such as rosaniline which has been linked
Please cite this article as: GeraldineDowling et al., Confirmatory analysis of malachite-green; leucomalachite green, crystal violet and leucocrystal
violet in salmon by liquid chromatography-tandem mass spectrometry, Analytica Chimica Acta (2006), doi:10.1016/j.aca.2006.08.045
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to increased risk of human bladder cancer. The leuco form of 
rosaniline induces renal, hepatic and lung tumors in mice [5]. C V 
has been implicated in the induction o f thyroid and liver tumors 
[6 ]. Studies show that LMG is an in vivo mutagen and the muta­
genicity of MG and LMG correlates with their tumorgenicities 
in mice [7]. MG has also been shown to cause DNA damage [8 ]. 
CV was found to be cytotoxic to mammalian cells [9] as was MG 
[10]. Compared to LMG, MG is much less toxic to cells [10]. 
No safe levels for the presence o f MG, LMG, CV and LCV in 
fish for human consumption could be established and therefore, 
detection of these compounds at sub jigk g - 1  levels is required.
Within the EU, each member state is required to monitor for 
MG and LMG residues with analytical methodology that at least 
meets theMRPL. The European minimum required performance 
limit (MRPL), a quality parameter for residue laboratories, is set 
as the sum o f MG and LMG at 2 (xg kg - 1 [ 11 ]. There is no MRPL 
set for CV so developed methods must be capable o f monitoring 
levels as low as is reasonably achievable.
Most methods currently used are based on the solvent extrac­
tion of MG and LMG from fish tissues using acetonitrile or 
methanol with aqueous buffer (pH 3—4.5) [12-25]. In the clean­
up of these samples a combination o f liquid/liquid partitioning 
and solid phase extraction is used. Bergwerff et al. [21] purified 
catfish, eel, trout, turbot and prawn samples by partitioning ace- 
tonitrile:Mclllvain pH 3 buffer (90:10 v/v) against chloroform 
before passing the chloroform extract through a Bakerbond™  
strong cation exchange solid phase extraction cartridge. This 
clean-up approach has been adopted by other groups using a sin­
gle solid phase extraction cartridge [1 2 ,2 0 ] or using dual solid 
phase extraction with aluminia and propylsulphonic acid car­
tridges [3,16,19]. Van Rhijn et al. [18] modified the method o f  
Bergwerff et al. [21] by eliminating the liquid/liquid partitioning 
step. Other methodologies eliminated the liquid/liquid partition­
ing steps and purified tissue extracts directly using Cj8 [24] and 
cyano [22] SPE cartridges. Swarbrick et al [26] used an alterna­
tive clean-up using activated charcoal instead o f C is SPE.
A number o f methods have been reported for the analysis o f  
MG, LMG, CV and LCV residues by visible light detection with 
oxidation o f the leucometabolites carried out either pre-column 
or post-column [3,14,16,19-21,23,27]. Other methods devel­
oped for the detection o f  these residues are based on this oxi­
dation but with detection by mass spectrometry [12,13,20,21]. 
Detection o f  these residues by mass spectrometry in the absence 
o f this oxidation has also been accomplished [15,18,24]. An 
alternative oxidation approach using 2,3-dichloro-5,6-dicyano- 
1,4-benzoquinone (DDQ) before the determination step to oxi­
dise LMG to MG has also been utilised [30,31]. Determination 
based on electrochemical detection [27], GC-M S [23] and spec­
trophotometry [17] has also been achieved.
The method developed in this study was based on the method 
developed by Van Rhijn et al. [18] but adapted to include 
CV, LCV, and deuterated internal standards for LMG and for 
MG. The method omits the often-proposed pre-column or post­
column oxidation step used in the determination of MG or CV. 
The method also omits the liquid/liquid partitioning stage often 
used in the clean-up of extracts containing these residues. The 
method is a simple extraction with acetonitrile:MclIvain buffer
Table 1
L C  gradient p rofile  for determ ination o f  M G , L M G , C V  and L C V
T im e (m in) C om pon en t A  (%) C om pon en t B (%)
0 .0 9 0 10
0 .5 9 0 10
3 .0 50 5 0
7 .2 10 90
14.5 10 90
16 .5 90 10
2 1 .0 90 10
C om p on en t A : am m on iu m  form ate b u ffe r+  w ater (5 + 9 5  v /v) w ith  2 0 0  [¿L o f  
form ic  acid; com p on en t B : am m on iu m  form ate buffer +  aceton itrile (5  +  95 v /v )  
w ith  2 0 0  (jL  o f  form ic  acid .
pH 3 (90:10 v/v), with clean-up using aromatic sulphonic acid 
solid phase extraction and LC-M S/M S analysis. The applica­
bility o f the method for regulatory control will be discussed.
2. Experimental
2.1. Materials and reagents
Water, methanol, acetonitrile, ethyl acetate and hexane 
(HiPerSolv grade) were obtained from BDH (Merck, Poole, 
Dorset, UK). Ammonium hydroxide (ACS grade) was obtained 
from Sigma (St. Louis, MO, USA). Citric acid (ACS grade) 
was obtained from Sigma (St. Louis, MO, USA). Disodium 
hydrogen phosphate (ACS grade) was obtained from Sigma (St. 
Louis, MO, USA). Ascorbic acid (ACS grade) was obtained 
from Huka (CH-9470 Buchs, Switzerland). MG, LMG and CV 
were purchased from Sigma. ¿5 -MG and ¿5 -LMG were obtained 
from Witega (Berlin, Germany). LCV was purchased from Dr. 
Ehrenstorfer (QMX Laboratories, UK). Primary stock standard 
solutions o f MG, LMG, ds -MG, ds-LMG, CV and LCV (stable 
for 3 months) were prepared in acetonitrile at a concentration 
o f 100 n g  mL_1. Intermediate single standards solutions of MG, 
LMG, ds -MG, ds -LMG, CV and LCV (stable for 1 month) were 
prepared in acetonitrile:water (50:50 v/v) at a concentration of 
1 jig mL_1. Mixed standard fortification solutions o f  MG, LMG, 
CV and LCV (stable for 1 month) were prepared in acetoni- 
trile:water (50:50 v/v) at concentrations o f 50 and 200 ng mL_1.
Table 2
M S /M S  param eters for determ ination  o f  M G , L M G , C V  and L C V
C om pound Transition Spray 
vo ltage  (V )
C ollision  (eV ) Rt (m in)
M G 3 2 9 > 3 1 3  (strong) 4 0 0 0 35 8.1
3 2 9  >  2 0 8  (w ea k ) 4 0 0 0 37 8.1
LM G 331 > 2 3 9  (strong) 4 0 0 0 35 13.2
331  > 3 1 6  (w eak ) 4 0 0 0 23 13.2
¿5-M G  (IS) 3 3 4 > 3 1 8 4 0 0 0 35 8.1
ds -L M G  (IS) 3 3 6  > 2 3 9 4 0 0 0 35 13.2
C V 3 72  >  3 5 6  (strong) 4 0 0 0 57 8.7
3 7 2  >  3 4 0  (w eak ) 4 0 0 0 4 0 8.7
L C V 3 7 4  > 3 5 8  (strong) 4 0 0 0 35 13.5
3 7 4 > 2 3 8  (w eak ) 4 0 0 0 30 13.5
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111 Mixed standard fortification solution of dj-MG and ¿5 -LMG
112 (stable for 1 month) was prepared in acetonitrileiwater (50:50
113 v/v) at a concentration o f lOOngmL- 1 . All standards were
114 stored at 4 °C. Bakerbond™ SCX cation exchange solid phase
115 extraction cartridges (3m L, 500 mg) were obtained from J.T. 
no Baker (Harbor City, USA). MclUvain pH 3 buffer was prepared 
117 by adding 0 .1 M citric acid (250 mL) and adjusting to pH 3 with 
11a 0.2 M disodium hydrogen phosphate and diluting to 1000 mL 
11a with water. Extraction solvent was prepared by making a solu- 
150 tion in the rado o f acetonitrile:Mclllvain pH 3 buffer (90:10 v/v). 
isi A  2% ammonium hydroxide solution in methanol was used as 
1:2 the solid phase extraction elution solvent. Injection solvent con- 
12a sisted of 1% ascorbic acid in acetonitrile: water (50:50 v/v).
154 2.2. LC conditions
1:5 The LC system consisted o f  a model Finnigan TSQ Quan­
ta turn Ultra (MS) coupled to a Finnigan Surveyor LC Pump 
1E7 and a Finnigan Surveyor Autosampler (Thermo Electron Cor- 
i:a poration, CA, USA). A gradient LC system (Table 1) using 
us ammonium formate:water (5:95 v/v mobile phase A) andammo- 
1!« nium formate:acetonitrile (5:95 v/v mobile phase B) at a flow 
1! 1 o f  0.350 jjlLmin- 1 , was used to separate the analytes on a Phe- 
152 nomenex 3 (xm Cjs 100 A  (100mm x  2.0 mm) (Phenomenex, 
i:a UK) column equipped with a guard column (10.0 mm x  2.0 mm 
1«  i.d.) packed with Hypersil™  (3.0 (im) Cg material (Thermo 
1;* Electron Corporation, UK). The column temperature was main-
1 m tained at 45 0 C . Data acquisition and integration were performed 
137 using XCalibur version 1.4 chromatographic management soft- 
15^  ware (Thermo Electron Corporation, CA, U SA). The LC system  
i:n was equilibrated for 30 min at a column oven temperature o f  
mi 45 °C. A  linear gradient (Table 1) was used ramping from 10% 
1-1 B to 90% B over 7.2 min: once at 90% B, the system was held 
v 2 for 7.3 min and returned to 10% B over a period of 2.0 min. 
no The runtime was 21 min. The described gradient LC system was 
1*4 shown to be suitable for the analysis o f MG, LMG, CV and LC V 
ms (Figs. 1 -4  (weak/strong transitions)).
1«  2.3. MS/MS parameters
i.t7 The analysis was performed using positive-ion electrospray
mb (ESI) interface with multiple reaction monitoring (MRM) mode. 
1.19 Two transitions per compound were used and the spray and col- 
1!» lision voltages were optimised as shown (Table 2). The MS/MS 
isi detector conditions were as follows: ion mode ES1+; gas sheath 
i;u pressure 60 psi; capillary temperature 375 °C; source CID 10 V; 
n5s collision pressure 1.5 Torr; collision gas argon.
1« 2.4. Salmon samples
155 Whole salmon obtained from a local supermarket were 
iso homogenised with bones in a bowl-blender (Waring, UK) and 
157 stored at — 20 °C in 150 mL glass jars. Laboratory samples of  
isa salmon tissue were analysed and those found to contain no 
149 detectable residues o f the analytes were used as negative con- 
ieo trols.
2.5. S a m p le  e x tr a c tio n  a n d  c le a n -u p
Salmon samples (2 g) were weighed into 50 mL polypropy­
lene tubes. Samples were fortified with internal standard at 
levels corresponding to 2.5 (igk g-1 by adding 50p.L portion 
of lOOngmL-1 mix solution o f ds-MG and ¿5 -LMG. Samples 
were fortified at levels corresponding to 1,1.5 and 2 |ig  kg-1 by 
adding 40, 60 and 80 jxL portions o f 50n gm L _1 mix solution 
o f MG, LMG, CV and LCV. After fortification, samples were 
held for 15 min prior to extraction. Acetonitrile:MclUvain pH
3 buffer (90:10 v/v) (20 mL) was added and the samples were 
homogenised (30 s). Samples were shaken (5 min) and sonicated 
(15 min). The samples were centrifuged (3000rpm, 5 min, 4 °C) 
and the supernatant was transferred to a clean polypropylene 
tube. The samples were re-extracted with acetonitrile:Mclllvain 
pH 3 buffer (90:10 v/v) as before. The supernatants were com­
bined and sample extracts were further purified by ion exchange 
solid phase extraction using Bakerbond SCX SPE cartridges. 
Sample extracts (40 mL) were loaded onto the cartridges (pre­
conditioned with 2 mL methanol, 2 m L  acetonitrile:Mclllvain 
buffer 90:10 v/v). The cartridges were washed with distilled 
water (1 mL), methanol (1 mL), ethyl acetate (1 mL), hexane 
(1 mL) and then dried using a vacuum pump (3 min). The car­
tridges were eluted with 2% ammonium hydroxide in methanol 
( 3 x 2  m L). The eluates were reduced to dryness under vacuum 
at 45 °C before re-dissolving in 250 jjlL  of 1% ascorbic acid in 
acetonitrile:water (50:50 v/v). An aliquot (20 pL) was injected 
onto the LC column.
2.6. Matrix matched calibration
Matrix matched calibration curves were prepared and used 
for quantification. Control tissue previously tested and shown 
to contain no residues was prepared as above (Section 2.4). 
One control tissue sample was used for each calibration stan­
dard level. Salmon samples (2g) were weighed into 50 m L  
polypropylene tubes. Samples were fortified with internal stan­
dard at levels corresponding to 2.5 jigk g -1 by adding 50 (jlL  
portion of lOOngmL-1 mix solution o f ¿5 -MG and ¿5 -LMG. 
Samples were fortified at levels corresponding to 0, 0.5, 1 
and 2 jig kg-1 by adding 0, 20, 40 and 80 |iL  portions of a 
50ngm L _1 standard solution. Samples were fortified at the 5 
and 10 (jLg kg-1 calibration levels by adding 50 and 100 jiL por­
tions o f a 200n gm L _1 standard solution. After fortification, 
samples were held for 15 min prior to extraction procedure as 
above (Section 2.5).
Calibration curves were prepared by plotting the response 
factor o f the strong transitions as a function of analyte concen­
tration (0-10 (igk g-1 ) to quantify samples.
2.7. Method validation
For estimation o f accuracy, bl ank salmon tissue samples were 
fortified with MG, LMG, C V  and LCV at 1,1.5 and 2.0 p.g kg- 1. 
Six replicate test portions, at each o f the three fortification levels, 
were analysed. Analysis o f the 18 test portions was carried out 
on three separate occasions. For the estimation o f the precision
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R esu lts  for repeatability  and w ithin-laboratory reproducibility  o f  m alachite green, leu co m a la ch ite  green , crystal v io let and leucociy'stal v io le t in  salm on
A n a ly te Fortification  
level ( ix g k g - 1 )
A ccuracy
A ssa y  1 repeatability A ssa y  2 repeatability A ss a y  3 repeatability W ithin-laboratory reproducibility
M ean R S D M ean R S D M ean R S D M ean R S D
M G 1.0 104 1.9 9 6 6 .9 107 2 .5 102 6 .2
1.5 108 3.3 9 8 7.1 113 3 .7 106 7 .6
2 .0 104 2.3 9 6 2 .9 1 09 4 .5 103 6.1
L M G 1.0 96 10.9 9 9 3 .0 102 0.1 100 6 .3
1.5 97 2 .7 97 6 .3 103 1.0 90 4 .7
2 .0 97 1.4 9 6 4 .3 9 8 3 .5 97 3 .2
C V 1.0 92 10.4 89 9.3 105 28 .8 96 2 0 .2
1.5 102 24.3 81 14.0 9 4 2 9 .0 92 2 4 .7
2 .0 111 15.1 9 0 2 0 .3 104 2 3 .5 101 2 0 .0
L C V 1.0 77 7.3 9 9 3 .0 100 5 .2 92 13.1
1.5 89 6 .0 1 02 9 .0 9 7 2 .3 96 8 .4
2 .0 9 6  J 8.7 103 6 .0 9 5 5 .8 98 7 .6
3. Results and discussion
3.1. Preliminary experiments
Hie LC-MS/MS method was developed to provide confirma­
tory data for the analysis of salmon for MG, LMG, C V and LC V. 
The MS/MS fragmentation conditions were investigated and col­
lision energies were optimised for each individual compound. 
For a method to be deemed confirmatory one precursor ion (par­
ent mass) and two daughters (corresponding to strong and weak 
ion) must be monitored (Table 2) this yields four identification 
points, which is a suitable confirmatory method in accordance 
with CD 2002/657/EC.
MG and LMG are separated on a Phenomenex Cis column 
with a retention time of 8.1 and 13.2 min, respectively. Simi­
larly CV and LCV are separated with a retention time of 8.7 
and 13.5 min, respectively. ¿5 -MG was used as IS for MG and 
similarly ds -LMG was utilised as internal standard for LMG. 
As there are no deuterated standards of CV and LCV currently 
available, ¿5 -MG and ¿5 -LMG were used as internal standard 
for these analytes as well.
3.2. Validation study
Validation of the method was according to procedures 
described in Commission Decision 2002/657/EC [29] covering 
specificity, calibration curve linearity, recovery (accuracy), pre­
cision, decision limit (CCa) and detection capability (CC^).
3.2.1. Specificity
The technique of LC—MS/MS itself offers a high degree of 
selectivity and specificity. To establish the selectivity/specificity 
of the method, salmon samples were fortified with the four ana­
lytes and the internal standards and non-fortified samples were 
also analysed. Interfering peaks were observed at the retention 
time for some transitions but upon quantification were so low as 
to be of little significance (Figs. 1^ 4-).
3.2.2. Linearity of the response 251
The linearity of the chromatographic response was tested with 252
matrix matched curves using six calibration points in the concen- 253
tration range of 0-10 jjLg kg-1 . The regression coefficients (r2) 2«
for all the calibration curves used in this study were >0.990. 255
3.2.3. Accuracy 2ss
The recovery of the method was determined using salmon 257
samples fortified at 1.0, 1.5 and 2 p.gkg_ 1  for each dye. Mean 250
corrected recovery (n = 6 ) of the analytes, determined in three 25a
separate assays shown in Table 3 was between 77 and 113% for 2™
MG, LMG, LCV and CV. 26,
3.2.4. Precision 262
The usefulness of suitable deuterated standards is demon- 203
strated in the excellent repeatability and within-laboratory repro- 2«
ducibility obtained for MG and LMG (Table 3). Although no 2h
deuterated analogue is available for LCV, still a very acceptable sm
repeatability and within-laboratory reproducibility is obtained 207
by using the IS of LMG. Less favourable is the situation for 2m
CV. The rather high RSD values obtained for both the repeata- 209
bility and within-laboratory reproducibility of CV (between 20 270
and 25%), even by applying correction by means of the IS of 271
MG indicates the necessity of the incorporation of a structurally 272
identical isotopically-labelled IS in the method (Table 4). 273
3.2.5. CCa and CCp 274
The decision limit (CCa) is defined as the limit above which 275
it can be concluded with an error probability of a, that a sam- 27a
pie contains the analyte. In general, for non-MRL substances an 277
Table 4
C alcu lated  C C a and C Cp values
CC a (pig k g - 1)  CCp  ( ( ig k g “ 1)
M G  0 .1 7  0 .3 0
L M G  0 .15  0 .35
C V  0 .35  0 .80
L C V  0 .1 7  0 .32
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